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Advances in Stereoselective 1,2-cis  
Glycosylation using C-2 Auxiliaries 
 
 
 
 
 
 
 
 
 
Part of this chapter has been published as a review:  
R.A. Mensink, T.J. Boltje, Chem. Eur. J. 2017, 23, 17637-17653. 
 
 
 
Abstract: The control of stereoselectivity in a glycosylation reaction remains one of the most 
challenging aspects of oligosaccharide synthesis. Especially the synthesis of 1,2-cis-glycosides 
is challenging and generally applicable methodology to prepare this linkage is needed to 
standardize oligosaccharide synthesis. This introductory chapter highlights the recent 
development of an elegant strategy employing a C-2 auxiliary to control the anomeric 
stereoselectivity in glycosylations. The various auxiliaries developed to date, their compatibility 
with protecting groups and monosaccharide types as well as mechanistic aspects are 
summarized. Furthermore, the application, advantages and limitations of C-2 auxiliaries in 
oligosaccharide synthesis are discussed.  
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  1.0 – Introduction  
 
The three major classes of macromolecules in biological systems comprise DNA, proteins and 
carbohydrates (also called glycans or saccharides).[1] Information encoded in DNA is transcribed 
and translated to direct protein synthesis. Hence, with the elucidation of the human genome 
came the expectation that all biological processes could be understood. However, our genetic 
blueprint proved insufficient to account for the origin of all biological processes. Other 
information-rich molecules that are not under direct genetic control must therefore play a major 
role.[2] Carbohydrates are a very important class of molecules in this respect and hence there is 
a growing appreciation that glycosylation dramatically increases protein complexity and 
function.[3] Similar to genomics for DNA and proteomics for proteins, “glycomics” is the study 
that seeks to identify and understand the structure and function of specific carbohydrate 
patterns in biological processes and the launch of the human glycome project is imminent.[3] A 
major obstacle in relating carbohydrate structure to function is the lack of pure and structurally 
well-defined carbohydrates and glycoconjugates. Because these compounds are difficult to 
isolate from natural sources, well-defined oligosaccharides can often only be obtained by 
chemical- or enzymatic synthesis.[4]  
 
1.1 – Oligosaccharide and glycosidic linkage structure 
 
Oligosaccharides are complex structures since they are often highly branched and the 
monomeric constituents (monosaccharides) are connected by glycosidic bonds which exist as 
either equatorial or axial diastereoisomers, called anomers. The anomeric stereochemistry is 
usually defined relative to the C-2 substituent (X), which can be axial (manno-type) or equatorial 
(gluco-type), as 1,2-cis or 1,2-trans, giving rise to four possibilities (Figure 1a). The anomeric 
configuration can also be defined as α-anomers (1,2-cis-D-glucotype and 1,2-trans-D-
mannotype) or β-anomers (1,2-cis-D-mannotype and 1,2-trans-D-glucotype). In addition, the 
C-2 substituent is most frequently an alcohol, amine or hydrogen. The structural differences in 
the C-2 substituent and its relative orientation with respect to the anomeric substituent may 
seem subtle, but can have major implications for the biological function. For example, amylose 
and cellulose are anomeric diastereoisomers of 1,4-linked glucose polymers, and while amylose 
is a food source and can be enzymatically converted into glucose, cellulose on the other hand 
forms very strong fibers and is a structural component of wood (Figure 1b). With the importance 
of anomeric selectivity in mind, the main challenge in carbohydrate synthesis is the 
regioselective and stereoselective introduction of glycosidic bonds.[4-5] Similar to other 
stereoselective reactions, the induction of diastereoselectivity during a glycosylation event can 
be achieved by the use of a chiral catalyst, neighboring group participation (NGP) and creating 
facial selectivity using remote chiral centers.[4-5] Since most of these methods rely on the relative 
stereochemistry of neighboring and remote stereocenters, methods that are effective for glucose 
are not necessarily applicable to galactose or mannose and vice versa. A generally applicable 
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glycosylation methodology is needed to make oligosaccharide synthesis routine work, similar to 
peptide and oligonucleotide synthesis.[6] 
 
 
 
Figure 1: Structures of anomeric linkages. a) Four different kinds of linkages found in nature; b) The anomeric 
configuration has a profound influence on the molecular structure, properties and biological function. For example, 
anomeric diastereoisomers amylose and cellulose have a different biological role as the first is a food source and the 
latter a structural component of wood. 
 
 
Ever since the groundbreaking report of the first stereoselective 1,2-trans glycosylation by 
Koenigs and Knorr,[7] general methods to prepare 1,2-trans glycosides are available and exploit 
neighboring group participation of a C-2-acyl group (Scheme 1).[5] When a glycosyl donor 
carrying an anomeric leaving group is activated to form intermediate oxocarbenium ion 1, this 
intermediate is rapidly trapped by the neighboring group to form intermediate 2, which can only 
be formed as a 1,2-cis fused ring system. A glycosyl acceptor (R2OH) can only attack 2 at the 
anomeric center from the β-face leading to the stereoselective formation of 1,2-trans glycoside 
4. The glycosyl acceptor can also add directly to the dioxolenium ion (2) leading to the formation 
of orthoester 3. The orthoester is not stable under acidic conditions and will rearrange to the 
desired 1,2-trans glycoside.[8] Numerous 2-O-acyl protecting groups have been developed to 
reduce orthoester formation and/or incorporate a latent nucleophile to enable selective removal 
in the presence of other esters. For example, the bulky pivaloyl ester (trimethyl acetyl ester) 
can be used to suppress orthoester formation due to steric shielding of the dioxolenium ion.[9]  
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Scheme 1: C-2 acyl participation reliably affords 1,2-trans glycosides (4) 
 
In general, the use of a 2-O-acyl functionality to synthesize 1,2-trans glycosides is very reliable, 
highly stereoselective and in the case of gluco-type donors, β-linked products will be obtained, 
whereas manno-type donors will give α-linked products. Furthermore, this strategy is also 
applicable to the synthesis of 2-deoxy-2-amino-glycosides using amine-protecting groups that 
can perform NGP. However, care needs to be taken when using an N-acetyl group for NGP as 
the corresponding glycosyl oxazoline is a commonly formed byproduct, but can be avoided by 
using lewis acid catalysis.[10] Alternatively, other amine protecting groups that can perform NGP 
such as phthalimido, tetrachlorophthalimido, trichloroacetyl, allyloxycarbonyl, and 2,2,2-
trichloroethyloxycarbonyl can be used.[11]  
In contrast, the introduction of 1,2-cis glycosidic linkages is much more challenging and requires 
glycosyl donors having a non-assisting functionality at C-2.[6] In general, these glycosylations 
are less selective and require optimization to achieve acceptable anomeric ratios. Recent 
advances in anomeric control have led to new methodologies to synthesize 1,2-cis linkages of 
monosaccharides such as glucose, galactose, mannose,[12] glucosamine,[13] galactosamine[14] 
and furanose sugars[15]. Although excellent, these methods are stereoselective via different 
mechanisms ranging from solvent effects,[16] directed aglycon delivery,[17] steric shielding,[14] 
SN2-like displacement of a quasi-stable intermediate,[12] stabilization of an oxocarbenium ion 
conformation[15, 18] and post glycosylation anomerization.[6, 19] Out of these methods, the 
directed aglycon delivery methodology, using a tether between the glycosyl donor and glycosyl 
acceptor to control anomeric selectivity is applicable to both gluco- and manno-type sugars.[17b, 
17c] However, the installation of a tether is additional work and the glycosylation yields can be 
moderate. This methodology therefore still lacks the applicability and reliability of NGP to 
prepare 1,2-cis glycosides. 
 
The next sections review the development of a methodology that employs a C-2 chiral auxiliary 
to achieve 1,2-cis glycosylation. Similar to the use of NGP to prepare 1,2-trans glycosides, this 
methodology has the potential to become a generally applicable method for 1,2-cis glycoside 
synthesis. Combined, these complementary methods would enable the stereoselective synthesis 
of the most frequently found linkage types in nature and thereby advance the glycomics effort.[6] 
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1.2 – Chiral auxiliaries for glucose and galactose 
 
The overall approach to achieve 1,2-cis stereoselectivity using C-2 chiral auxiliaries is depicted 
in Scheme 2a.[20] The chiral auxiliary is designed to trap the oxocarbenium ion from the β-face 
thereby blocking it and displacement of this intermediate should then result in the formation of 
1,2-cis-glycosides. To achieve this, a nucleophilic group is situated to form a six membered ring 
system upon participation, which either results in a cis- (7) or trans-decalin (8) system. It was 
envisioned that a chiral substituent could be used to favor the formation of the cis- or trans-
decalin system leading to 1,2-trans or 1,2-cis glycosides, respectively. In case of an S-
configured auxiliary, formation of cis-decaling intermediate 7 results in axial placement of the 
chiral substituent which in turn leads to an unfavorable 1,4-diaxial steric interaction. In contrast, 
formation of trans-decalin intermediate 8 leads to a more favorable equatorial substitution and 
is hence preferred. In addition, trans-decalin system 8 will have less gauche interactions than 
cis-decalin system 7. Therefore, the S-configuration is expected to favor 1,2-cis-glycoside 
formation by selectively forming trans-decalin intermediate 8. Similarly, the R-configured 
auxiliary was expected to favor 1,2-trans glycoside formation, since the cis-decalin intermediate 
(12) leads to equatorial placement of the phenyl substituent and prevents the 1,3-diaxial steric 
interaction that the trans-decalin (13) experiences (Scheme 2b). 
Scheme 2: A chiral a) S-configured auxiliary affords 1,2-cis glycosides (9) via a trans-configured decalin 8; b)  R-
configured auxiliary affords 1,2-trans glycosides (14) via cis-configured decalin 12. 
 
1.2.1 – 1st generation chiral auxiliaries 
 
The first generation of chiral auxiliaries employed an (S)-ethoxycarbonylbenzyl moiety 
containing an ethyl ester as the nucleophilic head group since esters are proven to perform NGP. 
The C-2 ethoxycarbonylbenzyl moiety was installed by reaction of ethylmandelate (16) with 
Cerny epoxide 15[21] and boron trifluoride (Table 1a).  
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a) Introduction of the ethoxycarbonylbenzyl moiety; b) Glycosylation results. a protocol A: donor (1 eq), R1OH (1.2 eq), 
DCM, -78oC, then TMSOTf (0.4 eq), -78 oC – 0 oC. 
 
Subsequent acetolysis of the 1,6-anhydro-bridge was carried out, followed by conversion into 
the trichloroacetimidate donors (S)-18 and (R)-18. Both the R and S isomer were prepared 
following this route and the resulting glycosyl imidates were evaluated as glycosyl donors (Table 
1b). As expected, the use of the S-configured auxiliary led to the selective formation of 1,2-cis 
glycosides with an α/β selectivity ranging from 20/1 to 12/1 depending on the nature of glycosyl 
acceptor (Table 1b, entries 1-3), whereas the use of the R-auxiliary led to the predominate 
formation of 1,2-trans-glycosides (Table 1b, entries 4-6) albeit with lower selectivity (α/β 
between 1/5 and 1/1 depending on the glycosyl acceptor). These results demonstrated that the 
chirality of the auxiliary is an important determinant of the anomeric selectivity. The protecting 
group pattern of the glycosyl donor was investigated in a subsequent study and found to be an 
important determinant of the stereoselectivity.[22] For example, replacement of the C-3 acetyl 
with a benzoyl protecting group maintained α-selectivity, yet substitution by an allyl ether 
diminished the α-selectivity considerably, α/β 4:1 (Table 1b, entries 7-8 and 9-10, resp.). The 
lack of absolute stereoselectivity was attributed to glycosylation via the oxocarbenium ion. 
Hence, it was hypothesized that increasing the nucleophilicity of the participating functionality 
and reducing the flexibility of rotatable bonds in the auxiliary would speed-up neighboring group 
participation and improve stereoselectivity.  
 
Table 1: Glycosylation with 1st generation auxiliaries. 
a)           
 
b)           
 
entry donor R1OH α / β 
yield  
(%) 
 
entry donor R1OH α / β 
yield  
(%) 
1 
 
A1 18/1 94  
7 
 
A2 >20/1 93 
2 A2 12/1 92      
3 A3 20/1 89 
 8 A3 7/1 88 
4 
 
A1 1/1 89  
9 
 
A2 4/1 95 
5 A2 1/3 88      
6 A3 1/5 91 
 10 A3 1/3 87 
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1.2.2 – 2nd generation chiral auxiliaries 
 
A second generation of chiral auxiliaries was designed to address these issues, employing  
a thiophenyl ether as the nucleophilic group.[23] The (S)-(phenylthiomethyl) benzyl moiety could 
be stereoselectively introduced by reaction of sugar alcohol 22 with (S)-
(phenylthiomethyl)benzyl acetate 21 in the presence of BF3.OEt2 (Table 2a).[24] These reactions 
proceed via anchimeric assistance of the thiophenyl group to form episulfonium intermediate 
23. Since double inversion occurs in this process, the stereochemistry of 21 is retained overall. 
This modification significantly improved 1,2-cis stereoselectivities and provided exclusively 1,2-
cis-glycosides (Table 2b). In general, glycosylations using the (S)-(phenylthiomethyl) benzyl 
moiety were observed to be slower than normal indicating the presence of a quasi-stable, slow-
reacting intermediate.  
 
       Table 2: Synthesis and glycosylation with 2nd generation auxiliaries 
a) Synthesis for the introduction of the C-2 chiral thioether auxiliary; b) Chiral auxiliaries designed to form cis- or 
trans-decalin sulfonium intermediates (entries 1–5) and protecting group variations (entries 6–11). a Protocol B: 
donor (1 eq), DCM, -78 oC, then TMSOTf (1 eq), -78 oC – 0 oC, then -78 oC, DTBMP (2 eq) and R2OH (1.2-1.5 eq). 
 
a)           
 
b)           
 
entry donor R2OH α / β 
yield  
(%) 
 
entry donor R2OH α / β yield  
(%) 
1 
 
A1 1/0 93  
6 
 
A1 2/1 83 
2 A3 1/0 85     
3 A4 1/0 95 7 A3 1/1 75 
4 
 
A4 1/1 88 
 
8 
 
A1 10/1 82 
9 A3 1/0 74 
5 
 
A4 8/1 86 
 
10 
 
A1 1/0 86 
 
11 A3 1/0 77 
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Low temperature NMR experiments showed the selective formation of a β-linked sulfonium ion 
intermediate. Again, the stereoselectivity was strongly dependent on the stereochemistry of the 
auxiliary. As expected, the (S)-auxiliary was 1,2-cis selective whilst the (R)-auxiliary was non-
selective (Table 2b, entries 1-3 and 4, resp.). Interestingly, an auxiliary lacking the chiral 
substituent was less selective than the (S)-(phenylthiomethyl) benzyl moiety, yet still gave a 
respectable α-selectivity (Table 2b, entry 5). Since the 1,2-cis-decalin system experiences more 
unfavorable gauche interactions than the 1,2-trans-decalin system, 1,2-cis-glycosides are still 
formed predominantly even though no chiral substituent is present (vide infra).  As in the case 
of the 1st generation auxiliaries (vide supra), the stereoselectivity was also strongly dependent 
on the type and distribution of protecting groups on the glycosyl donor (Table 2b, entries 6-
11).[25] For example, glycosylations of glucosyl donor (S)-24, protected with acetyl esters at C-
3, and C-6, gave the corresponding glucosides as only the α-anomer. However, similar 
glycosylations with glucosyl donor 26, protected with benzyl ethers gave no or very poor 
anomeric selectivity (Table 2b, entries 1-3 vs 6-7). To investigate this result, extensive NMR 
analysis on benzyl protected donor 26 (Figure 2b) was performed to establish the presence or 
absence of the important β-sulfonium ion. After activation of the imidate leaving group, low 
temperature NMR clearly showed the β-sulfonium ion had formed on the basis of the H-1 
chemical shift and coupling constant (Figure 2c) and the correlation of C-1 and H-8eq in the 
HMBC spectrum (Figure 2d).[25] 
 
 
Figure 2: 1H and 13C NMR detection of the β-sulfonium ion intermediate. a) Curtin-Hammett principle; b) 1H NMR 
spectrum of glucosyl donor 26 in CD2Cl2; c) 1H NMR spectrum of 26 after addition of TMSOTf at (-20 oC); d) 1H-13C 
HMBC spectrum of the β-sulfonium ion at -20 oC. A cross-peak was observed between C-1 and H8-eq. 
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No other species were detected and hence the β-substituted sulfonium ion is the main reaction 
intermediate. It is, however, not the only reactive intermediate as addition of an alcohol resulted 
in the formation of a mixture of anomers. This observation was rationalized by the classical 
Curtin-Hammett principle in which the glycosylation takes place via the much more reactive 
oxocarbenium ion when the rates of interconversion (k1 and k2) are faster than that of 
glycosylation (k4) (Figure 2a). More strongly electron-withdrawing groups such as the acetyl 
esters are expected to disfavor oxocarbenium ion formation and hence glycosylations takes 
place by an SN2 like displacement of the β-anomeric sulfonium ion leading to the formation of 
α-glycosides. On the other hand, glycosylations with donors having electron-donating benzyl 
protecting groups, involve an equilibrium between the corresponding sulfonium and 
oxocarbenium ions.[26] Glycosylations then take place mainly through the latter intermediate 
thereby diminishing the α-selectivity. In order to establish how many, what type and at which 
position electron-withdrawing protecting groups are needed to ensure α-selectivity, a number 
of differentially protected glycosyl donors (26-28, Table 2b, entries 6-11) were synthesized and 
tested. From the glycosylations it is clear that one acetyl ester is sufficient to ensure 
stereoselective glycosylation when present at the C-3 position.[25]  
 
To investigate this effect, DFT calculations were performed that simulated the SN1 and SN2 
pathways and the role the C-3 acetyl plays in both (Scheme 3).[27] These calculations showed 
that the C-3 acyl group destabilizes the oxocarbenium ion in the SN1 pathway thereby promoting 
the SN2 pathway, as was postulated in earlier reports.[22, 25] However, the calculated energy 
difference between the SN1 and SN2 pathway is too small to exclude one or the other. 
Furthermore, DFT studies revealed that in both the SN1 and SN2 pathway, the acceptor can 
engage in dual hydrogen bonding with the C-3 ester functionality and the C-2 oxygen (33) 
thereby directing the approach from the α-face (34). 
 
 
Scheme 3: Reaction intermediates according to DFT calculations of SN2 
transition state involving donor-acceptor hydrogen bonding. 
 
To further investigate if the observed intermediate sulfonium ion is a reactive intermediate or 
merely a resting state, the nature of the nucleophilic group was varied (Table 3).[27] Three 
auxiliary variants were prepared, containing either a thiophenyl ether (29), phenyl ether (30) 
or benzyl (31) moiety. The R and S configured auxiliaries were prepared giving rise to six 
variants in total. From the glycosylation results it is clear that the thiophenyl ether auxiliary 
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performs best and the phenyl ether auxiliary only performs slightly worse. The benzyl auxiliary 
cannot stabilize the oxocarbenium ion and hence glycosylation through this intermediate is 
expected in a less selective manner. In some cases however, benzyl auxiliary containing donor 
31 performed quite well, but the same is true for a donor protected with a C-2 benzyl (data not 
shown, α/β = 15:1 with acceptor A6).[27] Changing the S-configuration to the R-configuration 
had the largest effect on the auxiliaries that are expected to perform neighboring group 
participation (thiophenyl ether (29) and phenyl ether (30) auxiliary) suggesting a role of the 
sulfonium/oxonium ion in the reaction pathway.  
 
Table 3: Auxiliaries with various terminal groups, CH2, O, S, and chirality 
a protocol A: donor (1 eq), R1OH (1.5 eq), DCM, -70 oC, then TMSOTf (1 eq), -70 oC – -40 oC; protocol B: donor (1 eq), 
DCM, -70 oC, then TMSOTf (1 eq), -70 oC – -20 oC, then -70 oC, DTBMP (2 eq) and R1OH (1.5 eq), -70 oC – rt. 
 
In case of the R-auxiliary, the existence of the expected α-sulfonium ion was confirmed by NMR 
even though the main products of these donors were α-glycosides. This result emphasizes that 
the observed intermediate is not necessarily a reactive intermediate. In case of (S)-29, it is 
much more challenging to establish whether the intermediate sulfonium ion is a reactive 
intermediate since the observed α-product could either be formed by SN2 displacement or highly 
selective alternate pathways or a combination of both. The hallmark of an SN2 reaction is the 
overall second order reaction kinetics, first order in both reagents. Hence, reaction rates were 
measured at different concentrations of glycosyl acceptor to establish the reaction kinetics. The 
observed initial rates of reaction could be fitted to a second order rate equation and hence these 
results therefore support an SN2 displacement mechanism for glycosylation. Together with the 
results from the DFT calculations it was concluded that glycosylation occurs via a bimolecular 
mechanism in an SN2-like fashion.[27] 
 
entry donor 
prot- 
ocola 
R1OH α / β 
yield 
(%) 
 entry donor 
prot- 
ocola 
R1OH α / β 
yield 
(%) 
1 
 
B A1 1/0 93  10 
 
B A1 3/1 88 
2 B A5 1/0 63  11 B A5 3/1 70 
3 B A6 1/0 56  12 B A6 6/1 48 
4 
 
A A1 1/0 100 
 
13 
 
A A1 4/1 81 
5 A A5 12/1 87 14 A A5 2/1 92 
6 A A6 15/1 33 15 A A6 7/1 53 
7 
 
A A1 1/0 100  16 
 
A A1 10/1 83 
8 A A5 2/1 100 
 
17 A A5 1.5/1 62 
9 A A6 15/1 44 18 A A6 20/1 48 
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In addition to participation of chiral auxiliaries from the C-2 position, the participation from the 
C-6 position has also been studied to prepare α-2-deoxy sugars.[28] Indeed the use of the C-6 
auxiliary led to the stereoselective formation of α-2-deoxy-glycosides albeit with lower 
selectivity compared to the C-2 participation examples mentioned above. 
 
1.2.3 - Oxathiane glycosyl donors 
 
Another route towards trans-decalin sulfonium ions via an integrated oxathiane stereodirecting 
group was developed by Turnbull et al. to reduce the synthetic effort needed for the 
implementation of an α-directing moiety into the glycosyl donor (Scheme 4).[29] It was 
envisioned that the thioglycoside moiety could be activated by alkylation or arylation to provide 
a sulfonium ion intermediate for subsequent glycosylation (Scheme 5 and 6). The oxathiane 
precursor 36 was synthesized from glucose pentaacetate by conversion into the β-thiol, addition 
to 2-bromoacetophenone 35 and finally deacetylation (Scheme 4).[29] Reaction of 36 in acidic 
MeOH resulted in regio- and stereoselective cyclization to provide methyl ketal 37, in which the 
smaller methoxy group is in the axial position, where it also benefits from stabilization of the 
anomeric effect. Hence this method obviates the need for elaborate protecting group strategies 
to isolate the C-2 alcohol for incorporation of the chiral auxiliary. Additionally, since the 
formation of the methyl ketal is stereoselective, achiral starting materials can be used to 
construct a chiral auxiliary.  
 
 
Scheme 4: Synthesis of oxathianes. Reagents and conditions: i) a) thiourea, BF3.OEt2, MeCN; b) 35, Et3N; c) NaOMe, 
MeOH; ii) TsOH, MeOH; iii) TMSOTf, Et3SiH, DCE; iv) Ac2O, pyr; v) NaH, BnBr, DMF. 
 
Furthermore, the methyl ketal could be reduced in a stereoselective manner to provide 
oxathiane 40. Another advantage of the oxathiane donors is their stability during protecting 
group manipulations and the remaining triol could be protected with various protecting 
groups.[29-30] The activation of oxathiane donor 39 was investigated by methylation using 
trimethyloxonium tetrafluoroborate affording 43, which proved to be highly stable and could 
even be crystalized from hot ethanol.[31] The crystal structure revealed that the axial methoxy 
group stabilized the cation, thus making it less reactive. Glycosylation of sulfonium 43 with A2 
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was achieved in a microwave reactor at 150oC and subsequent acidic cleavage of the auxiliary 
afforded α-disaccharide 44 with an α/β ratio of >50:1 (83%, Scheme 5). 
 
 
Scheme 5: α-selective glycosylations of surprisingly stable activated oxathiane 43 and in-situ activation of donor 42. 
 
Sulfonium ion 42, which lacks the axial methoxy group, should be less stable and hence should 
glycosylate with more ease. Indeed, activation of 42 with methyl triflate, followed by 
glycosylation with A2 at room temperature proceeded smoothly, albeit with a significant 
decrease in stereoselectivity (α/β 3:1) and yield. The loss in yield was caused by competing S-
methyl transfer from the donor salt to the newly formed S-methyl sulfide in the C-2 auxiliary. 
The loss of stereoselectivity highlights the importance of the methyl ketal.  
The alkyl sulfonium ions proved to be stereoselective, yet quite unreactive and hence aryl 
sulfonium ions were investigated to improve the reactivity.[29-31] Arylation of oxathiane donors 
can be achieved by reaction with benzyne,[32] but the most efficient method made use of an 
electrophilic aromatic substitution of the sulfoxide derivative.[29-31] m-CPBA was used to oxidize 
oxathiane 46 to afford the corresponding sulfoxide glycosyl donor 47 (Scheme 6). 
 
 
     Scheme 6: Oxathiane glycosylation mechanism.  
 
Activation with Tf2O in the presence of 1,3,5-trimethoxybenzene (TMB) gave rise to arylated 
sulfonium ion 49 via electrophilic aromatic substitution of triflate 48.[33] This process required 
the use of highly electronrich aromatic compounds such as TMB and 1,3-dimethoxybenzene 
(DMB). The thereby formed aryl sulfonium ions proved to be much more reactive than their alkyl 
counterparts and also very stereoselective. In contrast to earlier auxiliaries, the methyl ketal 
oxathiane donors showed almost complete α-selectivity irrespective of the protecting group 
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pattern on the glycosyl donor (Table 4, entries 1-4). Furthermore, the stereoselectivity was 
excellent when galactose was used as a glycosyl donor (Table 4, entries 5-6).[29] 
The only drawback of the methyl ketal donors is that the acyclic methyl ketal formed after 
glycosylation proved to be labile, leading to the release of methanol which subsequently acted 
as a competing nucleophile. Additionally, the workup procedure resulted in further loss of the 
ketal functionality, thus the auxiliary was removed completely with BF3.OEt2 in methanol prior 
to workup. To address this issue the more stable ether oxathiane donors 54 and 55 were 
investigated.[30-32]  
 
a protocol C: donor (1 eq), DIPEA (1.2 eq), Tf2O (1.1 eq), 1,3,5-trimethoxybenzene (2.2 eq), DCE, -30 – -10 oC, then 
DIPEA (6eq) and R1OH (2.5 eq) then heated at 50 oC for 18h; protocol D: donor (1 eq), DTBMP (2.5 eq), Tf2O (1.1 eq), 
1,3,5-trimethoxybenzene (2.2 eq), DCM, -60 – -10 oC, then R1OH (1.2-2.5 eq) warmed to rt; protocol E: donor (1 eq), 
DTBMP (2 eq), Tf2O (1.1 eq), 1,3,5-trimethoxybenzene (1.5 eq), DCM, -10 oC, then cooled to -40 oC and R1OH (0.8 eq) 
-40 oC – rt. protocol F: donor (1 eq), DIPEA (1.2 eq), Tf2O (1.1 eq), 1,3,5-trimethoxybenzene (1.1 eq) in DCM  -30oC – 
rt, bpreactivation -60oC – -10oC, then A2, -10oC – rt, 12 days. TMP = 2,4,6-trimethoxyphenyl. 
 
Table 4: Glycosylations of various oxathiane donors. 
 
entry donor 
Prot- 
ocola 
R1OH 
α / β 
yield (%) 
   
entry donor 
Prot- 
ocola 
R1OH 
α / β 
yield (%) 
P1 P2  P2 
1 
 
C A2 
>50/1 
85 
-  13 
 
E A2 
1/0 
84 
2 C A4 
>50/1 
44 
-  14 E A3 
>15/1 
59 
3 
 
C A2 
>50/1 
89 
-  15 
 
E A2 
1/0 
98 
4 C A4 
>50/1 
72 
-  16 E A3 
7/1 
46 
5 
 
C A2 
>50/1 
79 
-  
17 
 
E A2 
>15/1 
85 
18 E A3 
>15/1 
64 
6 
 
C A2 
>50/1 
78 
-  19 
 
E A2 
1/0 
67 
7 
 
D A2 - 
7/1 
61 
 
20 
 
Eb A2 
13/1 
69 
8 D A4 - 
16/1 
71 
 
9 
 
D A2 - 
5/1 
67 
 
21 
 
F A2 
13/1 
60 
10 D A4 - 
5/1 
62 
 
11 
 
E A2 - 
1/0 
94 
 
22 
 
F A2 
12/1 
58 
12 E A4 - 
>25/1 
67 
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These donors proved to be more stable and provided disaccharides in higher yields. However, 
the stereoselectivity was reduced compared to the methyl ketal donors again highlighting the 
importance of this functionality. Whilst the methyl ketal donors provided good stereoselectivity 
in either acetylated (50) or benzylated (51) form, the ether variants (54 and 55) proved much 
more sensitive to the protecting group pattern on the donor.[30-31] This was further investigated 
by the synthesis and glycosylation of differentially protected oxathiane donors 56-61 (Table 4, 
entries 11-20). In general, the use of electron-withdrawing groups, especially at C-3, proved to 
be important to maintain α-selectivity which is in good agreement with aforementioned results. 
Additionally, temperature might also play an important role in the glycosylations as protocol D 
adds the acceptors at -10oC, whereas protocol E adds the acceptors at -40oC and the 
stereoselectivity is much higher in the latter protocol The mechanism of glycosylation of 
oxathiane donors was also investigated in silico using DFT calculations to establish the role of 
the sulfonium ion in the reaction pathway.[31] The SN1 and SN2 pathways of both ketal and ether 
sulfonium functionalities were investigated, but neither was in full agreement with the 
experimental results. It is however clear that the sulfonium ion does probably not react solely 
via an SN2 mechanism on which basis these glycosyl donors were designed.   
 
From the experimental results it was clear that the methyl ketal was vital for excellent 
stereoselectivity, but proved unstable after glycosylation. With this in mind, Turnbull et al. set 
out to improve the ketal stability by introducing a spiroketal (62 and 63).[34] This auxiliary 
conserves the cyclic nature even after it is displaced by the glycosyl acceptor, hence is more 
stable and cannot release a competing nucleophile. The spiroketal oxathianes 62 and 63 were 
prepared starting from a dihydropyran precursor using a similar strategy as used for the methyl 
ketals. Activation was achieved by oxidation to the sulfoxide and reaction with TMB followed by 
glycosylation. The reactions proceeded well with a lower acceptor concentration as intended 
since no competing nucleophile was released. The isolation of the disaccharides again proved to 
be more convenient after acidic removal of the ketal auxiliary. The glycosylation results reveal 
a loss of stereoselectivity with the spiroketal, α/β 13:1 (Table 4, entry 21, acetylated donor) 
and α/β 12:1 (Table 4, entry 22, benzylated donor) compared to their methyl ketal counterparts 
(α/β > 50:1, Table 4, entries 1 and 3) suggesting that the structure of the ketal is important for 
the stereoselectivity. It was noted that the glycosylation reaction was sluggish and tuning of the 
reactivity of the sulfonium ion by modifying the aryl structure was investigated. It was 
envisioned that the use of less electronrich DMB would lead to a less stabilized and therefore 
more reactive sulfonium ion. A competition experiment between oxathiane 62 activated with 
TMB or DMB showed that the DMB was indeed ~1.5 times more reactive. However, the increase 
in reactivity led to a decrease in selectivity in case of spiroketal donor 62 which is consistent 
with earlier findings. 
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1.3 – Achiral auxiliaries for glucosides and galactosides 
 
The observation made by Boons et al. that the achiral version of their auxiliary still provided 
mainly 1,2-cis-products (α/β 8:1, Table 2b, entry 5) inspired researchers to investigate the use 
of achiral auxiliaries as they are simpler to synthesize and do not require chiral starting 
materials. Fairbanks et al. investigated the role of the nucleophilic group in such achiral 
auxiliaries and variants containing a thiophene,[35] iodo and selenophenyl[36] or 2,4,6-
trimethoxythiophenyl group (Scheme 7 and 8).[37] Alkylation of the C-2 position in 64 with 2-
bromomethyl thiophene under standard conditions gave intermediate 65 which could be 
converted into glycosyl imidate 66 (Scheme 7).[35] 
 
  
Scheme 7: Synthesis of thiophene donor 66. 
  
The installation of the 2-(iodo)-ethyl-, 2-(selenophenyl)-ethyl- and 2-(2,4,6-
trimethoxythiophenyl)-ethyl ethers proved more challenging than expected. The best route 
relied on the 2-iodo-ethyl precursor 67 which was prepared by the conversion of a C-2 allyl 
ether via ozonolysis, reduction and subsequent iodination of the alcohol (Scheme 8).[36] 
Conversion of this intermediate into the glycosyl imidate afforded the 2-(iodo)-ethyl auxiliary 
donor 72. Nucleophilic displacement of the iodide using phenyl selenol or 2,4,6-
trimethoxythiophenol afforded hemiacetals 68 and 69 and subsequent imidation gave glycosyl 
donors 70 and 71.[36-37] Using this chemistry, a number of differentially protected glycosyl 
donors were prepared.  
 
 
Scheme 8: Synthesis of selenium, sulfur and iodide donors 70, 71 and 72, resp. Reagents and conditions: a) PhSeH 
or 2,4,6-trimethoxybenzenethiol, DIPEA, DMF; b) Cl3CCN, DBU, DCM, 0oC. 
 
1.3.1 – Glycosylation results 
 
The glycosylation results of glycosyl donors carrying achiral auxiliaries are summarized in Table 
5. The stereoselectivity with the thiophene based auxiliary was poor to moderate depending on 
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the type of protecting groups used.[35] Acetylated donor 73 was unselective (α/β 1:1), whereas 
the benzylated counterpart (66) was much more stereoselective (α/β 9:1). In the latter case, 
the stereoselectivity was also strongly dependent on the type of glycosyl acceptor (up to α/β 
30:1 for benzylidene protected mannose acceptors).[35a] In the case of both the acetyl and 
benzyl protected donor, low temperature NMR studies showed the presence of distorted β-
configured sulfonium intermediates.[35b] From the glycosylation results it is clear however, that 
these intermediates are probably not reactive intermediates. In a subsequent study, the use of 
a 2-(iodo)-ethyl or 2-(selenophenyl)-ethyl ether as a participating group was explored.[36] Very 
poor selectivity was observed in both cases with again the benzylated glycosyl donors 
performing better than their acetylated counterparts (Table 5, entries 2-3 vs 6-7).This result is 
the reverse of what would be expected based on the findings in earlier studies that show that 
electron-withdrawing groups on the glycosyl donor perform better than electron-donating 
ones.[25] Again low temperature NMR experiments were performed to detect reaction 
intermediates. In the case of the 2-(iodo)-ethyl auxiliary no iodonium ion could be detected for 
acetylated donor 74 or benzylated donor 72. Hence, it is clear that this group does not 
participate in the reaction. 
 
a protocol G: donor (1 eq) and A2 (2 eq) in DCM at -40oC (thiophene) or -78oC (I, SePh); protocol H: donor (1 eq) 
in DCM, -78oC, TMSOTf (1 eq), -78oC –  0oC, then -78oC, A2 (1.5 eq) and TTBP (2eq) then -78oC – rt. TTBP = 
2,4,6-tri-tert-butylpyrimidine. 
 
Table 5: Glycosylation results of donors carrying achiral auxiliaries. 
 
entry donor 
proto- 
cola 
R2OH α / β 
yield 
(%) 
kk. entry donor 
proto- 
cola 
R2OH α / β 
yield 
(%) 
1 
 
G A2 1/1 89  5 
 
G A2 9/1 84 
2 
 
G A2 1/2 76  6 
 
G A2 4/1 75 
3 
 
G A2 2/3 75  7 
 
G A2 5/1 80 
4 
 
H A2 5/1 63  8 
 
H A2 1/0 69 
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In the case of the 2-(selenophenyl)-ethyl auxiliary, a selenium ion was only detected in the case 
of acetylated donor 75. However, the stereoselectivity of donor 75 is lower than the benzylated 
counterpart (70) which does not show selenium ion formation in the VT-NMR studies. Hence in 
this case it is also unlikely that the observed stereoselectivity is a result of neighboring group 
participation.    
 
As a result, more electronrich participating groups were explored next. Inspired by the work of 
Turnbull et al. the 2,4,6-trimethoxythiophenyl participating group was explored.[37] This auxiliary 
showed much improved stereoselectivities with the acetylated donor (76) being moderately 
selective (α/β, 5:1) and benzylated donor 71 being fully α-selective for a range of glycosyl 
acceptors. This surprising result was rationalized by NMR experiments which showed the 
formation of a β-sulfonium ion in case of benzylated donor 71, but not in the case of acetylated 
counterpart 76. This result is surprising considering that similar chiral systems were much less 
selective.[25] The use of achiral auxiliaries has potential as evidenced by the use of the 2-(2,4,6-
trimethoxythiophenyl)-ethyl auxiliary (71) which was highly stereoselective. However, the 
synthesis of glycosyl donors containing such auxiliaries is still quite lengthy and does not offset 
the benefit of not having to use chiral starting materials.  
 
 1.4 – Application to complex oligosaccharide synthesis 
 
The true scope and limitations of synthetic methodologies are best established by their 
application in total syntheses. As can be seen in the previous sections, the protecting groups on 
the glycosyl donor and its relative stereochemistry as well as the structure of the auxiliary have 
a profound influence on the stereoselectivity. Application to total synthesis has revealed other 
aspects to keep in mind when using chiral auxiliaries such as protecting group compatibility, 
auxiliary removal, sterics and its potential with respect to solid phase synthesis. To date, three 
total syntheses of oligosaccharides using chiral auxiliaries have been reported.[30, 38] Absolute 
stereocontrol is especially important to enable solid phase oligosaccharide synthesis. Solid-
phase oligosaccharide synthesis (SPOS) offers the promise of increasing the speed of 
oligosaccharide assembly, primarily by eliminating intermediate purification steps and by 
automation.[39] Since no intermediate purification is undertaken, intractable mixtures of 
compounds will be formed if the glycosylations are not fully stereoselective. Not surprisingly, 
only a few examples of SPOS of oligosaccharides containing 1,2-cis-glycosides have been 
reported.[40] These rely on tedious separation of the anomers by high-performance liquid 
chromatography or the preparation of a 1,2-cis-linked disaccharide in solution, which after 
purification to remove the unwanted 1,2-trans-anomer, can be used in solid-phase synthesis. 
Thus, a major stumbling block in SPOS is the inability to reliably introduce 1,2-cis-glycosides 
with complete stereoselectivity.  
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1.4.1 – Synthesis of pentasaccharide found in Aconitum carmichaeli 
 
The use of chiral auxiliaries to address this issue was explored in the synthesis of a branched α-
linked pentasaccharide found in Aconitum carmichaeli that has the potential to be developed as 
an adjuvant.[41] The polysaccharide is composed of an α(1,6)-linked glucosyl backbone, 
branched with an α(1,3)-linked glucoside moiety. Such α-glucans are considerably challenging 
to synthesize on solid support due to the multitude of 1,2-cis-linkages and their branched 
structure. Pentasaccharide 84 from Aconitum carmichaeli was prepared from monosaccharide 
building blocks 78, (S)-24 and 81 (Scheme 9).[38a] By using orthogonal Alloc and Fmoc 
protecting groups, branching could be achieved. The Fmoc protecting group of 77 was removed 
by treatment with piperidine/DMF and coupled with auxiliary-containing glucosyl donor 78 to 
install the first 1,2-cis linkage. The couplings were performed by the addition of preformed 
sulfonium ion to the acceptor. Double couplings were performed to achieve full conversion. The 
Alloc function could be removed by treatment with Pd(PPh3)4 in a mixture of THF and AcOH to 
give the corresponding disaccharide acceptor. However, this acceptor could not be coupled with 
preactivated (S)-24. It was hypothesized that the C3′ hydroxyl is sterically shielded by the 
neighboring (S)-(phenylthiomethyl)benzyl ether. 
 
 
Scheme 9: Solid phase synthesis of branched pentaglucoside 84. Reagents and conditions: a) 10% v/v piperidine in 
DMF, 5 min, rt. b) 78, (S)-24 or 81, TMSOTf, DCM, MS4Å, 15 min, -40oC then added to acceptor, DTBMP, DCM, MS4Å, 
16h -40oC → rt, double coupling. c) BF3.Et2O, Ac2O/DCM 1/2 v/v, 16h, 0oC. d) 40 mol% Pd(PPh3)4, THF/AcOH 10/1 v/v, 
16h, rt. e) NaOMe, MeOH/DCM 1/1, 16h, rt. f) Ac2O, pyr 1/3 v/v; g) 20 wt% Pd(OH)2/C, H2, EtOH/H2O 1/1 v/v, 16h, rt, 
87%. 
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Thus, the auxiliary was converted into an acetyl ester by treatment with acetic anhydride in the 
presence of BF3.OEt2 affording 79. The Alloc was removed under standard conditions and 
coupling with pre-activated (S)-24 was now successful to yield resin-bound trisaccharide 80. A 
sequence of Fmoc removals and couplings with donor 81 gave rise to the complete protected 
pentasaccharide 82. The C-2 auxiliaries were removed on-resin under aforementioned 
conditions and the product was cleaved using NaOMe/MeOH affording pentasaccharide 83. 
Reacetylation was performed to aid purification and NMR analysis. No anomeric isomers of the 
completed product were detected which was obtained in an overall yield of 25% (90% per step, 
13 on-resin steps). Finally, target compound 84 was prepared by removal of the acetyl esters, 
using standard conditions followed by hydrogenolysis of the benzyl ethers using Pd(OH)2/C (20 
wt%) and H2 gas. The total synthesis of pentasaccharide 84 was the first example of a 
stereoselective solid-supported synthesis of an oligosaccharide having multiple 1,2-cis-
glycosidic linkages. A particularly interesting feature was that a relatively small excess (2.0 
equiv) of glycosyl donor was required to drive the glycosylations to completion. It is likely that 
the intermediate sulfonium ion is sufficiently stable to diffuse into the polymer support for 
glycosylation of the resin-bound sugar hydroxyls. However, a limitation of the C-2 auxiliary is 
that it may block the neighboring C-3 hydroxyl from reacting and hence requiring auxiliary 
removal prior to glycosylation at this site.  
 
1.4.2 – Synthesis of a tetrasaccharide found in Pseudallescheria boydii 
 
Similar α-glucans have also been isolated from various microbial sources such as 
Pseudallescheria boydii, producing a polysaccharide that is essential for conidial phagocytosis 
by macrophages and induction of innate immune responses in a TLR2-dependent manner. 
Tetrasaccharide 134 isolated from Pseudallescheria boydii was synthesized using oxathiane 
donors and a bi-directional approach.[30] Tetrasaccharide 96 contains an α(1,4)-linked backbone 
and α(1,6)-branching which could be prepared from monosaccharides building blocks 56, 84, 
85 and 88 (Scheme 10). It was envisioned that oxathiane 85 could serve as a latent-active 
glycosyl donor.[42] Hence, disaccharide 86 was prepared by coupling of preactivated 84 to 
glycosyl acceptor 85 with excellent selectivity. Activation of this disaccharide required oxidation 
to the sulfoxide and hence the C-2 auxiliary was removed to prevent oxidation at this site using 
10% TFA in DCM, followed by acetylation (87). Next, oxidation of the oxathiane with m-CPBA 
enabled sulfonium ion synthesis and coupling with amino spacer 88 with excellent selectivity 
(89, α-only). Fmoc removal allowed for α(1,4)-extension at the non-reducing end using 
preactivated 56 to afford trisaccharide 91 in good yield and excellent selectivity. Again, the 
auxiliary was removed prior to further extension to afford 92. Installation of the α(1,6)-branch 
was achieved after removal of the 2-methylnaphthyl ether (93) and coupling with preactivated 
56 afforded tetrasaccharide 94. The α-selectivity was moderate (α/β 8:1), but could be 
improved by the use of a different oxathiane sulfoxide donor. 
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Scheme 10: Synthesis of branched tetraglucoside 96. Reagents and conditions: a) 1,3,5-trimethoxybenzene, Tf2O, 
DTBMP, then 85, 88, 90 or 93; b) 10% TFA, DCM, then Ac2O, Pyr. c) m-CPBA, DCM d) 20% NMP in DMF e) DDQ, H2O, 
DCM f) NaOMe, MeOH, then H2, Pd(OH)2/C, tBuOH, H2O, AcOH. 
 
Final deprotection afforded tetrasaccharide 96. The use of oxathiane donors is very attractive 
since the oxathiane is stable during protecting group manipulations, can serve as a glycosyl 
acceptor and can be activated by oxidation to the corresponding sulfoxide which can be used as 
a glycosyl donor. A major drawback is that prior to oxidation of the oxathiane, the removal of 
C-2 auxiliaries is required to prevent oxidation at this position. Also, the oxathiane donors used 
in this study are less selective than the second generation Boons auxiliaries used on solid 
support.  
 
1.4.3 – Synthesis of a hexasaccharide found in Trypanosoma brucei 
 
Both the oxathiane donor and donor bearing a C-2 (S)-phenylthiomethylbenzyl ether were 
employed for the synthesis of oligosaccharide 111 found on the glycosylphosphatidylinositol 
(GPI) anchor of Trypanosoma brucei which is a parasite that causes sleeping sickness in humans 
and similar diseases in domestic animals (Scheme 11).[38b, 43] Hexasaccharide 111 consists of 
four galactose and two mannose monomers all linked via α-glycosidic bonds. The synthesis was 
carried out using a light fluorous tag (F) at the reducing end. This tag allows glycosylation to 
take place in solution, but facilitates purification by fluorous solid phase extraction (F-SPE) 
obviating the need for chromatography and is even amendable to automation.[44] The synthesis 
was rehearsed and optimized using traditional solution phase chemistry and the optimized 
procedure was next used to enable rapid synthesis using F-SPE. Each glycosylation was 
performed twice, in order to ensure complete conversion of the glycosyl acceptor. The synthesis 
started with the addition of preactivated oxathiane donor 98, to α-glucoside 97 bearing the 
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fluorous tag, forming the disaccharide as the α(1,3)-linkage only. Removal of the auxiliary with 
10% TFA in DCM afforded acceptor 99. Addition of preactivated oxathiane donor 103 to 99 did 
not result in product formation and using an excess of donor 103 resulted in a disappointing 
25% yield of the corresponding α-1,2-linked trisaccharide. This problem was overcome by 
implementation of the more reactive C-2 benzyl protected donor 100, activated by triflic acid, 
forming trisaccharide 101 with α/β 15:1. In order to avoid overoxidation, careful oxidative 
deprotection of the Nap ether was achieved using a small excess of DDQ in H2O, affording alcohol 
102. Addition of preactivated donor 103 and subsequent acidic deprotection of the C-2 auxiliary 
afforded tetrasaccharide 104 as only the α-anomer. Formation of pentasaccharide 106 by 
employing preactivated oxathiane donor 103, surprisingly resulted in a disappointing yield of 
20%. Addition of tetrasaccharide 104 to preactivated 105, followed by acidic removal of the 
auxiliary resulted in pentasaccharide 106 as only the α-anomer in 76% yield. Acetylation and 
subsequent removal of the Lev ester using hydrazinium acetate yielded acceptor 108. 
 
 
Scheme 11: Synthesis of Trypanosoma brucei GPI oligosaccharide 111. Reagents and conditions: a) 98 or 103, 1,3,5-
trimethoxybenzene, Tf2O, DTBMP, then 97 or 102. then 10% TFA, DCM; b) TfOH, DCM; c) DDQ, H2O, DCM; d) 105, 
TfOH, then 104, DTBMP, then 10% TFA, DCM; e) Ac2O, Pyr., DMAP; f) NH2NH2.AcOH, pyr.; g) 109, TMSOTf, 146, DCM; 
h) H2, Pd/C, MeOH, AcOH, then NaOMe, MeOH. 
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As discussed earlier, acyl participation in manno-type glycosylations reliably affords α-linked 
products and thus TMSOTf mediated glycosylation of mannoside 109 with acceptor 108 cleanly 
afforded hexasaccharide 110. Hydrogenation of the benzyl ethers and subsequent deacetylation 
afforded target hexasaccharide 111. The overall yield of the solution phase synthesis was 9%, 
whereas the fluorous-assisted solid phase synthesis afforded hexasaccharide 111 in 17% overall 
yield corresponding to an impressive 85% yield per reaction step. Additionally, the authors 
needed only six days to complete the synthesis, which can probably be sped up further by using 
automated fluorous-supported synthesis. The synthesis of this hexasaccharide highlights the 
progress made in the stereoselective synthesis of α-glycosides, but also shows one of its 
weaknesses. Combination of the bulky C-2 sulfonium intermediate with an unreactive acceptor 
(i.e. alcohol on C-2), affords poor to no glycosylation. 
 
1.5 – Summary and outlook 
 
The use of C-2 chiral auxiliaries for the stereoselective synthesis of 1,2-cis-glycosides holds 
considerable potential to become a general method to prepare this class of molecules. In most 
cases neighboring group participation of the C-2 auxiliary during glycosylation leads to the 
formation of a trans-decalin intermediate that can be displaced to form 1,2-cis-glycosides. 
Whether the observed trans-decalin intermediate is a reactive species or merely a resting state 
seems to be strongly dependent on the structure of the auxiliary and the protecting groups on 
the glycosyl donor (Scheme 12). In general, electron-withdrawing protecting groups perform 
better than electron-donating protecting groups yet more work is needed to establish the exact 
mechanism of sulfonium ion displacement. Auxiliaries containing a thioether as the nucleophilic 
group to produce sulfonium ion intermediates perform better than variants containing an ester, 
ether, seleno ether or iodo group. Furthermore, the structure of the C-2 auxiliary is another 
major factor that determines the stereoselectivity and auxiliaries carrying a chiral group tend to 
drastically improve 1,2-cis stereoselectivity. Given the fact that chiral auxiliaries are relatively 
expensive and an elaborate synthesis is required for their introduction, it would therefore be 
interesting to investigate achiral auxiliaries that potentially speed up the essential ring closing 
step. This could be done by making use of the gem-dimethyl effect (Chapter 2). 
 
 
Scheme 12: Factors that influence the reactivity of sulfonium ions in glycosylations. 
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Excellent 1,2-cis-selectivity was obtained in most cases, but especially sterically hindered 
glycosyl acceptors proved difficult to glycosylate. In these cases, more conventional glycosyl 
donors carrying a non-participation functionality proved to be more efficient. In conclusion, 
chiral auxiliaries to prepare 1,2-cis-glycosides is a promising technology which, combined with 
the well-established use of C-2 acyl participation to prepare 1,2-trans-glycosides, will provide 
access to the major linkage types found in natural oligosaccharides.  
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A Study on Stereoselective Glycosylation  
via Sulfonium Ion Intermediates 
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Abstract: The stereoselective synthesis of 1,2-cis-linkages can be achieved by an SN2-like 
displacement of glycosylation intermediates such as glycosyl triflates and sulfonium ions, 
provided that they exhibit the right balance between stability and reactivity. This chapter 
describes the use of an achiral auxiliary that can perform neighboring group participation to 
afford glycosyl sulfonium ions, aided by the Thorpe-Ingold effect. We investigated the 
glycosylation properties of the sulfonium ions and used variable temperature NMR studies to 
investigate their role in the glycosylation mechanism. The influence of the structure of the 
auxiliary, the protecting groups and stereochemistry of the glycosyl donor were investigated 
and led to the identification of a highly α-selective galactose donor. 
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2.1 – Introduction 
 
The main challenge of chemical oligosaccharide synthesis is the stereoselective synthesis of 
glycosidic bonds.[1] In general, 1,2-trans glycosides can be synthesized by exploiting 
neighboring group participation of a C-2 acyl group. The introduction of 1,2-cis glycosidic 
linkages is much more challenging and requires glycosyl donors having a non-assisting 
functionality at C-2.[2] In general, these glycosylations are less selective and require optimization 
to achieve acceptable anomeric ratios. Recent advances in anomeric control have led to new 
methodologies to synthesize 1,2-cis linkages of monosaccharides such as glucose, galactose, 
mannose,[3] glucosamine,[4] galactosamine[5] and furanose sugars.[6] Although excellent, these 
methods are stereoselective via different mechanisms ranging from solvent effects[7], directed 
aglycon delivery,[8] steric shielding,[5] SN2-like displacement of a quasi-stable intermediate,[3a] 
stabilization of an oxocarbenium ion conformation[6, 9] and post glycosylation anomerization.[10] 
Arguably, the development of a methodology that provides stereoselective 1,2-cis glycosylation 
using a generally applicable principle is more desirable as it allows for the use of standardized 
monosaccharide building blocks. In this respect, the formation of sulfonium ions holds 
considerable potential.[11] In particular, the use of C-2 auxiliaries to attain highly selective 1,2-
cis glycosylations via neighboring group participation allows for careful tuning of donor reactivity 
and stereoselectivity. First reported by Boons et al., C-2 chiral auxiliaries such as the (S)-
(phenylthiomethyl)benzyl ether can be employed for the stereoselective introduction of 1,2-cis 
glycosides such as α-glucosides and α-galactosides.[12] Neighboring group participation by the 
chiral auxiliary leads to a quasi-stable anomeric sulfonium ion (Scheme 1), which due to steric 
and electronic factors, is formed as a trans-decalin ring system. Subsequent SN2-like 
displacement of the sulfonium ion then leads to the stereoselective formation of α-glycosides.[13] 
 
  
Scheme 1: Selected examples of modifications on the C-2 auxiliary group capable of forming a cis directing sulfonium 
intermediate. 
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Although this methodology is highly stereoselective in many cases,[14] the stereoselectivity 
depends on the protecting groups on the glycosyl donor[14b, 14e] and the structure of the 
auxiliary[15] (Scheme 1). Since the intermediate α-sulfonium ion is in rapid equilibrium with the 
oxocarbenium ion, its formation alone is not a guarantee for α-selective glycosylation since it 
may not be a reactive intermediate in the glycosylation mechanism.[3b, 15b, 15d] 
This chapter reports a study aimed at simplifying the auxiliary by using an achiral 
participating group, which also benefits from the gem-dimethyl or Thorpe-Ingold effect in an 
effort to improve the α-selectivity by increasing the speed of the formation of the intermediate 
α-sulfonium ion (Scheme 2).[16] Cyclization of the C-2 participating group is needed to form the 
sulfonium ion intermediate and this process can be accelerated by the Thorpe-Ingold effect. In 
addition, we investigated the effects of the protecting groups on, and the stereochemistry of, 
the glycosyl donor (glucose and galactose) as well as two auxiliaries to evaluate the contribution 
of the Thorpe-Ingold effect. To this end, we prepared eight different glycosyl donors 13-20 
(Scheme 2). 
 
 
Scheme 2: A new auxiliary based on the Thorpe-Ingold effect. 
 
2.2 – Donor synthesis 
 
Glycosyl donors 13-20 were prepare in 4-6 steps starting from peracetylated glucose or 
galactose (Scheme 3). Regioselective C-2 deprotection and anomeric allylation of peracetylated 
precursors afforded 3-4 according to a reported procedure.[17] At this stage, the participating 
group was installed. In the case of the gem-dimethyl auxiliary, 3 and 4 were reacted with 
HO(CH3)2CCH2SPh and BF3.Et2O to afford 5 and 7 in 46% and 52% yield, respectively.[18] The 
moderate yield is a result of the reaction reaching equilibrium and unreacted material can be 
recovered. Derivatives 9 and 11, carrying an unsubstituted auxiliary, were prepared to compare 
the effect of gem-dimethyl substitution of the auxiliary group. The aforementioned condensation 
of 3-4 and the alcohol precursor (HO(CH2)2SPh) using BF3.Et2O proved unproductive. This was 
overcome by employing the corresponding bromide (Br(CH2)2SPh), silver perchlorate and silver 
carbonate, even though low yields of 9 and 11 (19-37%) were obtained. Despite the low yield, 
this route was preferred over the multistep route described by Fairbanks et al.[15d] To probe the 
influence of the protecting groups on the glycosylation, in addition to acetylated donors 5, 7, 9 
and 11, benzylated donors 6, 8, 10 and 12 were prepared via deacetylation, followed by 
benzylation, in good overall yields. Finally, the anomeric imidate leaving group was installed to 
afford glycosyl donors 13-20. 
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Scheme 3: Synthesis of glycosyl donors 13-20. Reagents and conditions: (i) allyl alcohol, BF3.OEt2, DCM, 0°C, 1h; 3, 
27%; 4, 40%; (ii) HO(CH3)2CCH2SPh, BF3.OEt2, DCM, 0°C, 30 min; 5, 47% ;7, 52%; (iii) Br(CH2)2SPh, AgClO4, Ag2CO3, 
toluene, 4Å MS 60oC; 9, 19%; 11, 37%; (iv) (a) K2CO3, MeOH (b) NaH, BnBr, DMF, 0°C; 6, 89%; 8, 80%; 10, 84%; 
12, 59%; (v) (a) Pd(PPh3)4, DCM/AcOH (10:1) (b) ClC(NPh)CF3, DBU, DCM, 0oC; 13, 88%; 14, 89%; 15, 96%; 16, 
71%; 17, 75%; 18, 61%; 19, 60%; 20, 69%. 
 
2.3 – Glycosylation results 
 
Next, glycosyl donors 13-16 were evaluated in the stereoselective glycosylations with glycosyl 
acceptor 21 (Table 1). Donors 13-16, carrying the gem-dimethyl substituted auxiliary were 
activated at -78 oC using TfOH and allowed to warm to 0oC. Next, after cooling to -78 oC, acceptor 
21 and 2,6-di-tert-butyl-4-methylpyridine (DTBMP) were added and the mixture was allowed to 
warm to rt. Both the benzyl- and acetyl-protected glucosyl donors 13 and 14 showed 
disappointing stereoselectivity with α/β ratios of 2/1 and 3/1, respectively (Table 1, entries 1-
2). In contrast, galactosyl donors 15 and 16 proved to be more selective with α/β ratios of 19/1 
and 4/1, respectively (Table 1, entries 3-4). In each case the acetylated donor was more 
selective than the benzylated counterpart and the galacto-type sugar was more selective than 
the gluco-type. Most notably, donor 15 proved to be very selective (19/1) and could also be 
used to stereoselectively glycosylate secondary acceptor 22, affording disaccharide 28 with an 
α/β ratio of 16/1 (Table 1, entry 5). To assess the influence of the participating group on the 
stereoselectivity, two glycosylations were performed with C-2 benzyl-protected galactosyl donor 
23, thus carrying no participating group at C-2 (Table 1, entries 6 and 7). 
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Table 1: Glycosylations results of donors 13-16 and 23 
a Ratios were determined by integration of key NMR signals of the crude reaction mixture, b Isolated yield, c Acceptor 
21 was added at rt. 
 
 
In this case the α-selectivity was much lower (~5/1) illustrating the importance of the auxiliary. 
These results indicate the importance of a variety of reaction parameters on the 
stereoselectivity. Glycosylation intermediates such as glycosyl sulfonium ions and triflates can 
be responsible for stereoselectivity via an SN2-like displacement.[3a, 13-14, 19] However, the 
presence of such an intermediate does not necessarily mean it is a (main) factor that determines 
the stereoselectivity.[14b, 15b, 15d] The trend we observed that the armed benzylated donors (14, 
16, 18 and 20) are less selective than their disarmed acetylated counterparts (13, 15, 17 and 
19) is in line with earlier findings reported by Boons et al.[14b] The loss of stereoselectivity was 
attributed to increased stabilization of the oxocarbenium ion and non-selective glycosylation via 
this intermediate. 
 
 
 
 
entry donor R2OH P α / βa 
yield 
(%)b 
k entry donor R2OH P α / βa 
yield 
(%)b 
1 
 
21 24 3/1 87  5 
 
22 28 16/1 63 
2 
 
21 25 3/2 
2/1c 
82 
78c 
 6 
 
21 29 5/1 93 
3 
 
21 26 19/1 24/1c 
91 
38c 
 7 
 
22 30 6/1 66 
4 
 
21 27 4/1 50        
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2.4 – Mechanistic studies 
 
To understand the differences in stereoselectivity, we performed variable temperature NMR 
experiments to identify reaction intermediates.[20] Glucosyl donors 13 (Figure 1) and 14 (Figure 
2) were activated in CD2Cl2 at -78 °C with TfOH. Next 1H, 1H-TOCSY, 1H-13C HSQC and 1H-13C 
HMBC spectra were recorded at -78 °C, -20 °C and at -20 °C again after the sample was allowed 
to warm up to rt outside the probe. After activation at -78 °C, both a downfield shift of the H-8 
protons and a strong C1-H8 correlation in the HMBC spectra confirmed the formation of a cyclic 
sulfonium ion. Further analysis showed two sulfonium ion anomers had formed. Somewhat 
surprisingly, the α-sulfonium ion was identified as a major species at low temperature and had 
adopted a 1C4 conformation as was concluded from TOCSY spectra with coupling constants below 
5 Hz, consistant with protons in an equatorial-equatorial conformation. The samples were slowly 
heated (to -40 oC, -20 oC and rt) and additional spectra were recorded. Glycosyl triflates were 
not detected according to 1H-19F HOESY experiments and for both 13 and 14 the kinetic product, 
the α-sulfonium ion, was formed after rapid cyclization of the auxiliary. In both cases, 
anomerization to the more stable β-sulfonium ion occurs as the temperature increases and is 
faster for armed donor 14. The presence of an α/β mixture of sulfonium ions may explain the 
poor glycosylation selectivity of 13 (α/β = 3/1) and 14 (α/β = 3/2). Critically, reducing the 
temperature did not result in the reformation of the α-sulfonium ion, thus equilibration between 
the α- and β-sulfonium ion is slow and the Curtin-Hammett principle may be excluded between 
these intermediates. However, the oxocarbenium intermediate may also be an important 
intermediate in these glycosylation reactions and should therefore not be excluded. 
 
Figure 1: VT-NMR analysis of glycosylation intermediates of donors 13 and 14. a) Activation of 13 leads to α- and β-
sulfonium intermediates, b) Temperature dependant 1H NMR study, c) 1H-13C HMBC correlation of C1-H8. 
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Figure 2: a) Activation of 14 leads to α- and β-sulfonium intermediates, b) Temperature dependant 1H NMR study, c) 
1H-13C HMBC correlation of C1-H8. 
 
 
To test this hypothesis, NMR studies of highly selective galactosyl donor 15 were performed, 
which gave a 19/1 α/β ratio. Hence, if glycosylation takes place via the β-sulfonium ion, it would 
be expected to be the major intermediate. However, activation of 15 with triflic acid in CD2Cl2 
at -20 °C afforded mainly the α-sulfonium ion δ(H-1)/δ(C-1) 6.53/101.2 ppm (Figure 3). Again, 
the α-sulfonium ion had adopted the 1C4 conformation and converted into the more stable β-
sulfonium ion as the temperature was increased. On the basis of these results it seems unlikely 
that the α-selectivity of galactosyl donor 15 is a result of an SN2 reaction with the β-sulfonium 
ion, unless the glycosylation starts taking place at a temperature at which conversion of the α-
sulfonium ion to the β-sulfonium ion is complete. To observe the temperature at which 
glycosylation takes place, another VT-NMR experiment was performed in which glycosyl acceptor 
21 was added and the sample was gradually warmed (Figure 4). NMR analysis revealed the slow 
conversion of α-sulfonium ion to β-sulfonium ion δ(H-1)/δ(C-1) 5.63/86.7 ppm occured between 
-40°C and 0°C and was followed by glycosylation at approximately 0°C. The observation that 
conversion to the β-sulfonium ion required relatively high temperatures and was followed by 
glycosylation, led us to investigate the effect of temperature on the stereoselectivity. Donors 14 
and 15 were activated at low temperature and allowed to warm to room temperature to 
maximize the formation of β-sulfonium ion. Next, acceptor was added at this temperature (Table 
1, entries 2C-3c). However, even though VT-studies showed an improvement in the ratio of β-
sulfonium ion intermediate present, only a marginal improvement in the stereoselectivity was 
observed. 
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Figure 3: VT-NMR analysis of glycosylation intermediates of donor 15. a) Activation of 15 leads to α- and β-sulfonium 
intermediates; b) Temperature dependant 1H NMR study; c) 1H-13C HMBC correlation of C1-H8. 
 
This led us to conclude that for glucosyl donors 13 and 14, the sulfonium ion is likely a resting 
state and glycosylation takes place via the oxocarbenium ion pathway in a non-selective manner. 
In case of galactosyl donor 15, it is difficult to determine the reason for the highly α-selective 
glycosylation. NMR experiments indicate temperature dependent conversion of the α-sulfonium 
ion to the β-sulfonium ion followed by stereoselective glycosylation indicating that SN2-like 
displacement may be responsible for the observed α-selectivity. The difference in selectivity 
between sulfonium ions derived from 13 and 15 may be explained by the fact that galactose is 
more reactive than glucose which is expected to affect the balance between the sulfonium ion 
and oxocarbenium ion.[21] This difference in reactivity is also reflected in the anomerization of 
the α-sulfonium ion to the β-sulfonium ion, which is almost complete for 15 at 0oC whereas a 
1/1 mixture is still present at room temperature for 13. However, the α-selectivity could also 
be the result of a more selective alternative pathway. The possibility of remote neighboring 
group participation by the C-4 acetyl is often invoked to explain the formation of α-
galactosides.[22] Computational experiments support this possibility, yet efforts to trap the 
intermediate have failed.[23] Recently, Yu et al. reported the isolation of a glucose-1,2,4-
orthoester byproduct formed during a glycosylation which indicated that remote participation 
from the C-4 position is possible.[24]  
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Figure 4: VT-NMR analysis of glycosylation intermediates of donor 15. a) Activation of 15 leads to α- and β-sulfonium 
intermediates; b) 15 pre-activation; c) post-activation; d) temperature dependent glycosylation with 21. 
 
2.5 – Synthesis of control compounds 
 
In addition to the protecting group type and donor stereochemistry we evaluated the 
influence of the structure of the auxiliary and thus the Thorpe-Ingold effect using glycosyl 
donors 17-20. These donors lack the gem-dimethyl substituent and are expected to be 
more in equilibrium with the oxocarbenium ion intermediate. The aforementioned 
glycosylation protocol was used to glycosylate 21 (See Table 2, entries 1-4).  
 
 
 
 
Table 2: Glycosylation results of donors 17-20 
 
entry donor P α/βa yield
b 
(%) 
k entry donor P α/βa yield
b 
(%) 
1 
 
31 1/1 75  3 
 
33 10/1 81 
2 
 
32 3/2 73  4 
 
34 4/1 71 
a
 Ratios were determined by integration of key NMR signals of the crude reaction mixture  
b Isolated yield. 
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These donors were less selective than 13-16, but did show a similar trend. Again, the acetylated 
glycosyl donors were more selective than their benzylated counterparts and the galactosyl 
donors were more selective than the glucosyl donors. 
 
2.6 – Mechanistic study of control compounds 
 
In order to explain the high α-selectivity of donor 19 (Table 2, entry 3), an additional VT-NMR 
study was performed to identify reaction intermediates (see Figure 5). At -78°C both anomeric 
sulfonium ions were formed with the α-sulfonium ion as a mixture of conformers. Warming the 
mixture resulted in formation of the 4C1 α-sulfonium and also the formation of a fourth 
unidentified species. 
 
 
 
Figure 5: a) VT-NMR analysis of glycosylation intermediates of 19; b) Sulfonium ion species observed after activation 
of 19; c) 1H-13C HMBC spectrum of the sulfonium ion intermediates. 
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This suggests that in the absence of the gem-dimethyl substituents, the 1C4 α-sulfonium 
ion is less stable and converts to the 4C1 α-sulfonium ion conformer instead of direct 
conversion to the β-sulfonium ion. In addition, even after warming to room temperature, 
the anomerization towards the β-sulfonium ion is incomplete in contrast to donor 15. 
Eventhough donor 19 showed good α-selectivity, the selectivity was lower than that of 
donor 15 which carried a gem-dimethyl auxiliary. Due to the gem-dimethyl effect we 
expect the sulfonium ion to form rapidly, which may explain this result. By comparing 
the results of acetylated galactose donors 15, 19 and 23 the influence of the C-2 
substituent becomes clear. The C-2 benzyl derivative is the least selective (α/β = 5/1), 
as expected, followed by the unsubstituted auxiliary (α/β = 10/1) and finally the gem-
dimethyl-auxiliary (α/β = 19/1). 
 
2.7 – Auxiliary deprotection  
 
Finally, we explored the removal of the auxiliary on disaccharides 26 and 28. Using a mixture 
of TFA and dichloromethane, the C-2 alcohols were produced in good yield (Scheme 4). These 
mild conditions are compatible with ester and ether protecting groups. 
 
 
Scheme 4: Removal of the auxiliary. Reagents and conditions: (i) TFA/DCM, 26; 85%, 28; 54% 
 
2.8 – Conclusion  
 
It is clear that formation of a β-sulfonium ion intermediate alone is not sufficient to 
guarantee α-selective glycosylation since the sulfonium ion may just serve as resting 
state. Conversely, in case of galactosyl donor 15, it is difficult to determine the reason 
for the highly α-selective glycosylation. NMR experiments indicate temperature 
dependent conversion of the α-sulfonium ion to the β-sulfonium ion followed by 
stereoselective glycosylation indicating that SN2-like displacement may be responsible for 
the observed α-selectivity. However, the α-selectivity could also be the result of a more 
selective alternative pathway e.g. remote group participation. Even though chiral 
auxiliaries are more selective in most cases, galactosyl donor 15 is an attractive 
alternative since it is easily prepared in 5 steps and highly α-selective. 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 44
Chapter 2
44
 
44 
2.9 – Experimental  
 
General remarks: 1H and 13C NMR spectra were recorded on a Bruker Avance III 400 MHz or on a Bruker Avance III 
500 MHz spectrometer. Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS). NMR 
data is presented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, 
m = multiplet and/or multiple resonances), coupling constant in hertz (Hz), integration, assignment. All NMR signals 
were assigned on the basis of 1H-NMR, 13C-NMR, COSY, HSQC, HMBC and TOCSY experiments. Mass spectra were 
recorded on a Thermo Finnigan LCQ Advantage Max (MS) mass spectrometer. High resolution mass spectra were 
recorded on an JEOL AccuTOF CS JMS-T100CS (HRMS) mass spectrometer. Automatic flash column chromatography 
was performed by using a Biotage Isolera Spektra One, using SNAP cartridges (Biotage, 30-100 µm, 60 Å), 10-50 g. 
TLC-analysis was conducted on Silicagel F254 (Merck KGaA) with detection by UV-absorption (254 nm) where applicable 
and by spraying with either a 10% sulphuric acid in methanol stain, a potassium permanganate stain or a cerium 
molybdate followed by charring at ~300°C. MeCN, DCM, Et2O, THF and toluene were freshly distilled and anhydrous 
DMF purchased from Sigma Aldrich was used. Molecular sieves (4Å) were flame activated under vacuum prior to use. 
All reactions requiring an inert atmosphere were either under an argon or nitrogen atmosphere using flame-dried flasks.   
 
Allyl 3,4,6-tri-O-acetyl-α/β-D-glucopyranoside (3) 
Same procedure as 4, but β-D-glucose pentaacetate (5.00 g, 12.81mmol) was used instead. 
Product was isolated as a mixture of anomers: β-anomer (27%): 1H NMR (400 MHz, CDCl3) δ 5.99 
– 5.88 (m, 1H), 5.37 – 5.30 (m, 1H), 5.29 – 5.23 (m, 1H), 5.13 (t, J = 9.5 Hz, 1H, H-3), 5.04 (t, 
J = 9.7 Hz, 1H, H-4), 4.42 (d, J = 7.8 Hz, 1H, H-1), 4.28 (dd, J = 12.3, 4.9 Hz, 1H, H-6), 4.19 – 4.05 (m, 1H, H-6), 
3.68 (ddd, J = 9.8, 4.9, 2.4 Hz, 1H, H-5), 3.61 (dd, J = 9.4, 7.8 Hz, 1H, H-2), 2.43 (br, 1H), 2.09 (s, 3H), 2.08 (s, 3H), 
2.03 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.74, 170.71, 169.67, 133.29, 118.53, 101.63, 74.42, 72.15, 71.87, 70.60, 
68.42, 62.10, 20.83, 20.77, 20.66. HR ESI-TOF MS (m/z) calcd for C15H22O9 [M + Na]+ 369.1186, found 369.1166. 
 
Allyl 3,4,6-tri-O-acetyl-β-D-galactopyranoside (4) 
To a mixture of β-D-galactose pentaacetate (5.00 g, 12.81 mmol) and dry allyl alcohol (3.48 mL, 
51.20 mmol) in anhydrous DCM (50 mL), was added BF3.Et2O (2.44 mL, 19.21 mmol) under a 
nitrogen atmosphere at 0 °C. The solution was stirred at 0 °C for 1 h, then at room temperature 
overnight, then poured into ice-water and extracted with EtOAc. The organic phases were combined, dried with MgSO4, 
filtered, concentrated under reduced pressure and purified via silica flash column chromatography to afford 4 (1.77 g, 
40%). NMR was consistent with literature values.[17] HRMS (m/z) calcd for C15H22O9 [M + Na]+ 369.1162, found 
369.1170. 
 
 
General method A 
A mixture of 3 or 4 (1 eq), 2-methyl-1-(phenylthio)propan-2-ol (1.5 eq) and 4 Å MS in DCM (0.1 M) was cooled to 0 
°C. BF3.OEt2 (1.5 eq) was added and the reaction was quenched with Et3N after 1h, after which the MS were filtered off. 
The solution was extracted with a sat. NaHCO3 solution (2x) and brine, dried over MgSO4, filtered and concentrated in 
vacuo. Silica flash column chromatography (0-40% EA/Hept) afforded the pure products. 
 
 
General method B 
Compound 3 or 4 (1.8 g, 5.2 mmol) were dissolved in dry toluene (35 mL) at room temperature. 2-bromo ethyl phenyl 
sulfide (1.57 ml, 10.4 mmol), molecular sieves (5 g), Ag2CO3 (3.6 g, 13.0 mmol) and AgClO4 (1.6 g, 7.8 mmol) were 
added. The reaction mixture was heated to 55 °C and allowed to react protected from light for 5 days. After reaching 
room temperature, the precipitate was filtrated through celite and rinsed with toluene. Toluene was evaporated in vacuo, 
and the residue was purified by flash column chromatography (ethyl acetate : heptane 10-50%) to afford the pure 
product, 17-38%. 
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General method C 
Acetylated precursor 5,7,9 or 11 was dissolved in MeOH and K2CO3 (0.3 eq) was added. The solution was left to stir 
until no starting material was observed via TLC. After filtration, the volatiles were removed in vacuo. The residue was 
dissolved in DMF, cooled to 0 °C and NaH (5eq) (60% in mineral oil) was added in portions. BnBr was added and the 
mixture was left to warm to RT overnight. The mixture was quenched with MeOH and the volatiles were removed in 
vacuo. The residue was dissolved in EtOAc and washed with sat. NaHCO3 and brine (x2), dried with MgSO4, filtered and 
concentrated in vacuo. The residue was purified using flash column chromatography (0-40% EtOAC-Heptane) affording 
the pure product. 
 
General method D 
Allyl glycoside (5-12) (1 eq) was dissolved in a mixture of DCM and AcOH (10:1) and Pd(PPh3)4 (0.3 eq) was added. 
The mixture was left to stir for 1h after which the volatiles were removed in vacuo. The residue was purified using flash 
column chromatography (0-20% EtOAc – Heptane), affording the pure product. The anomeric alcohol was dissolved in 
dry DCM (0.1 molar) and cooled to 0 °C under inert conditions. 1,8-Diazabicyclo[5.4.0]undeC-7-ene (1,5 eq) and 2,2,2-
trifluoro-N-phenylacetimidoyl chloride (1.1 eq) were added and left to stir for 2h. The volatiles were removed in vacuo 
and the residue was purified using flash column chromatography (10-50% EtOAc – Heptane) affording the pure products. 
 
General method E 
Glycosyl imidate (2 eq, (13-20)) was dissolved in dry DCM under inert conditions and 4Å MS were added. The mixture 
was cooled to -78 °C and triflic acid (2 eq) was added. When the starting material had been completely consumed, a 
precooled mixture of acceptor 21 (1eq) or 22 (1eq), 4Å MS and 2,6-di-tert-butyl-4-methylpyridine (4 eq) in dry DCM 
was added and the mixture was left to warm to RT overnight. The suspension was filtered, diluted in DCM and extracted 
with a sat. NaHCO3 solution and brine, dried (MgSO4), filtered and concentrated in vacuo. The residue was purified using 
silica flash column chromatography (10-50% EtOAc – heptane, v/v) affording the pure products. 
 
Allyl 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-glucopyranoside (5) 
3 (560 mg, 1.62 mmol) via protocol A afforded 5 (47%). 1H-NMR (500 MHz, CDCl3) δ 7.35-7.23 
(m, 4H), 7.17-7.13 (m, 1H), 5.98-5.89 (m, 1H), 5.29 (ddd, J = 17.2, 3.0, 1.5 Hz, 1H), 5.20 (ddd, 
J = 10.4, 2.6, 1.2 Hz, 1H), 5.07 (t, J = 9.3 Hz, 1H, H-3), 4.99 (t, J = 9.7 Hz, 1H, H-4), 4.37-4.32 
(m, 1H), 4.34 (d, J = 7.5 Hz, 1H, H-1), 4.27 (dd, J = 12.2, 4.9 Hz, 1H, H-6), 4.11 (dt, J = 9.7 Hz, 
1H), 4.10 (dd, J = 12.1, 2.1 Hz, 1H, H-6), 3.66 (dd, J = 9.0, 7.6 Hz, 1H, H-2), 3.65-3.62 (m, 1H, H-5), 3.09 (d, J = 
12.6 Hz, 1H), 3.05 (d, J = 12.6 Hz, 1H), 2.08 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.31 (s, 3H), 1.26 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 170.70, 169.90 (x2), 169.76(x2), 137.87, 133.56, 128.99, 128.76, 125.67, 118.11, 102.03 (C-1), 
78.24, 74.39 (C-3), 72.61 (C-2), 71.45 (C-5), 70.99, 68.93 (C-4), 62.20 (C-6), 46.55, 26.44, 25.93, 21.01, 20.76, 
20.67. HRMS (m/z) calcd for C25H34O9S [M + Na]+ 533.1821, found 533.1832. 
 
Allyl 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-glucopyranoside (6) 
5 (0.71 mg, 1.38 mmol) via protocol C afforded 6 (807 mg, 89 %). 1H NMR (500 MHz, CDCl3) δ 
7.38 – 7.18 (m, 17H), 7.15 – 7.07 (m, 3H), 5.96 (dddd, J = 17.2, 10.4, 6.3, 5.4 Hz, 1H), 5.28 (dq, 
J = 17.2, 1.6 Hz, 1H), 5.17 (dq, J = 10.4, 1.3 Hz, 1H), 4.95 (d, J = 11.2 Hz, 1H), 4.84 (d, J = 11.1 
Hz, 1H), 4.77 (d, J = 10.8 Hz, 1H), 4.61 (d, J = 12.2 Hz, 1H), 4.54 (d, J = 12.2 Hz, 1H), 4.51 (d, 
J = 10.8 Hz, 1H), 4.37 (ddt, J = 12.5, 5.5, 1.5 Hz, 1H), 4.28 (d, J = 7.4 Hz, 1H, H-1), 4.09 (ddt, J = 12.5, 6.3, 1.3 Hz, 
1H), 3.72 (dd, J = 10.7, 2.1 Hz, 1H, H-6), 3.66 (dd, J = 10.7, 4.8 Hz, 1H, H-6’), 3.59 (t, J = 8.9 Hz, 1H, H-2), 3.58 (t, 
J = 8.9 Hz, 1H, H-4), 3.48 (t, 9.0 Hz, 1H, H-3), 3.44 (ddd, J = 9.8, 4.8, 2.1 Hz, 1H, H-5), 3.19 (d, J = 12.5 Hz, 1H), 
3.10 (d, J = 12.5 Hz, 1H), 1.34 (s, 3H), 1.32 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 138.55, 138.15, 138.11, 138.00, 
134.10, 128.72 (x2), 128.66 (x2), 128.35 (x2), 128.34 (x2), 128.32 (x2), 127.91 (x2), 127.79 (x2), 127.72, 127.60, 
127.38, 127.34 (x2), 125.38, 117.54, 102.26, 84.94, 78.41, 78.00, 75.82, 74.92, 74.79, 74.77, 73.47, 70.68, 68.92, 
46.33, 26.72, 26.15. HRMS (m/z) calcd for C40H46O6S [M + Na]+ 677.2913, found 677.2905. 
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Allyl 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-β-D-galactopyranoside (7) 
4 (0.79 g, 3.33 mmol) via protocol A afforded 7 (52%). 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.21 
(m, 4H), 7.14 (ddt, J = 7.9, 6.8, 1.3 Hz, 1H), 5.95 (dddd, J = 17.3, 10.4, 6.3, 5.5 Hz, 1H), 5.37 (dd, 
J = 3.4, 1.2 Hz, 1H, H-4), 5.30 (dq, J = 17.1, 1.6 Hz, 1H), 5.20 (dq, J = 10.4, 1.3 Hz, 1H), 4.83 (dd, 
J = 9.9, 3.4 Hz, 1H, H-3), 4.37 (ddt, J = 12.5, 5.6, 1.4 Hz, 1H), 4.33 (d, J = 7.6 Hz, 1H), 4.17 (dd, 
J = 11.2, 6.6 Hz, 1H), 4.14-4.09 (m, 1H), 4.10 (dd, J = 11.3, 7.0 Hz, 1H), 3.85 (dd, J = 6.8, 1.2 Hz, 1H, H2), 3.83 (dd, 
J = 9.7, 7.7 Hz, 1H, H-5) 3.11 (d, J = 12.6 Hz, 1H), 3.07 (d, J = 12.6 Hz, 1H), 2.13 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H), 
1.32 (s, 3H), 1.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.41, 170.22, 169.91, 137.97, 133.60, 128.81 (x2), 128.74 
(x2), 125.60, 118.07, 102.35, 77.95, 72.64, 71.09, 70.32, 69.68, 67.68, 61.40, 46.59, 26.26, 26.21, 20.84, 20.71, 
20.69. HRMS (m/z) calcd for C25H34O9S [M + Na]+ 533.1821, found 533.1835. 
 
Allyl 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-β-D-galactopyranoside (8) 
7 (0.75 g, 1.47 mmol) via protocol C afforded 8 (0.77 g, 80%). 1H NMR (500 MHz, CDCl3) δ 7.38 – 
7.17 (m, 19H), 7.13 – 7.08 (m, 1H), 5.93 (dddd, J = 17.3, 10.4, 6.3, 5.4 Hz, 1H), 5.25 (dq, J = 
17.2, 1.6 Hz, 1H), 5.13 (dq, J = 10.4, 1.3 Hz, 1H), 4.89 (d, J = 11.6 Hz, 1H), 4.72 (d, J = 11.7 Hz, 
1H), 4.67 (d, J = 11.7 Hz, 1H), 4.58 (d, J = 11.6 Hz, 1H), 4.46 (d, J = 11.7 Hz, 1H), 4.41 (d, J = 
11.8 Hz, 1H), 4.35 (ddt, J = 12.5, 5.4, 1.5 Hz, 1H), 4.24 (d, J = 7.6 Hz, 1H, H-1), 4.05 (ddt, J = 12.5, 6.3, 1.4 Hz, 1H), 
3.97 (dd, J = 9.6, 7.5 Hz, 1H, H-2), 3.87 (dd, J = 2.7, 1.1 Hz, 1H, H-4), 3.58 (d, J = 6.3 Hz, 2H, H-6), 3.55 – 3.48 (m, 
1H, H-5), 3.35 (dd, J = 9.6, 2.7 Hz, 1H, H-3), 3.18 (d, J = 12.5 Hz, 1H), 3.14 (d, J = 12.5 Hz, 1H), 1.35 (s, 3H), 1.33 
(s, 3H).
 
13C NMR (126 MHz, CDCl3) δ 138.68, 138.31, 138.28, 137.94, 134.24, 128.64 (x2), 128.54 (x2), 128.41 (x2), 
128.36 (x2), 128.23 (x2), 128.12 (x2), 127.85 (x2), 127.76, 127.58 (x2), 127.54, 127.48, 125.25, 117.32, 102.52, 
82.53, 77.95, 74.47, 73.62, 73.55, 73.37, 73.11, 71.92, 70.57, 68.94, 46.12, 26.56, 26.26. HRMS (m/z) calcd for 
C40H46O6S [M + Na]+ 677.2913, found 677.2906. 
 
Allyl 3,4,6-tri-O-acetyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranoside (9) 
3 (1.80 g, 5.20 mmol) via protocol B afforded 9 (0.48 g, 19%). 1H NMR (500 MHz, CDCl3) δ 7.36 
– 7.25 (m, 8H), 7.23 – 7.16 (m, 2H), 5.96 – 5.84 (m, 2H), 5.41 (t, J = 9.7 Hz, 1H), 5.36 – 5.31 
(m, 1H), 5.29 (dq, J = 17.3, 1.6 Hz, 1H), 5.25 – 5.18 (m, 2H), 5.12 (t, J = 9.5 Hz, 1H), 5.02 – 
4.97 (m, 2H), 4.44 (d, J = 7.8 Hz, 1H), 4.36 (ddt, J = 12.8, 5.2, 1.5 Hz, 1H), 4.27 (ddd, J = 12.3, 
4.7, 3.0 Hz, 2H), 4.20 (ddt, J = 12.9, 5.2, 1.5 Hz, 1H), 4.15 – 3.97 (m, 5H), 3.79 – 3.61 (m, 4H), 3.52 (dd, J = 10.0, 
3.6 Hz, 1H), 3.31 (dd, J = 9.6, 7.8 Hz, 1H), 3.08 – 3.01 (m, 3H), 2.09 (s, 3H), 2.08 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 
2.01 (s, 3H), 2.00 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.67, 170.63, 170.18, 170.02, 169.84, 169.69, 135.92, 
135.60, 133.41, 133.20, 129.52, 129.27, 129.01, 128.95, 126.37, 126.16, 118.53, 117.84, 101.98, 95.44, 79.82, 
78.08, 73.74, 71.75, 71.54, 71.26, 70.53, 69.95, 68.72, 68.65, 68.58, 67.35, 62.07, 61.99, 52.97, 33.41, 20.86, 20.74, 
20.73, 20.66, 20.65. HRMS (m/z) calcd for C23H30O9S [M + Na]+ 505.1508, found 505.1508. 
 
Allyl 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranoside (10) 
 9 (0.74 g, 0.97 mmol) via protocol C afforded 10 (0.51 g, 84%). 1H NMR (500 MHz, CDCl3) δ 
7.37 – 7.21 (m, 17H), 7.21 – 7.10 (m, 3H), 5.97 – 5.84 (m, 1H), 5.29 (ddq, J = 17.4, 14.7, 1.6 
Hz, 1H), 5.22 – 5.11 (m, 1H), 4.99 (d, J = 3.6 Hz, 1H), 4.94 (dd, J = 10.9, 5.1 Hz, 1H), 4.84 – 
4.76 (m, 2H), 4.68 – 4.44 (m, 3H), 4.40 – 4.32 (m, 2H), 4.22 – 4.13 (m, 1H), 4.13 – 4.03 (m, 
2H), 3.94 (t, J = 9.3 Hz, 1H), 3.91 – 3.62 (m, 4H), 3.60 – 3.52 (m, 1H), 3.49 – 3.40 (m, 1H), 3.31 – 3.25 (m, 1H), 
3.15 – 3.08 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 138.83, 138.59, 138.21, 138.16, 138.09, 137.96, 134.00, 133.70, 
129.46, 129.38, 129.07, 128.99, 128.93, 128.90, 128.42, 128.40, 128.38, 128.36, 128.33, 128.30, 128.00, 127.96, 
127.95, 127.91, 127.89, 127.88, 127.79, 127.76, 127.73, 127.70, 127.65, 127.63, 127.61, 127.57, 126.25, 125.97, 
118.31, 117.30, 102.30 (β-C-1), 95.43 (α-C-1), 84.58, 82.88, 81.85, 81.17, 77.79, 77.64, 75.79, 75.68, 75.11, 75.01, 
73.47, 71.28, 70.29, 69.92, 68.91, 68.42, 68.19, 33.48, 33.44. HRMS (m/z) calcd for C38H42O6S [M + Na]+ 649.2600, 
found 649.2590. 
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Allyl 3,4,6-tri-O-acetyl-2-O-(2-(phenylthio)ethyl)-α/β-D-galactopyranoside (11) 
4 (100 mg, 0.29 mmol) via protocol B afforded 11 (52 mg, 37%). 1H NMR (500 MHz, CDCl3) δ 7.36 
– 7.25 (m, 4H), 7.20 – 7.16 (m, 1H), 5.90 (dddd, J = 17.2, 10.5, 6.0, 5.3 Hz, 1H), 5.35 (dd, J = 
3.4, 0.9 Hz, 1H, H-4), 5.30 (dq, J = 17.3, 1.6 Hz, 1H), 5.20 (ddd, J = 10.5, 2.7, 1.3 Hz, 1H), 4.92 
(dd, J = 10.2, 3.5 Hz, 1H, H-3), 4.43 (d, J = 7.7 Hz, 1H, H-1), 4.38 (ddt, J = 12.8, 5.3, 1.5 Hz, 1H), 
4.18 – 4.06 (m, 3H, H-6, H-6), 4.00 (ddd, J = 10.3, 7.3, 6.1 Hz, 1H), 3.83 (td, J = 6.8, 1.0 Hz, 1H, H-5), 3.76 (tdd, J 
= 10.1, 7.2, 4.7 Hz, 1H), 3.49 (dd, J = 10.2, 7.7 Hz, 1H, H-2), 3.12 – 3.01 (m, 2H), 2.13 (s, 3H), 2.04 (s, 3H), 2.00 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.36, 170.13, 170.04, 136.10, 133.47, 129.05 (x2), 128.89 (x2), 126.02, 
117.78, 102.30, 77.09, 72.09, 71.48, 70.57, 70.39, 67.34, 61.33, 33.33, 20.71, 20.67, 20.65. HRMS (m/z) calcd for 
C23H30O9S [M + Na]+ 505.1508, found 505.1515. 
 
Allyl 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-galactopyranoside (12) 
11 (0.47 g, 0.97 mmol) via protocol B afforded 12 (0.37 g, 59%). 1H NMR (500 MHz, CDCl3) δ 7.70 
– 7.64 (m, 1H), 7.57 – 7.52 (m, 1H), 7.50 – 7.44 (m, 1H), 7.41 – 7.13 (m, 17H), 5.96 – 5.86 (m, 
1H), 5.60 (d, J = 4.3 Hz, 1H), 5.57 (d, J = 4.3 Hz, 1H), 5.53 – 5.47 (m, 1H), 5.38 – 5.32 (m, 1H), 
5.29 (dq, J = 17.2, 1.6 Hz, 1H), 5.21 – 5.15 (m, 1H), 4.99 (d, J = 3.5 Hz, 1H), 4.93 (d, J = 4.7 Hz, 
1H), 4.91 (d, J = 4.8 Hz, 1H), 4.82 (d, J = 2.2 Hz, 1H), 4.79 (d, J = 2.7 Hz, 1H), 4.70 (d, J = 3.3 Hz, 1H), 4.68 (d, J = 
3.6 Hz, 1H), 4.63 – 4.36 (m, 12H), 4.23 – 3.76 (m, 13H), 3.70 – 3.52 (m, 4H), 3.17 – 3.06 (m, 2H). 13C NMR (126 
MHz, CDCl3) δ 138.79, 138.64, 138.40, 138.13, 137.99, 137.90, 133.91, 132.15, 132.07, 131.96, 131.94, 129.31, 
128.93, 128.56, 128.55, 128.47, 128.45, 128.40, 128.39, 128.29, 128.24, 128.21, 128.04, 128.01, 127.98, 127.96, 
127.87, 127.86, 127.75, 127.72, 127.67, 127.64, 127.58, 127.55, 127.52, 127.49, 127.43, 126.08, 118.09, 104.27, 
103.68, 100.66, 97.64, 96.08, 85.53, 81.38, 79.85, 78.84, 78.77, 77.84, 77.59, 77.49, 75.13, 74.81, 74.41, 73.46, 
73.21, 72.88, 72.84, 72.74, 72.64, 72.44, 71.56, 71.46, 71.40, 71.36, 70.14, 69.55, 69.43, 68.97, 68.24, 68.22, 68.15, 
33.35. HRMS (m/z) calcd for C38H42O6S [M + Na]+ 649.2600, found 649.2582 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-
gluco-pyranoside (13): 5 (310 mg, 0.66 mmol) via protocol D afforded 13 (0.39 g, 88%). 1H NMR (500 MHz, CDCl3) 
δ 7.37 – 7.09 (m, 8H), 6.81 (d, J = 7.5 Hz, 2H), 6.54 (br, 1H, H-1), 5.37 (t, J = 9.7 Hz, 1H, H-
3), 5.12 (t, J = 9.9 Hz, 1H, H-4), 4.33 (dd, J = 12.3, 3.7 Hz, 1H, H-6), 4.21 – 4.08 (m, 2H, H-2, 
H-6), 3.93 (d, J = 7.0 Hz, 1H, H-5), 3.08 (d, J = 12.9 Hz, 1H), 3.02 (d, J = 12.9 Hz, 1H), 2.11 
(s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 1.32 (s, 3H), 1.30 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
170.55, 169.78, 169.73, 143.29, 137.31, 129.23 (x2), 128.87 (x2), 128.78 (x2), 125.99 (x2), 124.36, 119.37, 77.91, 
71.15, 69.80, 69.59, 68.04, 61.52, 46.43, 25.52, 25.25, 20.92, 20.72, 20.65. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-
gluco-pyranoside (14): 6 (0.71 g, 1.38 mmol) via protocol D afforded 14 (0.81 g, 89%). 1H NMR (500 MHz, CDCl3) 
δ 7.47 – 7.01 (m, 21H), 6.88 – 6.75 (m, 4H), 6.52 (br, 1H, α-H-1), 5.55 (br, 1H, β-H-1), 5.01 
– 4.77 (m, 3H), 4.76 – 4.37 (m, 9H), 4.22 – 3.49 (m, 9H), 3.46 – 3.29 (m, 1H), 3.19 – 3.01 
(m, 2H), 1.40 – 1.25 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 143.64, 138.58, 138.49, 138.45, 
138.40, 137.99, 137.93, 137.88, 137.81, 137.78, 137.76, 128.92, 128.91, 128.78, 128.76, 
128.69, 128.66, 128.59, 128.41, 128.38, 128.36, 128.34, 128.26, 128.24, 128.12, 127.98, 127.88, 127.85, 127.78, 
127.76, 127.68, 127.65, 127.64, 127.60, 127.48, 127.45, 125.69, 125.57, 125.52, 124.01, 119.30, 82.04, 78.27, 
77.61, 77.09, 75.80, 75.30, 75.05, 75.00, 74.65, 74.33, 73.53, 73.47, 73.44, 73.38, 73.32, 73.13, 72.98, 72.18, 70.33, 
68.73, 68.41, 68.28, 68.00, 46.65, 45.95, 26.16, 25.99, 25.84, 24.85. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-
galacto-pyranoside (15): 7 (296 mg, 0.63 mmol) via protocol D afforded 15 (96 %). 1H NMR 
(500 MHz, CDCl3) δ 7.40 – 6.94 (m, 8H), 6.83 (d, J = 7.6 Hz, 2H), 6.54 (br, 1H, H-1), 5.54 (d, J 
= 3.1 Hz, 1H, H-4), 5.20 (dd, J = 10.5, 3.3 Hz, 1H, H-3), 4.36 (s, 1H, H-2), 4.21 – 4.08 (m, 3H, 
H-5, H-6, H-6), 3.09 (d, J = 12.9 Hz, 1H), 3.04 (d, J = 12.9 Hz, 1H), 2.16 (s, 3H), 2.06 (s, 3H), 
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2.02 (s, 3H), 1.32 (s, 4H), 1.31 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 170.36, 169.95, 169.76, 137.39, 129.10 (x2), 
128.87 (x2), 128.82, 128.78 (x2), 128.75, 125.96, 124.30, 119.41, 119.11, 77.75, 68.88, 68.70, 68.04, 65.99, 61.35, 
46.24, 25.73, 25.13, 20.77, 20.68, 20.64. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-
galacto-pyranoside (16): 8 (0.69 g, 1.13 mmol) via protocol D afforded 16 (0.63g 71%). 1H NMR (500 MHz, CDCl3) 
δ 7.91 (s, 1H), 7.58 – 7.52 (m, 2H), 7.44 – 7.17 (m, 18H), 7.17 – 7.03 (m, 2H), 6.85 – 6.72 (m, 
2H), 5.55 (br, 1H, β-H-1), 4.88 (d, J = 11.5 Hz, 1H), 4.73 – 4.65 (m, 2H), 4.58 (d, J = 11.4 Hz, 
1H), 4.48 (d, J = 11.7 Hz, 1H), 4.41 (d, J = 11.7 Hz, 1H), 4.22 – 4.12 (m, 1H), 3.94 – 3.88 (m, 
1H), 3.68 – 3.58 (m, 2H), 3.39 (s, 1H), 3.15 (d, J = 12.6 Hz, 1H), 3.11 (d, J = 12.7 Hz, 1H), 1.35 
(s, 6H). 13C NMR (126 MHz, CDCl3) δ 143.63, 138.39, 137.98, 137.87, 137.76, 135.01, 129.33, 128.92, 128.90, 128.69, 
128.59, 128.41, 128.37, 128.34, 128.24, 128.12, 127.88, 127.76, 127.68, 127.65, 127.64, 126.34, 125.52, 124.02, 
120.45, 119.29, 96.90 (C-1), 82.02, 78.26, 74.64, 74.34, 73.43, 73.32, 73.12, 70.33, 68.29, 46.64, 26.15, 25.83. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-acetyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranoside 
(17): 9 (0.47mg, 0.97 mmol) via protocol D afforded 17 (0.45 g, 75%). 1H NMR (500 MHz, 
CDCl3) δ 7.40 – 7.07 (m, 15H), 6.88 – 6.75 (m, 3H), 6.57 (br, 1H, α-H-1), 5.64 (br, 1H, β-H-
1) 5.42 (t, J = 9.7 Hz, 1H), 5.22 – 5.00 (m, 2H), 4.28 (td, J = 13.5, 13.1, 4.2 Hz, 2H), 4.21 – 
4.04 (m, 3H), 3.96 (dt, J = 10.2, 6.6 Hz, 1H), 3.89 – 3.80 (m, 1H), 3.76 (dt, J = 10.2, 6.9 Hz, 
1H), 3.73 – 3.64 (m, 2H), 3.61 – 3.51 (m, 1H), 3.06 (t, J = 6.6 Hz, 4H), 2.09 (s, 3H), 2.06 (s, 2H), 2.05 (s, 2H), 2.04 
(s, 4H), 2.04 (s, 1H), 2.02 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 170.54, 170.51, 169.98, 169.96, 169.71, 169.61, 
143.16, 143.04, 135.59, 135.44, 129.62, 129.56, 129.05, 129.02, 128.83, 128.79, 126.48, 126.42, 124.54, 119.30, 
119.13, 78.77, 77.31, 73.61, 72.43, 71.59, 71.37, 70.61, 69.98, 67.91, 67.77, 61.50, 33.51, 20.83, 20.80, 20.69, 
20.68, 20.62, 20.60. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranoside 
(18): 10 (0.47 g, 0.75 mmol) via protocol D afforded 18 (0.35 g, 61%). 1H NMR (500 MHz, 
CDCl3) δ 7.71 – 6.99 (m, 23H), 6.92 – 6.69 (m, 2H), 6.56 (br, 1H), 5.56 (br, 1H), 4.99 – 4.89 
(m, 1H), 4.86 – 4.75 (m, 2H), 4.61 (d, J = 12.1 Hz, 1H), 4.55 – 4.47 (m, 2H), 4.02 – 3.84 (m, 
2H), 3.82 – 3.40 (m, 5H), 3.13 – 3.05 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 138.28, 137.86, 
129.41, 129.30, 128.98, 128.93, 128.75, 128.68, 128.43, 128.40, 128.35, 127.99, 127.91, 127.83, 127.76, 127.73, 
127.68, 127.65, 126.26, 126.17, 124.27, 119.30, 84.26, 81.55, 80.35, 75.74, 75.71, 75.52, 75.32, 75.04, 73.48, 
73.38, 73.06, 71.60, 70.35, 67.94, 33.53. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-acetyl-2-O-(1-(phenylthio)ethyl)-α/β-D-
galactopyranoside (19): 11 (0.20 g, 0.41 mmol) via protocol D afforded 19 (0.15 g, 60%). 1H NMR (500 MHz, 
CDCl3) δ 7.38 – 7.09 (m, 16H), 6.88 – 6.76 (m, 4H), 6.59 (br, 1H, α-H-1), 5.65 (s, 1H), 5.51 (s, 
1H), 5.37 (s, 1H), 5.27 (dd, J = 10.6, 3.2 Hz, 1H), 4.96 (s, 1H), 4.33 (s, 1H), 4.17 – 4.04 (m, 
4H), 4.00 – 3.66 (m, 6H), 3.14 – 3.02 (m, 4H), 2.16 (s, 3H), 2.14 (s, 3H), 2.06 (s, 3H), 2.01 (s, 
6H), 2.00 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.33, 170.28, 170.02, 169.92, 169.88, 169.86, 
129.42, 129.28, 129.01, 128.99, 128.82, 128.78, 126.37, 126.28, 124.49, 124.43, 119.34, 119.11, 76.03, 73.76, 
72.08, 71.78, 71.50, 70.63, 69.21, 68.98, 67.70, 67.01, 61.36, 60.99, 33.40, 20.75, 20.69, 20.66, 20.64, 20.61. 
 
N-phenyl-2,2,2-trifluoroacetimidate 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-
galactopyranoside (20): 12 (0.25 g, 0.40 mmol) via protocol D afforded 20 (0.21 g, 69%). 1H NMR (500 MHz, 
CDCl3) δ 7.38 – 7.05 (m, 23H), 6.79 (d, J = 7.9 Hz, 2H), 5.57 (s, 1H), 4.91 (d, J = 11.5 Hz, 1H), 
4.73 (d, J = 11.8 Hz, 1H), 4.70 (d, J = 11.8 Hz, 1H), 4.59 (d, J = 11.5 Hz, 1H), 4.44 (d, J = 11.6 
Hz, 1H), 4.39 (d, J = 11.6 Hz, 1H), 3.97 (t, J = 6.9 Hz, 2H), 3.92 – 3.80 (m, 3H), 3.64 – 3.42 (m, 
3H), 3.12 (td, J = 6.9, 3.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 143.48, 138.30, 138.08, 137.69, 
136.06, 129.11 (x2), 128.90 (x2), 128.62(x2), 128.45(x2), 128.42, 128.39 (x2), 128.26(x2), 128.21(x2), 127.90(x2), 
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127.80, 127.74, 127.68, 127.56 (x2), 126.02, 124.12, 119.30, 81.64, 78.66, 74.72, 74.34, 73.46, 73.13, 73.02, 71.73, 
68.07, 33.42. 
 
Methyl 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzoyl-α-D-glucopyranoside (24): 13 (106 mg, 0.17 mmol) via protocol E afforded 24 as an anomeric mixture, 
3:1 (α/β) (137 mg, 87%). 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.81 (m, 7H), 7.55 – 7.10 (m, 
18H), 6.16 (t, J = 9.7 Hz, 1H), 5.42 (t, J = 9.9 Hz, 1H), 5.36 (t, J = 9.6 Hz, 1H), 5.27 – 5.19 
(m, 2H, α-H-1), 5.14 (d, J = 3.6 Hz, 1H, β-H-1), 5.04 (t, J = 9.2 Hz, 1H), 4.99 (t, J = 9.7 Hz, 
1H), 4.93 (t, J = 9.7 Hz, 1H), 4.89 (d, J = 3.4 Hz, 1H, α-H-1`), 4.42 – 4.31 (m, 2H, α-H-1`), 
4.28 – 4.16 (m, 2H), 4.11 – 4.03 (m, 1H), 3.98 (ddd, J = 11.1, 7.4, 2.3 Hz, 1H), 3.88 (dd, J 
= 10.7, 7.9 Hz, 1H), 3.79 (dd, J = 11.1, 7.7 Hz, 1H), 3.70 (ddd, J = 13.7, 10.4, 2.6 Hz, 2H), 3.66 – 3.59 (m, 1H), 3.51 
(s, 3H), 3.44 (s, 3H), 3.14 (d, J = 12.7 Hz, 1H), 3.07 (d, J = 12.8 Hz, 1H), 3.04 (d, J = 12.9 Hz, 1H), 2.98 (d, J = 12.8 
Hz, 1H), 2.12 (s, 3H), 2.02 (s, 6H), 2.01 (s, 3H), 2.00 (s, 3H), 1.94 (s, 3H), 1.26 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
170.71, 170.62, 169.91, 169.86, 169.81, 169.77, 165.82, 165.76, 165.71, 165.44, 137.78, 137.40, 133.51, 133.47, 
133.34, 133.05, 129.92, 129.89, 129.85, 129.82, 129.63, 129.60, 129.19, 129.15, 129.10, 129.02, 129.00, 128.81, 
128.80, 128.73, 128.46, 128.44, 128.39, 128.24, 125.82, 125.76, 103.05 (α-C-1`), 98.82 (α-C-1’), 96.87 (α-C-1), 
96.61 (β-C-1), 78.39, 77.28, 74.32, 72.50, 72.20, 71.96, 71.40, 71.17, 70.59, 70.42, 70.24, 70.01, 69.71, 69.29, 
68.96, 68.87, 68.80, 68.75, 67.50, 67.34, 62.25, 62.08, 55.88, 55.66, 46.39, 46.18, 26.16, 25.96, 25.84, 25.69, 20.99, 
20.80, 20.69, 20.66, 20.55. HRMS (m/z) calcd for C50H54O17S [M + Na]+ 981.2979, found 981.2986. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzoyl-α-D-glucopyranoside (25): 14 (100 mg) via protocol E afforded 25 as an anomeric mixture, (α/β), (95 
mg, 82%). Product was isolated as an anomeric mixture 3:2 (α:β) 1H NMR (500 MHz, CDCl3) 
δ 8.01 – 7.82 (m, 6H), 7.55 – 7.05 (m, 33H), 6.16 (td, J = 9.9, 2.6 Hz, 1H), 5.48 (dt, J = 
48.4, 9.9 Hz, 1H), 5.28 – 5.20 (m, 1H), 5.18 (d, J = 3.6 Hz, 1H, H-1’), 5.15 (d, J = 3.5 Hz, 
1H, H-1’), 4.93 (dd, J = 11.2, 7.1 Hz, 1H), 4.89 (d, J = 3.3 Hz, 1H α-H-1), 4.81 (dd, J = 11.1, 
6.7 Hz, 1H), 4.73 (dd, J = 14.1, 11.0 Hz, 1H), 4.59 (d, J = 12.1 Hz, 1H), 4.49 (d, J = 11.1 
Hz, 1H), 4.44 (d, J = 9.9 Hz, 1H), 4.41 – 4.34 (m, 2H), 4.27 (d, J = 7.4 Hz, 1H. β-H-1), 4.02 (dd, J = 10.9, 2.1 Hz, 
1H), 3.93 – 3.81 (m, 2H), 3.79 – 3.73 (m, 1H), 3.71 – 3.60 (m, 2H), 3.63 – 3.51 (m, 2H), 3.45 (s, 3H), 3.43 (s, 3H), 
3.25 (d, J = 12.6 Hz, 1H), 3.12 (t, J = 11.8 Hz, 1H), 3.01 (d, J = 12.7 Hz, 1H) 1.36 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H), 
1.28 – 1.24 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 165.80, 165.76, 165.72, 165.42, 165.25, 138.83, 138.55, 138.06, 
138.01, 137.99, 137.88, 137.66, 133.31, 133.28, 133.27, 132.98, 129.89, 129.88, 129.84, 129.63, 129.61, 129.24, 
129.22, 129.06, 128.95, 128.91, 128.82, 128.75, 128.68, 128.36, 128.35, 128.31, 128.30, 128.29, 128.23, 128.21, 
128.18, 127.96, 127.85, 127.74, 127.68, 127.64, 127.55, 127.51, 127.38, 127.33, 127.30, 127.28, 125.60, 125.45, 
103.30 (β-C-1), 99.65 (α-C-1), 96.78(α-C-1’), 96.68 (α-C-1’), 84.79, 81.04, 78.15, 78.10, 77.80, 77.10, 75.73, 75.61, 
74.82, 74.80, 74.73, 74.68, 73.44, 73.40, 73.20, 72.24, 72.06, 70.62, 70.40, 70.21, 70.03, 69.63, 69.09, 68.90, 68.87, 
68.59, 68.26, 67.20, 55.80, 55.66, 46.20, 46.01, 26.38, 26.31, 26.24, 25.63. HRMS (m/z) calcd for C65H66O14S [M + 
Na]+ 1125.4071, found 1025.4086. 
 
Methyl 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-
tri-O-benzoyl-α-D-glucopyranoside (26): 15 (109 mg, 0.17 mmol) via protocol E afforded 26 as an anomeric 
mixture, 19:1 (α/β (75 mg, 91%). 1H NMR (500 MHz, CDCl3) δ 8.01 – 7.91 (m, 4H), 7.88 – 
7.82 (m, 2H), 7.54 – 7.45 (m, 2H), 7.43 – 7.11 (m, 12H), 6.16 (t, J = 9.8 Hz, 1H), 5.51 – 5.43 
(m, 2H, H-4 & H-4’), 5.26 (dd, J = 10.2, 3.7 Hz, 1H, H-2’), 5.22 (dd, J = 10.5, 3.2 Hz, 1H, H-
3), 5.21 (d, J = 3.6 Hz, 1H, H-1’), 4.93 (d, J = 3.4 Hz, 1H, H-1), 4.43 – 4.38 (m, 1H, H-5), 
4.36 (ddd, J = 9.8, 7.4, 1.6 Hz, 1H, H-5’), 4.12 (dd, J = 11.3, 5.8 Hz, 1H, H-6), 4.01 (d, J = 
7.2 Hz, 1H, H-2), 3.99 (dd, J = 10.5, 3.5 Hz, 1H, H-6), 3.89 (dd, J = 10.9, 7.4 Hz, 1H, H-6’), 3.72 (dd, J = 10.9, 1.7 
Hz, 1H, H-6’), 3.49 (s, 3H), 3.08 (d, J = 12.8 Hz, 1H), 3.02 (d, J = 12.8 Hz, 1H), 2.13 (s, 3H), 2.04 (s, 3H), 1.99 (s, 
3H), 1.28 (s, 3H), 1.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.50, 170.09, 169.75, 165.78, 165.71, 165.39, 137.53, 
133.41, 133.30, 133.01, 129.90 (x2), 129.82 (x2), 129.61 (x2), 129.18, 129.03, 128.91 (x2), 128.79 (x2), 128.41 
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(x2), 128.36 (x2), 128.21 (x2), 125.77, 99.50, 96.68, 77.15, 72.10, 70.47, 69.69, 69.03, 68.75, 68.62, 67.39, 67.11, 
66.44, 62.02, 55.65, 46.08, 25.97, 25.55, 20.81, 20.70, 20.64. HRMS (m/z) calcd for C50H54O17S [M + Na]+ 981.2979, 
found 981.2983. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-
tri-O-benzoyl-α-D-glucopyranoside (27): 20 (50 mg, 0.13 mmol) via protocol E afforded 27 as an anomeric 
mixture, 4:1 (α/β) (31 mg, 50%). 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.84 (m, 6H), 7.55 – 
7.06 (m, 29H), 6.14 (t, J = 9.8 Hz, 1H), 5.52 (t, J = 9.9 Hz, 1H), 5.24 (dd, J = 10.3, 3.7 Hz, 
1H), 5.13 (d, J = 3.7 Hz, 1H, α-H-1), 4.92 (d, J = 11.3 Hz, 1H), 4.86 (d, J = 3.3 Hz, 1H, α-H-
1’), 4.80 (d, J = 11.8 Hz, 1H), 4.66 (d, J = 11.9 Hz, 1H), 4.57 (d, J = 11.2 Hz, 1H), 4.43 (d, J 
= 11.9 Hz, 1H), 4.38 – 4.31 (m, 2H), 4.15 (dd, J = 10.1, 3.5 Hz, 1H), 4.04 (t, J = 6.6 Hz, 1H), 
3.96 – 3.91 (m, 1H), 3.87 (dd, J = 11.4, 7.0 Hz, 1H), 3.79 (dd, J = 10.1, 2.7 Hz, 1H), 3.74 (dd, J = 11.3, 2.1 Hz, 1H), 
3.51 – 3.42 (m, 2H), 3.40 (s, 1H), 3.38 (s, 3H), 3.17 (d, J = 12.7 Hz, 1H), 3.04 (d, J = 12.7 Hz, 1H), 1.32 (s, 4H), 
1.31 (s, 4H). 13C NMR (126 MHz, CDCl3) δ 165.77, 138.93, 138.77, 138.08, 133.28, 129.92, 129.87, 129.82, 129.64, 
129.29, 129.13, 128.99, 128.75, 128.73, 128.38, 128.35, 128.34, 128.24, 128.23, 128.16, 127.75, 127.75, 127.61, 
127.57, 127.57, 127.52, 127.37, 127.28, 125.47, 100.25 (α-C-1’), 96.72 (α-C-1), 77.56, 77.16, 75.66, 74.86, 73.28, 
73.23, 72.17, 70.67, 69.85, 69.66, 69.31, 68.83, 68.64, 67.45, 55.56, 45.65, 26.35, 25.56. HRMS (m/z) calcd for 
C65H66O14S [M + Na]+ 1125.4071, found 1025.4084. 
 
Methyl 3,4,6-tri-O-acetyl-2-O-(2-methyl-1-(phenylthio)propanyl)-α/β-D-galactopyranosyl-(1→4)-2,3,6-
tri-O-benzyl-α-D-glucopyranoside (28): 15 (100 mg, 0.16 mmol) via protocol E afforded 28 as an anomeric 
mixture, 16:1 (α/β) (90 mg, 63%). 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.19 (m, 19H), 7.15 – 
7.10 (m, 1H), 5.50 (d, J = 3.3 Hz, 1H, α-H-1), 5.38 (dd, J = 3.3, 1.6 Hz, 1H), 5.18 (dd, J = 
10.6, 3.2 Hz, 1H), 5.05 (d, J = 12.0 Hz, 1H), 4.87 (d, J = 12.0 Hz, 1H), 4.67 (d, J = 12.0 Hz, 
1H), 4.60 (d, J = 3.5 Hz, 1H, α-H-1’), 4.57 (s, 2H), 4.55 (d, J = 12.0 Hz, 1H), 4.23 (ddd, J = 
7.7, 6.3, 1.6 Hz, 1H), 4.06 – 4.03 (m, 2H), 4.00 (dd, J = 10.9, 7.4 Hz, 1H), 3.91 (ddd, J = 
11.0, 3.3, 1.8 Hz, 2H), 3.86 (dd, J = 10.9, 6.3 Hz, 1H), 3.76 – 3.71 (m, 1H), 3.62 (dd, J = 11.0, 2.0 Hz, 1H), 3.60 – 
3.56 (m, 1H), 3.35 (s, 3H), 2.95 (s, 2H), 2.11 (s, 3H), 1.99 (s, 3H), 1.90 (s, 3H), 1.15 (s, 3H), 1.14 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 170.23, 170.11, 169.79, 139.12, 137.94, 137.93, 137.74, 128.89, 128.72, 128.44, 128.39, 128.32, 
128.27, 128.13, 128.11, 127.97, 127.88, 127.58, 127.54, 127.35, 126.91, 126.58, 125.63, 97.95 (α-C-1), 97.67 (α-
C-1’), 81.18, 80.01, 77.51, 73.75, 73.47, 73.21, 72.64, 69.42, 68.89, 68.65, 68.27, 67.22, 66.52, 61.38, 55.22, 55.20, 
46.06, 25.82, 24.88, 20.86, 20.67, 20.58. HRMS (m/z) calcd for C50H60O14S [M + Na]+ 939.3601, found 939.3611. 
 
Methyl 3,4,6-tri-O-acetyl-2-O-benzyl-α/β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (29): 23 (40 mg, 0.07 mmol) via protocol E afforded 29 as an anomeric mixture, 5:1 (α/β), (29 
mg, 93%). 1H NMR (500 MHz, CDCl3) δ 8.03 – 7.91 (m, 4H), 7.89 – 7.82 (m, 2H), 7.60 – 
7.48 (m, 2H), 7.45 – 6.98 (m, 14H), 6.20 – 6.12 (m, 1H), 5.52 – 5.41 (m, 2H), 5.35 (ddd, J 
= 10.3, 6.9, 3.4 Hz, 1H), 5.27 – 5.20 (m, 2H, α-H-1`), 4.82 (d, J = 3.5 Hz, 1H, α-H-1), 4.71 
(d, J = 12.4 Hz, 1H), 4.57 (d, J = 12.3 Hz, 1H), 4.40 – 4.29 (m, 2H), 4.12 – 4.05 (m, 1H), 
3.96 (dd, J = 11.3, 7.2 Hz, 1H), 3.88 – 3.80 (m, 2H), 3.55 (dd, J = 10.8, 2.0 Hz, 1H), 3.49 
(s, 2H), 3.47 – 3.45 (m, 1H), 2.10 (s, 2H), 2.01 (s, 2H), 1.98 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 170.46, 170.12, 
169.93, 165.77, 165.73, 165.34, 138.11, 133.49, 133.32, 133.05, 129.92, 129.89, 129.87, 129.64, 129.17, 129.04, 
128.84, 128.46, 128.43, 128.38, 128.37, 128.28, 128.24, 127.85, 127.69, 97.27 (α-C-1`), 96.71 (α-C-1), 73.68, 
73.13, 72.09, 70.41, 69.62, 69.43, 68.69, 68.50, 66.66, 66.43, 62.02, 55.57, 20.79, 20.68, 20.65. HRMS (m/z) calcd 
for C47H48O17 [M + Na]+ 907.2789, found 907.2805. 
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Methyl 3,4,6-tri-O-acetyl-2-O-benzyl-α/β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (30): 23 (94 mg, 0.17 mmol) via protocol E afforded 30 as an anomeric mixture, 6:1 (α/β) (46 mg, 
66%). 1H NMR (500 MHz, CDCl3) δ 7.49 (dt, J = 7.5, 1.2 Hz, 2H), 7.37 – 7.19 (m, 16H), 7.16 
– 7.11 (m, 2H), 7.05 – 7.01 (m, 2H), 6.41 (d, J = 3.6 Hz, 0H), 5.77 (d, J = 3.7 Hz, 1H), 5.36 
(dd, J = 3.5, 1.9 Hz, 2H), 5.31 (dd, J = 3.3, 1.4 Hz, 1H), 5.28 – 5.21 (m, 4H), 5.00 (d, J = 
11.7 Hz, 1H), 4.82 (d, J = 16.0 Hz, 2H), 4.77 – 4.72 (m, 2H), 4.71 – 4.53 (m, 6H), 4.45 (s, 
2H), 4.42 (dd, J = 9.7, 5.9 Hz, 2H), 4.30 (dd, J = 11.4, 7.2 Hz, 2H), 4.12 – 4.02 (m, 4H), 3.97 – 3.91 (m, 2H), 3.90 – 
3.84 (m, 2H), 3.83 – 3.75 (m, 3H), 3.67 (dd, J = 11.0, 1.9 Hz, 1H), 3.57 (dd, J = 9.5, 3.5 Hz, 1H), 3.39 (s, 3H), 2.17 
(s, 3H), 2.09 (s, 3H), 2.07 (s, 3H), 2.05 (s, 3H), 1.94 (s, 3H), 1.91 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.54, 
170.35, 170.18, 170.14, 169.93, 139.09, 138.06, 137.87, 137.77, 134.89, 130.46, 128.53, 128.44, 128.39, 128.27, 
128.25, 128.23, 128.17, 128.14, 128.10, 128.06, 128.04, 127.97, 127.95, 127.91, 127.75, 127.67, 127.65, 127.60, 
127.52, 127.48, 127.35, 127.04, 126.54, 126.27, 124.21, 97.64, 97.29, 81.76, 80.19, 74.17, 73.37, 73.25, 73.14, 
69.55, 69.36, 69.13, 69.04, 68.94, 68.63, 68.34, 68.00, 66.60, 66.43, 62.82, 61.72, 61.55, 55.24, 20.91, 20.77, 20.67. 
HRMS (m/z) calcd for C47H54O14 [M + Na]+ 865.3411, found 865.3424. 
 
Methyl 3,4,6-tri-O-acetyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-
D-glucopyranoside (31): 17 (100 mg, 0.16 mmol) via protocol E afforded 31 as an anomeric mixture, 1:1 (α/β), (57 
mg, 75%). 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.92 (m, 5H), 7.89 – 7.83 (m, 2H), 7.57 – 
7.48 (m, 2H), 7.46 – 7.12 (m, 21H), 6.36 (d, J = 3.6 Hz, 1H), 6.16 (t, J = 9.5 Hz, 1H), 5.58 
(d, J = 8.2 Hz, 1H), 5.50 – 5.34 (m, 3H), 5.28 – 5.20 (m, 2H), 5.02 – 4.93 (m, 3H), 4.85 (d, 
J = 3.5 Hz, 1H), 4.46 (d, J = 7.8 Hz, 1H), 4.36 (ddd, J = 9.9, 7.5, 1.9 Hz, 1H), 4.32 – 4.17 
(m, 4H), 4.06 (ddt, J = 11.5, 9.2, 2.2 Hz, 2H), 3.89 (dd, J = 10.8, 7.6 Hz, 1H), 3.82 – 3.59 
(m, 6H), 3.51 (s, 4H), 3.43 (s, 2H), 3.09 – 2.99 (m, 5H), 2.09 (d, J = 0.5 Hz, 5H), 2.02 (s, 3H), 2.01 (s, 3H), 1.99 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 170.64, 170.61, 169.98, 169.95, 169.86, 169.82, 165.80, 165.70, 165.35, 135.59, 
133.52, 133.35, 133.07, 129.91, 129.87, 129.80, 129.63, 129.60, 129.52, 129.50, 129.44, 129.22, 129.13, 129.03, 
129.01, 128.98, 128.97, 128.93, 128.70, 128.46, 128.39, 128.24, 126.38, 126.36, 126.31, 126.13, 126.10, 104.14, 
103.39, 97.79, 96.83, 96.65, 96.45, 93.41, 89.15, 79.81, 79.71, 78.64, 78.24, 78.10, 73.91, 73.70, 73.62, 72.43, 
72.13, 71.91, 71.75, 71.60, 71.54, 71.51, 71.41, 71.36, 71.29, 71.14, 70.35, 70.24, 70.15, 69.67, 69.62, 68.75, 68.60, 
68.56, 68.53, 68.51, 67.96, 67.88, 67.44, 67.12, 66.75, 62.00, 61.97, 61.56, 57.36, 55.63, 55.61, 55.48, 33.44, 33.41, 
33.40, 33.38, 20.97, 20.86, 20.84, 20.74, 20.72, 20.68, 20.66, 20.64, 20.62, 20.60. HRMS (m/z) calcd for C48H50O17S 
[M + Na]+ 953.2666, found 953.2643. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-
D-glucopyranoside (32): 18 (100 mg, 0.13 mmol) via protocol E afforded 32 as an anomeric mixture, 3:2 (α/β) 
(51mg, 73%). 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.83 (m, 6H), 7.54 – 7.08 (m, 29H), 6.14 
(t, J = 9.9 Hz, 1H), 5.52 (dd, J = 10.3, 9.5 Hz, 1H), 5.24 (dd, J = 10.2, 3.7 Hz, 1H), 5.17 (d, 
J = 3.7 Hz, 1H, α-H-1’), 4.92 (d, J = 3.5 Hz, 1H, α-H-1), 4.86 (d, J = 11.0 Hz, 1H), 4.80 (d, 
J = 11.1 Hz, 1H), 4.72 (d, J = 11.0 Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.44 (d, J = 11.1 Hz, 
1H), 4.39 (d, J = 12.1 Hz, 1H), 4.32 (ddd, J = 9.8, 6.8, 2.2 Hz, 1H), 3.92 – 3.84 (m, 3H), 
3.82 – 3.75 (m, 2H), 3.70 – 3.60 (m, 3H), 3.53 (dd, J = 10.7, 2.1 Hz, 1H), 3.45 – 3.41 (m, 4H), 3.14 – 3.02 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 165.82, 165.76, 165.24, 138.77, 138.50, 137.92, 135.80, 133.33, 133.02, 129.92, 
129.90, 129.64, 129.37, 129.23, 129.05, 128.92, 128.39, 128.37, 128.35, 128.32, 128.24, 128.22, 127.89, 127.62, 
127.59, 127.48, 127.46, 126.14, 96.97 (α-C-1), 96.71 (α-C-1’), 81.42, 80.96, 77.50, 75.42, 74.76, 73.39, 72.18, 
70.56, 70.31, 69.93, 68.52, 68.20, 66.68, 55.61, 33.38. HRMS (m/z) calcd for C63H62O14S [M + Na]+ 1097.3758, found 
1097.3740.  
 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 52
Chapter 2
52
 
52 
Mehtyl 3,4,6-tri-O-acetyl-2-O-(1-(phenylthio)ethyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-
D-glucopyranoside (33): 19 (90 mg, 0.15 mmol) via protocol E afforded 33 as an anomeric mixture, 10:1 (α/β) 
(55mg, 81%). 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.93 (m, 4H), 7.87 – 7.82 (m, 2H), 7.55 – 
7.49 (m, 2H), 7.45 – 7.21 (m, 11H), 7.18 – 7.12 (m, 1H), 6.16 (dd, J = 10.2, 9.5 Hz, 1H), 
5.48 (dd, J = 10.4, 9.5 Hz, 1H), 5.43 (dd, J = 3.4, 1.3 Hz, 1H), 5.29 (dd, J = 10.6, 3.4 Hz, 
1H), 5.25 (dd, J = 10.2, 3.7 Hz, 1H), 5.21 (d, J = 3.7 Hz, 1H, α-H-1’), 4.99 (d, J = 3.5 Hz, 
1H, α-H-1), 4.41 – 4.30 (m, 2H), 4.10 (dd, J = 11.3, 5.8 Hz, 1H), 3.97 (dd, J = 11.3, 7.2 Hz, 
1H), 3.89 (dd, J = 10.9, 7.3 Hz, 1H), 3.81 – 3.71 (m, 3H), 3.67 (dd, J = 10.9, 2.0 Hz, 1H), 3.49 (s, 3H), 3.07 (ddd, J 
= 7.4, 6.5, 1.8 Hz, 2H), 2.12 (s, 3H), 2.02 (s, 3H), 1.96 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.48, 170.11, 169.87, 
165.78, 165.72, 165.36, 135.79, 133.50, 133.34, 133.06, 129.92, 129.91, 129.87, 129.63, 129.28, 129.15, 129.01, 
128.93, 128.78, 128.46, 128.39, 128.25, 126.21, 126.00, 97.19 (α-C-1), 96.73 (α-C-1’), 74.63, 72.05, 70.39, 70.16, 
69.63, 69.41, 68.62, 68.50, 66.70, 66.51, 62.00, 55.62, 33.31, 20.80, 20.70, 20.68. HRMS (m/z) calcd for C48H50O17S 
[M + Na]+ 953.2666, found 953.2650. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(1-(phenylthio)ethyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-
α-D-glucopyranoside (34): 20 (50 mg, 0.07 mmol) via protocol E afforded 34 as an anomeric mixture, 16:1 (α/β) 
(25 mg, 71%). 1H NMR (500 MHz, CDCl3) δ 8.05 – 7.79 (m, 6H), 7.58 – 7.05 (m, 29H), 6.12 
(t, J = 9.8 Hz, 1H), 5.52 (t, J = 9.9 Hz, 1H), 5.25 (dd, J = 10.3, 3.7 Hz, 1H), 5.12 (d, J = 3.7 
Hz, 1H, β-H-1’), 4.97 – 4.84 (m, 2H, β-H-1), 4.82 – 4.65 (m, 3H), 4.64 – 4.49 (m, 2H), 4.47 
– 4.23 (m, 5H), 4.05 – 3.72 (m, 6H), 3.72 – 3.40 (m, 5H), 3.35 (s, 2H), 3.21 – 2.98 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 165.76, 165.32, 138.69, 138.04, 133.33, 133.01, 129.92, 
129.82, 129.63, 129.23, 128.87, 128.82, 128.37, 128.36, 128.34, 128.31, 128.29, 128.28, 128.23, 128.22, 128.19, 
128.16, 128.12, 128.09, 128.05, 127.87, 127.83, 127.73, 127.66, 127.59, 127.54, 127.52, 127.51, 127.47, 127.43, 
127.38, 127.35, 125.99, 97.68 (α-C-1), 96.73 (α-C-1’), 78.16, 74.96, 74.78, 73.22, 72.75, 72.08, 70.63, 70.07, 69.58, 
69.26, 68.60, 68.39, 66.64, 55.44, 33.25. HRMS (m/z) calcd for C63H62O14S [M + Na]+ 1097.3758, found 1097.3790. 
 
Methyl 3,4,6-tri-O-acetyl-α/β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (35): 
26 (65 mg, 0.07 mmol) was dissolved in 2 ml dry DCM under inert conditions and 0.2 ml TFA 
was added. The mixture was left to stir for 1 h, after which the volatiles were removed. Silica 
flash column chromatography (40-80% EtOAC-heptane) afforded 35 as an anomeric mixture 
19:1 (α/β) (46 mg, 85%). 1H NMR (500 MHz, CDCl3) δ 8.01 – 7.93 (m, 4H), 7.89 – 7.83 (m, 
2H), 7.56 – 7.49 (m, 2H), 7.45 – 7.36 (m, 5H), 7.32 – 7.25 (m, 2H), 6.16 (t, J = 9.5 Hz, 1H), 
5.65 (t, J = 9.9 Hz, 1H), 5.42 (dd, J = 3.4, 1.2 Hz, 1H), 5.26 (d, J = 9.5 Hz, 2H, β-H-1’), 5.19 – 5.13 (m, 2H, β-H-1), 
4.31 – 4.23 (m, 2H), 4.05 (dd, J = 11.3, 5.9 Hz, 1H), 4.01 (dd, J = 11.3, 7.1 Hz, 1H), 3.93 (dd, J = 11.7, 4.9 Hz, 1H), 
3.80 (dd, J = 11.8, 2.0 Hz, 1H), 3.48 (s, 3H), 2.55 (d, J = 10.9 Hz, 1H), 2.14 (s, 3H), 2.08 (s, 3H), 1.95 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 170.66, 170.41, 170.16, 165.76, 165.38, 133.62, 133.38, 133.13, 129.93, 129.88, 129.67, 
129.04, 128.96, 128.66, 128.50, 128.40, 128.27, 98.559 (α-C-1’), 97.06 (α-C-1), 72.11, 70.66, 70.31, 68.96, 68.63, 
68.32, 67.20, 66.95, 65.59, 61.95, 55.79, 20.88, 20.65, 20.59. HRMS (m/z) calcd for C40H42O17 [M + Na]+ 817.2320, 
found 817.2334. 
 
Methyl 3,4,6-tri-O-acetyl-α/β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (36): 
28 (25 mg, 0.03 mmol) was dissolved in 2 ml dry DCM under inert conditions and 0.2 ml TFA 
was added. The mixture was left to stir for 1 h, after which the volatiles were removed. Silica 
flash column chromatography (40-80% EtOAC-heptane) afforded 36 as an anomeric mixture 
16:1 (α/β) (11 mg, 54%) 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.24 (m, 15H), 5.35 (dd, J = 3.3, 
1.3 Hz, 1H), 5.22 (d, J = 3.6 Hz, 1H), 5.11 (d, J = 10.7 Hz, 1H), 5.05 (dd, J = 10.6, 3.2 Hz, 
1H), 4.73 (d, J = 10.8 Hz, 1H), 4.70 (d, J = 12.0 Hz, 1H), 4.64 – 4.49 (m, 4H), 4.24 (td, J = 6.6, 1.4 Hz, 1H), 4.04 – 
3.95 (m, 3H), 3.93 – 3.80 (m, 3H), 3.72 – 3.65 (m, 2H), 3.60 (dd, J = 9.5, 3.5 Hz, 1H), 3.54 (d, J = 11.7 Hz, 1H), 
3.38 (s, 3H), 2.09 (s, 3H), 2.00 (s, 3H), 1.99 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.63, 170.32, 170.14, 137.78, 
137.53, 137.32, 128.55, 128.34, 128.30, 128.24, 128.18, 128.13, 127.80, 127.64, 127.61, 101.50, 97.82, 80.43, 
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80.11, 78.13, 75.58, 73.28, 73.13, 70.57, 70.09, 68.17, 68.09, 67.82, 67.56, 61.93, 55.42, 29.68, 20.83, 20.68, 20.61. 
HRMS (m/z) calcd for C40H48O14 [M + Na]+ 775.2942, found 775.2943. 
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Abstract: To date, a general and reliable glycosylation procedure for α-glucosides remains 
elusive. In this respect, the application of neighboring group participation (NGP) of C-2 chiral 
auxiliaries has greatly improved the α-selectivity, but the synthetic effort is extensive. This 
chapter reports a novel four-step synthesis to produce either an α-, or β-directing donor using 
a C-2 stereo-directing group. In addition, an important factor to obtain good stereoselectivity is 
the protecting groups on glycosyl donors. Benzylic protecting groups tend to diminish α-
selectivity and investigation of the negative inductive effect of substituted benzyl protecting 
groups on the stereoselectivity revealed that the 2,4-dichlorobenzyl protecting group provided 
much improved α-selectivity. 
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3.1 – Introduction 
 
The main challenge of chemical oligosaccharide synthesis is the stereoselective synthesis of the 
glycosidic bond.[1] A unified methodology that allows for a late stage introduction of a stereo-
directing group (1,2-trans and 1,2-cis linkages) would enable the use of standardized 
monosaccharide building blocks. Unfortunately, this generally applicable methodology is still 
missing. 1,2-trans Glycosides can be synthesized by exploiting neighboring group participation 
of a C-2 acyl group, whereas previous research summarized in Chapter 1[2] and Chapter 2[3], 
exemplify that the stereoselective synthesis of 1,2-cis glycosidic linkages can be accomplished 
using a β-sulfonium intermediate. The use of a C-2 acyl group to provide 1,2-trans linkages is 
very stereoselective and applicable to manno- and gluco-type sugars. In contrast, the use of β-
sulfonium ions to prepare 1,2-cis-linkages does not always ensure good stereoselectivity. Critical 
determinants in this respect are the structure of the auxiliary and the protecting groups on the 
glycosyl donor. Furthermore, the introduction of the (chiral) auxiliary is quite laborious and takes 
place at an early stage in the building block synthesis using current methodology. In theory, the 
β-sulfonium ion intermediate can be prepared by making three disconnections, two of which 
have been explored (Scheme 1). In 2005, Boons et al. pioneered the formation of the β-
sulfonium ion intermediate (1) by using a 2-O-(S)-(phenylthiomethyl)benzyl ether participating 
group and an anomeric imidate leaving group (2, Scheme 1).[1a, 4]  
 
 
Scheme 1: Retrosyntheses of the β-sulfonium ion. 
 
Turnbull et al. subsequently reported the synthesis of a prearranged bicyclic oxathiane 
intermediate (3) that could be activated by oxidation and subsequent electrophilic aromatic 
substitution to afford β-sulfonium ion intermediate 1.[5] The third, so far unexplored 
disconnection is the bond between the sulfur and the auxiliary skeleton. This disconnection 
would yield a thioglycoside precursor which is a frequently used anomeric protecting/leaving 
group and would allow for late stage introduction of the C-2 auxiliary. The use of an ethylene 
glycol derived auxiliary was explored because it is the simplest achiral auxiliary that could yield 
a β-sulfonium ion. Furthermore, Fairbanks et al. reported full α-selectivity using a very similar 
armed 3,4,6-tribenzylated donor (8) utilizing an achiral auxiliary carrying a 2,4,6-
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trimethoxythiophenyl (STMP) moiety (Scheme 2b).[6] This result was intriguing since we only 
obtained an α/β ratio of 3/2 using donor 4d which only differs in the thiophenyl moiety (Scheme 
2a). Hence, we set out to explore the possibility to generate 6d from precursor 4d by triflation 
which would greatly streamline donor synthesis. In addition, we systematically investigated the 
contribution of the thiophenyl moiety as this was the only difference between our donor (4d) 
and the one reported by Fairbanks et al. (8). To this end, we prepared a series of thioglycoside 
precursors with increasingly electron-donating thiophenyl moieties, id est 4-methoxyphenyl 
(PMP), 2,6-dimethoxyphenyl (DMP) and 2,4,6-trimethoxyphenyl (TMP). 
 
 
Scheme 2: Syntheses of the β-sulfonium ion via a) This manuscript, Chapter 2; b) Fairbanks’ donor; c) this study. 
Reagents and conditions: i) 1) TfOH, DCM, -78°C – 0°C, 2) ROH, DTBMP, DCM, -78°C – rt; ii) 1) TMSOTf (1 eq), DCM, 
-78°C to 0°C, 2) ROH (1.2 eq), TTBP (2 eq) -78°C to rt, 16h; iii) 1) Tf2O (1.5 eq), DTBMP (4 eq), DCM, -40°C to 0°C, 
30 min, 2) ROH (1.2 eq), -78°C to rt, 16h. DTBMP = 2,6-di-tert-butyl-4-methylpyridine, TTBP = 2,4,6-tri-tert-
butylpyrimidine. 
 
3.2 – Donor synthesis I 
 
To prepare a series of glycosyl donors, we used a simple and efficient three step synthesis 
starting from commercially available D-glucal (8). Introduction of the benzyl protecting groups 
was achieved using standard conditions to provide glucal 10 in an excellent 98% yield. Next, a 
combination of NaHCO3, H2O, oxone and acetone was used to generate dimethyldioxirane 
(Murray’s reagent) in situ and epoxidation of 10 resulted in a 1,2-cis configured epoxide.[7] 
Notably, the reaction had to remain basic and hence solid NaHCO3 was added occasionally to 
keep the reaction going. After a simple work-up, consisting of extraction of the water layer with 
DCM and concentration of the combined organic layers in vacuo, the epoxide was opened with 
ZnCl2 and the appropriate thiophenyl to provide 12a-d. In most cases this procedure led to the 
formation of an anomeric mixture from which the desired β-anomer could be separated by 
silicagel flash column chromatography. Next, a 2-(2-bromoethoxy)tetrahydro-2H-pyran 
auxiliary was installed on the C-2 position, which after subsequent deprotection with pTsOH in 
methanol afforded glucosyl donors 4a-d (Table 1, entries 1-4). Having observed improved 
selectivity with the galacto-type donors in Chapter 2[3], we decided to also include this C-4 
epimer of glucose in our study.  
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 58
Chapter 3
58
 
58 
Table 1: Donor Syntheses I 
 
entry type Ar 
yield (%) k 
entry type Ar 
yield (%) 
i) ii) iii)  i) ii) iii) 
1 glc Ph 10 (98) 12a (37) 4a (81)  5 gal Ph 11 (87) 13a (64) 14a (20) 
2 glc PMP - 12b (47) 4b (70)  6 gal PMP - 13b (26) 14b (69) 
3 glc DMP - 12c (39) 4c (81)  7 gal DMP - 13c (55) 14c (66) 
4 glc TMP - 12d (76) 4d (83)  8 gal TMP - 13d (59) 14d (41) 
Reagents and conditions: i) 1) BnBr, NaH, DMF, 0°C; ii) 1) acetone, DCM, aq. NaHCO3, oxone, 2) corresponding 
thiol, ZnCl2, DCM, -78°C; iii) 1) NaH, DMF, Br(CH2)2OTHP, 0°C, 2) p-TsOH, MeOH. glc = glucose-type; gal = 
galactose-type; PMP = p-methoxyphenyl; DMP = 2,6-dimethoxyphenyl; TMP = 2,4,6-trimethoxyphenyl. 
 
 
In this case, the donor synthesis started out from commercially available D-galactal (9) and 
followed the same steps mentioned above, affording galactose donors 14a-d (Table 1, entries 
5-8). It is worth noting that after opening of the epoxide with ZnCl2 and the appropriate thiol, 
separation of the galacto-type anomers was rather tedious. 
 
 
3.3 – Glycosylation results I 
 
 
Glycosylation of donors 4a-d and 14a-d, was achieved by activation with Tf2O in the presence 
of 2,6-di-tert-butyl-4-methylpyridine (DTBMP) at -40°C. After thin layer chromatography (TLC) 
indicated complete consumption of the starting material, the temperature was raised to 0°C 
which initiated the formation of β-sulfonium ions 6a-d. Next, the mixture was cooled to    -78°C 
and acceptor 19 was added. Slowly raising the temperature to room temperature (rt) overnight 
afforded the corresponding glycosides, 7a-d and 18a-d (Table 2, entries 1-4 and 5-8, resp.).  
 
Table 2: Glycosylation results I 
 
entry donor type Ar yield (%)a α / βb   . entry donor type Ar yield (%)a α / βb 
1 4a glc Ph 71 2.5/1  5 14a gal Ph 55 3/1 
2 4b glc PMP 62 2.5/1  6 14b gal PMP 36 3/1 
3 4c glc DMP 83 3.5/1  7 14c gal DMP 37 6/1 
4 4d glc TMP 76 4/1  8 14d gal TMP 59 7/1 
a isolated yield; b anomeric ratios were determined via key integrals in 1H-NMR and/or 13C spectra of the crude reaction 
mixtures. glc = glucose; gal = galactose; PMP = p-methoxyphenyl; DMP = 2,6-dimethoxyphenyl; TMP = 2,4,6-
trimethoxyphenyl. 
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In both the glucose and galactose series, disscharide product formed with moderate to good 
yield indicating that triflation of the C-2 glycol substituent indeed led to thioglycoside alkylation 
and subsequent glycosylation. Furthermore, the expected trend that a more electronrich 
aromatic thiophenyl group provides better α-selectivity was indeed observed. However the 
stereoselectivity of donor 4d was far from the reported exclusive α-selectivity (Table 2, entry 4, 
α/β = 4/1).[6] As the used donors and corresponding activation method in both methodologies 
are different, we synthesized donor 8 and exactly followed the reported glycosylation procedure. 
The ratio was determined by NMR analysis of the crude reaction mixture and in our hands the 
reaction again provided an α/β ratio of 4/1, highlighting that the activation method was not 
responsible for the discrepancy between the result we obtained and that reported by Fairbanks 
et al. (α/β = 1/0). 
 
 
Scheme 3: Glycosylation of donor 8 on our laboratory resulted in an α/β mixture of 4/1, as 
opposed to α-only in Fairbanks’ laboratory (α/β = 1:0). 
 
 
These results led us to investigate the reaction intermediates via variable temperature (VT) NMR 
studies. Donor 4d and DTBMP were dissolved in CD2Cl2 and cooled to -78°C (Figure 1a). Triflic 
anhydride was added (Figure 2b) after which 19F NMR revealed the formation of a new compound 
(intermediate alkyl triflate 15d). Additionally, TLC analysis indicated the complete consumption 
of starting material and formation of a more apolar compound, which is an important observation 
as 4d could also serve as a glycosyl acceptor if it were not fully consumed. Temperature was 
then slowly raised to -20°C and the peak indicating the formation of 15d in the 19F spectrum 
disappeared again. 1H-NMR revealed the formation of a new compound, as a significant 
downfield shift of H-1 from 4.30 (d, J = 10.1 Hz) to 5.48 (d, J = 9.5 Hz) ppm in combination 
with a downfield shift of the H-8 protons from 3.22 ppm for both protons to 3.54 and 4.56 ppm 
for Hax and Heq indicated the formation of β-sulfonium 6d (Figure 1c). After 30 minutes, another 
measurement showed the formation of a single new compound (Figure 1d). An 1H-13C-HMBC 
spectrum showed a 3JC1,H8 correlation at 81.54 and 3.54 ppm (Figure 1e), which can only exist 
when a sulfonium ion is formed. These results represent the same intermediate as the one found 
by Fairbanks et al. and both suggest β-sulfonium 6d as the major intermediate species after 
activation. However, from the experimental result it is clear that 6d may not be a reactive 
intermediate which reacts via an SN2-like displacement, as an α/β ration of 4/1 is obtained after 
glycosylation. The above results also show that the triflation of the ethylene glycol auxiliary can 
lead to highly pure β-sulfonium ion intermediates which represents a new methodology for 
thioglycoside activation. 
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Figure 1: VT-NMR study of donor 4d. a) pre-activation at -80°C; b) post-activation at -80°C (15d); c) 
increasing temperature to -20°C shows the formation of 6d; d) 30 minutes later only 6d remains; e) 
HMBC shows C1-H8 correlation indicating ring closure.   
 
To improve the stereoselectivity of β-sulfonium ion mediated glycosylations, electron-
withdrawing protecting groups on the glycosyl donor can be used (see chapter 1). Electron-
withdrawing protecting groups on glycosyl donors are assumed to destabilize the oxocarbenium 
ion and therefore, as the sulfonium intermediate is further away from the withdrawing 
substituents this intermediate should be better stabilized and subsequent SN2-like displacement 
of this intermediate stereoselectively results in α-glycosides.[8] 
Hence, we set to explore the influence of the inductive effect of the O-3, O-4 and O-6 protecting 
groups. To minimize the contribution of other mechanism such as remote participation we 
excluded ester protecting groups and instead used increasingly electron-withdrawing benzyl 
ethers. Jensen and coworkers investigated the reactivity for various para substituted benzylated 
donors and found that reactivity follows the trend OMe > H > Cl > CN. Glycosylation of the 
respective para substituted benzyl donors afforded a similar trend for the α/β ratio where the α-
selectivity increases with the associated strength of the positive inductive effect, 1/5 > 1/3 > 
1/1 = 1/1 (OMe > H > Cl > CN, resp.).[9] These results suggest an inductive influence of the p-
substituents and we sought to investigate this further. 
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3.4 – Donor synthesis II 
 
In order to be able to estimate the contribution of the of the electron-withdrawing substituents, 
we compared the acid dissociation constant (pKa) values of the corresponding substituted phenol 
derivatives, which follow the trend that Jensen and co-workers observed.[9] In addition to 
phenol, p-chlorophenol and p-cyanophenol, we selected 2,4- and 2,6-dichlorophenol as their 
pKa values are lower than  p-cyanophenol and thus suggest better α-selectivity (Table 3).[10]  
 
 
Table 3: Substituted phenol derivatives and related pKa values. 
phenol 
 
 
   
 
pKa 10.10 9.99 9.41 7.97     7.89 6.79 
 
 
 
Thus, four gluco- and galacto-type donors consisting of p-chlorobenzyl (PCB), p-cyanobenzyl 
(PCNB), 2,4- and 2,6-dichlorobenzyl (DCB) protecting groups were synthesized (Table 3). The 
anomeric TMP thioether provided the best selectivity in the previous screening and was therefore 
selected as anomeric group for this study (Table 2). The same reaction steps as in section 3.2 
were followed, which afforded products 24a-c, and 25a-c in moderate to good yields. Especially 
the epoxidation step occasionally provided moderate yields. PCNB donors 24d and 25d were 
obtained from PCB compounds 24a and 25a following an elegant procedure based on a method 
from Seeberger, Buchwald and Plante[11] using K4[Fe(CN)6]·3H2O as the cyanide donor and 5 
mol% tBuXPhos-Pd-G3 as the metal catalyst.[9] Unfortunately, dichlorinated benzyl ether failed 
to afford the corresponding dicyanated products under these conditions. 
 
 
Table 4: Donor syntheses 
 
Entry Type R 
yield (%) 
d Entry Type R 
yield (%) 
i) ii) iii) iv) i) ii) iii) iv) 
1 glc PCB 20a (88) 22a (61) 24a (82) -  5 gal PCB 21a (90) 23a (60) 25a (85) - 
2 glc PCNB - - - 24d (88)  6 gal PCNB - - - 25d (93) 
3 glc 2,4-DCB 20b (90) 22b (50) 24b (72) -  7 gal 2,4-DCB 21b (46) 23b (26) 25b (74) - 
4 glc 2,6-DCB 20c (89) 22c (38) 24c (59) -  8 gal 2,6-DCB 21c (92) 23c (51) 25c (63) - 
Reagents and conditions: i) 1) corresponding benzyl halide, NaH, DMF, 0°C; ii) 1) acetone, DCM, aq. NaHCO3, oxone, 2) 2,4,6-
trimethoxybenzene thiol, ZnCl2, DCM, -78°C; iii) 1) NaH, DMF, Br(CH2)2OTHP, 0°C, 1h, 2) p-TsOH, MeOH; iv) 24a or 25a, 
K4[Fe(CN6)]·3H2O, tBuXPhos-Pd-G3 (5 mol%), KOAc, H2O:dioxane (1:1 v/v), 100°C, 1h. glc = glucose; gal = galactose; PCB = p-
chlorobenzyl; PCNB = p-cyanobenzyl; DCB = dichlorobenzyl; TMP = 2,4,6-trimethoxyphenyl. 
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3.5 – Glycosylation results II 
 
Glycosylation of donor 24a containing PCB protecting groups already revealed slightly improved 
selectivity, α/β = 5/1, compared to benzylated donor 4d, α/β = 4/1 (Table 5, entries 1 and 2). 
Increasing polarization by using the PCNB and 2,4-DCB protecting groups further improved α-
selectivity up to α/β = 9/1 for 2,4-DCB glucose donor 24d (Table 5, entry 4). Switching one of 
the chloride substituents from the para to the ortho position resulted in a 33% drop in 
stereoselectivity (Table 4, entry 5). Hence, 2,6-DCB donor 24c did not follow the hypothesized 
trend that a lower pKa affords better α-selectivity. This could be the result of the different 
orientation of the dipoles associated with the electron-withdrawing chlorine substituents or 
possibly steric factors due to ortho-ortho-substitution on the aromatic ring. With this in mind, it 
would be very interesting to investigate the contribution of protecting groups at individual 
positions to gain more insight. Similar studies with ester protecting groups have shown that the 
O-3 position is most important to achieve α-glycosides.[8] Interestingly, the galacto-series 
(donor 25a-d) again displayed better inherent α-selectivity following the same trend as was 
observed for the gluco-type counterparts. The most selective galactosyl donor (25b) afforded 
disaccharide 31b with a ratio of 13/1. 
 
Table 5: Glycosylation results 
 
entry donor type R yield (%)a α / βb . entry donor type R yield (%)a α / βb 
1c 4d glc Bn 76 4/1  6c 11d gal Bn 59 7/1 
2 24a glc PCB 75 5/1  7 25a gal PCB 33 9/1 
3 24d glc PCNB 65 7.5/1  8 25d gal PCNB 87 12.5/1 
4 24b glc 2,4-DCB 81 9/1  9 25b gal 2,4-DCB 68 13/1 
5 24c glc 2,6-DCB 84 6/1  10 25c gal 2,6-DCB 70 8.5/1 
a isolated yield; b anomeric ratios were determined via key integrals in 1H-NMR and/or 13C spectra of the crude 
reaction mixtures; c results adopted from Table 2. glc = glucose; gal = galactose; PCB = p-chlorobenzyl; PCNB 
= p-cyanobenzyl; DCB = dichlorobenzyl; TMP = 2,4,6-trimethoxyphenyl. 
 
To further explore the scope of the most successful glucose donor 24b, we glycosylated glycosyl 
acceptor 32 as it is protected with an anomeric thioether. Glycosyl building blocks carrying an 
anomeric thioether group are now regularly used, as they are stable to a wide range of functional 
group transformations, protecting group manipulations, as well as several activation procedures 
for glycosylation and, selective coupling is not easy to achieve.[12] We envisioned that 
preactivation of 24b with triflic anhydride would yield the intermediate sulfonium ion and 
subsequent addition of 32 would lead to disaccharide without activation of 32. Indeed, donor 
24b could be coupled to anomeric thioglycoside 32, using the Tf2O activation method resulting 
in disaccharide 33, albeit with a lower α-selectivity α/β = 5/1 (50%, Scheme 4).  
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Scheme 4: The newly designed activation method allows for orthogonal glycosylation steps.  
  
Another important challenge is the removal of the auxiliary. This can be achieved by activation 
of the thioether with MeOTf/TTBP in DCM resulting in sulfonium ion 34 and subsequent 
treatment with KOtBu to afford the free alcohol at C-2 in 73% (Scheme 5, 35).[6] 
 
 
Scheme 5: Treatment of 30b with MeOTf followed by KOtBu results in the free C-2 alcohol. 
 
3.6 – Control compounds synthesis 
 
In order to provide evidence that the 2-O-(hydroxyethyl) auxiliary is indeed involved in the α-
selective glycosylation reaction pathway, we introduced a 2-O-benzyl as well as a 2-O-propyl 
group which are both non-participating substituents. The chain length of the C-2 auxiliary was 
also elongated by one more carbon to investigate the effect of ring size. The above substituents 
were introduced on both the benzyl and the 2,4-DCB protecting group as the first is the standard 
and the latter gave the highest selectivity in the previous screening.  
 
Table 6: Synthesis of control compounds 
 
entry donor R R1 method 
yield 
(%) 
h entry donor R R1 method 
yield 
(%) 
1 38a Bn Bn i) 73  5 39a 2,4-DCB Bn i) 60 
2 38b Bn (CH2)2Me i) 86  6 39b 2,4-DCB (CH2)2Me i) 84 
3 38c Bn (CH2)3OH i) then ii) 62  7 39c 2,4-DCB (CH2)3OH i) then ii) 73 
4 38d Bn Ac iii) 88  8 39d 2,4-DCB Ac iii) 69 
DCB = dichlorobenzyl; TMP = 2,4,6-trimethoxyphenyl. 
 
To this end, building blocks containing Bn groups (12d) and 2,4-DCB groups (22b) were reacted 
with NaH and the respective alkyl bromide (benzyl bromide, n-propyl bromide (36), or 2-(3-
bromopropoxy)tetrahydro-2H-pyran (37)). Subsequent pTsOH mediated deprotection of the 
latter THP ether afforded the desired control donors in 60-86% yield (Table 6, entries 1-3 and 
5-7). Fundamentally, in order for this methodology to be a universal procedure for 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 64
Chapter 3
64
 
64 
stereoselective glycosylations, synthesis of β-glycosides should also be achieved. This route 
lends itself perfectly for late stage introduction of the C-2 directing group, and the C-2 alcohol 
of thioethers 9d and 19b could easily be modified with a β-directing acyl group by reacting it 
with acetic anhydride in pyridine, obtaining 35d and 36d in 88% and 69% yield, resp. (Table 
6, entries 4 and 8). 
 
3.7 – Control compounds results 
 
As donors 38a,b and 39a,b do not contain an alcohol which can be triflated to initiate the 
glycosylation reaction, another activating method had to be used. The NIS/TfOH combination is 
an excellent method for thioether activation[13] and 38a,b and 39a,b were glycosylated 
accordingly (Table 7, entries 1-2 and 5-6). Benzyl protected donors 38a,b proved unselective 
(entries 1-2), whereas the use of 2,4-DCB protecting groups (39a,b) did increase the anomeric 
ratios (entries 5-6). This indicates that the 2,4-DCB protecting group inherently makes the 
glycosylation reaction more α-selective, independent of the C-2 substituent. Combining these 
results with the results from section 3.5, where we used the model 2-O-(2-hydroxyethyl) 
auxiliary, we can clearly see an increase in α-selectivity when an auxiliary is used (Table 5, entry 
4, α/β = 9/1). Glycosylation of donor 38c and 39c, bearing a 2-O-(3-hydroxypropanyl) auxiliary 
considerably reduces the anomeric rations for both the Bn and 2,4-DCB protected donors to α/β 
= 2/1 and 2.5/1, respectively (Table 7, entries 3 and 7). Id est, with the C-2 auxiliary increased 
by 1 carbon, anomeric control is diminished. This provides evidence that the chair-like 
conformation of the original donors’ β-sulfonium ion intermediate is needed to afford improved 
α-selectivity. Finally, glycosylation of donors 38d and 39d carrying an C-2 acetyl auxiliary both 
afforded the β-glycoside only, as expected (Table 7, entries 4 and 8). Combined with the 
improved selectivity of the 2,4-DCB protected carbohydrates, these results bring a universal 
glycosylation procedure, in which one can choose the stereoselective outcome of this reaction, 
considerably closer. 
 
 
Table 7: Glycosylation of control compounds 
 
entry product R R1 method 
yield  
(%)a 
α / βb v entry product R R1 method 
yield  
(%)a 
α / βb 
1 40a Bn Bn i) 68 1.4/1  5 41a 2,4-DCB Bn i) 57 4/1 
2 40b Bn (CH2)2Me i) 65 1.2/1  6 42b 2,4-DCB (CH2)2Me i) 51 3/1 
3 40c Bn (CH2)3OH ii) 71 2/1  7 43c 2,4-DCB (CH2)3OH ii) 49 2.5/1 
4 40d Bn Ac i) 83 <1/20  8 44d 2,4-DCB Ac i) 60 <1/20 
a Isolated yield; b anomeric ratios were determined via key integrals in 1H- and 13C-NMR spectra of the crude reaction mixtures. 
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3.8 – Conclusions 
 
We have developed a unique activation methodology for the formation of the challenging α-
glucosidic bond. Donors equipped with electron-deficient 2,4-DCB protecting groups show 
enhanced α-selectivity on themselves which is significantly improved by introduction of the 
participating 2-O-(hydroxyethyl) auxiliary. Especially galacto-type donors reach an α/β ratio of 
13/1, equivalent to 92% α-galactosides. With the simple building block synthesis and the 
possibility for late stage introduction of an α-or β-directing auxiliary, a universal procedure for 
the respective stereoselective glycosylations has now come closer than ever. 
 
3.9 – Experimental section 
 
General methods: For general methods please refer to section 2.9. 
 
General procedure A: D-glucal or D-galactal was dissolved in dry DMF (0.2 M) under inert atmosphere and cooled to 
0oC. NaH (8 eq; 60% dispersion in mineral oil) was added and the reaction mixture was stirred for 30 minutes, after 
which the corresponding benzylating agent (5 eq) was added. The reaction was stirred for 16h at ambient temperature 
after which it was quenched with MeOH. The mixture was concentrated under reduced pressure and taken up in DCM 
(100 mL) and water (100 mL). The aqueous layer was extracted with DCM (2 x 100 mL). The combined organic layers 
were washed with brine (100 mL), dried (MgSO4), filtered and concentrated under reduced pressure to yield the crude 
product.  
 
General procedure B: To a cooled (0oC) solution of a benzylated glycal (2.4 mmol) in DCM (10 mL) were added 
acetone (1 mL) and sat. aq. NaHCO3 (17 mL). The mixture was stirred vigorously, and a solution of oxone (4.8 mmol) 
in H2O (6 mL) was added dropwise over 15 min. The mixture was stirred vigorously at 0oC for 30 min and then at rt 
until TLC indicated consumption of the starting material. The organic phase was separated and the aqueous phase was 
extracted with DCM (2x 10 mL). The combined organic phases were dried (Na2SO4) and concentrated in vacuo. The 
crude mixture was dissolved in dry DCM (23 mL). MS (4Å) and the corresponding thiol (3.6 mmol) were added under 
inert atmosphere. The mixture was cooled to -78oC and stirred for 15 minutes. A 1M solution of ZnCl2 in Et2O (0.24 
mmol) was added and the mixture was stirred overnight while slowly warmed up to rt. The reaction was quenched with 
TEA and purified with silicagel flash column chromatography to obtain the pure product.  
 
General procedure C: An anomeric thioether with a free 2-OH (12a-d, 13a-d, 22a-c or 23a-c) was dissolved in dry 
DMF (0.1 M) and cooled to 0oC. NaH (4 eq; 60% dispersion in mineral oil) was added and the mixture was stirred at 0oC 
for 15 min, after which the appropriate auxiliary (Br(CH2)3OTHP or 37) was added (4 eq). The reaction was stirred for 
16h at ambient temperature, after which it was quenched with MeOH. The reaction mixture was concentrated under 
reduced pressure and were taken up in MeOH (25 mL). pTsOH was added until a pH of 2 was reached. The reaction was 
stirred for 4 h and subsequently concentrated under reduced pressure. The residue was dissolved in EtOAc (20 mL) and 
washed with water (3 x 20 mL). The organic layer was dried (MgSO4), filtered and concentrated under reduced pressure 
to yield the crude product.  
 
General procedure D: Thioglucosides 12d or 22b were dissolved in dry DMF (0.1 M) and cooled to 0oC. NaH (4 eq; 
60% dispersion in mineral oil) was added and the mixture was stirred at 0oC for 15 min, after which benzyl- or propyl 
bromide was added (4 eq). The reaction was stirred for 16h at ambient temperature, after which it was quenched with 
MeOH. The reaction mixture was concentrated under reduced pressure and the residue was taken up in EtOAc (20 mL). 
The organic layer was washed with water (3 x 20 mL), brine (20 mL), dried (MgSO4), filtered and concentrated under 
reduced pressure yielding the crude product.  
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General glycosylation procedure E: the corresponding glycosyl donors (0.50 mg) and DTBMP (4 eq) were dissolved 
in dry DCM (2 mL). MS (4Å) were added under inert atmosphere and the mixture was stirred at -40oC for 15 min. Tf2O 
(1.5 eq) was added and the mixture was allowed to slowly warm up to 0oC and stirred at 0oC for 30 min. When TLC 
analysis indicated complete consumption of the triflated intermediate, the mixture was cooled down to -78oC and the 
appropriate acceptor (2 eq) was added. The reaction was left to warm up to rt in 16 hours and was subsequently taken 
up in EtOAc (20 mL) and filtered. The filtrate was washed with aq. Na2S2O3 (20 mL, 10%), brine (20 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure to yield the crude product.  
 
General glycosylation procedure F: One of glycosyl donors 38a,b,d or 39a,b,d (0.05 g) and acceptor 37 (2 eq) 
were dissolved in dry DCM (2 mL). MS (4Å) were added and the mixture was cooled to -5oC. NIS (1.1 eq) and TfOH (0.2 
eq) were added and the reaction was stirred for 2h. The reaction was quenched with Et3N and taken up in EtOAc (20 
mL) and filtered. The filtrate was washed with aq Na2S2O3 sol (20 mL, 10%), brine (20 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure to yield the crude product. 
 
Phenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside (4a): 
Via general procedure C. Silicagel flash column chromatography (0% → 30% - EtOAc in n-heptane) 
afforded 4a (0.12 gr, 81%). TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.4; 1H NMR (500 MHz, 
CDCl3) δ 7.61 – 7.54 (m, 2H), 7.38 – 7.15 (m, 17H), 4.91 (d, J = 10.9 Hz, 1H), 4.85 (d, J = 10.9 
Hz, 1H), 4.80 (d, J = 10.8 Hz, 1H), 4.64 – 4.56 (m, 2H), 4.57 (d, J = 9.8 Hz, 1H (H-1)), 4.54 (d, J 
= 12.0 Hz, 1H), 3.89 (ddd, J = 10.7, 5.8, 3.0 Hz, 1H), 3.83 (ddd, J = 10.7, 6.0, 3.0 Hz, 1H), 3.78 (dd, J = 10.9, 2.0 
Hz, 1H, (H-6)), 3.72 (dd, J = 10.9, 4.5 Hz, 1H, (H-6)), 3.70 – 3.61 (m, 4H, (H-3, H-4)), 3.50 (ddt, J = 6.6, 4.6, 1.9 
Hz, 1H, (H-5)), 3.40 – 3.33 (m, 1H, (H-2)), 2.72 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 138.15, 137.87, 137.83, 133.21, 
131.93, 128.92, 128.50, 128.44, 128.33, 127.89, 127.86, 127.84, 127.64, 127.59, 127.57, 87.50 (C-1), 86.62 (C-3), 
80.63 (C-2), 79.12 (C-5), 77.94 (C-4), 77.25, 77.00, 76.75, 75.85, 74.99, 74.72, 73.41, 68.82 (C-6), 62.29. HRMS 
(m/z): [M+Na]+ calcd for C35H38O6S, 609.2287; found, 609.2275 
 
4-Methoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside (4b):  
Via general procedure C. Silicagel flash column chromatography (0% → 30% - EtOAc in 
n-heptane) afforded 4b (0.13 gr, 70%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.4; 1H 
NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.9 Hz, 2H), 7.30 – 7.16 (m, 13H), 7.12 (dd, J = 
7.5, 2.1 Hz, 2H), 6.67 (d, J = 8.8 Hz, 2H), 4.83 (d, J = 10.9 Hz, 1H), 4.76 (d, J = 10.9 
Hz, 1H), 4.72 (d, J = 10.9 Hz, 1H), 4.57 – 4.42 (m, 4H), 4.36 (d, J = 9.7 Hz, 1H), 3.83 (ddd, J = 10.7, 5.4, 3.1 Hz, 
1H), 3.76 (ddd, J = 10.7, 6.1, 3.1 Hz, 1H), 3.72 – 3.51 (m, 11H, (H-3, H-4, H-6, H-6)), 3.38 (ddd, J = 9.5, 4.3, 1.9 
Hz, 1H, (H-5)), 3.22 (dd, J = 9.7, 8.6 Hz, 1H, (H-2)), 2.72 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 159.79, 138.24, 
137.90, 137.85, 135.18, 128.49, 128.43, 128.32, 127.86, 127.84, 127.63, 127.54, 122.74, 114.41, 87.84 (C-1), 86.64 
(C-3), 80.47 (C-2), 79.02 (C-5), 77.96 (C-4), 75.80, 74.97, 74.66, 73.40, 73.26, 68.88 (C-6), 62.29, 55.25; HRMS 
(m/z): [M+Na]+ calcd for C36H40O7S, 639.2392; found, 639.2382 
 
2,6-Dimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside (4c):  
Via general procedure C. Silicagel flash column chromatography (0% → 30% - EtOAc in n-
heptane) afforded 4c (0.16 gr, 81%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.30; 1H NMR 
(500 MHz, CDCl3) δ 7.37 – 7.21 (m, 14H), 7.17 (dd, J = 7.3, 2.2 Hz, 2H), 6.56 (d, J = 8.3 Hz, 
2H), 4.87 (s, 2H), 4.79 (d, J = 10.8 Hz, 1H), 4.55 (d, J = 10.9 Hz, 1H), 4.53 (d, J = 10.0 Hz, 
1H (H-1)), 4.49 (d, J = 11.9 Hz, 1H), 4.46 (d, J = 11.9 Hz, 1H), 4.05 (ddd, J = 10.9, 5.7, 2.5 Hz, 1H), 3.95 (ddd, J = 
10.8, 6.7, 2.4 Hz, 1H), 3.84 (m, 7H), 3.75 – 3.67 (m, 2H, (H-6)), 3.66 – 3.59 (m, 2H, (H-3, H-6)), 3.59 – 3.48 (m, 2H, 
(H-4)), 3.43 – 3.32 (m, 2H, (H-2, H-5)); 13C NMR (126 MHz, CDCl3) δ 161.01, 138.35, 138.24, 137.94, 130.43, 128.50, 
128.42, 128.26, 127.93, 127.88, 127.82, 127.80, 127.51, 108.57, 104.33, 87.92 (C-1), 87.23 (C-3), 81.74 (C-2), 
79.63 (C-5), 78.20 (C-4), 75.75, 74.98, 74.94, 73.58, 69.41 (C-6), 61.87, 56.25; HRMS (m/z): [M+Na]+ calcd for 
C37H42O8S, 669.2498; found, 669.2495. 
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2,4,6-trimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside (4d):  
via general procedure C starting from 9d (0.33 g, 0.52 mmol). The crude product was 
purified by silicagel flash column chromatography (30% to 60% EtOAc in n-heptane) 
afforded 4d as a white solid (0.294 g, 83%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 
0.21. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.11 (m, 18H), 6.12 (s, 2H), 4.87 (s, 2H), 4.78 
(d, J = 10.8 Hz, 1H), 4.55 (d, J = 10.9 Hz, 1H), 4.48 (s, 2H), 4.38 (d, J = 9.9 Hz, 1H, H-1), 4.05 (ddd, J = 10.8, 5.6, 
2.5 Hz, 1H), 3.94 (ddd, J = 10.8, 6.8, 2.5 Hz, 1H), 3.82 (s, 7H), 3.79 (s, 3H), 3.74 – 3.67 (m, 2H, H-6a), 3.64 – 3.58 
(m, 3H, H-3, H-6b), 3.49 (t, J = 9.4 Hz, 1H, H-4), 3.39 – 3.31 (m, 2H, H-2, H-5). 13C NMR (126 MHz, CDCl3) δ 162.32, 
162.13, 138.40, 138.27, 137.94, 128.49, 128.42, 128.26, 127.95, 127.89, 127.82, 127.80, 127.79, 127.51, 99.96, 
91.19, 88.74 (C-1), 87.22 (C-3), 81.60 (C-2), 79.60 (C-5), 78.19 (C-4), 75.75, 74.97, 74.88, 73.64, 69.58 (C-6), 
61.85, 56.21, 55.34; HRMS (m/z): [M+Na]+ calcd for C38H44O9S, 699.2604; found, 699.2583. 
 
Methyl 3,4,6-tribenzyl-2-O-(2-benzenethioethyl)-α/β-D-glucopyranosyl-(1→6)- 2,3,4-O-tribenzoyl-α-D-
glucopyranoside (7a): Via general procedure E and donor 4a Silicagel flash column chromatography (0% → 40% - 
EtOAc in n-heptane) afforded 7a as an anomeric mixture (α/β = 2.5/1, 69 mg, 71%). TLC: 
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.5; 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.8 Hz, 
2H), 7.93 (d, J = 7.8 Hz, 2H), 7.85 (d, J = 7.8 Hz, 2H), 7.55 – 7.44 (m, 2H), 7.44 – 7.17 
(m, 24H), 7.17 – 7.05 (m, 3H), 6.14 (t, J = 9.9 Hz, 1H, (H-3')), 5.53 (t, J = 9.9 Hz, 1H, 
(H-4')), 5.25 (dd, J = 10.3, 3.7 Hz, 1H, (H-2')), 5.18 (d, J = 3.7 Hz, 1H, (H-1')), 4.92 (d, 
J = 3.5 Hz, 1H, (H-1)), 4.87 (d, J = 11.0 Hz, 1H), 4.80 (d, J = 11.1 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 
12.1 Hz, 1H), 4.45 (d, J = 11.0 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.32 (ddd, J = 9.7, 6.6, 2.0 Hz, 1H, (H-5')), 3.93 – 
3.83 (m, 3H, (H-6', H-3)), 3.83 – 3.75 (m, 2H, H-5), 3.72 – 3.59 (m, 3H, (H-6', H-4, H-6)), 3.52 (dd, J = 10.9, 2.0 Hz, 
1H, H-6), 3.48 – 3.39 (m, 4H, (H-2)), 3.17 – 3.00 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 165.82, 165.78, 165.24, 
138.78, 138.49, 137.92, 133.32, 133.02, 129.91, 129.89, 129.86, 129.81, 129.64, 129.38, 129.23, 129.05, 128.91, 
128.40, 128.38, 128.36, 128.31, 128.30, 128.23, 128.22, 127.88, 127.86, 127.61, 127.60, 127.47, 126.14, 96.99 (C-
1), 96.74 (C-1'), 81.41 (C-3), 80.97 (C-2), 77.52 (C-4), 75.41, 74.76, 73.38, 72.17 (C-2'), 70.59 (C-3'), 70.33 (C-5), 
69.92, 69.64 (C-4'), 68.53 (C-5'), 68.23 (C-6), 66.64 (C-6'), 55.61, 33.40. HRMS (m/z): [M+Na]+ calcd for C63H62O14S, 
1079.3758; found, 1097.3798 
 
Methyl 3,4,6-tribenzyl-2-O-(2-(4-methoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-O-
tribenzoyl-α-D-glucopyranoside (7b): Via general procedure E and donor 4b. Silicagel flash column chromatography 
(0% → 40% - EtOAc in n-heptane) afforded 7b as an anomeric mixture (α/β = 2.5/1, 76 
mg, 62%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.5; 1H NMR (500 MHz, CDCl3) δ 7.98 
(d, J = 7.7 Hz, 2H), 7.92 (d, J = 7.7 Hz, 2H), 7.85 (d, J = 7.7 Hz, 2H), 7.49 (dt, J = 16.8, 
7.4 Hz, 2H), 7.44 – 7.20 (m, 22H), 7.14 – 7.05 (m, 2H), 6.78 (d, J = 8.3 Hz, 2H), 6.13 (t, 
J = 9.9 Hz, 1H, (H-3')), 5.53 (t, J = 9.9 Hz, 1H, (H-4')), 5.25 (dd, J = 10.2, 3.7 Hz, 1H, 
(H-2')), 5.18 (d, J = 3.7 Hz, 1H, (H-1')), 4.92 (d, J = 3.5 Hz, 1H, (H-1)), 4.86 (d, J = 11.0 Hz, 1H), 4.79 (d, J = 11.0 
Hz, 1H), 4.71 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 12.2 Hz, 1H), 4.44 (d, J = 11.0 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 
4.32 (ddd, J = 9.8, 6.8, 2.2 Hz, 1H, (H-5')), 3.92 – 3.81 (m, 3H, (H-6', H-3, H-5)), 3.81 – 3.66 (m, 6H, (H-6')), 3.66 – 
3.56 (m, 2H, (H-4, H-6)), 3.52 (dd, J = 10.7, 2.0 Hz, 1H, (H-6)), 3.46 – 3.37 (m, 4H, (H-2)), 3.07 – 2.88 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 165.82, 165.78, 165.25, 159.03, 138.79, 138.51, 137.92, 133.48, 133.31, 133.02, 129.91, 
129.89, 129.65, 129.24, 129.07, 128.93, 128.38, 128.36, 128.32, 128.29, 128.24, 128.22, 127.91, 127.87, 127.62, 
127.60, 127.46, 125.75, 114.60, 97.05 (C-1), 96.74 (C-1'), 81.41 (C-3), 80.92 (C-2), 77.50 (C-4), 75.41, 74.76, 73.38, 
72.18 (C-2'), 70.60 (C-3'), 70.32 (C-5), 70.06, 69.63 (C-4'), 68.54 (C-5'), 68.24 (C-6), 66.63 (C-6'), 55.61, 55.30, 
35.38. HRMS (m/z): [M+Na]+ calcd for C64H64O15S, 1127,3864; found, 1127,3879. 
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Methyl 3,4,6-tribenzyl-2-O-(2-(2,6-dimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)- 2,3,4-O-
tribenzoyl-α-D-glucopyranoside (7c): Via general procedure E and donor 4c. Silicagel flash column chromatography 
(0% → 40% - EtOAc in n-heptane) afforded 7c (51 mg,  83%) as an α/β mixture. TLC: 
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.95 (m, 2H), 
7.95 – 7.89 (m, 2H), 7.85 (dd, J = 8.4, 1.4 Hz, 2H), 7.55 – 7.44 (m, 2H), 7.39 (dt, J = 
18.0, 7.7 Hz, 3H), 7.35 – 7.17 (m, 20H), 7.11 (dd, J = 7.7, 1.9 Hz, 2H), 6.50 (d, J = 8.4 
Hz, 2H), 6.12 (t, J = 9.8 Hz, 1H, (H-3')), 5.49 – 5.41 (m, 1H, (H-4')), 5.23 (dd, J = 10.2, 
3.7 Hz, 1H, (H-2')), 5.16 (d, J = 3.8 Hz, 1H, (H-1')), 4.92 (d, J = 3.4 Hz, 1H, (H-1)), 4.84 (d, J = 10.9 Hz, 1H), 4.78 
(d, J = 11.0 Hz, 1H), 4.67 (d, J = 10.9 Hz, 1H), 4.44 (d, J = 11.1 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.33 (ddd, J = 
9.9, 7.3, 2.1 Hz, 1H, (H-5')), 3.93 – 3.76 (m, 9H, (H-6', H-3, H-5)), 3.72 – 3.63 (m, 4H, (H-6', H-6)), 3.60 (dd, J = 
10.1, 8.9 Hz, 1H, (H-4)), 3.53 (dd, J = 10.7, 2.0 Hz, 1H, (H-6)), 3.50 – 3.36 (m, 4H, (H-2)), 3.01 (dt, J = 12.9, 7.3 
Hz, 1H), 2.97 – 2.87 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 165.81, 165.73, 165.31, 161.05, 138.81, 138.60, 137.99, 
133.30, 133.00, 129.90, 129.75, 129.63, 129.24, 129.07, 128.87, 128.37, 128.35, 128.30, 128.25, 128.22, 128.19, 
127.95, 127.85, 127.59, 127.53, 127.41, 127.40, 109.39, 104.00, 97.05 (C-1), 96.63 (C-1'), 81.45 (C-3), 81.01 (C-
2), 77.44 (C-4), 75.34, 74.69, 73.36, 72.19 (C-2'), 70.98, 70.57 (C-3'), 70.28 (C-5), 69.74 (C-4'), 68.41 (C-5'), 68.29 
(C-6), 66.81 (C-6'), 56.07, 55.57, 33.37; HRMS (m/z): [M+Na]+ calcd for C65H66O16S, 1157.3969; found, 1157.3954. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-(2,4,6-trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-(16)-2,3,4-tri-
O-benzoyl-α-D-glucopyranoside (7d): via general procedure E starting from glucosyl donor 4d (48 mg; 0.071 mmol) 
and using acceptor 19. The crude product was purified by silicagel flash column 
chromatography (10% to 40% EtOAc in n-heptane) affording 7d as an anomeric mixture 
(63 mg, 76%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.35. 1H NMR 1H NMR (500 MHz, 
CDCl3) δ 7.97 (dd, J = 8.4, 1.4 Hz, 2H), 7.92 (dd, J = 8.3, 1.4 Hz, 2H), 7.85 (dd, J = 8.4, 
1.4 Hz, 2H), 7.53 – 7.44 (m, 2H), 7.43 – 7.34 (m, 3H), 7.34 – 7.22 (m, 17H), 7.11 (dd, J 
= 7.7, 1.8 Hz, 2H), 6.11 (m, 3H, (H-3')), 5.45 (dd, J = 10.3, 9.5 Hz, 1H, (H-4')), 5.23 (dd, J = 10.2, 3.7 Hz, 1H, (H-
2')), 5.16 (d, J = 3.7 Hz, 1H, (H-1')), 4.93 (d, J = 3.4 Hz, 1H, (H-1)), 4.84 (d, J = 10.9 Hz, 1H), 4.79 (d, J = 11.1 Hz, 
1H), 4.66 (d, J = 10.9 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 4.43 (d, J = 11.1 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.34 
(ddd, J = 10.0, 7.4, 2.1 Hz, 1H, (H-5')), 3.92 – 3.86 (m, 2H, (H-6', H-5)), 3.79, m, 10H, (H-3)), 3.72 – 3.58 (m, 5H, 
(H-6', H-4, H-6)), 3.53 (dd, J = 10.7, 2.0 Hz, 1H, (H-6)), 3.44 – 3.36 (m, 4H, (H-2)), 2.91 (ddd, J = 12.9, 8.3, 6.5 Hz, 
1H), 2.82 (ddd, J = 12.9, 8.4, 7.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 165.79, 165.71, 165.30, 162.01, 161.79, 
138.81, 138.60, 137.96, 133.28, 132.99, 129.89, 129.61, 129.24, 129.07, 128.85, 128.36, 128.33, 128.29, 128.23, 
128.21, 128.17, 127.96, 127.86, 127.58, 127.51, 127.40, 127.38, 100.78, 97.10 (C-1), 96.62 (C-1'), 90.93, 81.45 (C-
3), 81.03 (C-2), 77.42 (C-4), 75.34, 74.67, 73.35, 72.18 (C-2'), 70.98, 70.57 (C-3'), 70.26 (C-5), 69.72 (C-4'), 68.40 
(C-5'), 68.28 (C-6), 66.81 (C-6'), 56.01, 55.56, 55.32, 33.89; HRMS (m/z): [M+Na]+ calcd for C66H68O17S, 1187.4075; 
found, 1187.4118. 
 
3,4,6-Tri-O-benzyl-D-glucal (10):  
Via general procedure A starting from D-glucal (5.13 g, 35.1 mmol) using BnBr as the benzylating agent. 
The crude product was purified by silicagel flash column chromatography (0% to 30% EtOAc in n-
heptane) affording 7 (13.3 g, 91%). TLC (EtOAc/n-heptane, 30/70 v/v): Rf = 0.55. 1H NMR: (500 MHz, CDCl3) δ 7.37 
– 7.21 (m, 15H), 6.42 (dd, J = 6.1, 1.3 Hz, 1H, H-1), 4.87 (dd, J = 6.2, 2.7 Hz, 1H, H-2), 4.83 (d, J = 11.3 Hz, 1H), 
4.66 – 4.61 (m, 2H), 4.61 – 4.53 (m, 3H), 4.21 (ddd, J = 6.2, 2.7, 1.3 Hz, 1H, H-3), 4.06 (ddd, J = 8.3, 5.1, 2.9 Hz, 
1H, H-5), 3.86 (dd, J = 8.7, 6.2 Hz, 1H, H-4), 3.83 – 3.72 (m, 2H, H-6); 13C NMR: (126 MHz, CDCl3) δ 144.71 (C-1), 
138.32, 138.17, 137.98, 128.47, 128.35, 128.28, 127.89, 127.77, 127.71, 127.63, 99.93 (C-2), 76.74 (C-5), 75.73 
(C-3), 74.40 (C-4), 73.75, 73.51, 70.45, 68.52 (C-6).  
 
3,4,6-tri-O-benzyl-β-D-galactal (11): 
Via general procedure A and benzyl bromide. Silicagel flash column chromatography (0% - 30% EtOAc in 
n-heptane) afforded 8 (12.392 g, 87%). TLC: (EtOAc/n-heptane,50/50 v/v): Rf = 0.74; 1H NMR (500 
MHz, CDCl3) δ 7.37 – 7.22 (m, 15H), 6.36 (dd, J = 6.2, 1.4 Hz, (H-1)), 4.85 (ddd, J = 8.5, 6.6, 4.1 Hz, 
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1H, H-2), 4.67 – 4.58 (m, 3H), 4.50 (d, J = 11.9 Hz, 1H), 4.42 (d, J = 11.9 Hz, 1H), 4.21 – 4.15 (m, H-3, H-5), 3.96 
– 3.92 (m, H-4), 3.78 (dd, J = 10.1, 7.2 Hz, H-6a), 3.65 (dd, J = 10.2, 5.1 Hz, H-6b). 13C NMR (126 MHz, CDCl3) δ 
144.21 (C-1), 138.52, 138.39, 138.01, 128.40, 128.34, 128.17, 127.92, 127.71, 127.58, 127.46, 99.99 (C-2), 75.72 
(C-5), 73.44, 73.35, 71.30 (H-4), 70.91, 70.77 (C-3), 68.46 (H-6). HRMS (m/z): [M+Na]+ calcd for C27H28O4, 439.1885; 
found, 439.1877. 
 
Phenyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (12a): 
 Via general procedure B starting from 10 and thiophenol. Silicagel flash column chromatography 
(0% → 30% - EtOAc in n-heptane) afforded 12a (0,30 gr, 37%). TLC: (EtOAc/n-heptane, 30/70 
v/v): Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.52 (m, 2H), 7.37 – 7.16 (m, 18H), 4.91 (d, J 
= 11.2 Hz, 1H), 4.86 – 4.80 (m, 2H), 4.61 (d, J = 12.1 Hz, 1H), 4.57 (d, J = 10.9 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 
4.50 (d, J = 9.6 Hz, 1H, (H-1)), 3.79 (dd, J = 10.9, 2.0 Hz, 1H, (H-6)), 3.73 (dd, J = 11.0, 4.5 Hz, 1H, (H-6)), 3.64 – 
3.46 (m, 4H, (H-2, H-3, H-4, H-5)), 2.45 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 138.40, 138.21, 137.98, 132.81, 131.74, 
128.89, 128.45, 128.36, 128.29, 127.99, 127.92, 127.89, 127.74, 127.57, 127.51, 87.96(C-1), 85.88(C-3), 79.34(C-
5), 77.27(C-4), 75.27, 75.00, 73.36, 72.53(C-2), 68.92(C-6). HRMS (m/z): [M+Na]+ calcd for C33H34O5S, 565.2025; 
found, 565.2022 
 
4-Methoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (12b): 
 Via general procedure B starting from 10 and 4-methoxythiophenol. Silicagel flash column 
chromatography (0% → 30% - EtOAc in n-heptane) afforded 12b (0.12 gr, 47%). TLC: 
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.7; 1H NMR (500 MHz, CDCl3) δ 7.50 (d, J = 8.8 Hz, 
1H), 7.38 – 7.15 (m, 14H), 6.76 (d, J = 8.8 Hz, 1H), 4.93 – 4.78 (m, 3H), 4.64 – 4.51 (m, 
3H), 4.36 (d, J = 9.6 Hz, 1H, (H-1)), 3.80 – 3.72 (m, 5H, (H-6, H-6, OMe)), 3.61 – 3.53 (m, 2H, (H-3, H-4)), 3.50 
(ddd, J = 7.4, 4.3, 2.1 Hz, 1H, (H-5)), 3.40 (dd, J = 9.6, 8.4 Hz, 1H, (H-2)), 2.41 (s, 1H). 13C NMR (126 MHz, CDCl3) 
δ 160.15, 138.49, 138.38, 138.08, 136.01, 128.52, 128.43, 128.35, 128.01, 127.98, 127.81, 127.64, 127.56, 121.08, 
114.51, 88.03(C-1), 85.90(C-3), 79.43(C-5), 77.36(C-4), 75.34, 75.09, 73.45, 72.28(C-2), 69.03(C-6), 55.32. HRMS 
(m/z): [M+Na]+ calcd for C34H36O6S, 595.2130; found, 595.2134 
 
2,6-Dimethoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (12c): 
Via general procedure B starting from 10 and 2,6-dimethoxythiophenol. Silicagel flash column 
chromatography (0% → 30% - EtOAc in n-heptane) afforded 12c (0.44 g, 39%). TLC: 
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.6; 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.08 (m, 16H), 
6.56 (d, J = 8.4 Hz, 2H), 5.04 (d, J = 11.1 Hz, 1H), 4.79 (dd, J = 11.0, 1.7 Hz, 2H), 4.57 – 
4.50 (m, 2H), 4.46 (d, J = 11.7 Hz, 1H), 4.29 (d, J = 9.6 Hz, 1H, H-1), 3.83 (m, 7H), 3.79 (d, J = 2.7 Hz, 2H, (H-6, H-
6)), 3.61 (t, J = 8.7 Hz, 1H, (H-3)), 3.53 (dd, J = 9.7, 8.7 Hz, 1H, (H-4)), 3.46 (dt, J = 9.7, 2.7 Hz, 1H, (H-5)), 3.32 
(ddd, J = 9.5, 8.6, 1.9 Hz, 1H, (H-2)). 13C NMR (126 MHz, CDCl3) δ 162.17, 138.83, 138.43, 138.30, 131.56, 128.27, 
128.26, 128.20, 127.92, 127.84, 127.65, 127.56, 127.47, 127.40, 105.00, 104.56, 88.43 (C-1), 85.61 (C-3), 79.96 
(C-5), 76.88 (C-4), 75.15, 75.02, 73.59, 73.48 (C-2), 69.12 (C-6), 56.39. HRMS (m/z): [M+Na]+ calcd for C35H38O7S, 
625.2236; found, 625.2223 
 
2,4,6-Trimethoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (12d):  
Via general procedure B starting from 10 (1.9 g; 4.54 mmol) and 1,3,5-
trimethoxybenzene. The crude product was purified by silicagel flash column 
chromatography (10% to 40% EtOAc in n-heptane) yielding 12d (0.35 g, 76%). TLC 
(EtOAc/n-heptane 40/60 v/v): Rf = 0.41. 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.13 (m, 
15H), 6.11 (s, 2H), 5.04 (d, J = 11.0 Hz, 1H), 4.79 (dd, J = 11.0, 2.6 Hz, 2H), 4.54 (dd, J = 11.2, 7.6 Hz, 2H), 4.45 
(d, J = 11.6 Hz, 1H), 4.20 (d, J = 9.4 Hz, 1H, H-1), 3.84 – 3.77 (m, 11H, H-2, H-6), 3.61 (t, J = 8.8 Hz, 1H, H-3), 3.54 
(t, J = 9.3 Hz, 1H, H-4), 3.46 (ddd, J = 9.7, 3.2, 2.0 Hz, 1H, H-5), 3.28 (ddt, J = 9.5, 8.7, 2.5 Hz, 1H, H-2). 13C NMR 
(126 MHz, CDCl3) δ 163.18, 162.96, 138.95, 138.56, 138.40, 128.30, 128.24, 127.97, 127.89, 127.73, 127.59, 127.49, 
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127.45, 96.19, 91.51, 88.48 (C-1), 85.62 (C-3), 80.01 (C-5), 76.93 (C-4), 75.19, 75.07, 73.71, 73.24 (C-2), 73.13, 
69.17 (C-6), 56.36, 55.39. HRMS (m/z): [M+Na]+ calcd for C36H40O8S, 655.2342; found, 655.2339. 
 
Phenyl 3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (13a):                                   
Via general procedure B and thiophenol. Silicagel flash column chromatography (0% 30% - 
Diethylether in toluene) afforded 13a (0.57 g, 64%). TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 
0,38; 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.53 (m, 2H), 7.52 – 7.48 (m, 2H), 7.39 – 7.17 (m, 16H), 
5.70 (d, J = 5.5 Hz), 4.89 (d, J = 11.4 Hz, 2H), 4.75 (dd, J = 13.9, 11.7 Hz, 2H), 4.70 – 4.63 (m, 
2H), 4.59 - 4.56 (d, J = 7.0 Hz, 2H), 4.55 – 4.41 (m, 2H, H-1), 4.01 (t, J = 9.4 Hz, H-2), 3.98 (d, J = 2.7 Hz, H-4), 
3.67 – 3.64 (m, 3H, H-6, H-5), 3.58 (dd, J = 9.4, 6.0 Hz, 1H, H-6), 3.47 (dd, J = 9.2, 2.8 Hz, H-3). 13C NMR (126 MHz, 
CDCl3) δ 138.65, 138.40, 138.01, 137.93, 137.85, 137.77, 134.04, 132.60, 132.20, 132.00, 128.92, 128.83, 128.63, 
128.58, 128.55, 128.45, 128.42, 128.31, 128.18, 128.02, 128.01, 127.93, 127.87, 127.84, 127.81, 127.79, 127.77, 
127.74, 127.69, 127.57, 127.45, 127.32, 126.99, 88.52 (C-1), 83.23 (C-3), 77.63 (C-5),74.81, 74.41, 73.61, 73.48, 
73.22 (C-4), 72.44, 72.35, 69.09 (C-2), 68.70 (C-6); HRMS (m/z): [M+Na]+ calcd for C33H34O5S, 565.2024; found, 
565.2014. 
 
4-methoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (13b): 
Via general procedure B and 4-methoxythiophenol. Silicagel flash column chromatography 
(0% - 30% Diethyl ether in toluene) afforded 13b (0.19 g, 26%). TLC: 
(Diethylether/toluene, 20/80 v/v): Rf = 0,65; 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.7 
Hz, 2H), 7.38 – 7.18 (m, 15H), 6.75 (d, J = 8.8 Hz, 2H), 4.87 (d, J = 11.5 Hz, 1H), 4.69 
(dd, J = 11.9 Hz, 2H), 4.55 (d, J = 11.5 Hz, 1H), 4.46 (q, J = 11.7 Hz, 2H), 4.40 (d, J = 9.5 
Hz, H-1), 3.95 (d, J = 2.6 Hz, H-4), 3.91 (td, J = 9.4, 1.5 Hz, H-2), 3.74 (s, 3H), 3.69 – 3.58 (m, H-6a, H-6b, H-5), 
3.45 (dd, J = 9.3, 2.7 Hz, H-3), 2.45 (d, J = 1.8 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 159.84, 138.73, 138.06, 137.91, 
135.33, 128.54, 128.45, 128.14, 127.92, 127.85, 127.83, 127.70, 127.62, 127.38, 122.22, 114.41, 88.85 (C-1), 83.24 
(C-3), 77.56 (C-5), 74.30, 73.59, 73.25 (C-4), 72.42, 68.95 (C-2), 68.72 (C-6); HRMS (m/z): [M+Na]+ calcd for 
C34H36O6S, 595.2130; found, 595.2110. 
 
2,6-dimethoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (13c): 
Via general procedure B and 2,6-dimethoxythiophenol. Silicagel flash column chromatography 
(0% - 30% diethyl ether in toluene) afforded 13c (0.667 g, 55%). TLC: (Diethylether/toluene, 
20/80 v/v): Rf = 0,52; 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.19 (m, 15H), 7.16 – 7.11 (m, 
2H), 6.59 (d, J = 8.4 Hz, 1H), 4.89 (d, J = 11.7 Hz, 1H), 4.83 (d, J = 12.2 Hz, 1H), 4.71 (d, J 
= 12.0 Hz, 1H), 4.49 (d, J = 11.7 Hz, 1H), 4.42 (dd, J = 11.7 Hz, 2H), 4.26 (d, J = 9.4 Hz, H-
1), 3.90 – 3.69 (m, 3H, H-2, H-4), 3.65 – 3.50 (m, H-5, H-6a, H-6b), 3.45 (dd, J = 9.4, 2.8 Hz, H-3). 13C NMR (126 
MHz, CDCl3) δ 161.97, 139.11, 138.68, 137.98, 131.26, 128.38, 128.34, 127.99, 127.86, 127.73, 127.53, 127.47, 
127.26, 127.05, 104.67, 89.81 (C-1), 82.73 (C-3), 77.61 (C-5), 74.14 (C-4), 74.12, 73.48, 72.74, 70.49 (C-2), 68.51 
(C-6), 56.47. HRMS (m/z): [M+Na]+ calcd for C35H38O7S, 625.2235; found, 625.2228. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (13d): 
Via general procedure B and 2,4,6-trimethoxythiophenol. Silicagel flash column 
chromatography (0% - 30% diethyl ether in toluene) afforded 13d (0.61 g, 59%). TLC: 
(EtOAc/n-heptane, 50/50 v/v): Rf = 0,44; 1H NMR (400 MHz, CDCl3) δ 7.40 - 7.10 (m, 
15H), 6.16 (s, 2H), 4.89 (d, J = 11.8 Hz, 1H), 4.84 (d, J = 12.2 Hz, 1H), 4.71 (d, J = 12.2 
Hz, 1H), 4.44 (dt, J = 11.5 Hz, 3H), 4.17 (d, J = 9.3 Hz, H-1), 3.87 (d, J = 2.6 Hz, H-4), 
3.82 (s, 3H), 3.81 (s, 6H), 3.76 - 3.51 (m, H-2), 3.46 (dd, J = 9.5, 2.8 Hz, H-3, H-5, H-6a, H-6b). 13C NMR (126 MHz, 
CDCl3) δ 162.95, 162.82, 162.29, 139.19, 138.74, 138.01, 128.39, 128.35, 127.98, 127.86, 127.74, 127.55, 127.47, 
127.19, 127.04, 97.71, 91.60, 90.63, 89.92 (C-1), 82.68 (C-3), 77.51 (C-5), 74.19 (C-4), 74.06, 73.49, 72.75, 70.20 
(C-2), 68.50 (C-6), 56.43, 56.02, 55.43, 55.41. HRMS (m/z): [M+Na]+ calcd for C36H40O8S, 655.2341; found, 655.2327. 
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Phenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside (14a): 
Via general procedure C. Silicagel flash column chromatography (0% - 30% diethyl ether in 
toluene) afforded 14a (0.117 g, 20%). TLC: (Diethylether/toluene, 50/50 v/v): Rf = 0,61; 1H 
NMR (500 MHz, CDCl3) δ 7.55 – 7.51 (m, 5H), 7.36 – 7.13 (m, 15H), 4.89 (d, J = 11.4 Hz, 1H), 
4.73 (d, J = 11.6 Hz, 1H), 4.62 (d, J = 11.6 Hz, 1H), 4.57 (d, J = 11.5 Hz, 1H), 4.54 (d, J = 9.6 
Hz, H-1), 4.45 (q, J = 11.7 Hz, 2H), 4.00 (d, J = 2.4 Hz, H-4), 3.86 – 3.80 (m, 2H, H-2), 3.68 – 
3.58 (m, 2H, H-5, H-6a, H-6b), 3.55 (dd, J = 9.3, 2.7 Hz, H-3). 13C NMR (126 MHz, CDCl3) δ 131.42, 129.05, 128.86, 
128.60, 128.46, 128.24, 128.07, 127.95, 127.86, 127.84, 127.79, 127.56, 127.24, 125.31, 87.97 (C-1), 83.97 (C-3), 
77.28 (C-5), 77.23 (C-2), 75.03, 74.52, 73.62, 72.87 (C-4), 72.17, 68.61 (C-6), 62.27, 60.41. HRMS (m/z): [M+Na]+ 
calcd for C35H38O6S, 609.3386; found, 609.2274. 
 
4-methoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside (14b): 
Via general procedure C. Silicagel flash column chromatography (0% - 40% EtOAc in n-
heptane) afforded 14b (0.142 gr, 67%). TLC: (Diethylether/toluene, 50/50 v/v): Rf = 0,61; 
1H NMR (500 MHz, CDCl3) δ 7.53 – 7.47 (m, 2H), 7.36 – 7.23 (m, 15H), 6.73 (d, J = 8.8 
Hz, 2H), 4.87 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.62 (d, J = 11.6 Hz, 1H), 
4.55 (d, J = 11.5 Hz, 1H), 4.49 – 4.40 (m, 2H, H-1), 3.98 (d, J = 2.4 Hz, H-4), 3.86 (t, J = 
4.4 Hz, 2H), 3.74 (s, 3H, H-2), 3.65 (dd, J = 10.4, 5.6 Hz, 2H, H-6a, H-6b), 3.59 – 3.51 (m, H-3, H-5), 3.07 (t, J = 6.2 
Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 159.55, 138.58, 137.82, 137.40, 134.56, 128.58, 128.44, 128.19, 128.03, 
127.93, 127.84, 127.80, 127.73, 127.49, 123.41, 114.39, 88.55 (C-1), 84.02 (C-3), 77.22 (C-5), 77.17 (C-2), 74.99, 
74.41, 73.59, 72.84 (C-4), 72.12, 68.63 (C-6), 62.28, 55.25. HRMS (m/z): [M+Na]+ calcd for C36H40O7S, 639.2392; 
found, 639.2376. 
 
2,6-dimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside (14c):  
Via general procedure C. Silicagel flash column chromatography (0% - 50% EtOAc in n-heptane) 
afforded 14c (0.465 gr, 66%). TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0,35; 1H NMR (500 
MHz, CDCl3) δ 7.35 (d, J = 4.6 Hz, 2H), 7.33 – 7.18 (m, 15H), 6.54 (d, J = 8.4 Hz, 1H), 4.88 
(d, J = 11.6 Hz, 1H), 4.71 (d, J = 11.6 Hz, 1H), 4.64 (d, J = 11.6 Hz, 1H), 4.56 (d, J = 11.5 
Hz, 1H), 4.44 (d, J = 9.8 Hz, H-1), 4.37 (dd, J = 11.6 Hz, 2H), 4.06 (ddd, J = 11.1, 5.6, 2.3 
Hz, 1H), 3.94 (ddd, J = 11.2, 6.3, 2.0 Hz, 1H), 3.91 (d, J = 2.2 Hz, H-4), 3.82 (s, 3H), 3.79 – 3.73 (m, 1H, H-2), 3.71 
– 3.64 (m, 1H), 3.62 – 3.53 (m, H-6a, H-6b), 3.49 (dd, J = 9.2, 2.8 Hz, H-3), 3.44 (t, J = 6.3 Hz, H-5), 1.67 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 161.01, 138.67, 137.98, 137.96, 130.23, 128.49, 128.36, 128.17, 127.95, 127.81, 
127.73, 127.63, 127.47, 109.26, 104.30, 88.93 (C-1), 84.67 (C-3), 78.32 (C-2), 77.50 (C-5), 75.13, 74.44, 73.52, 
73.43 (C-4), 72.31, 69.08 (C-6), 61.81, 56.18. HRMS (m/z): [M+Na]+ calcd for C37H42O8S, 669.2398; found, 669.2484. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside (14d):  
Via general procedure C. Silicagel flash column chromatography (0% - 20% EtOAc in 
toluene) afforded 14d (0.162 g, 41%). TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0,30; 1H 
NMR (400 MHz, CDCl3) δ 7.39 – 7.17 (m, 15H), 6.11 (s, 2H), 4.88 (d, J = 11.6 Hz, 1H), 
4.68 (dd, J = 28.1, 11.6 Hz, 2H), 4.55 (d, J = 11.7 Hz, 1H), 4.37 (q, J = 11.6 Hz, 2H), 4.30 
(d, J = 9.8 Hz, H-1), 4.06 (ddd, J = 11.3, 5.3, 2.6 Hz, 1H), 3.99 – 3.87 (m, 1H, H-4), 3.80 
(m, 10H), 3.72 (t, J = 9.5 Hz, 1H, H-2), 3.63 – 3.51 (m, H-6a, H-6b), 3.48 (dd, J = 9.2, 2.8 Hz, H-3), 3.42 (t, J = 6.3 
Hz, H-5). 13C NMR (126 MHz, CDCl3) δ 162.20, 162.15, 138.72, 138.03, 138.02, 128.49, 128.36, 128.16, 127.97, 
127.95, 127.80, 127.74, 127.63, 127.45, 100.75, 91.15, 89.80 (C-1), 84.70 (C-3), 78.13 (C-2), 77.43 (C-5), 75.08, 
74.39, 73.55, 73.40 (C-4), 72.31, 69.20 (C-6), 61.78, 56.15, 55.35. HRMS (m/z): [M+Na]+ calcd for C38H44O9S, 
699.2603; found, 699.2593. 
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Methyl 3,4,6-tri-O-benzyl-2-O-(2-(benzenethio)ethyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-O-tribenzoyl-
α-D-glucopyranoside (18a): Via general procedure E. Silicagel flash column chromatography (0% - 20% -diethyl 
ether in toluene) afforded 18a as an anomeric mixture (61 mg, 55%). TLC: (Et2O/toluene, 
30/70 v/v): Rf = 0,50; 1H NMR (500 MHz, CDCl3) δ 8.13 – 7.79 (m, 6H), 7.54 – 7.06 (m, 
29H), 6.12 (t, J = 9.8 Hz, 1H), 5.52 (t, J = 9.9 Hz, 1H), 5.28 – 5.22 (m, 1H), 5.13 (d, J = 
3.5 Hz, H-1’), 4.94 – 4.86 (m, H, H-1), 4.76 (dd, J = 11.9, 3.6 Hz, 1H), 4.68 (d, J = 11.9 
Hz, 1H), 4.55 (t, J = 11.3 Hz, 1H), 4.34 (dt, J = 12.0 Hz, 3H), 3.99 (t, J = 6.4 Hz, 1H), 3.86 
(m, 6H), 3.65 (d, J = 11.1 Hz, 1H), 3.52 – 3.39 (m, 2H), 3.36 (m, 3H), 3.11 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 165.79, 165.34, 138.73, 138.66, 138.07, 133.34, 133.03, 129.94, 129.84, 129.65, 129.29, 
129.27, 129.14, 128.99, 128.89, 128.39, 128.36, 128.33, 128.29, 128.25, 128.21, 127.67, 127.61, 127.54, 127.50, 
127.45, 97.72 (C-1), 96.77 (C-1’), 78.20, 77.37, 75.02, 74.80, 73.24, 72.79, 72.11, 70.68, 70.10, 69.61, 69.30, 68.64, 
68.42, 66.65, 55.47. HRMS (m/z): [M+Na]+ calcd for C63H62O15S, 1113.3707; found, 1113.3652. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-(4-methoxybenzenethio)ethyl)-α/β-D-galactopyranosyl-(1→6)-2,3,4-O-
tribenzoyl-α-D-glucopyranoside (18b): Via general procedure E. Silicagel flash column chromatography (0% - 25% 
diethyl ether in toluene) afforded 18b as an anomeric mixture (32 mg, 36%). TLC: 
(Diethylether/toluene, 50/50 v/v): Rf = 0,64; 1H NMR (500 MHz, CDCl3) δ 8.03 – 7.81 (m, 
6H), 7.55 – 7.10 (m, 26H), 6.76 (d, J = 8.6 Hz, 2H), 6.13 (m, 1H), 5.53 (t, J = 9.9 Hz, 1H), 
5.24 (td, J = 10.2, 3.5 Hz, 2H), 5.13 (d, J = 3.5 Hz, H-1’), 4.95 – 4.85 (m, 1H, H-1), 4.76 
(m, 1H), 4.67 (m, 1H), 4.54 (d, J = 11.3 Hz, 1H), 4.43 – 4.24 (m, 3H), 3.99 (t, J = 6.4 Hz, 
1H), 3.93 – 3.84 (m, 4H), 3.84 – 3.71 (m, 6H), 3.67 (d, J = 10.3 Hz, 2H), 3.45 (m, 2H), 
3.38 (m, 3H), 3.00 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 165.79, 165.35, 158.96, 138.79, 138.69, 138.09, 133.38, 
133.33, 133.03, 132.69, 129.94, 129.84, 129.66, 129.30, 129.14, 129.00, 128.40, 128.36, 128.32, 128.26, 128.21, 
128.20, 127.68, 127.61, 127.54, 127.49, 127.43, 114.57, 97.77 (C-1), 96.78 (C-1’), 78.21, 77.34, 75.10, 74.80, 73.24, 
72.84, 72.12, 70.70, 70.18, 69.60, 69.32, 68.67, 68.44, 66.65, 55.48, 55.31, 35.33. HRMS (m/z): [M+Na]+ calcd for 
C64H64O15S, 1127.3863; found, 1127.3816. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-(2,6-dimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-
O-tribenzoyl-α-D-glucopyranoside (18c): Via general procedure E. Silicagel flash column chromatography (0% - 
25% diethyl ether in toluene) afforded 18c as an anomeric mixture (39 mg, 37%). TLC: 
(EtOAc/n-heptane, 50/50 v/v): Rf = 0,68; 1H NMR (500 MHz, CDCl3) δ 8.01 – 7.81 (m, 6H), 
7.53 – 7.12 (m, 25H), 6.47 (d, J = 8.4 Hz, 2H), 6.11 (t, J = 9.8 Hz, H-3’), 5.45 (t, J = 9.9 
Hz, H-4’), 5.23 (dd, J = 10.2, 3.6 Hz, H-2’), 5.11 (d, J = 3.5 Hz, H-1’), 4.92 (d, J = 3.2 Hz, 
H-1), 4.87 (d, J = 11.4 Hz, 1H), 4.74 (d, J = 12.1 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.52 
(d, J = 11.3 Hz, 1H), 4.42 – 4.32 (dd, 2H), 4.30 (t, J = 9.3 Hz, H-5’), 4.01 (t, J = 6.5 Hz, 
H-5), 3.92 – 3.83 (m, H-2, H-4, H-6a’), 3.83 – 3.62 (m, 8H, H-3, H-6b’), 3.45 (t, J = 6.1 Hz, H-6a, H-6b), 3.33 (s, 3H), 
3.06 – 2.87 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 165.77, 165.39, 161.08, 138.86, 138.74, 138.11, 133.31, 133.02, 
129.93, 129.86, 129.64, 129.29, 129.15, 128.93, 128.40, 128.37, 128.27, 128.25, 128.20, 128.18, 127.68, 127.61, 
127.50, 127.43, 127.35, 103.99, 97.74 (C-1), 96.67 (C-1’), 78.21 (C-3), 77.49 (C-2), 75.17 (C-4), 74.79, 73.23, 72.77, 
72.12 (C-2’), 71.18, 70.67 (C-3’), 69.70 (C-4’), 69.22 (C-5), 68.64 (C-6), 68.31 (C-5’), 66.73 (C-6’), 56.07, 55.41, 
33.41. HRMS (m/z): [M+Na]+ calcd for C65H66O16S, 1157.3969; found, 1157.3926. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-(1→6)-
2,3,4-O-tribenzoyl-α-D-glucopyranoside (18d): Via general procedure E. Silicagel flash column chromatography 
(0% - 30%  EtOAc in n-heptane) afforded 18d (45 mg, 59%). TLC: (EtOAc/n-heptane, 
50/50 v/v): Rf = 0,64; 1H NMR (400 MHz, CDCl3) δ 8.02 – 7.80 (m, 6H), 7.54 – 7.21 (m, 
24H), 6.14 – 6.01 (m, 2H, H-3'), 5.48 – 5.41 (m, H-4'), 5.23 (dd, J = 10.2, 3.7 Hz, H-2'), 
5.12 (t, J = 3.8 Hz, H-1'), 4.94 (d, J = 3.3 Hz, H-1), 4.88 (d, J = 11.4 Hz, 1H), 4.75 (d, J 
= 12.0 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 11.4 Hz, 1H), 4.43 – 4.27 (m, 2H, 
H-5'), 4.01 (t, J = 6.7 Hz, H-5), 3.91 – 3.77 (m, 3H, H-2, H-3, H-4, H-6'), 3.77 – 3.63 (m, 
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8H, H2-6'), 3.45 (dd, J = 6.5, 3.4 Hz, H2-6), 3.32 (s, 3H), 3.02 – 2.71 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 165.79, 
165.76, 165.41, 162.08, 161.77, 138.91, 138.76, 138.14, 133.32, 133.03, 129.95, 129.87, 129.66, 129.31, 129.17, 
128.94, 128.41, 128.38, 128.28, 128.26, 128.24, 128.20, 127.69, 127.62, 127.51, 127.45, 127.36, 97.77 (C-1), 96.68 
(C-1'), 90.92, 78.23 (C-3), 77.55 (C-2), 75.22 (C-4), 74.80, 73.24, 72.82, 72.14 (C-2'), 71.18, 70.68 (C-3'), 69.71 (C-
4'), 69.23 (C-5), 68.66 (C-6), 68.32 (C-5'), 66.74 (C-6'), 56.03, 55.41, 55.35. HRMS (m/z): [M+Na]+ calcd for 
C66H68O17S, 1187.4074; found, 1187.4038. 
 
3,4,6-Tri-O-(4-chlorobenzyl)-D-glucal (20a):  
Via general procedure A starting from D-glucal (8) (2.0 g, 13.7 mmol) using 4-chlorobenzyl chloride 
(11.0 g, 68 mmol) as the benzylating agent. The crude product was purified by silicagel flash column 
chromatography (0% to 20% EtOAc in n-heptane) yielding 20a (6.23 g, 88%). TLC (EtOAc/n-heptane 
40/60 v/v): Rf = 0.76. 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.19 (m, 11H), 7.16 – 7.10 (m, 2H), 6.41 (dd, J = 6.1, 1.4 
Hz, 1H, H-1), 4.85 (dd, J = 6.2, 2.6 Hz, 1H, H-2), 4.75 (d, J = 11.6 Hz, 1H), 4.58 (d, J = 11.8 Hz, 2H), 4.54 (d, J = 
12.2 Hz, 1H), 4.50 – 4.45 (m, 2H), 4.18 (ddd, J = 6.3, 2.6, 1.4 Hz, 1H, H-3), 4.01 (ddd, J = 8.8, 4.8, 2.7 Hz, 1H, H-
5), 3.81 (dd, J = 8.9, 6.3 Hz, 1H, H-4), 3.77 (dd, J = 10.7, 4.8 Hz, 1H, H-6a), 3.72 (dd, J = 10.8, 2.7 Hz, 1H, H-6b). 
13C NMR (126 MHz, CDCl3) δ 144.88 (C-1), 136.77, 136.63, 136.43, 133.54, 133.49, 133.46, 129.04, 129.01, 128.96, 
128.60, 128.57, 99.73 (C-2), 76.70 (C-5), 76.01 (C-3), 74.45 (C-4), 72.93, 72.73, 69.62, 68.48 (C-6); HRMS (m/z): 
[M+Na]+ calcd for C27H25Cl3O4, 541.0716; found, 541.0707. 
 
3,4,6-Tri-O-(2,4-dichlorobenzyl)-D-glucal (20b):  
Via general procedure A starting from D-glucal (8) (1.7 g, 11.6 mmol) using 2,4-dichloro-1-
(chloromethyl)benzene as the benzylating agent. The crude product was purified by silicagel flash 
column chromatography (0% to 20% EtOAc in n-heptane) yielding 20b (6.39 g, 90%). TLC 
(EtOAc/n-heptane 40/60 v/v): Rf = 0.76. 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.26 (m, 9H), 7.25 – 7.15 (m, 3H), 6.45 
(dd, J = 6.1, 1.4 Hz, 1H, H-1), 4.92 (dd, J = 6.2, 2.5 Hz, 1H, H-2), 4.89 (d, J = 12.7 Hz, 1H), 4.73 (d, J = 12.8 Hz, 
1H), 4.71 – 4.66 (m, 1H), 4.63 (d, J = 13.4 Hz, 1H), 4.56 (dd, J = 13.1, 3.7 Hz, 2H), 4.28 (ddd, J = 6.4, 2.6, 1.4 Hz, 
1H, H-3), 4.07 (ddd, J = 9.1, 4.5, 2.6 Hz, 1H, H-5), 3.95 – 3.87 (m, 2H, H-4, H-6a), 3.82 (dd, J = 10.7, 2.7 Hz, 1H, H-
6b). 13C NMR (126 MHz, CDCl3) δ 145.03 (C-1), 134.53, 134.50, 134.34, 133.94, 133.87, 133.75, 133.36, 133.33, 
133.23, 129.95, 129.89, 129.81, 129.69, 129.63, 129.15, 129.07, 129.05, 129.01, 127.18, 127.10, 127.07, 127.03, 
99.59 (C-2), 76.69 (C-3), 76.61 (C-5), 74.64 (C-4), 71.03, 70.19, 69.87, 69.31, 68.95 (C-6), 66.97. HRMS (m/z): 
[M+Na]+ calcd for C27H22Cl6O4, 642.9547; found, 642.9545. 
 
3,4,6-Tri-O-(2,6-dichlorobenzyl)-D-glucal (20c):  
Via general procedure A starting from D-glucal (8) (1.00 g, 6.84 mmol) using 2-(bromomethyl)-
1,3-dichlorobenzene as the benzylating agent. The crude product was purified by silicagel flash 
column chromatography (0% to 20% EtOAc in n-heptane) yielding 20c (3.80 g, 89%). TLC 
(EtOAc/n-heptane 40/60 v/v): Rf = 0.71. 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.26 (m, 8H, CH Ar), 7.22 – 7.12 (m, 4H, 
CH Ar), 6.44 (dd, J = 6.1, 1.3 Hz, 1H, H-1), 5.14 (d, J = 10.5 Hz, 1H), 4.97 (dd, J = 6.2, 2.9 Hz, 1H, H-2), 4.91 – 4.84 
(m, 3H), 4.82 (d, J = 10.9 Hz, 1H), 4.77 (d, J = 10.8 Hz, 1H), 4.30 – 4.25 (m, 1H, H-3), 4.11 (ddd, J = 9.1, 5.9, 3.6 
Hz, 1H, H-5), 3.87 – 3.77 (m, 3H, H-4, H-6). 13C NMR (126 MHz, CDCl3) δ 144.89 (C-1), 137.01, 136.92, 136.85, 
133.58, 133.50, 133.36, 129.95, 129.88, 129.77, 128.44, 128.33, 128.30, 99.36 (C-2), 76.32 (C-5), 75.76 (C-3), 
74.72 (C-4), 69.46 (C-6), 67.71, 67.55, 66.94, 64.67. HRMS (m/z): [M+Na]+ calcd for C27H22Cl6O4, 642.9547; found, 
642.9528. 
 
3,4,6-tri-O-(4-chlorobenzyl)-β-D-galactal (21a): 
Via general procedure A and 4-chlorobenzylbromide. Silicagel flash column chromatography (0% - 30% 
EtOAc in n-heptane) afforded 21a (0.12 gr, 47%). TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0,37; 1H 
NMR (500 MHz, CDCl3) δ 7.25 (m, 12H), 6.36 (dd, J = 6.3, 1.4 Hz, H-1), 4.84 (ddd, J = 6.3, 3.0, 1.2 
Hz, H-2), 4.79 (d, J = 12.0 Hz, 1H), 4.61 (d, J = 12.1 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 12.1 Hz, 1H), 
4.49 (d, J = 12.1 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.17 (m, H-3, H-5), 3.91 (m, H-4), 3.74 (dd, J = 10.1, 7.2 Hz, H-
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6a), 3.63 (dd, J = 10.1, 5.1 Hz, H-6b). 13C NMR (126 MHz, CDCl3) δ 144.30 (C-1), 136.84, 136.73, 136.37, 133.54, 
133.52, 133.38, 132.57, 129.24, 129.12, 128.69, 128.58, 128.56, 128.50, 99.59 (C-2), 75.46 (C-5), 72.63, 72.54, 
71.63 (C-4), 70.78 (C-3), 70.18, 68.22 (C-6); HRMS (m/z): [M+Na]+ calcd for C27H25Cl3O4, 541.0716; found, 541.0709. 
 
3,4,6-tri-O-(2,4-dichlorobenzyl)-β-D-galactal (21b): 
Via general procedure A and 2,4-dichlorobenzylchloride. Silicagel flash column chromatography 
(0% - 30% EtOAc in n-heptane) afforded 21b (3.88 g, 46%). TLC: (EtOAc/n-heptane, 30/70 
v/v): Rf = 0,60; 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.15 (m, 9H), 6.41 (dd, J = 6.2, 1.3 Hz, H-
1), 4.93 – 4.87 (m, 1H, H-2), 4.72 (d, J = 6.6 Hz, 1H), 4.69 (d, J = 6.6 Hz, 1H), 4.66 – 4.58 (m, 2H), 4.51 (d, J = 13.0 
Hz, 1H), 4.32 – 4.26 (m, H-3, H-5), 4.08 – 4.04 (m, H-4), 3.87 – 3.76 (m, H-6a, H-6b). 13C NMR (126 MHz, CDCl3) δ 
144.43 (C-1), 134.70, 134.65, 134.22, 133.95, 133.76, 133.61, 133.12, 133.02, 130.07, 130.01, 129.56, 129.15, 
129.01, 128.90, 127.11, 127.07, 99.52 (C-2), 75.30 (C-5), 72.37 (H-4), 71.64 (C-3), 69.97, 69.86, 68.58 (C-6), 67.77; 
HRMS (m/z): [M+Na]+ calcd for C27H22Cl6O4, 642.9547; found, 642.9545. 
 
3,4,6-tri-O-(2,6-dichlorobenzyl)-β-D-galactal (21c): 
Via general procedure A and 2,6-dichlorobenzylchloride. Silicagel flash column chromatography 
(0% - 30% EtOAc in n-heptane) afforded 21c (7.80 g, 92%). TLC: (EtOAc/n-heptane, 30/70 
v/v): Rf = 0,60; 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.09 (m, 9H), 6.34 (dd, J = 6.2, 1.3 Hz, H-
1), 5.13 (d, J = 10.6 Hz, 1H), 4.99 – 4.87 (m, 2H, H-2), 4.84 (d, J = 10.5 Hz, 1H), 4.78 – 4.69 (m, 2H), 4.27 (m, H-3, 
H-5), 4.06 – 4.00 (m, H-4), 3.92 – 3.74 (m, H-6a, H-6b). 13C NMR (101 MHz, CDCl3) δ 144.11 (C-1), 137.13, 136.99, 
136.94, 133.97, 133.79, 133.38, 129.81, 129.77, 128.35, 128.31, 128.30, 99.81 (C-2), 75.67 (C-5), 73.10 (C-4), 
72.06 (C-3), 68.67 (C-6), 67.63, 67.57, 66.63. HRMS (m/z): [M+Na]+ calcd for C27H22Cl6O4, 642.9547; found, 
642.9544. 
 
2,4,6-trimethoxyphenyl 3,4,6-Tri-O-(4-chlorobenzyl)-1-thio-β-D-glucopyranoside (22a): via general 
procedure B starting from 20a (1.0 g, 1.9 mmol). The crude product was purified by silicagel 
flash column chromatography (0% to 30% EtOAc in n-heptane) to afford 22a as white solid 
(0.84 g, 61%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.52. 1H NMR (500 MHz, CDCl3) δ 7.28 
– 7.19 (m, 8H), 7.12 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.11 (s, 2H), 4.99 (d, J = 11.4 Hz, 1H), 4.75 – 4.62 
(m, 2H), 4.50 (d, J = 11.7 Hz, 1H), 4.47 (d, J = 11.3 Hz, 1H), 4.38 (d, J = 11.7 Hz, 1H), 4.18 (d, J = 9.4 Hz, 1H, H-
1), 3.85 (d, J = 2.0 Hz, 1H), 3.81 (s, 9H), 3.77 – 3.73 (m, 2H, H-6a, H-6b), 3.56 (t, J = 8.7 Hz, 1H, H-3), 3.47 (t, J = 
9.2 Hz, 1H, H-4), 3.42 (dt, J = 9.7, 2.5 Hz, 1H, H-5), 3.26 (td, J = 9.1, 2.0 Hz, 1H, H-2). 13C NMR (126 MHz, CDCl3) δ 
163.13, 163.02, 137.32, 136.93, 136.74, 133.34, 133.26, 133.24, 129.20, 129.00, 128.90, 128.42, 128.39, 91.46, 
88.41 (C-1), 85.44 (C-3), 79.88 (C-5), 76.74 (C-4), 74.22, 74.05, 73.24 (C-2), 72.90, 69.03 (C-6), 56.33, 55.38; 
HRMS (m/z): [M+Na]+ calcd for C36H37Cl3O8S, 757.1172; found, 757.1148. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-β-D-glucopyranoside (22b): via general 
procedure B starting from 20a (2.01 g, 3.22 mmol). The crude product was purified by 
silicagel flash column chromatography (0% to 30% EtOAc in n-heptane) to afford 22b as 
white solid (1.35 g, 50%).  TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.52. 1H NMR (500 MHz, 
CDCl3) δ 7.41 (d, J = 8.2 Hz, 1H), 7.33 (d, J = 2.0 Hz, 1H), 7.27 (d, J = 2.1 Hz, 1H), 7.25 – 7.23 (m, 2H), 7.18 – 7.13 
(m, 3H), 7.09 (dd, J = 8.3, 2.1 Hz, 1H), 6.12 (s, 2H), 5.08 (d, J = 12.8 Hz, 1H), 4.77 (m, 2H), 4.58 (d, J = 12.8 Hz, 
1H), 4.52 (d, J = 12.9 Hz, 1H), 4.46 (d, J = 12.8 Hz, 1H), 4.20 (d, J = 9.5 Hz, 1H, H-1), 3.85 (d, J = 2.0 Hz, 1H), 3.81 
(m, 11H, H-6a, H-6b), 3.62 (t, J = 8.7 Hz, 1H, H-3), 3.55 (dd, J = 9.7, 8.7 Hz, 1H, H-4), 3.46 (dt, J = 9.7, 2.6 Hz, 1H, 
H-5), 3.27 (ddd, J = 9.5, 8.7, 2.0 Hz, 1H, H-2). 13C NMR (126 MHz, CDCl3) δ 163.17, 163.05, 135.21, 134.74, 134.73, 
133.67, 133.63, 133.57, 133.35, 133.21, 132.97, 130.14, 130.03, 129.63, 128.93, 128.85, 126.99, 126.89, 96.05, 
91.49, 88.42 (C-1), 85.70 (C-3), 79.39 (C-5) 76.74 (C-4), 73.17 (C-2), 71.22, 71.13, 69.99, 69.62 (C-6), 56.37, 55.42. 
HRMS (m/z): [M+Na]+ calcd for C36H34Cl6O8S, 859.0003; found, 858.9974. 
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2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-1-thio-β-D-glucopyranoside (22c):  
Via general procedure B starting from 20c (1.98 g; 3.18 mmol). The crude product was 
purified by silicagel flash column chromatography (0% to 30% EtOAc in n-heptane) yielding 
the products 22c (1.011 g; 1.20 mmol; 38%) and 58b (0.335 g; 0.399 mmol; 12%).  TLC 
(EtOAc/n-heptane 20/80 v/v): Rf = 0.48. 1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 
2H), 7.14 (td, J = 8.9, 7.5 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 6.94 (dd, J = 8.5, 7.5 Hz, 1H), 6.10 (s, 2H), 5.40 (d, J = 
10.7 Hz, 1H), 5.06 (d, J = 10.7 Hz, 1H), 4.93 (d, J = 11.3 Hz, 1H), 4.85 (d, J = 11.3 Hz, 1H), 4.63 (d, J = 10.6 Hz, 
1H), 4.55 (d, J = 10.5 Hz, 1H), 4.21 (d, J = 9.6 Hz, 1H, H-1), 3.83 (d, J = 2.2 Hz, 1H), 3.80 (s, 6H), 3.76 (s, 3H), 3.74 
(t, J = 8.4 Hz, 1H, H-3), 3.71 – 3.68 (m, 2H, H-6), 3.51 (dd, J = 9.9, 8.3 Hz, 1H, H-4), 3.43 (ddd, J = 9.9, 3.5, 2.4 Hz, 
1H, H-5), 3.34 (ddd, J = 9.5, 8.5, 2.2 Hz, 1H, H-2). 13C NMR (126 MHz, CDCl3) δ 163.15, 162.94, 136.91, 136.87, 
136.72, 134.51, 134.05, 133.91, 129.53, 129.49, 129.39, 128.29, 128.09, 128.04, 91.34, 88.14 (C-1), 85.99 (C-3), 
80.43 (C-5), 76.30 (C-4), 73.21 (C-2), 70.12 (C-6), 68.53, 68.11, 56.25, 55.36; HRMS (m/z): [M+Na]+ calcd for 
C36H34O8SCl6, 859.0003; found, 859.0004. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(4-chlorobenzyl)-1-thio-β-D-galactopyranoside (23a):  
Via general procedure B and 2,4,6-trimethoxythiophenol. Silicagel flash column chromatography 
(0% - 20% - Et2O in toluene) afforded 23a (0.85 g, 60%). TLC: (Et2O/toluene, 20/80 v/v): Rf = 
0,39; 1H NMR (500 MHz, CDCl3) δ 7.36 – 6.98 (m, 12H), 6.17 (s, 2H), 4.82 (d, J = 11.9 Hz, 
1H), 4.80 (d, J = 11.9 Hz, 1H), 4.69 – 4.63 (m, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.39 (d, J = 11.9 
Hz, 1H), 4.34 (d, J = 11.9 Hz, 1H), 4.15 (d, J = 9.3 Hz, H-1), 3.86 – 3.78 (m, 9H, H-4), 3.73 – 3.65 (m, H-2), 3.61 – 
3.49 (m, H-5, H-6a, H-6b), 3.43 (dd, J = 9.4, 2.8 Hz, H-3). 13C NMR (126 MHz, CDCl3) δ 162.99, 162.89, 137.53, 
137.22, 136.36, 133.58, 133.20, 132.73, 129.12, 128.76, 128.57, 128.48, 128.21, 128.13, 97.46, 91.53, 90.60, 89.82 
(C-1), 82.58 (C-3), 77.23 (C-5), 74.41 (C-4), 73.17, 72.68, 72.10, 70.25 (C-2), 68.30 (C-6), 56.42, 56.00, 55.40. 
HRMS (m/z): [M+Na]+ calcd for C36H37Cl3O8S, 757.1172; found, 757.1148. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-β-D-galactopyranoside (23b):  
Via general procedure B and 2,4,6-trimethoxythiophenol. Silicagel flash column 
chromatography (0% - 20% - Et2O in toluene) afforded 23b (0.70 g, 26%). TLC: 
(Et2O/toluene, 20/80 v/v): Rf = 0,49; 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.00 (m, 9H), 6.19 
(s, 2H), 4.92 (d, J = 13.3 Hz, 1H), 4.85 (d, J = 13.5 Hz, 1H), 4.75 (d, J = 13.4 Hz, 1H), 4.54 
(d, J = 12.7 Hz, 1H), 4.48 (d, J = 13.5 Hz, 1H), 4.44 (d, J = 12.7 Hz, 1H), 4.20 (d, J = 9.0 Hz, H-1), 3.96 (d, J = 2.5 
Hz, H-4), 3.89 – 3.75 (m, 9H), 3.71 – 3.56 (m, H-2, H-5, H-6a, H-6b), 3.53 (dd, J = 9.2, 2.5 Hz, H-3). 13C NMR (126 
MHz, CDCl3) δ 163.15, 162.94, 135.49, 134.99, 134.09, 134.04, 133.76, 133.59, 133.11, 132.96, 131.99, 130.24, 
129.83, 129.16, 129.03, 128.94, 128.85, 128.43, 128.22, 127.05, 126.78, 125.29, 97.14, 91.46, 89.54 (C-1), 82.91 
(C-3), 76.84 (C-5), 74.76 (C-4), 70.59, 70.07 (C-2), 69.90, 69.65, 68.38 (C-6), 56.44, 55.38. HRMS (m/z): [M+Na]+ 
calcd for C36H34Cl6O8S, 859.0003; found, 859.0024. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-1-thio-α/β-D-galactopyranoside (23c):  
Via general procedure B and 2,4,6-trimethoxythiophenol. Silicagel flash column 
chromatography (0% - 25% - diethyl ether in toluene) afforded 23c (0.98 g, 51%). TLC: 
(Diethylether/toluene, 20/80 v/v): Rf = 0,52; 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.00 (m, 
18H), 6.06 (s, 4H), 5.51 (d, J = 5.4 Hz, H-1(α)), 5.30 (d, J = 9.8 Hz, 1H), 5.21 (d, J = 10.6 
Hz, 1H), 5.13 (dd, J = 13.1, 10.2 Hz, 2H), 4.98 (d, J = 10.3 Hz, 1H), 4.90 (d, J = 10.6 Hz, 1H), 4.82 (d, J = 9.8 Hz, 
1H), 4.74 (d, J = 10.7 Hz, 1H), 4.71 – 4.66 (m, 3H), 4.63 (d, J = 10.1 Hz, 1H), 4.55 (dd, J = 8.0, 5.0 Hz, H-5(α)), 4.43 
(dt, J = 9.7, 4.7 Hz, H-2(α)), 4.23 – 4.17 (m, H-1(β), H-4(α)), 3.91 (d, J = 7.7 Hz, H-3(α), H-4(β)), 3.85 – 3.67 (m, 
18H, H-2(β), H-6a(α), H-6a(β)), 3.57 (m, H-3(β), H-5(β), H-6b(β)), 3.51 – 3.48 (s, OH(β)), 3.29 (dd, J = 8.7, 4.8 Hz, 
H-6b(α)), 2.89 (d, J = 4.6 Hz, OH(α)). 13C NMR (126 MHz, CDCl3) δ 162.79, 162.67, 162.63, 162.36, 162.29, 162.14, 
137.85, 137.12, 136.96, 136.91, 136.87, 136.86, 136.80, 134.41, 134.21, 134.10, 133.55, 133.45, 133.41, 130.06, 
129.94, 129.91, 129.76, 129.65, 129.36, 129.05, 128.45, 128.37, 128.34, 128.24, 128.15, 127.93, 125.32, 105.89, 
98.85, 98.25, 91.61, 90.89, 90.63, 89.87 (C-1(β)), 88.20 (C-1(α)), 84.31 (C-3(β)), 81.50 (C-3(α)), 77.94 (C-5(β)), 
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75.32 (C-4(β)), 74.45 (C-4(α)), 71.10 (C-5(α)), 70.49 (C-2(β)), 69.18 (C-6(β)), 69.11 (C-2(α), 68.90, 68.54, 68.52 
(C-6(α)), 68.40, 67.55, 67.47, 67.43, 56.38, 56.01, 55.98, 55.42, 55.34, 55.33. HRMS (m/z): [M+Na]+ calcd for 
C36H34Cl6O8S, 859.0003; found, 859.0031. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(4-chlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside 
(24a): via general procedure C starting from 22a (0.18 g; 0.21 mmol). The crude product was 
purified by silicagel flash column chromatography (20% to 60% EtOAc in n-heptane) affording 
24a as a white solid (0.11 g, 59%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.24. 1H NMR (500 
MHz, CDCl3) δ 7.31 – 7.19 (m, 9H), 7.18 – 7.13 (m, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.12 (s, 2H), 
4.84 (d, J = 11.3 Hz, 1H), 4.75 (d, J = 11.3 Hz, 1H), 4.66 (d, J = 11.3 Hz, 1H), 4.49 (d, J = 11.3 Hz, 1H), 4.45 (d, J = 
11.9 Hz, 1H), 4.42 (d, J = 12.0 Hz, 1H), 4.39 (d, J = 9.9 Hz, 1H, H-1), 4.01 (ddd, J = 10.7, 5.5, 2.5 Hz, 1H), 3.93 (ddd, 
J = 10.7, 6.8, 2.5 Hz, 1H), 3.82 (s, 6H), 3.80 (s, 3H), 3.74 – 3.68 (m, 1H), 3.67 (dd, J = 11.4, 2.0 Hz, 1H, H-6a), 3.63 
– 3.51 (m, 2H, H-3, H-6b), 3.45 (t, J = 9.4 Hz, 1H, H-4), 3.37 – 3.28 (m, 2H, H-2, H-5); 13C NMR (126 MHz, CDCl3) δ 
162.35, 162.06, 136.78, 136.64, 136.32, 133.56, 133.54, 133.28, 129.14, 128.89, 128.61, 128.54, 128.40, 99.68, 
91.15, 88.48 (C-1), 87.04 (C-4), 81.69 (C-2), 79.42 (C-5), 78.05 (C-3), 74.84, 74.73, 73.98, 72.78, 69.39 (C-6), 
61.83, 56.18, 55.33; HRMS (m/z): [M+Na]+ calcd for C38H41Cl3O9S, 801.1435; found, 801.1399. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-gluco-
pyranoside (24b): via general procedure C starting from 22b (0.56 g; 0.67 mmol). The crude product was purified 
by silicagel flash column chromatography (30% to 60% EtOAc in n-heptane) affording 24b 
as a white solid (0.45 g, 76%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.35. 1H NMR (500 
MHz, CDCl3) δ 7.39 (d, J = 8.3 Hz, 1H), 7.33 (d, J = 2.1 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 
7.29 (d, J = 2.1 Hz, 1H), 7.24 (d, J = 2.0 Hz, 1H), 7.19 (dd, J = 8.3, 2.1 Hz, 1H), 7.18 – 
7.13 (m, 2H), 7.10 (dd, J = 8.3, 2.0 Hz, 1H), 6.12 (s, 2H), 4.92 (d, J = 13.1 Hz, 1H), 4.81 (d, J = 13.1 Hz, 1H), 4.71 
(d, J = 12.7 Hz, 1H), 4.59 (d, J = 12.7 Hz, 1H), 4.54 (d, J = 13.0 Hz, 1H), 4.47 (d, J = 13.0 Hz, 1H), 4.41 (d, J = 9.9 
Hz, 1H, H-1), 4.01 – 3.87 (m, 2H), 3.83 (s, 6H), 3.80 (s, 3H), 3.79 – 3.67 (m, 5H, H-6), 3.64 (t, J = 8.8 Hz, 1H, H-3), 
3.55 (t, J = 9.4 Hz, 1H, H-4), 3.49 (s, 1H), 3.41 – 3.32 (m, 2H, H-2, H-5); 13C NMR (126 MHz, CDCl3) δ 162.39, 162.09, 
134.72, 134.63, 134.28, 133.90, 133.68, 133.35, 133.12, 132.71, 130.12, 129.73, 129.27, 128.98, 128.94, 128.92, 
127.11, 127.00, 126.98, 99.74 , 91.18, 88.66 (C-1), 87.24 (C-3), 81.73 (C-2), 79.03 (C-5), 78.10 (C-4), 74.89, 71.66, 
71.10, 70.00 (C-6), 61.85, 56.23, 55.35. HRMS (m/z): [M+Na]+ calcd for C38H38Cl6O9S, 903.0265; found, 903.0224. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-gluco-
pyranoside (24c): via general procedure C starting from 22c (0.18 g; 0.21 mmol). The crude product was purified by 
silicagel flash column chromatography (20% to 60% EtOAc in n-heptane) affording 24c as 
a white solid (0.11 g, 59%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.27. 1H NMR (500 
MHz, CDCl3) δ 7.31 (d, J = 8.0 Hz, 2H), 7.28 – 7.20 (m, 4H), 7.20 – 7.03 (m, 3H), 6.01 (s, 
2H), 5.22 – 5.07 (m, 2H), 4.90 (s, 2H), 4.55 – 4.42 (m, 2H), 4.40 (d, J = 9.9 Hz, 1H, H-1), 
3.96 – 3.82 (m, 2H), 3.78 (m, 7H, H-3), 3.73 – 3.62 (m, 5H, H-6a), 3.59 (dd, J = 11.1, 5.6 Hz, 1H), 3.54 – 3.45 (m, 
2H, H-4, H-6b), 3.43 – 3.28 (m, 3H, H-2, H-5). 13C NMR (126 MHz, CDCl3) δ 162.27, 162.07, 136.75, 136.71, 134.38, 
133.91, 133.77, 129.86, 129.81, 129.57, 128.38, 128.17, 99.56, 91.06, 88.24 (C-1), 87.88 (C-3), 81.68 (C-2), 79.97 
(C-5), 78.40 (C-4), 74.25 (C-7), 70.55 (C-6), 69.54, 68.62, 67.69, 62.04, 56.13, 55.16. HRMS (m/z): [M+Na]+ calcd 
for C38H38O9SCl6, 903.0265; found, 903.0276. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(4-cyanobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-glucopyranoside 
(24d): 24a (0.2 mmol), tBuXPhos-Pd-G3 (0.01 mmol, 5 mol%), tBuXPhos (0.01 mmol, 5 
mol%) and K4[Fe(CN)6]·3H2O (0.3 mmol) were added to a solution of dioxane (1.3 mL) and 
0.05 M KOAc in degassed water (1.3 mL) The mixture was vigorously at 100°C for 4h. The 
reaction was cooled to rt and diluted with EtOAc (50 mL) and brine (50 mL). The aqueous 
layer was further extracted with EtOAc (2x 25 mL). The combined organic layers were dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue was purified using silicagel flash column chromatography (0-80% 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 77
A Novel Synthetic Route for Stereoselective Glycosylation
3
77
 
77 
EtOAc in n-heptane to obtain the product 24d (0.16 g, 93%). TLC: (EtOAc/n-heptane, 60/40 v/v): Rf = 0,16. 1H NMR 
(500 MHz, CDCl3) δ 7.61 – 7.22 (m, 12H), 6.13 (s, 2H), 4.96 (d, J = 12.5 Hz, 1H), 4.79 (d, J = 12.5 Hz, 1H), 4.74 (d, 
J = 12.5 Hz, 1H), 4.62 (d, J = 12.5 Hz, 1H), 4.53 (q, J = 12.8 Hz, 2H), 4.45 (d, J = 9.9 Hz, H-1), 3.96 (dd, J = 5.2, 2.7 
Hz, 2H), 3.82 (d, J = 6.5 Hz, 9H), 3.69 (m, 1H, H-6a, H-6b), 3.61 (t, J = 8.9 Hz, H-3), 3.51 (t, J = 9.4 Hz, H-4), 3.41 
– 3.33 (m, H-2, H-5). 13C NMR (126 MHz, CDCl3) δ 162.47, 162.07, 143.77, 143.42, 143.17, 132.29, 132.22, 132.11, 
127.81, 127.49, 127.39, 118.74, 118.56, 118.50, 111.64, 111.61, 111.34, 99.42, 91.22, 88.26 (C-1), 87.21 (C-3), 
81.88 (C-2), 79.25 (C-5), 78.27 (C-4), 74.92, 74.39, 73.71, 72.70, 69.72 (C-6), 61.87, 56.25, 55.40.δ HRMS (m/z): 
[M+Na]+ calcd for C41H41N3O9S, 774.2461; found, 774.2465. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(4-chlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside 
(25a): Via general procedure C. Silicagel flash column chromatography (0% - 50% Et2O in 
toluene) afforded 25a (0.51 g, 85%). TLC: (Et2O/toluene, 30/70 v/v): Rf = 0,21; 1H NMR (500 
MHz, CDCl3) δ 7.35 – 7.09 (m, 12H), 6.11 (s, 2H), 4.78 (d, J = 11.9 Hz, 1H), 4.63 (m, 2H), 4.48 
(d, J = 11.9 Hz, 1H), 4.39 (d, J = 11.7 Hz, 1H), 4.32 – 4.27 (m, 1H, H-1), 4.04 (ddd, J = 10.9, 
5.6, 2.3 Hz, 1H), 3.96 – 3.89 (m, 1H), 3.81 – 3.72 (m, 10H, H-4), 3.68 (t, J = 9.5 Hz, 1H), 3.60 
– 3.51 (m, H-6a, H-6b), 3.49 – 3.39 (m, H-3, H-5). 13C NMR (126 MHz, CDCl3) δ 162.29, 162.14, 137.04, 136.40, 
136.39, 133.63, 133.58, 133.22, 129.20, 128.99, 128.77, 128.69, 128.54, 128.33, 100.47, 91.13, 89.75 (C-1), 84.57 
(C-3), 78.18 (C-2), 77.19 (C-5), 75.13, 73.77 (C-4), 73.64, 72.72, 71.62, 69.00 (C-6), 61.76, 56.15, 55.36. HRMS 
(m/z): [M+Na]+ calcd for C38H41Cl3O9S, 801.1434; found, 801.1419. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-galacto-
pyranoside (25b): Via general procedure C. Silicagel flash column chromatography (0% - 20% Et2O in toluene) 
afforded 25b (0.39 g, 74%). TLC: (Et2O/toluene, 30/70 v/v): Rf = 0,37; 1H NMR (500 MHz, 
CDCl3) δ 7.48 – 7.10 (m, 9), 6.13 (s, 2H), 4.91 (d, J = 13.2 Hz, 1H), 4.75 (m, 2H), 4.55 (d, 
J = 13.2 Hz, 1H), 4.51 (d, J = 12.6 Hz, 1H), 4.40 (d, J = 12.6 Hz, 1H), 4.33 (d, J = 9.8 Hz, 
H-1), 4.05 – 3.99 (m, 1H, H-4), 3.93 – 3.87 (m, 1H), 3.86 – 3.75 (m, 10H), 3.76 – 3.64 (m, 
1H, H-6a, H-2), 3.61 (dd, J = 9.3, 5.5 Hz, H-6b), 3.58 – 3.50 (m, H-3, H-5). 13C NMR (126 
MHz, CDCl3) δ 162.39, 162.22, 135.04, 134.23, 134.12, 134.04, 133.85, 133.39, 133.20, 132.36, 130.36, 129.76, 
129.75, 129.17, 129.13, 129.03, 128.63, 128.22, 127.28, 127.01, 127.00, 125.29, 100.33, 91.13, 89.99 (C-1), 84.92 
(C-3), 78.18 (C-2), 76.71 (C-5), 75.20, 74.60 (C-4), 71.11, 69.95, 69.05, 68.91 (C-6), 61.78, 56.17, 55.38. HRMS 
(m/z): [M+Na]+ calcd for C38H38Cl6O9S, 903.0265; found, 903.0303. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-2-O-(2-hydroxyethyl)-1-thio-β-D-galacto-
pyranoside (25c): Via general procedure C. Silicagel flash column chromatography (0% - 30% Et2O in toluene) 
afforded 25c (1.0061 g, 63%). TLC: (Et2O/toluene, 30/70 v/v): Rf = 0,37; 1H NMR (500 
MHz, CDCl3) δ 7.33 – 7.05 (m, 9H), 6.05 (s, 2H), 5.31 (d, J = 9.5 Hz, 1H), 5.04 – 4.93 (m, 
2H), 4.71 (d, J = 9.5 Hz, 1H), 4.68 (s, 2H), 4.30 (d, J = 9.8 Hz, H-1), 4.15 – 4.07 (m, 1H), 
4.04 (d, J = 1.8 Hz, 1H), 3.93 – 3.65 (m, 11H, H-2, H-6a), 3.63 (dd, J = 10.0, 5.4 Hz, H-
6b), 3.56 (dd, J = 9.2, 2.4 Hz, H-3), 3.47 (t, J = 5.8 Hz, H-5). 13C NMR (126 MHz, CDCl3) δ 
162.23, 162.17, 137.05, 136.81, 136.72, 134.06, 133.58, 133.50, 130.11, 129.90, 129.70, 129.03, 128.46, 128.35, 
128.22, 128.12, 125.30, 100.58, 91.06, 89.96 (C-1), 86.15 (C-3), 77.81 (C-5), 77.70 (C-2), 75.00, 74.65 (C-4), 69.98 
(C-6), 68.60, 67.65, 67.54, 61.70, 56.24, 56.08, 55.40, 55.27, 38.34. HRMS (m/z): [M+Na]+ calcd for C38H38Cl6O9S, 
903.0265; found, 903.0278. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(4-cyanobenzyl)- 2-O-(2-hydroxyethyl)-1-thio-β-D-galactopyranoside 
(25d): 25a (0.2 mmol), tBuXPhos-Pd-G3 (0.01 mmol, 5 mol%), tBuXPhos (0.01 mmol, 5 
mol%) and K4[Fe(CN)6]·3H2O (0.3 mmol) were added to a solution of dioxane (1.3 mL) and 
0.05 M KOAc in degassed water (1.3 mL) The mixture was vigorously at 100°C for 4h. The 
reaction was cooled to rt and diluted with EtOAc (50 mL) and brine (50 mL). The aqueous layer 
was further extracted with EtOAc (2x 25 mL). The combined organic layers were dried (MgSO4), 
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filtered and concentrated under reduced pressure. The residue was purified using silicagel flash column chromatography 
(0-100% EtOAc in n-heptane to obtain the product 25d (0.16 g, 93%). (0.169 g, 88%).TLC: (EtOAc/n-heptane, 60/40 
v/v): Rf = 0,08. 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.24 (m, 12H), 6.13 (s, 1H), 4.92 (d, J = 12.7 Hz, 1H), 4.79 (s, 
2H), 4.57 (d, J = 12.7 Hz, 1H), 4.50 (d, J = 12.7 Hz, 1H), 4.42 (d, J = 12.7 Hz, 1H), 4.35 (d, J = 9.8 Hz, H-1), 4.03 
(ddd, J = 10.7, 5.5, 2.3 Hz, 1H), 3.97 – 3.90 (m, 1H, H-4), 3.82 (m, 10H), 3.75 – 3.58 (m, 1H, H-2, H-6a, H-6b), 3.55 
– 3.48 (m, H-3, H-5). 13C NMR (126 MHz, CDCl3) δ 162.44, 162.15, 143.80, 143.29, 143.22, 132.38, 132.20, 132.09, 
127.80, 127.53, 127.41, 118.73, 118.60, 118.55, 111.73, 111.58, 111.32, 100.08, 91.15, 89.70 (C-1), 84.72 (C-3), 
78.37 (C-2), 76.94 (C-5), 75.25, 74.84 (C-4), 73.74, 72.53, 71.59, 69.33 (C-6), 61.76, 56.18, 55.41. HRMS (m/z): 
[M+Na]+ calcd for C41H41N3O9S, 774.2461; found, 774.2448. 
 
Methyl 3,4,6-tri-O-(4-chlorobenzyl)-2-O-(2-(2,4,6-trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-
(16)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (30a): via general procedure E starting from glucosyl donor 24a 
(67 mg, 0.086 mmol) and using acceptor 19. The crude product was purified by silicagel 
flash column chromatography (20% to 60% EtOAc in n-heptane) yielding 30a as an 
anomeric mixture (α/β = 7.5/1, 82 mg, 75%). TLC (/toluene 20/80 v/v): Rf = 0.61; 1H 
NMR (500 MHz, CDCl3) δ 8.00 – 7.95 (m, 2H), 7.93 – 7.90 (m, 2H), 7.87 – 7.83 (m, 
2H), 7.55 – 7.14 (m, 22H), 6.99 (d, J = 8.4 Hz, 2H), 6.16 – 6.07 (m, 3H, H-3’), 5.47 
(dd, J = 10.3, 9.5 Hz, 1H, H-4’), 5.23 (dd, J = 10.1, 3.7 Hz, 1H, H-2’), 5.17 (d, J = 3.6 Hz, 1H, H-1’), 4.93 (d, J = 3.4 
Hz, 1H, H-1), 4.82 (d, J = 11.3 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.58 (d, J = 11.3 Hz, 1H), 4.51 (d, J = 12.3 Hz, 
1H), 4.35 (d, J = 11.5 Hz, 1H), 4.34 – 4.29 (m, 1H, H-5’), 4.32 (d, J = 12.4 Hz, 1H), 3.91 – 3.74 (m, 12H, H-3, H-5, 
H-6a’), 3.72 – 3.55 (m, 4H, H-6a, H-6b’), 3.53 (dd, J = 10.1, 8.9 Hz, 1H, H-4), 3.48 (dd, J = 10.7, 2.1 Hz, 1H, H-6b), 
3.42 (s, 3H), 3.38 (dd, J = 9.7, 3.5 Hz, 1H, H-2), 2.90 (ddd, J = 12.9, 9.0, 5.8 Hz, 1H), 2.81 (ddd, J = 13.0, 9.1, 5.9 
Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 165.84, 165.73, 165.28, 162.01, 161.83, 137.27, 136.91, 136.34, 133.47, 
133.35, 133.20, 133.16, 133.04, 129.90, 129.87, 129.62, 129.21, 129.17, 129.14, 129.02, 128.84, 128.51, 128.48, 
128.39, 128.38, 128.37, 128.36, 128.24, 100.79, 96.94 (C-1), 96.68 (C-1’), 90.95, 81.30 (C-3), 81.01 (C-2), 77.32 
(C-4), 74.38, 73.73, 72.55, 72.16 (C-2’), 70.83, 70.52 (C-3’), 70.06 (C-5), 69.63 (C-4’), 68.40 (C-5’), 68.25 (C-6), 
66.70 (C-6’), 56.05, 55.52, 55.35, 33.96; HRMS (m/z): [M+Na]+ calcd for C66H65Cl3O17S, 1289.2906; found, 1289.2888. 
 
Methyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-
(16)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (30b): via general procedure E starting from glucosyl donor 24b 
(0.051 g; 0.058 mmol) using acceptor 19. The crude product was purified by silicagel 
flash column chromatography (0% to 30% EtOAc in n-heptane) yielding 24b as an 
anomeric mixture (α/β = 9/1, 69 mg, 81%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 
0.40. 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.95 (m, 2H), 7.94 – 7.89 (m, 2H), 7.88 – 
7.83 (m, 2H), 7.54 – 7.45 (m, 2H), 7.45 – 7.27 (m, 12H), 7.25 – 7.08 (m, 6H), 6.14 
(t, J = 9.8 Hz, 1H, H-3’), 6.09 (s, 2H), 5.48 (dd, J = 10.3, 9.5 Hz, 1H, H-4’), 5.24 (dd, J = 10.2, 3.7 Hz, 1H, H-2’), 5.19 
(d, J = 3.7 Hz, 1H, H-1’), 4.96 (d, J = 3.4 Hz, 1H, H-1), 4.90 (d, J = 12.9 Hz, 1H), 4.76 (d, J = 13.1 Hz, 1H), 4.67 (d, 
J = 12.9 Hz, 1H), 4.59 (d, J = 13.2 Hz, 1H), 4.52 (d, J = 13.1 Hz, 1H), 4.42 (d, J = 13.3 Hz, 1H), 4.35 (ddd, J = 9.8, 
7.2, 2.0 Hz, 1H, H-5’), 3.94 – 3.82 (m, 3H, H-5, H-3, H-6a’), 3.81 (s, 3H), 3.78 (s, 6H), 3.71 (dd, J = 10.9, 2.0 Hz, 1H, 
H-6b’), 3.69 – 3.52 (m, 5H, H-4, H-6), 3.46 (s, 3H), 3.42 (dd, J = 9.7, 3.4 Hz, 1H, H-2), 2.84 (dddd, J = 40.2, 12.9, 
9.2, 5.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 165.86, 165.75, 165.33, 162.00, 161.85, 135.13, 134.88, 134.28, 
133.77, 133.47, 133.46, 133.41, 133.38, 133.35, 133.15, 133.08, 132.62, 130.02, 129.93, 129.89, 129.86, 129.65, 
129.23, 129.08, 129.04, 129.03, 128.83, 128.81, 128.80, 128.42, 128.40, 128.26, 127.01, 126.87, 126.86, 100.70, 
96.94 (C-1), 96.77 (C-1’), 90.95, 81.58 (C-3), 80.97 (C-2), 77.45 (C-4), 72.17 (C-2’), 71.37, 70.96, 70.88, 70.55 (C-
3’), 70.01 (C-5), 69.76, 69.62 (C-4’), 68.87 (C-6), 68.46 (C-5’), 66.78 (C-6’), 56.05, 55.58, 55.36, 33.86. HRMS (m/z): 
[M+Na]+ calcd for C66H62Cl6O17S, 1391.1737; found, 1391.1701. 
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Methyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxyphenylthio)ethyl)-α/β-D-
glucopyranosyl-(16)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (30c): via general procedure E starting from 
glucosyl donor 24c (50 mg, 0.057 mmol) and using acceptor 19. The crude product 
was purified by silicagel flash column chromatography (0% to 40% Et2O in toluene) 
yielding 30c as an anomeric mixture (α/β = 5/1, 66 mg, 84%). TLC (Et2O/toluene 
20/80 v/v): Rf = 0.61 1H NMR (500 MHz, CDCl3) δ 7.98 (dt, J = 8.4, 1.2 Hz, 2H), 
7.94 – 7.91 (m, 2H), 7.85 (ddt, J = 7.1, 5.2, 1.6 Hz, 3H), 7.54 – 7.04 (m, 40H), 
6.16 – 6.10 (m, 2H, H-3’), 6.09 (s, 3H), 5.46 – 5.32 (m, 1H, H-4’), 5.23 (d, J = 10.2, 3.7 Hz, 1H, H-2’), 5.14 (d, J = 
3.7 Hz, 1H, H-1’), 5.09 (d, J = 11.4 Hz, 1H), 4.98 – 4.92 (m, 1H), 4.92 – 4.85 (m, 3H, H-1), 4.83 – 4.62 (m, 4H), 4.39 
– 4.26 (m, 2H, H-5’, β-H-1), 3.96 – 3.87 (m, 3H, H-6a’, H-3, H-5), 3.87 – 3.77 (m, 13H), 3.74 – 3.68 (m, 1H, H-6a), 
3.65 – 3.59 (m, 3H, H-6b’, H-6b), 3.58 – 3.53 (m, 2H, H-4), 3.47 (dd, J = 10.0, 5.3 Hz, 1H), 3.45 – 3.41 (m, 4H), 3.31 
(dd, J = 9.6, 3.4 Hz, 1H, H-2), 2.97 – 2.76 (m, 1H), 2.69 (ddd, J = 12.9, 9.9, 6.0 Hz, 1H). 13C NMR (126 MHz, CDCl3) 
δ 165.80, 165.76, 165.73, 165.38, 165.28, 162.08, 162.03, 161.99, 161.87, 161.80, 161.64, 137.85, 136.97, 136.81, 
136.74, 136.71, 136.65, 134.66, 134.60, 134.46, 134.15, 133.97, 133.86, 133.62, 133.52, 133.45, 133.27, 132.98, 
129.93, 129.79, 129.68, 129.65, 129.50, 129.45, 129.41, 129.30, 129.18, 129.16, 129.02, 128.87, 128.37, 128.33, 
128.26, 128.22, 128.18, 125.29, 104.10, 103.44 (β-C-1), 101.56, 100.74, 97.44, 96.64, 96.55 (α-C-1), 96.49 (C-1’), 
91.00, 90.90, 84.80, 82.69, 82.25, 81.86 (C-3), 81.47, 80.96 (C-2), 78.04 (C-4), 77.86, 77.80, 74.91, 74.58, 72.23 
(C-2’), 72.18, 71.66, 70.67 (C-3’), 70.60, 70.55, 70.16 (C-5), 69.86, 69.84 (C-4’), 69.69 (C-6), 69.33, 69.09, 68.92, 
68.87, 68.81, 68.61 (C-5’), 68.54, 68.46, 67.71, 67.62, 66.72 (C-6’), 56.10, 56.07, 56.04, 55.66, 55.64, 55.37, 55.35, 
55.34, 33.91, 33.65, 33.60. HRMS (m/z): [M+Na]+ calcd for C66H62Cl6O17S, 1391.1737; found, 1391.1744. 
 
Methyl 3,4,6-tri-O-(4-cyanobenzyl)-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-
(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (30d): Via general procedure E. Silicagel flash column 
chromatography (0% - 60% EtOAc in n-heptane) afforded product (64 mg, 65%). TLC: 
(Et2O/toluene, 40/60 v/v): Rf = 0,36; 1H NMR (500 MHz, CDCl3) δ 8.01 – 7.18 (m, 
27H), 6.12 (d, J = 12.3 Hz, 2H, H-3’), 5.51 (t, J = 9.9 Hz, H-4’), 5.23 (dd, J = 10.2, 
3.7 Hz, H-2’), 5.19 (d, J = 3.6 Hz, H-1’), 5.00 (d, J = 12.5 Hz, 1H), 4.97 (d, J = 3.4 Hz, 
H-1), 4.82 (d, J = 12.8 Hz, 1H), 4.67 (d, J = 12.6 Hz, 1H), 4.56 (d, J = 13.6 Hz, 2H), 
4.44 (d, J = 13.2 Hz, 1H), 4.35 – 4.29 (m, H-5’), 3.95 – 3.84 (m, H-3, H-5, H-6a’), 3.80 (d, J = 20.3 Hz, 9H), 3.75 – 
3.52 (m, 2H, H-4, H-6b’, H-6a, H-6b)), 3.44 (s, H-2), 2.92 – 2.78 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 165.90, 
165.76, 165.30, 162.00, 161.90, 144.24, 143.79, 143.42,  133.45, 133.14, 132.21, 132.14, 132.05, 129.91, 129.84, 
129.62, 129.17, 128.96, 128.86, 128.45, 128.41, 128.29, 127.78, 127.61, 127.16, 118.75, 118.67, 118.57, 111.46, 
111.41, 111.17, 100.86, 96.82 (C-1’), 96.81 (C-1), 91.03, 81.62 (C-3), 81.03 (C-2), 77.69 (C-4), 74.14, 73.53, 72.40, 
72.10 (C-2’), 70.56, 70.48 (C-3’), 69.94 (C-5), 69.53 (C-4’), 69.01 (C-6), 68.45 (C-5’), 66.68 (C-6’), 60.39, 56.08, 
55.55, 55.40, 34.18. 
 
Methyl 3,4,6-tri-O-(4-chlorobenzyl)-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-
(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (31a): Via general procedure E. Silicagel flash column 
chromatography (0% - 40%  EtOAc in n-heptane) afforded 31a (27 mg, 33%). TLC: 
(EtOAc/n-heptane, 60/40 v/v): Rf = 0,75; 1H NMR (500 MHz, CDCl3) δ 8.08 – 7.82 (m, 
6H), 7.55 – 7.05 (m, 21H), 6.10 (m, 2H, H-3’), 5.49 (t, J = 9.9 Hz, H-4’), 5.23 (dd, J = 
10.2, 3.7 Hz, H-2’), 5.15 (d, J = 3.6 Hz, H-1’), 4.95 (d, J = 3.3 Hz, H-1), 4.79 (d, J = 11.6 
Hz, 1H), 4.74 (d, J = 12.1 Hz, 1H), 4.58 (d, J = 12.1 Hz, 1H), 4.45 (d, J = 11.6 Hz, 1H), 
4.37 (d, J = 12.1 Hz, 1H), 4.33 – 4.24 (m, 1H, H-5’), 3.99 (t, J = 6.7 Hz, H-5), 3.89 – 
3.73 (m, 9H, H-2, H-3, H-4, H-6a’), 3.72 – 3.63 (m, 2H, H-6b’), 3.46 – 3.37 (m, H-6a, H-6b), 2.94 – 2.78 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 165.82, 165.75, 165.38, 162.06, 161.80, 137.32, 137.07, 136.47, 133.44, 133.35, 133.32, 
133.12, 133.05, 129.94, 129.83, 129.64, 129.32, 129.25, 129.09, 129.03, 128.92, 128.88, 128.74, 128.57, 128.43, 
128.38, 128.36, 128.26, 128.22, 125.30, 97.68 (C-1), 96.76 (C-1’), 90.93, 78.13 (C-3), 77.55 (C-2), 75.48 (C-4), 
73.99, 72.46, 72.22, 72.12 (C-2’), 70.97, 70.60 (C-3’), 69.62 (C-4’), 69.00 (C-5), 68.59 (C-6), 68.29 (C-5’), 66.70 (C-
6’), 56.05, 55.41, 55.36, 34.06. HRMS (m/z): [M+Na]+ calcd for C66H65Cl3O17S, 1289.2905; found, 1289.2852. 
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Methyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxythiophenyl)ethyl)-α-D-galactopyranosyl-
(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (31b): Via general procedure E. Silicagel flash column 
chromatography (0% - 40% EtOAc in n-heptane) afforded 31b as an anomeric 
mixture (53 mg, 68%). TLC: (EtOAc/n-heptane, 50/50 v/v): Rf = 0,50; 1H NMR (500 
MHz, CDCl3) δ 7.94 – 7.72 (m, 6H), 7.48 – 6.93 (m, 18H), 6.11 – 5.99 (m, 2H, H-3’), 
5.33 (t, J = 9.9 Hz, H-4’), 5.16 (dd, J = 10.2, 3.7 Hz, H-2’), 5.12 (d, J = 9.9 Hz, 1H), 
5.04 (d, J = 3.6 Hz, H-1’), 4.98 (d, J = 10.6 Hz, 1H), 4.81 (s, H-1), 4.72 – 4.49 (m, 
4H), 4.31 – 4.20 (m, H-5’), 4.04 (t, J = 6.3 Hz, H-5), 3.94 (s, H-4), 3.83 – 3.60 (m, 
10H, H-2, H-3, H-6a’, H-6b’, H-6a), 3.54 (td, J = 10.1, 6.0 Hz, 1H), 3.42 (dd, J = 9.3, 5.4 Hz, H-6b), 2.91 – 2.64 (m, 
2H). 13C NMR (126 MHz, CDCl3) δ 165.74, 165.71, 165.40, 162.10, 161.77, 137.19, 136.86, 136.78, 134.18, 134.12, 
133.49, 133.30, 133.28, 132.99, 129.92, 129.88, 129.86, 129.67, 129.64, 129.53, 129.30, 129.21, 128.87, 128.40, 
128.34, 128.24, 128.23, 128.08, 100.94, 97.94 (C-1), 96.65 (C-1’), 90.91, 79.59 (C-3), 77.50 (C-2), 75.89 (C-4), 
72.09 (C-2’), 71.63, 70.68 (C-3’), 69.87 (C-4’), 69.56 (C-5), 68.79, 68.71(C-6), 68.46 (C-5’), 68.27, 67.43, 67.24 (C-
6’), 56.04, 55.52, 55.35, 33.89. HRMS (m/z): [M+Na]+ calcd for C66H62Cl6O17S, 1391.1736; found, 1391.1805. 
 
Methyl 3,4,6-tri-O-(2,6-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxybenzenethio) ethyl)-α-D-
galactopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (31c): Via general procedure E. Silicagel flash 
column chromatography (0% - 40% EtOAc in n-heptane) afforded 31c as an anomeric 
mixture (55 mg, 70%).TLC: (EtOAc/n-heptane, 50/50 v/v): Rf = 0,61; 1H NMR (400 
MHz, CDCl3) δ 8.01 – 7.79 (m, 6H), 7.54 – 7.10 (m, 18H), 6.12 (t, J = 9.8 Hz, H-3’), 
6.09 (s, 2H), 5.51 (t, J = 9.80 Hz, H-4’), 5.25 (dd, J = 10.2, 3.6 Hz, H-2’), 5.18 (d, J 
= 3.6 Hz, H-1’), 5.00 (s, H-1), 4.91 (d, J = 12.9 Hz, 1H), 4.81 (d, J = 13.0 Hz, 1H), 
4.69 (d, J = 13.0 Hz, 1H), 4.58 (d, J = 12.9 Hz, 1H), 4.44 (d, J = 13.1 Hz, 1H), 4.37 
– 4.28 (m, 2H, H-5’), 4.08 (t, J = 6.7 Hz, H-5), 3.96 (s, H-4), 3.93 – 3.84 (m, H-2, H-3, H-6a’), 3.79 (m, 9H), 3.73 – 
3.62 (m, 2H, H-6b’), 3.60 – 3.44 (m, H-6a, H-6b), 2.96 – 2.76 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 165.80, 165.77, 
165.39, 162.04, 161.80, 135.00, 134.32, 133.77, 133.63, 133.58, 133.37, 133.34, 133.23, 133.18, 133.15, 133.06, 
130.18, 129.94, 129.80, 129.67, 129.64, 129.25, 129.10, 129.02, 128.91, 128.88, 128.87, 128.41, 128.36, 128.26, 
127.10, 127.05, 126.92, 97.75 (C-1), 96.84 (C-1’), 90.95, 78.58 (C-3), 77.51 (C-2), 76.03 (C-4), 72.10 (C-2’), 71.22, 
70.98 (C-6), 70.64 (C-3’), 69.72, 69.65, 69.61 (C-4’), 68.97 (C-5), 68.94, 68.32 (C-5’), 66.84 (C-6’), 56.05, 55.51, 
55.36, 34.03. HRMS (m/z): [M+Na]+ calcd for C66H62Cl6O17S, 1391.1736; found, 1391.1784. 
 
Methyl-3,4,6-tri-O-(4-cyanobenzyl)-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-
(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (31d): Via general procedure E. Silicagel flash column 
chromatography (0% - 40% - EtOAc in n-heptane) afforded 31d as an anomeric mixture 
(86 mg, 87%). TLC: (EtOAc/n-heptane, 60/40 v/v): Rf = 0,51; 1H NMR (500 MHz, 
CDCl3) δ 8.02 – 7.78 (m, 6H), 7.66 – 7.24 (m, 21H), 6.11 (m, 2H, H-3’), 5.54 (t, J = 
9.9 Hz, H-4’), 5.24 (dd, J = 10.2, 3.6 Hz, H-2’), 5.17 (d, J = 3.6 Hz, H-1’), 5.02 (d, J = 
2.9 Hz, H-1), 4.95 (m, 2H), 4.72 (d, J = 13.1 Hz, 1H), 4.56 (d, J = 12.6 Hz, 1H), 4.44 
(d, J = 13.1 Hz, 1H), 4.37 (d, J = 13.1 Hz, 1H), 4.29 (ddd, J = 10.1, 6.1, 2.0 Hz, H-5’), 
4.07 (t, J = 6.6 Hz, H-5), 3.96 – 3.86 (m, H-2, H-3, H-4, H-6a’), 3.82 (s, 3H), 3.77 (s, 6H), 3.75 – 3.60 (m, 2H, H-
6b’), 3.56 – 3.45 (m, H-6a, H-6b). 13C NMR (126 MHz, CDCl3) δ 165.87, 165.75, 165.39, 162.04, 161.87, 144.33, 
143.93, 143.40, 133.43, 133.42, 133.13, 132.27, 132.14, 132.10, 129.92, 129.78, 129.60, 129.19, 128.99, 128.92, 
128.45, 128.40, 128.30, 127.79, 127.47, 127.39, 118.77, 118.70, 111.46, 111.38, 111.20, 100.94, 97.58 (C-1), 96.90 
(C-1’), 91.00, 78.50 (C-3), 77.74 (C-2), 76.67 (C-4), 74.03, 72.52, 72.20, 72.03 (C-2’), 70.58, 70.55 (C-3’), 69.51 (C-
4’), 69.13 (C-6), 68.89 (C-5), 68.32 (C-5’), 66.70 (C-6’), 56.07, 55.48, 55.41, 34.28. HRMS (m/z): [M+Na]+ calcd for 
C69H65N3O17S, 1262.3932; found, 1262.3873. 
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Phenyl 3,4,6-Tri-O-(o,p-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-
(16)-2,3,4-tri-O-benzyl-1-thio-β-D-galactopyranoside (33): Via general procedure E starting from 
glucosyldonor 24b (0.044 g; 0.050 mmol) using acceptor 32. The crude product was 
purified by silicagel flash column chromatography (10% to 30% EtOAc in n-heptane) 
affording 33 (0.035 g, 50%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.53. 1H NMR 
(500 MHz, CDCl3) δ 7.50 – 7.44 (m, 2H), 7.38 – 6.89 (m, 29H), 6.01 (s, 2H), 4.92 (d, 
J = 11.5 Hz, 1H), 4.84 (d, J = 13.0 Hz, 1H), 4.82 (d, J = 3.6 Hz, 1H, H-1), 4.74 (d, J 
= 10.2 Hz, 1H), 4.70 – 4.60 (m, 6H), 4.60 – 4.51 (m, 3H, H-1’), 4.45 (d, J = 13.0 Hz, 
1H), 4.32 (d, J = 13.2 Hz, 1H), 3.93 – 3.82 (m, 3H, H-2’, H-5, H-6a’), 3.81 – 3.77 (m, 2H, H-3, H-4’), 3.77 – 3.70 (m, 
2H), 3.68 (s, 6H), 3.67 – 3.60 (m, 3H, H-5’, H-6a), 3.60 – 3.49 (m, 5H, H-3’, H-4, H-6b, H-7), 3.43 (dd, J = 10.0, 4.4 
Hz, 1H, H-6b’), 3.35 (dd, J = 9.6, 3.6 Hz, 1H, H-2), 2.83 – 2.65 (m, 2H, C-8). 13C NMR (126 MHz, CDCl3) δ 161.97, 
161.86, 138.53, 138.23, 138.18, 135.22, 134.68, 134.50, 134.19, 133.79, 133.49, 133.39, 132.80, 132.67, 131.26, 
130.11, 129.58, 129.33, 129.01, 128.85, 128.77, 128.44, 128.36, 128.33, 128.27, 127.88, 127.77, 127.74, 127.63, 
127.60, 126.95, 126.87, 100.69 , 97.11 (C-1), 90.96, 87.96 (C-1’), 84.04 (C-3’), 81.94 (C-3), 81.03 (C-2), 77.71 (C-
4), 77.25 (C-2’), 77.17 (C-5), 75.67, 74.35 (C-4’), 74.33, 73.04, 71.47, 71.15 (C-7), 71.11, 69.87 (C-5), 69.81, 68.88 
(C-6), 67.89 (C-6’), 56.04, 55.37, 34.06 (C-8). HRMS (m/z): [M+Na]+ calcd for C71H70O13S2Cl6, 1431.2228; found, 
1431.2277. 
 
Methyl 3,4,6-Tri-O-(o,p-dichlorobenzyl)-α-D-glucopyranosyl-(16)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (35): 30b (36 mg, 0.026 mmol) was dissolved in dry DCM (10 mL). MeOTf (4.6 µL, 0.041 mmol) 
and TTBP (14 mg, 0.055 mmol) were added and the reaction mixture was refluxed for 
4 h at 40oC, after which the mixture was allowed to cool down to rt. KOtBu (68 mg, 
0.041 mmol) was added and the mixture was stirred at rt for 1h, after which the mixture 
was diluted with DCM (15 mL) and washed with water (20 mL), sat. aq. NaHCO3 (20 
mL) and brine (20 mL). The organic layer was dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude product was purified by silicagel flash column chromatography (20% to 40% EtOAc 
in n-heptane) affording 35 (22 mg, 73%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.24. 1H NMR (500 MHz, CDCl3) δ 
8.01 – 7.96 (m, 2H), 7.96 – 7.90 (m, 2H), 7.90 – 7.84 (m, 2H), 7.56 – 7.27 (m, 15H), 7.23 – 7.09 (m, 4H), 6.15 (t, J 
= 9.9 Hz, 1H, H-3’), 5.67 (t, J = 9.9 Hz, 1H, H-4’), 5.28 (dd, J = 10.1, 3.7 Hz, 1H, H-2’), 5.23 (d, J = 3.7 Hz, 1H, H-
1’), 5.08 – 5.03 (m, 1H, H-1), 5.01 (d, J = 12.8 Hz, 1H), 4.83 (d, J = 12.8 Hz, 1H), 4.80 (d, J = 12.9 Hz, 1H), 4.57 (d, 
J = 13.0 Hz, 1H), 4.55 (d, J = 13.3 Hz, 1H), 4.41 (d, J = 13.3 Hz, 1H), 4.28 (ddd, J = 10.3, 4.6, 2.2 Hz, 1H, H-5’), 3.93 
(dd, J = 11.8, 4.6 Hz, 1H, H-6a’), 3.84 – 3.71 (m, 4H, H-2, H-3, H-5, H-6b’), 3.67 (dd, J = 10.7, 3.6 Hz, 1H, H-6a), 
3.65 – 3.60 (m, 1H, H-4), 3.54 (dd, J = 10.6, 1.9 Hz, 1H, H-6b), 3.47 (s, 3H), 2.65 (s, 1H). 13C NMR (126 MHz, CDCl3) 
δ 165.83, 165.80, 165.35, 135.04, 134.73, 134.25, 133.73, 133.64, 133.58, 133.41, 133.22, 133.22, 133.14, 132.86, 
130.20, 129.95, 129.85, 129.75, 129.68, 129.47, 129.14, 128.99, 128.98, 128.90, 128.88, 128.81, 128.49, 128.43, 
128.29, 127.05 – 126.99 (m), 126.92, 98.55 (C-1), 97.13 (C-1’), 83.45 (C-3), 77.18 (C-4), 73.27 (C-2), 72.12 (C-2’), 
71.43, 71.03, 70.49 (C-5), 70.44 (C-3’), 69.73, 69.16 (C-4), 68.88 (C-6), 68.55 (C-5’), 65.57 (C-6’), 55.77. HRMS 
(m/z): [M+Na]+ calcd for C55H48O14Cl6, 1165.1073; found, 1165.1048.  
 
2,4,6-trimethoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (38a):  
via general procedure D starting from 12d (98 mg, 0.155 mmol) using BnBr as the benzylation 
agent. The crude product was purified by silicagel flash column chromatography (0% to 30% 
EtOAc in n-heptane) affording 38a as a white solid (81 mg, 73%). TLC (EtOAc/n-heptane 40/60 
v/v): Rf = 0.53. 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H), 7.38 – 7.14 (m, 19H), 6.10 (s, 2H), 5.15 (d, J = 
10.3 Hz, 1H), 4.91 (d, J = 10.9 Hz, 1H), 4.84 – 4.76 (m, 3H), 4.69 (d, J = 9.7 Hz, 1H, H-1), 4.56 (d, J = 10.9 Hz, 1H), 
4.46 – 4.32 (m, 2H), 3.78 (s, 6H), 3.75 (s, 3H), 3.74 – 3.55 (m, 4H, H-2, H-3, H-6), 3.52 (dd, J = 9.8, 8.9 Hz, 1H, H-
4), 3.37 (ddd, J = 9.8, 5.6, 1.7 Hz, 1H, H-5). 13C NMR (101 MHz, CDCl3) δ 162.22, 162.04, 138.67, 138.65, 138.60, 
138.16, 128.42, 128.39, 128.27, 128.24, 128.21, 127.96, 127.87, 127.86, 127.74, 127.63, 127.60, 127.45, 99.80, 
91.24, 86.87 (C-3), 86.78 (C-1), 82.57 (C-2), 79.81 (C-5), 78.16 (C-4), 75.76, 75.21, 74.96, 73.63, 69.62 (C-6), 
56.17, 55.29. HRMS (m/z): [M+Na]+ calcd for C43H46O8S, 745.2811; found, 745.2783. 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 82
Chapter 3
82
 
82 
2,4,6-Trimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-propyl-1-thio-β-D-glucopyranoside (38b):  
via general procedure D starting from 12d (99 mg, 0.156 mmol) using propyl bromide as the 
alkylating agent. The crude product was purified by silicagel flash column chromatography (0% 
to 30% EtOAc in n-heptane) yielding 38b (91 mg, 87%) as a white solid.  TLC (EtOAc/n-heptane 
40/60 v/v): Rf = 0.54. 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.23 (m, 19H), 7.21 – 7.12 (m, 4H), 
6.10 (s, 2H), 4.94 (d, J = 10.9 Hz, 1H), 4.87 – 4.75 (m, 2H), 4.63 (d, J = 9.8 Hz, 1H, H-1), 4.53 (d, J = 11.0 Hz, 1H), 
4.43 – 4.29 (m, 2H), 4.03 – 3.92 (m, 1H), 3.81 (s, 6H), 3.74 (s, 4H), 3.71 (dd, J = 11.6, 1.8 Hz, 1H, H-6a), 3.64 – 
3.54 (m, 2H, H-3, H-6b), 3.49 – 3.43 (m, 1H, H-4), 3.41 – 3.30 (m, 2H, H-2, H-5), 1.68 (h, J = 7.1 Hz, 2H), 0.96 (t, J 
= 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 162.08, 128.39, 128.35, 128.18, 127.92, 127.83 127.82, 127.68, 127.59, 
127.37, 91.23, 86.89 (C-3), 86.31 (C-1), 82.69 (C-2), 79.85 (C-5), 78.07 (C-4), 75.68, 75.00, 74.91, 73.56, 69.61 (C-
6), 56.19, 55.24, 23.62, 10.56; HRMS (m/z): [M+Na]+ calcd for C39H46O8S, 697.2811; found, 697.2786. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(benzyl)-2-O-(3-hydroxypropyl)-1-thio-β-D-glucopyranoside (38c):  
via general procedure C starting from 12d (124 mg; 0.192 mmol) using Br(CH2)3OTHP as the 
alkylating agent. The crude product was purified by silicagel flash column chromatography (10% 
to 60% EtOAc in n-heptane) yielding 38c as a white solid (84 mg, 62%). TLC (EtOAc/n-heptane 
40/60 v/v): Rf = 0.25. 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.08 (m, 15H), 6.11 (s, 2H), 4.91 (d, 
J = 10.9 Hz, 1H), 4.84 (d, J = 10.9 Hz, 1H), 4.79 (d, J = 10.9 Hz, 1H), 4.57 – 4.52 (m, 2H, H-1), 4.41 (d, J = 11.7 Hz, 
1H), 4.38 (d, J = 11.7 Hz, 1H), 4.07 – 4.00 (m, 2H), 3.97 – 3.89 (m, 1H), 3.83 (s, 6H), 3.76 (s, 3H), 3.70 (dd, J = 
11.6, 1.7 Hz, 1H, H-6a), 3.62 (t, J = 8.9 Hz, 1H, H-3), 3.57 (dd, J = 11.6, 5.8 Hz, 1H, H-6b), 3.46 (t, J = 9.4 Hz, 1H, 
H-4), 3.34 (dd, J = 10.0, 8.8 Hz, 1H, H-2), 3.32 – 3.28 (m, 1H, H-5), 3.09 (t, J = 6.9 Hz, 1H), 1.96 – 1.84 (m, 1H), 
1.82 – 1.73 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 162.29, 162.25, 138.51, 138.48, 138.04, 128.43, 128.35, 128.19, 
127.89, 127.84, 127.71, 127.69, 127.44, 98.77, 91.18, 86.98 (C-1), 86.72 (C-3), 82.07 (C-2), 79.76 (C-5), 77.99 (C-
4), 75.66, 74.89, 73.64, 71.41, 69.58 (C-6), 60.61, 56.18, 55.27, 32.69.  
 
2,4,6-Trimethoxyphenyl 3,4,6-tri-O-benzyl-2-O-acetyl-1-thio-β-D-glucopyranoside (38d):  
To a solution of 12d (58 mg, 0.092 mmol) in pyridine (2 ml), was added acetic anhydride (1 mL). 
The solution was stirred for 4 h at rt before it was concentrated in vacuo. Silicagel flash column 
chromatography (0% → 30% - EtOAc in n-heptane) of the residue afforded 38d (56 mg, 91%). 
TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.21 (m, 13H), 7.18 (dd, J = 7.5, 
2.0 Hz, 2H), 6.09 (s, 2H), 5.04 (dd, J = 10.0, 8.7 Hz, 1H, (H-2)), 4.77 (dd, J = 11.0, 4.2 Hz, 2H), 4.67 (d, J = 11.3 Hz, 
1H), 4.57 – 4.54 (m, 2H, (H-1)), 4.48 (d, J = 11.8 Hz, 1H), 4.43 (d, J = 11.7 Hz, 1H), 3.77 (d, J = 9.6 Hz, 10H, (H-
6)), 3.69 – 3.58 (m, 3H, (H-3, H-4, H-6)), 3.41 (ddd, J = 9.5, 5.3, 1.8 Hz, 1H, H-5); 13C NMR (126 MHz, CDCl3) δ 
169.51, 162.16, 138.37, 138.18, 137.93, 128.39, 128.37, 128.22, 127.96, 127.85, 127.81, 127.77, 127.67, 127.45, 
99.23, 91.16, 85.79 (C-1), 84.74 (C-3), 79.95 (C-5), 77.97 (C-4), 75.17, 74.96, 73.57, 72.90 (C-2), 69.31 (C-6), 
56.12, 55.27, 21.06. HRMS (m/z): [M+Na]+ calcd for C38H42O9S, 697.2447; found, 697.2445 
 
2,4,6-trimethoxyphenyl 2-O-benzyl-3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-β-D-glucopyranoside (39a):  
via general procedure D starting from 22b (0.074 g, 0.088 mmol) using BnBr as the 
benzylation agent. The crude product was purified by silicagel flash column chromatography 
(0% to 30% EtOAc in n-heptane) yielding 39a as a white solid (49 mg, 60%). TLC (EtOAc/n-
heptane 40/60 v/v): Rf = 0.57. 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.02 (m, 18H), 6.09 (s, 2H), 5.15 (d, J = 10.4 Hz, 
1H), 4.94 (d, J = 13.1 Hz, 1H), 4.80 – 4.67 (m, 5H, H-1), 4.59 (d, J = 12.7 Hz, 1H), 4.48 (d, J = 12.9 Hz, 1H), 4.39 
(d, J = 12.9 Hz, 1H), 3.79 (s, 7H), 3.76 (s, 3H), 3.75 – 3.64 (m, 3H, H-6, H-3), 3.63 – 3.53 (m, 2H, H-2, H-4), 3.38 
(ddd, J = 9.9, 5.3, 1.9 Hz, 1H, H-5). 13C NMR (126 MHz, CDCl3) δ 162.09, 162.03, 138.19, 135.43, 135.01, 134.74, 
134.46, 133.75, 133.59, 133.45, 133.33, 133.04, 132.73, 130.44, 130.13, 129.68, 129.42, 128.90, 128.88, 128.79, 
128.54, 128.44, 128.32, 128.23, 128.17, 127.65, 126.96, 126.95, 99.52, 91.17, 86.69 (C-1, C-3), 82.44 (C-2), 79.12 
(C-5), 78.08 (C-4), 75.12, 71.65, 71.04, 69.97, 56.16, 55.25; HRMS (m/z): [M+Na]+ calcd for C43H40O8SCl6, 949.0473; 
found, 949.0464. 
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2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-propyl-1-thio-β-D-glucopyranoside (39b):  
via general procedure D starting from 22b (0.10 g, 0.12 mmol) and 1-bromopropane as the 
alkylating agent. The crude product was purified by silicagel flash column chromatography 
(30% to 60% EtOAc in n-heptane) yielding 39b as a white solid (88 mg, 84%). TLC 
(EtOAc/n-heptane 40/60 v/v): Rf = 0.35. 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 8.3 Hz, 
1H), 7.38 – 7.02 (m, 8H), 6.08 (s, 2H), 4.98 (d, J = 13.2 Hz, 1H), 4.78 (d, J = 13.3 Hz, 1H), 4.73 (d, J = 12.7 Hz, 1H), 
4.67 (d, J = 9.8 Hz, 1H, H-1), 4.57 (d, J = 12.7 Hz, 1H), 4.44 (d, J = 12.9 Hz, 1H), 4.34 (d, J = 12.9 Hz, 1H), 3.97 (dt, 
J = 8.5, 7.0 Hz, 1H), 3.82 (s, 6H), 3.75 (s, 3H), 3.71 (dd, J = 11.4, 1.9 Hz, 1H, H-6a), 3.66 – 3.60 (m, 3H, H-3, H-6b), 
3.51 (t, J = 9.4 Hz, 1H, H-4), 3.40 (dd, J = 9.8, 8.7 Hz, 1H, H-2), 3.35 (ddd, J = 9.9, 5.5, 1.8 Hz, 1H, H-5), 1.66 – 
1.53 (m, 2H), 0.93 – 0.85 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 161.98, 161.88, 135.13, 134.76, 134.49, 133.74, 
133.57, 133.43, 133.34, 133.03, 132.67, 130.12, 129.68, 129.32, 128.90, 128.87, 128.81, 126.97, 126.94, 126.92, 
91.18, 86.79 (C-3), 86.22 (C-1), 82.72 (C-2), 79.16 (C-5), 78.04 (C-4), 74.99, 71.55, 69.98 (C-6), 69.94, 56.20, 
56.18, 56.15, 55.25, 55.22, 23.50, 10.46. 
 
2,4,6-trimethoxyphenyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(3-hydroxypropyl)-1-thio-β-D-gluco-
pyranoside (39c): via general procedure C starting from 22b (0.100 g, 0.119 mmol) using 
Br(CH2)3OTHP as the alkylating agent. The crude product was purified by silicagel flash 
column chromatography (20% to 50% EtOAc in n-heptane) affording 39c as a white solid 
(78 mg, 73%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.25. 1H NMR (500 MHz, CDCl3) δ 
7.40 (d, J = 8.3 Hz, 1H), 7.31 (dd, J = 14.1, 2.1 Hz, 2H), 7.28 – 7.23 (m, 5H), 7.22 – 7.09 (m, 6H), 6.09 (s, 2H), 4.97 
(d, J = 13.0 Hz, 1H), 4.79 (d, J = 13.0 Hz, 1H), 4.74 (d, J = 12.8 Hz, 1H), 4.61 – 4.54 (m, 2H, H-1), 4.47 (d, J = 12.8 
Hz, 1H), 4.38 (d, J = 12.9 Hz, 1H), 4.10 – 4.00 (m, 1H), 3.96 – 3.85 (m, 2H), 3.85 -3.75 (m, 10H), 3.70 (dd, J = 11.4, 
2.0 Hz, 1H, H-6a), 3.68 – 3.59 (m, 2H, H-3, H-6b), 3.51 (t, J = 9.4 Hz, 1H, H-4), 3.42 – 3.29 (m, 2H, H-2, H-5), 2.99 
(t, J = 6.9 Hz, 1H), 1.92 – 1.79 (m, 1H), 1.79 – 1.65 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 162.35, 162.24, 134.90, 
134.72, 134.43, 133.80, 133.66, 133.64, 133.38, 133.02, 132.84, 130.17, 129.63, 129.48, 128.93, 128.92, 127.07, 
126.98, 126.95, 98.59, 91.18, 86.93 (C-1), 86.70 (C-3), 82.10 (C-2), 79.17 (C-5), 78.05 (C-4), 71.55, 71.27 (C-7), 
71.08, 70.02 (C-6), 70.01, 60.44, 56.23, 55.29, 32.70; HRMS (m/z): [M+Na]+ calcd for C39H40O9SCl6, 917.0422; found, 
917.0403.  
 
2,4,6-trimethoxyphenyl 2-O-acetyl-3,4,6-tri-O-(o,p-dichlorobenzyl)-1-thio-β-D-glucopyranoside (39d): 
22b (0.105 g; 0.125 mmol) was dissolved in pyridine (2 mL) and Ac2O (1 ml). The reaction 
mixture was stirred at ambient temperature 4h, before it was concentrated in vacuo. Silicagel 
flash column chromatography (0% to 30% EtOAc in n-heptane) afforded 39d as a white solid 
(76 mg, 69%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.43; 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.26 (m, 5H), 7.22 – 
7.10 (m, 4H), 6.09 (s, 2H), 5.07 (dd, J = 10.0, 8.7 Hz, 1H, H-2), 4.78 (d, J = 13.1 Hz, 1H), 4.75 (d, J = 12.7 Hz, 1H), 
4.69 (d, J = 13.0 Hz, 1H), 4.65 – 4.57 (m, 2H, H-1), 4.52 (d, J = 13.0 Hz, 1H), 4.44 (d, J = 13.0 Hz, 1H), 3.80 (s, 6H), 
3.78 (s, 3H), 3.77 – 3.63 (m, 4H, H-3, H-4, H-6), 3.43 (ddd, J = 9.6, 4.9, 2.1 Hz, 1H, H-5), 2.02 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 169.51, 162.23, 162.12, 134.62, 134.48, 134.23, 133.99, 133.71, 133.66, 133.30, 132.61, 130.07, 
129.92, 129.67, 129.04, 128.92, 128.79, 127.20, 127.01, 99,16, 91.19, 85.80 (C-1), 85.12 (C-3), 79.38 (C-5), 77.94 
(C-4), 72.88 (C-2), 71.32, 71.16, 69.95, 69.71 (C-6), 56.17, 55.30, 21.07; HRMS (m/z): [M+Na]+ calcd for 
C38H36Cl6O9S, 901.0109; found, 901.0103. 
 
Methyl 2,3,4,6-Tetra-O-benzyl-1-thio-α/β-D-glucopyranosyl-(16)-2,3,4-tri-O-benzoyl-α-D-gluco-
pyranoside (40a): via general procedure F starting from glucosyl donor 38a (0.40 g; 
0.059 mmol). The crude product was purified by silicagel flash column chromatography 
(10% to 40% EtOAc in n-heptane) yielding 40a as a mixture of isomers (0.0467 g; 0.045 
mmol; 68%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.57. 1H NMR (500 MHz, CDCl3) δ 
8.01 – 7.89 (m, 8H), 7.87-7.83 (m, 4H), 7.52 – 7.45 (m, 4H), 7.45 – 7.08 (m, 46H), 6.21 
– 6.16 (m, 1H), 6.14 (t, J = 8.5 Hz, 1H), 5.53 (dd, J = 10.3, 9.5 Hz, 1H), 5.48 (dd, J = 10.3, 9.5 Hz, 1H), 5.28 – 5.19 
(m, 4H), 5.06 (d, J = 10.8 Hz, 1H), 4.91 (d, J = 11.0 Hz, 2H), 4.84 – 4.71 (m, 6H, α-H-1), 4.69 (d, J = 10.8 Hz, 1H), 
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4.63 (d, J = 12.2 Hz, 1H), 4.56 – 4.42 (m, 6H, β-H-1), 4.41 – 4.34 (m, 2H), 4.32 (ddd, J = 10.4, 6.6, 2.2 Hz, 1H), 4.13 
(dd, J = 11.0, 2.2 Hz, 1H), 3.96 (t, J = 9.3 Hz, 1H), 3.89 – 3.78 (m, 3H), 3.68 – 3.40 (m, 13H), 3.38 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 165.81, 165.81, 165.75, 165.45, 165.23, 138.86, 138.59, 138.56, 138.46, 138.37, 138.10, 138.07, 
137.91, 133.38, 133.32, 133.04, 133.03, 129.91, 129.88, 129.66, 129.64, 129.26, 129.23, 129.08, 129.06, 129.01, 
128.90, 128.45 – 128.27 (m), 128.27 – 128.15 (m), 127.95, 127.91, 127.89, 127.85, 127.75, 127.72, 127.65, 127.62, 
127.56, 127.54, 127.47, 127.46, 103.98 (β-C-1), 97.23 (α-C-1), 96.78, 96.74, 84.54, 82.34, 81.72, 79.97, 77.65, 
77.56, 75.70, 75.67, 75.51, 75.00, 74.96, 74.89, 74.80, 74.77, 73.50, 73.42, 73.39, 73.28, 73.10, 72.24, 72.12, 70.61, 
70.51, 70.22, 69.90, 69.63, 69.00, 68.85 , 68.64, 68.56, 68.27, 66.64, 55.58, 55.51. HRMS (m/z): [M+Na]+ calcd for 
C62H60O14, 1051.3881; found, 1051.3851. 
 
Methyl 3,4,6-Tri-O-benzyl-2-O-propyl-1-thio-α-D-glucopyranosyl-(16)-2,3,4-tri-O-benzoyl-α-D-gluco-
pyranoside (40b): via general procedure F starting from glucosyl donor 38b (40 mg, 
0.059 mmol). The crude product was purified by silicagel flash column chromatography 
(0% to 40% EtOAc in n-heptane) affording 40b as a mixture of anomers (37 mg, 62%); 
TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.32. 1H NMR (500 MHz, CDCl3) δ 8.17 – 7.81 
(m, 13H), 7.62 – 7.10 (m, 38H), 6.14 (t, J = 9.8 Hz, 1H, H-3’), 5.56 – 5.50 (m, 1H, H-
4’), 5.24 (dd, J = 10.1 Hz, 3.7 Hz, 1H, H-2’), 5.18 (d, J = 3.6 Hz, 1H, H-1’), 4.97 (d, J = 3.4 Hz, 1H, H-1), 4.85 – 4.77 
(m, 2H), 4.74 (d, J = 11.0 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.45 (d, J = 11.1 Hz, 1H), 4.40 (d, J = 12.1 Hz, 1H), 
4.36 – 4.31 (m, 1H, H-5’), 3.94 – 3.84 (m, 4H, H-3, H-6a), 3.71 (dd, J = 11.2, 2.1 Hz, 1H, H-6a’), 3.68 – 3.49 (m, 5H, 
H-4, H-6b’, H-6, H-7), 3.48 – 3.41 (m, 6H), 1.67 – 1.56 (m, 2H), 0.98 – 0.81 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 
167.35, 166.95, 165.97, 165.88, 165.81, 165.27, 138.95, 138.65, 138.03, 133.43, 133.40, 133.35, 133.33, 133.05, 
130.09, 129.76, 129.67, 129.29, 129.20, 129.12, 129.10, 128.99, 128.50, 128.46, 128.20, 127.98, 127.89, 127.62, 
127.47, 127.45, 97.13 (C-1), 96.75 (C-1’), 81.55 (C-3), 80.70 (C-2), 77.51 (C-4), 75.44, 74.78, 72.94 (C-2’), 72.23 
(C-7), 70.66 (C-3), 70.38, 70.12 (C-4), 69.73 (C-4’), 69.65, 68.69 (C-5’), 68.38 (C-6), 66.64 (C-6’), 55.63, 55.47, 
23.32, 10.55. HRMS (m/z): [M+Na]+ calcd for C58H60O14, 1003.3881; found, 1003.3837. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-(2-(2,4,6-trimethoxyphenylthio)propyl)-1-thio-α/β-D-glucopyranosyl-
(16)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (40c): via general procedure E starting from glucosyl donor 38c 
(56 mg, 0.081 mmol). The crude product was purified by silicagel flash column 
chromatography (10% to 40% EtOAc in n-heptane) yielding 40c as an anomeric mixture 
(α/β = 2/1, 68 mg, 71%). 1H NMR (500 MHz, CDCl3) δ 7.98 – 7.71 (m, 10H), 7.50 – 
6.97 (m, 48H), 6.05 (s, 1H), 6.02 (s, 2H), 5.41 (t, J = 9.9 Hz, 1H), 5.35 (t, J = 9.9 Hz, 
1H), 5.19 – 5.13 (m, 2H), 5.11 (d, J = 3.6 Hz, 1H, α-H-1’), 5.10 (d, J = 3.7 Hz, 1H, β-
H-1’), 4.86 (d, J = 3.4 Hz, 1H, α-H-1), 4.83 – 4.66 (m, 4H), 4.67 – 4.57 (m, 2H), 4.49 (d, J = 12.0 Hz, 1H), 4.45 – 
4.39 (m, 2H), 4.37 (d, J = 11.0 Hz, 1H), 4.33 (d, J = 12.0 Hz, 1H), 4.30 – 4.22 (m, 2H, β-H-1), 3.98 – 3.90 (m, 1H), 
3.86 – 3.75 (m, 4H), 3.74 (s, 2H), 3.72 (s, 3H), 3.70 (s, 3H), 3.70 (s, 9H), 3.69 – 3.49 (m, 7H), 3.49 – 3.39 (m, 3H), 
3.37 – 3.28 (m, 2H) 3.35 (s, 3H), 3.34 (s, 3H), 3.14 (ddd, J = 7.6, 6.3, 2.4 Hz, 1H), 2.77 – 2.63 (m, 2H), 1.77 – 1.56 
(m, 2H); 13C NMR (126 MHz, CDCl3) δ 165.75, 165.71, 165.32, 165.22, 162.07, 162.05, 161.57, 161.55, 138.83, 
138.57, 138.10, 138.05, 137.98, 133.30, 133.26, 133.21, 132.97, 132.96, 129.85, 129.80, 129.76, 129.59, 129.21, 
129.19, 129.05, 128.86, 128.37, 128.33, 128.28, 128.27, 128.24, 128.20, 128.19, 128.15, 127.93, 127.91, 127.84, 
127.83, 127.80, 127.65, 127.63, 127.61, 127.55, 127.54, 127.48, 127.46, 127.37, 127.35, 103.90 (β-C-1), 101.60, 
101.26, 96.86 (α-C-1), 96.68 (β-C-1’), 96.60 (α-C-1), 90.94, 90.90, 84.46, 82.52, 81.35, 80.68, 77.46, 77.42, 77.25, 
77.00, 76.75, 75.50, 75.28, 74.84, 74.77, 74.68, 73.33, 73.31, 72.16, 72.05, 71.65, 70.59, 70.50, 70.26, 69.81, 69.64, 
69.44, 68.98, 68.81, 68.66, 68.44, 68.33, 66.67, 56.04, 56.01, 55.48, 55.41, 55.25, 31.82, 31.31, 30.90, 30.87, 30.44, 
29.73, 22.63. HRMS (m/z): [M+Na]+ calcd for C67H70O17S, 1201.4231; found, 1201.4233. 
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Methyl 3,4,6-tribenzyl-2-O-acetyl-β-D-glucopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside 
(40d): Via general procedure F. Silicagel flash column chromatography (0% → 40% - 
EtOAc in n-heptane) afforded 40d (42 mg,  83%). TLC: (EtOAc/n-heptane, 40/60 v/v): 
Rf = 0.5; 1H NMR (500 MHz, CDCl3) δ 7.90 (dd, J = 8.4, 1.4 Hz, 2H), 7.87 – 7.82 (m, 
2H), 7.77 (dd, J = 8.3, 1.4 Hz, 2H), 7.45 – 7.40 (m, 2H), 7.36 – 7.12 (m, 20H), 7.08 
(dd, J = 7.4, 2.2 Hz, 2H), 6.06 (t, J = 9.7 Hz, 1H, H-3'), 5.34 (dd, J = 10.3, 9.4 Hz, 1H, H-4'), 5.15 (dd, J = 10.1, 3.6 
Hz, 1H, H-2'), 5.12 (d, J = 3.6 Hz, 1H, H-1'), 4.96 (dd, J = 9.2, 7.9 Hz, 1H, H-2), 4.70 (dd, J = 11.1, 7.8 Hz, 2H), 4.60 
(d, J = 11.4 Hz, 1H), 4.47 (d, J = 2.8 Hz, 1H), 4.44 (d, J = 1.5 Hz, 1H), 4.37 (d, J = 12.2 Hz, 1H), 4.35 (d, J = 8.0 Hz, 
1H, H-1), 4.19 (ddd, J = 9.7, 7.3, 1.9 Hz, 1H, H-5'), 3.99 (dd, J = 10.9, 1.9 Hz, 1H, H-6'), 3.65 – 3.54 (m, 5H, H-6', 
H-6, H-6, H-3, H-4), 3.43 – 3.34 (m, 4H, H-5), 1.93 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.50, 165.79, 165.67, 
165.34, 138.13, 137.97, 137.83, 133.38, 133.30, 133.00, 129.89, 129.82, 129.60, 129.22, 129.04, 128.83, 128.39, 
128.37, 128.28, 128.20, 127.97, 127.81, 127.78, 127.70, 127.67, 127.53, 101.31, 96.60 (C-1'), 82.82 (C-3), 77.78 
(C-4), 75.16 (C-5), 75.02, 74.99, 73.37, 73.03 (C-2), 72.10 (C-2'), 70.52 (C-3'), 69.48 (C-4'), 68.66 (C-5'), 68.42 (C-
6), 68.36 (C-6'), 55.30, 20.92. HRMS (m/z): [M+Na]+ calcd for C57H56O12, 980.3619; found, 980.3578. 
 
Methyl 2-O-benzyl-3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-α-D-glucopyranosyl-(16)- 2,3,4-tri-O-
benzoyl-α-D-glucopyranoside (41a): via general procedure F starting from glucosyl donor 39a (0.489 g; 0.053 
mmol). The crude product was purified by silicagel flash column chromatography (0% 
to 30% EtOAc in n-heptane) yielding 41a as a mixture of isomers (α/β = 4/1, 37 mg, 
57%). TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.62. 1H NMR (500 MHz, CDCl3) δ 
8.03 – 7.76 (m, 8H), 7.57 – 7.07 (m, 30H), 6.21 – 6.11 (m, 1H, H-3’), 5.60 – 5.54 
(m, 1H, H-4’), 5.28 – 5.19 (m, 2H, H-1’, H-2’), 5.05 (d, J = 10.9 Hz, 1H), 4.98 (d, J 
= 12.9 Hz, 1H), 4.94 (d, J = 13.0 Hz, 1H), 4.83 – 4.66 (m, 5H, H-1), 4.66 – 4.48 (m, 4H), 4.45 (d, J = 13.4 Hz, 1H), 
4.39 (d, J = 13.3 Hz, 1H), 4.33 (ddd, J = 10.3, 6.3, 2.0 Hz, 1H, H-5’), 4.13 (dd, J = 11.0, 2.2 Hz, 1H), 3.99 (t, J = 9.2 
Hz, 1H, H-3), 3.91 – 3.83 (m, 2H, H-5, H-6a’), 3.83 – 3.73 (m, 1H), 3.72 – 3.69 (m, 1H), 3.67 – 3.50 (m, 6H, H-2, H-
4, H-6, H-6b’), 3.47 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 165.84, 165.81, 165.74, 165.47, 165.22, 138.12, 138.05, 
135.14, 134.97, 134.86, 134.46, 134.35, 134.22, 133.78, 133.74, 133.67, 133.52, 133.50, 133.44, 133.37, 133.30, 
133.25, 133.22, 133.09, 132.67, 130.19, 129.48, 129.35, 127.67, 127.08, 126.76, 96.96 (C-1), 96.87 (C-1’), 84.51, 
82.00, 81.63 (C-3), 80.01 (C-2), 77.58, 77.47 (C-4), 74.65, 74.56, 72.99, 72.21 (C-2’), 72.07, 71.59, 71.52, 71.06, 
70.98, 70.58 (C-3’), 70.40, 69.95 (C-5), 69.89, 69.84, 69.72, 69.46 (C-4’), 69.23, 69.00, 68.85 (C-6), 68.59 (C-5’), 
66.55 (C-6’), 55.60, 55.57; HRMS (m/z): [M+Na]+ calcd for C62H54O14Cl6, 1257.1513; found, 1257.1537. 
 
Methyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-propyl-1-thio-α/β-D-glucopyranosyl-(16)-2,3,4-tri-O-
benzoyl-α-D-glucopyranoside (41b): : Via general procedure F starting from glucosyl donor 39b (50 mg; 0.057 
mmol) using acceptor 19. The crude product was purified by silicagel flash column 
chromatography (10% to 60% EtOAc in n-heptane) yielding 41b as an anomeric 
mixture (α/β = 3/1, 35 mg, 51%) TLC (EtOAc/n-heptane 40/60 v/v): Rf = 0.8. α-
Anomer: 1H NMR (500 MHz, CDCl3) δ 7.98 – 7.71 (m, 6H), 7.51 – 6.93 (m, 15H), 
6.08 (t, J = 9.8 Hz, 1H, H-3’), 5.48 (t, J = 9.9 Hz, 1H, H-4’ ), 5.18 (dd, J = 10.1, 3.7 
Hz, 1H, H-2’), 5.14 (d, J = 3.7 Hz, 1H, H-1’), 4.94 – 4.89 (m, 2H, H-1), 4.72 (d, J = 13.1 Hz, 1H), 4.67 (d, J = 13.1 
Hz, 1H), 4.53 (d, J = 13.4 Hz, 1H), 4.46 (d, J = 13.1 Hz, 1H), 4.35 (d, J = 13.2 Hz, 1H), 4.30 – 4.22 (m, 1H, H-5’), 
3.91 – 3.78 (m, 3H, H-3, H-5, H-6’a), 3.71 – 3.32 (m, 10H, H-6a, H-6’b, H-6b, H-4, H-2), 1.57 – 1.45 (m, 2H), 0.87 – 
0.76 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 165.90, 165.80, 165.24, 135.26, 134.91, 134.32, 133.73, 133.48, 133.46, 
133.43, 133.39, 133.30, 133.16, 133.09, 132.66, 129.95, 129.94, 129.86, 129.84, 129.82, 129.75, 129.67, 129.64, 
129.61, 129.59, 129.25, 129.15, 129.04, 129.01, 128.96, 128.95, 128.92, 128.86, 128.81, 128.48, 128.43, 128.42, 
128.32, 128.28, 128.25, 127.02, 126.95, 126.88, 126.86, 96.88 (C-1), 96.85 (C-1’), 81.48 (C-3), 80.72 (C-2), 77.41 
(C-4), 72.80, 72.18 (C-2’), 71.38, 70.98, 70.59 (C-3’), 70.08 (C-5’), 69.76, 69.50 (C-4’), 68.95, 68.70(C-5), 66.56, 
55.63, 23.25, 10.48. HRMS (m/z): [M+Na]+ calcd for C58H54Cl6O14, 1207.1504; found, 1207.1568. 
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Methyl 3,4,6-tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-trimethoxyphenylthio)propyl)-α/β-D-
glucopyranosyl-(16)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (41c): via general procedure E starting from 
glucosyl donor 41c (51 mg, 0.058 mmol) using acceptor 19. The crude product was 
purified by silicagel flash column chromatography (0% to 30% EtOAc in n-heptane) 
affording 41c as a mixture of isomers (α/β = 2.5/1, 39 mg, 49%). TLC (EtOAc/n-
heptane 40/60 v/v): Rf = 0.43.  1H NMR (500 MHz, CDCl3) δ 8.03 – 7.83 (m, 7H), 7.55 
– 7.08 (m, 22H), 6.18 – 6.10 (m, 1H, H-3’), 6.09 (s, 2H), 5.52 (t, J = 10.0 Hz, 1H, H-
4’), 5.25 (dd, J = 10.1, 3.7 Hz, 1H, H-2’), 5.21 (d, J = 3.7 Hz, 1H, H-1’), 4.97 (d, J = 3.4 Hz, 1H, H-1), 4.90 (d, J = 
13.0 Hz, 1H), 4.77 (d, J = 13.0 Hz, 1H), 4.69 (d, J = 13.1 Hz, 1H), 4.59 (d, J = 13.3 Hz, 1H), 4.56 – 4.50 (m, 1H), 
4.42 (d, J = 13.3 Hz, 1H), 4.34 (ddd, J = 10.4, 6.7, 2.0 Hz, 1H, H-5’), 3.96 – 3.84 (m, 3H, H-3, H-5, H-6a’), 3.79 (m, 
9H), 3.77 – 3.52 (m, 6H, H-4, H-6, H6b’, H-7), 3.46 (s, 3H), 3.44 – 3.38 (m, 1H, H-2), 2.84 – 2.62 (m, 2H), 1.83 – 
1.62 (m, 2H).13C NMR (126 MHz, CDCl3) δ 165.86, 165.78, 165.29, 162.09, 161.65, 135.20, 134.91, 134.35, 133.72, 
133.47, 133.41, 133.38, 133.29, 133.12, 133.08, 132.65, 129.99, 129.94, 129.85, 129.67, 129.65, 129.25, 129.06, 
128.89, 128.84 – 128.75 (m), 128.42, 128.38, 128.27, 127.03, 126.88, 126.85, 101.22, 96.78 (C-1’), 96.70 (C-1), 
90.95, 81.40 (C-3), 80.73 (C-2), 77.42 (C-4), 72.19 (C-2’), 71.32, 70.95, 70.61 (C-3’), 70.05 (C-5), 69.75, 69.56 (C-
4’), 69.30, 68.96 (C-6), 68.52 (C-5), 66.65 (C-6’), 56.08, 55.57, 55.33, 30.83, 29.60. HRMS (m/z): [M+Na]+ calcd for 
C67H64Cl6O17S, 1405.1893; found, 1405.1883. 
 
Methyl 2-O-acetyl-3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-β-D-glucopyranosyl-(16)- 2,3,4-tri-O-benzoyl-
α-D-glucopyranoside (41d): via general procedure F starting from glucosyl donor 39d (51 mg; 0.058 mmol). The 
crude product was purified by silicagel flash column chromatography (10% to 30% 
EtOAc in n-heptane) affording 41d (41 mg, 60%). TLC (EtOAc/n-heptane 40/60 
v/v): Rf = 0.57. 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.95 (m, 2H), 7.95 – 7.88 (m, 
2H), 7.87 – 7.81 (m, 2H), 7.54 – 7.47 (m, 2H), 7.44 – 7.23 (m, 16H), 7.22 – 7.10 
(m, 5H), 6.13 (t, J = 9.7 Hz, 1H, H-3’), 5.42 (dd, J = 10.3, 9.4 Hz, 1H, H-4’), 5.26 – 5.16 (m, 2H, H-1’, H-2’), 5.10 – 
5.02 (m, 1H, H-2), 4.78 (d, J = 13.0 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H), 4.70 (d, J = 12.9 Hz, 1H), 4.62 (d, J = 12.5 
Hz, 1H), 4.54 (d, J = 13.4 Hz, 1H), 4.46 (d, J = 7.9 Hz, 1H, H-1), 4.45 (d, J = 13.4 Hz, 1H), 4.25 (ddd, J = 10.3, 7.0, 
2.0 Hz, 1H, H-5’), 4.07 (dd, J = 11.0, 2.0 Hz, 1H, H-6a’), 3.77 – 3.68 (m, 4H, H-3, H-4, H-6), 3.65 (dd, J = 10.9, 7.0 
Hz, 1H, H-6b’), 3.53 – 3.47 (m, 1H, H-5), 3.45 (s, 3H), 2.05 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.51, 165.83, 
165.71, 165.40, 134.42, 134.33, 134.16, 134.06, 133.81, 133.69, 133.48, 133.36, 133.32, 133.16, 133.07, 132.76, 
129.92, 129.82, 129.71, 129.69, 129.63, 129.23, 129.08, 129.05, 128.96, 128.87, 128.82, 128.44, 128.41, 128.25, 
101.27 (C-1), 96.73 (C-1’), 83.28 (C-3), 77.71 (C-4), 74.89 (C-5), 73.00 (C-2), 72.09 (C-2’), 71.28, 71.19, 70.49 (C-
3’), 69.84, 69.50 (C-4’), 69.03 (C-6), 68.69 (C-5’), 68.27 (C-6’), 55.41, 20.98. HRMS (m/z): [M+Na]+ calcd for 
C57H50Cl6O15, 1207.1179; found, 1207.1173. 
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Stereoselective β-Mannosylation via  
Neighboring Group Participation 
 
 
 
 
 
 
 
This chapter has been published as: 
R.A. Mensink*, H. Elferink*, P.B. White, T.J. Boltje, Angew. Chem. Int. Ed. 2016, 55, 11217-11220 
 
 
 
Abstract: The stereoselective synthesis of glycosidic bonds is the main challenge in 
oligosaccharide synthesis. In order for oligosaccharide synthesis to become a routine process, 
broadly applicable and highly reliable glycosylation methods are needed. In this respect, 
neighboring group participation (NGP) of C-2 acyl substituents can be used to provide 1,2-trans-
glycosides. Recently, the application of NGP has been extended to the preparation of 1,2-cis-
glycosides with the advent of C-2 chiral auxiliaries. However, this methodology has been strictly 
limited to the synthesis of 1,2-cis-gluco type sugars. This chapter reports the design and 
synthesis of novel mannosyl donors that provide 1,2-cis-mannosides via NGP of thioether 
auxiliaries. A key element in our design is the use of 1C4 locked mannuronic acid lactones to 
enable the NGP of the C-2 auxiliary. In addition to C-2 participation we identified a new mode 
of remote participation of the C-4 benzyl to provide 1,2-cis-mannosides. 
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4.1 – Introduction 
 
The most challenging aspect of oligosaccharide synthesis is the stereoselective synthesis of 
glycosidic bonds.[1] In order for oligosaccharide synthesis to become a routine process, broadly 
applicable and highly reliable glycosylation methods are needed. In this respect, the most 
promising methodology is based on the neighboring group participation (NGP) of C-2 acyl 
substituents to provide 1,2-trans-glycosides.[1b] This methodology is broadly applicable to 
manno- and gluco type sugars and has been applied to (automated) solid phase oligosaccharide 
synthesis (SPOS).[2]  
Recently, the application of NGP has been extended to the preparation of 1,2-cis-glycosides with 
the advent of C-2 chiral auxiliaries (Scheme 1a).[3] In the approach, a C-2 (S)-
(phenylthiomethyl)benzyl ether is used to trap the oxocarbenium-ion from the β-face resulting 
in the formation of 1,2-cis-glycosides. This methodology holds great promise to become a 
generally applicable principle for the synthesis of 1,2-cis-glycosides.[4] However, this 
methodology has been strictly limited to the synthesis of 1,2-cis-gluco type sugars. The trans-
decalin sulfonium ion intermediate is unlikely formed in mannose and the most likely 
intermediate would be a cis-decalin system which would provide the 1,2-trans-mannoside 
instead (Scheme 1b). Conversely, an alternative method to prepare β-mannosides has been 
developed by Crich and co-workers, but this method is mostly limited to the synthesis of β-
mannosides.[5] We therefore explored the possibility to prepare β-mannosides using NGP since 
this method is applicable to other classes of carbohydrates as well. This chapter reports a new 
strategy to enable NGP for the synthesis for 1,2-cis-mannosides by use of the 1C4 conformation. 
In this conformation and using an (R)-configured auxiliary, the formation of a trans-decalin 
intermediate is possible (Scheme 1c). 
 
Scheme 1: General overview of NGP in manno- and glucotype donors: a) Neighboring group participation by a chiral 
auxiliary in gluco- and galacto-type donors resulting in the 1,2-cis product; b) C-2 participation of the auxiliary in the 
4C1 conformation resulting in the cis-decalin system and hence 1,2-trans-mannosides; c) A ringflip into the 1C4 
conformation favors the trans-decalin system. Attack of the acceptor at the beta (axial) position results in the β-
mannoside.  
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Three new mannose donors were designed to study the effect of conformation on neighboring 
group participation and the stereoselectivity of the ensuing glycosylation (9a-9c, Scheme 2).[6] 
To obtain the desired 1C4 conformation, we used a 6,3-lactone bridge that can be introduced by 
oxidation of the 3,6-diol precursor using TEMPO/BAIB.[7] Critically, this mild oxidation method is 
chemoselective and compatible with thioethers.[8] Typically, the sulfonium ions are obtained 
after pre-activation of glycosyl imidates. However, early attempts to prepare glycosyl imidates 
of glycosyl lactones failed because the intermediate lactol underwent ring opening. Hence, we 
selected the carboxybenzyl leaving group as it is compatible with thioethers and can be 
introduced at an early stage.[9]  
 
4.2 – Donor synthesis 
 
Synthesis of 9a-c started from known benzylidene protected thiomannosides 1a/b (scheme 
2).[10] The benzylidenes in 1a/b were reductively opened to the C-4 position to give the 
corresponding 3,6-diols 2a/b which, after acetylation, afforded 3a/b in good yields. 
Thiomannosides 3a/b were used to glycosylate 2-(allylcarboxy)benzyl[11] (ACB) alcohol using 
NIS/TfOH[12] to give 4a/b. Next, the 2-methylnaphthyl ether of 4a was cleaved by DDQ 
oxidation to give alcohol 5. The (R)-(phenylthiomethyl)benzyl ether was introduced with 
retention of stereochemistry by BF3-Et2O promoted activation of (R)-1-phenyl-2-
(phenylthio)ethyl acetate.[3a] To prepare donor 9a, 6 was deallylated with Pd(PPh3)4. Next, 4b 
and 6 were deacetylated using KOtBu in allyl alcohol to obtain diols 7a and 7b, respectively. 
Because the thioether moiety is readily oxidized using most traditional oxidation methods, the 
aforementioned chemoselective TEMPO/BAIB method was chosen.[7] Oxidation of 7a/b (60-
80%) proceeded with moderate yields to provide 1C4 mannolactones 8a/b. Finally, compounds 
8a/b were deallylated to afford glycosyl donors 9b/c. 
 
 
Scheme 2: Synthesis of the mannosyl donors 9a-c. Reagents and conditions: i) BH3.THF, Bu2BOTf, THF; 2a, 97%; 2b, 
70%; ii) Ac2O, Pyridine; 3a, 95 %; 3b 95%; (iii) ACB, NIS, TfOH, DCM; 4a, 82 %; 4b, 82%; (iv) 4a, DDQ, DCM/H2O; 
5, 75%; v) (R)-PhCH(OAc)CH2SPh, BF3.Et2O, DCM; 6, 70%; (vi) AllylOH, KOtBu; 7a, 85%; 7b, 87% (vii) TEMPO, BAIB, 
H2O/DCM; 8a, 60%; 8b, 80%; viii) Pd(PPh3)4, AcOH/DCM; 9a, 90 %; 9b, 85%, 9c (90%). 
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4.3 – Glycosylation results 
 
Next, we glycosylated donors 9a-c with glycosyl acceptors 10 and 11 (Table 1, entries 1-6). 
Donors 9a-b and 9c were preactivated at low temperature (-40oC and -78oC, respectively) with 
1.0 eq Tf2O in the presence of 2,6-di-tert-butyl-4-methylpyridine (DTBMP) as a base. All donors 
were activated almost instantaneously and reactions with 9a and 9b were allowed to warm up 
to -20oC before addition of the acceptor. As expected, donor 9a produced mainly α-mannosides, 
presumably via a cis-decalin sulfonium ion intermediate (Table 1, entries 1 and 4). In contrast, 
glycosylation with 9b showed excellent β-selectivity in respectable yields (entries 2 and 5). The 
β-selectivity observed in these glycosylation supports the hypothesis that the reaction proceeds 
via an SN2 like displacement of the proposed equatorial sulfonium ion.[13] However, donor 9c, 
which because of the high reactivity was activated at lower temperature (-78oC), produced 
exclusively β-mannosides with both the primary and secondary acceptor (Table 1, entries 3 and 
6). These results indicate that reactive intermediates other than the α-sulfonium ion are also 
important for the observed β-selectivity.  
 
Table 1: Glycosylation Results of donors 9a-9c. 
a isolated yields; b ratios were determined by integration of key NMR signals of the crude reaction mixture; c the 
stereochemistry was determined by determination of the 1JC1,H1 coupling: axial H-1 (≈160Hz) or equatorial H-1 
(≈170Hz)[14]; d using 2.0 eq of glycosyl donor; e using 2.0 eq of acceptor; f as inseparable mixture with 14c. 
 
4.4 – Mechanistic studies 
 
In order to explain the results of the glycosylations shown in Table 1, VT-NMR studies were 
performed on donors 9a-9c to identify reaction intermediates. 4C1 donor 9a was mixed with 2.0 
eq of DTBMP in CD2Cl2 at -20oC (Figure 1a) and activated with 1.0 eq of Tf2O in an NMR tube. 
At this temperature 1H-NMR showed a single species (Figure 1b). A 1H-TOCSY experiment 
(irradiation of δ = 5.21 ppm, figure 1c) revealed a major downfield shift of H-1 to 5.56 ppm and 
 
entry donor R1OH 
yielda 
(%) 
α / βb 
1JC1-H1c 
(Hz) 
 
entry Donor R1OH 
yielda 
(%) 
α / βb 
1JC1-H1c 
(Hz) 
1 
 
10 82d 10/1 170 
 
4 
 
11 71d >20/1 175 
2 
 
10 61
d 
52e >1/20 172 
 
5 
 
11 58d >1/20 176 
3 
 
10 87
d,f 
70e >1/20 172 
 
6 
 
11 37d >1/20 176 
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in combination with 1H-13C-HSQC and 1H-13C HMBC NMR spectra, which revealed a C1-H8 
correlation, it was concluded that the 1,2-trans decalin intermediate was formed. 
 
 
 
Figure 1: VT-NMR study of donor 9a: i) 2.0 eq DTBMP + 1.0 eq Tf2O; ii) 10 or 11. a) Donor 9a pre-activation at -
20oC; b) Donor 9a post-activation at -20oC; c) 1H-TOCSY of the activated donor 9a; d) 1H-13C HMBC spectrum of 9b, 
with overlay of a proton decoupled 1H-13C HSQC, post-activation. 
 
 
As depicted in figure 2, 1C4 donor 9b (Figure 2a) was activated at -30oC under the 
aforementioned conditions. At -20oC, a clean spectrum of a single species was observed (Figure 
2b). A 1H-1H TOCSY NMR (Figure 2c) with irradiation of H-2 and H-4 revealed a major downfield 
shift of H-1 (δ 5.06 ppm → δ 7.46 ppm). Furthermore, a strong correlation between C-1 and H-
8ax (δ 4.23 ppm) and to a minor extend with H-8eq (δ 4.82 ppm) in the 1H-13C-HMBC spectrum 
(Figure 2d) indicated formation of a ring system. The 3JH1,H2 coupling of 6.0 Hz supports a diaxial 
orientation and suggests an α-sulfonium ion. 
The observation of the β-sulfonium ion after activation of 9a and the α-sulfonium ion found 
following activation of 9b supports the hypothesis that these intermediates are displaced by the 
alcohol to provide α- and β-mannosides, respectively.[13] However, glycosylation with mannosyl 
donor 9c were also highly β-selective. Previously, high α-selectivity was observed in 
glycosylations with galacturonic acid lactones.[7] The selectivity was attributed to the disarmed 
nature of the acceptor although exemptions were reported in a later study.[15] The observed β-
selectivity could also be explained by pseudoaxial attack on the 3H4 oxocarbenium ion to provide 
the observed 1,2-cis addition.[16] Finally, anomeric triflate species may also be important 
intermediates.[17]  
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 94
Chapter 4
94
 
94 
 
 
 
Figure 2: VT-NMR study of donor 9b: i) 2.0 eq DTBMP + 1.0 eq Tf2O; ii) 10 or 11. a) Donor 9b pre-activation at -
30oC; b) Donor 9b post-activation at -20oC; c) 1H-TOCSY of the activated donor 9b; d) 1H-13C HMBC spectrum of 9b, 
with overlay of a proton decoupled 1H-13C HSQC, post-activation.  
 
 
 
To investigate the reaction intermediates, donor 9c was activated at -80oC, A VT-NMR study at 
-80oC showed a mixture of several species (Figure 3a). Close examination with 19F NMR showed 
triflated intermediates were present and 1H-19F HOESY (Figure 3c) in combination with 1H-13C-
HSQC and 1H-13C-HMBC characterized these species as an anomeric triflate and to our surprise, 
benzyltriflate. In order to observe the stability of the triflate, the sample was heated gradually 
until one species remained at -20oC (Figure 3b). Extensive NMR studies showed a strong H1-C4 
correlation which, together with the formation of benzyl triflate, led us to conclude that tricyclic 
compound 14c had formed.  
 
We propose that upon activation of donor 9c, intermediate oxocarbenium ion 12c is stabilized 
by the C-4 benzyl ether to form 13c (Scheme 3). In absence of the acceptor, this intermediate 
ultimately results in the formation of 14c and benzyl triflate. The formation of 14c and benzyl 
triflate indicate NGP of the C-4 benzyl which may also explain the high β-selectivity of 9b.[18] 
Careful examination of the glycosylation mixture indeed showed the presence of 14c as a side 
product in moderate quantities.  
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Figure 3: VT-NMR study of donors 9c: i) 2.0 eq DTBMP + 1.0 eq Tf2O; iii) Raising temperature. a) 1H NMR spectrum 
of activated donor 9c at -80oC; b) at -20oC; c) 1H-19F HOESY spectrum of activated donor 9c. 
 
A batch experiment to reproduce 14c from 9c was performed and gave 14c in good yield 
(Scheme 4, 79%). Unlike earlier reported 1,4-anhydro sugars, 1,4-anhydro-6,3-lactone 14c 
was stable and no polymerization or furanose formation was observed.[19] In addition to remote 
participation of the C-4 benzyl ether, the expected 3H4 conformation of the oxocarbenium ion 
may also lead to β-product (Scheme 4).[16] 
 
 
Scheme 3: Proposed Remote Participation in mannuronic acid lactones 9b and 9c. 
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In principle, although not observed in the NMR study at -20oC, C-4 benzyl participation could 
also occur in 9b and indeed tricyclic compound 14b could be retrieved as a side product in the 
glycosylation reaction. The formation of 14b as a side product may explain the moderate yields 
observed (Table 1, entries 1-4). Although 14b is ultimately formed, VT-NMR experiments show 
that sulfonium ion formation is highly favored at -20oC. Therefore, in case of 9b, an additional 
pathway via sulfonium ion 15 may lead to β-mannosides, but the observed selectivity is more 
likely to be a result of the aforementioned alternative pathways (Scheme 3). 
 
 
 
Scheme 4: Synthesis of tricyclic mannoside 14c. 
 
 
4.5 – Reverting to the 4C1 conformation 
 
Finally, the opening of mannuronic acid lactones 16-19 with Dowex(H+) in MeOH reverted the 
conformation to the 4C1 and afforded the corresponding methyl esters 20-23 in high yield.[16b, 
20] The orientation of H-1 was confirmed using the 1JC1-H1 coupling constants, again confirming 
the 1,2-cis substitution (Table 2, entries 1,2,4 and 5).[14] Additionally, mannuronic acid lactone 
14 was selectively reduced to its corresponding mannose analogue using K-selectride to obtain 
24 in 90% yield (see Table 2, entry 3).[21] This may be an attractive way to prepare β-
mannosides found in the human core N-glycan.  
 
Table 2: Opening of the dissacharide lactones. 
a isolated yields; b as an inseparable mixture with 14c; c reagent was K-selectride in THF; d the stereochemistry was 
determined by determination of the 1JC1,H1 coupling: axial H-1 (≈160Hz) or equatorial H-1 (≈170Hz)[14] 
 
entry lactone product 
yielda  
(%) 
1JC1-H1 
(Hz)d 
k 
entry lactone product 
yielda  
(%) 
1JC1-H1 
(Hz)d 
1 
  
90 156 
 
4 
  
91 155 
2 
 
 
89b 160 
 
5 
 
 
80 156 
3c 
  
90 155 
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4.6 – Conclusion 
 
We have shown that chiral auxiliaries can be used to prepare β-mannosides via NGP. To make 
trans-decalin sulfonium ion formation possible, it is imperative to use 1C4 mannosides. Due to 
this conformation, however, the C-4 benzyl substituent is also able to engage in remote NGP 
and provide 1,2-cis-mannosides. Although good alternatives for β-mannosylation are available, 
this method relies on neighboring group participation which is a generally applicable method. 
Hence, the use of NGP to prepare 1,2-cis-glycosides of gluco- and manno-type sugars is now 
possible bringing a unified procedure for 1,2-cis glycosylation one step closer. 
 
4.7 – Experimental section 
 
General methods: For general remarks, please refer to section 2.9. 
 
Phenyl 4-O-benzyl-2-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranoside (2a)[22]  
 To a cooled (0oC) solution of phenyl 4,6-O-benzylidene-2-O-(2-methylnaphthyl)-1-thio-α-D-
mannopyranoside[10a] (6.3 g, 12.6 mmol) in THF (60 mL) was 63 mL of 1.0 M BH3 in THF (62.9 mL, 
62.9 mmol) was added under stirring under inert atmosphere. To the solution 1M Bu2BOTf in DCM 
(12.5 mL, 12.5 mmol) was added and the reaction stirred for 1 hr. The solution was neutralized with 
Et3N (5 mL) quenched with methanol and was concentrated in vacuo. Silicagel flash column chromatography (0% → 
30% - EtOAc in n-heptane) of the residue afforded 2a (6.0 g, 95 %) as colorless oil. TLC: (EtOAc/n-heptane, 30/70 
v/v): Rf = 0.25; 1H NMR (500 MHz, CDCl3) δ 7.89 – 7.24 (m, 17H, CH Ar), 5.56 (d, J = 1.0 Hz, 1H, H-1), 4.93 (d, J = 
11.1 Hz, 1H, CHHNap), 4.89 (d, J = 11.8 Hz, 1H, CHHPh), 4.75 (d, J = 11.8 Hz, 1H, CHHPh), 4.69 (d, J = 11.1 Hz, 1H, 
CHHNap), 4.15-4.11 (m, 1H, H-5), 4.07 (dd, J = 3.7, 1.4 Hz, 1H, H-2), 4.02 (td, J = 9.1, 3.6 Hz, 1H, H-3), 3.87 – 3.82 
(m, 2H, H-6a, H-6b), 3.80 (m, 1H, H-4), 2.40 (d, J = 9.1 Hz, 1H, , C-3HOH), 1.77 (dd, J = 7.5, 5.7 Hz, 1H, C-6HHOH); 
13C NMR (126 MHz, CDCl3) δ 132.04, 129.12, 128.63, 128.52, 128.06, 127.93 (2 x), 127.77, 127.06, 126.40, 126.28, 
125.76, 85.42(C-1), 79.72(C-2), 76.52(C-4), 75.05, 72.80, 72.54(H-5), 72.23(C-3), 62.18(C-6); HRMS (m/z): 
[M+Na]+ calcd for C30H30O5S, 525.1712; found, 525.1711; [α]25D = +77.7 (c = 0.23, CHCl3). 
 
Phenyl 2,4-di-O-benzyl-1-thio-α-D-mannopyranoside (2b)[23]  
To a solution of phenyl 4,6-O-benzylidene-2-O-benzyl-1-thio-α-D-mannopyranoside[24] (3.2 g, 7.1 
mmol) in THF (30 mL) was added 1.0 M BH3 in THF (28.4 mmol, 24 mL) under stirring at 0
oC and 
inert atmosphere. 1.0 M Bu2BOTf in DCM (7.8 mL, 7.8 mmol) was added and the reaction stirred for 
1h. The reaction was quenched by addition of triethylamine (5 mL) and methanol (10 mL) and concentrated in vacuo. 
Silicagel flash column chromatography (0% → 50% - EtOAc in n-heptane) of the residue afforded 2b (2.3 g, 71 %) as 
a pale oil. TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.15.  
 
Phenyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranoside (3a):  
To a solution of 2a (4.3 g, 8.6 mmol) in pyridine (40 ml), acetic anhydride (20 mL) was added. The 
solution was stirred for 16h at rt before it was concentrated in vacuo. Silicagel flash column 
chromatography (0% → 30% - EtOAc in n-heptane) of the residue afforded 3a (4.8 g, 95%) as a 
colorless oil. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.60; 1H NMR (500 MHz, CDCl3) δ 7.87 – 7.22 
(m, 17H, Ar), 5.56 (d, J = 1.8 Hz, 1H, H-1), 5.23 (dd, J = 9.3, 3.3 Hz, 1H, H-3), 4.83 (d, J = 12.2 Hz, 1H, CHHNap), 
4.72 (d, J = 11.2 Hz, 1H, CHHNap), 4.67 (d, J = 12.2 Hz, 1H, CHHPh), 4.60 (d, J = 11.2 Hz, 1H, CHHPh), 4.43 – 4.38 
(m, 1H, H5), 4.35 – 4.31 (m, 2H, H-6a, H-6b), 4.18 (dd, J = 3.2, 2.0 Hz, 1H, H-2), 4.01 (t, J = 9.5 Hz, 1H, H-4), 2.04 
(s, 3H, CH3 Ac), 1.96 (s, 3H, CH3 Ac): 13C NMR (126 MHz, CDCl3) δ 170.74, 170.03, 137.72, 134.89, 133.70, 133.17, 
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133.10, 131.89 -125.80, 85.36(C-1), 77.28, 77.08(C-2), 77.03, 76.77, 74.82, 73.83(C-3), 73.57(C-4), 72.60, 70.70(C-
5), 63.35(C-6), 20.99, 20.88. HRMS (m/z): [M+Na]+ calcd for C34H34O7S, 609.1923; found, 609.1912.  
 
Phenyl 3,6-di-O-acetyl-2,4-di-O-benzyl-1-thio-α-D-mannopyranoside (3b)[23] 
 To a solution of 2b (2.5 g, 5.5 mmol) in pyridine (40 ml) acetic anhydride (20 mL) was added. The 
solution was stirred for 16h at rt before it was concentrated in vacuo. Silicagel flash column 
chromatography (0% → 30% - EtOAc in n-heptane) of the residue afforded 3b (2.7 g, 93%) as a 
colorless oil. TLC: (EtOAc/n-heptane, 25/75 v/v): Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.44 
(m, 2H, CH Ar), 7.39 – 7.24 (m, 13H, CH Ar), 5.55 (d, J = 1.9 Hz, 1H, H-1), 5.21 (dd, J = 9.3, 3.3 Hz, 1H, H-3), 4.72 
(d, J = 11.2 Hz, 1H, CHHPh), 4.69 (d, J = 12.2 Hz, 1H, CHHPh), 4.60 (d, J = 11.2 Hz, 1H, CHHPh), 4.50 (d, J = 12.1 
Hz, 1H, CHHPh), 4.39 (ddd, J = 9.7, 4.5, 3.2 Hz, 1H, H-5), 4.34 – 4.31 (m, 2H, H-6a, H-6b), 4.16 – 4.09 (m, 1H, H-
2), 3.99 (t, J = 9.5 Hz, 1H, H-4), 2.03 (s, 3H, CH3 Ac), 1.99 (s, 3H, CH3 Ac); 13C NMR (126 MHz, CDCl3) δ 170.75, 
170.05, 137.72, 137.48, 133.76, 131.82, 129.05, 128.53, 128.46, 128.00, 127.97, 127.87, 127.80, 127.66, 85.15(C-
1), 76.92(C-2), 74.84, 73.85(C-3), 73.50(C-4), 72.28, 70.63(C-5), 63.33(C-6), 21.03, 20.87; HRMS (m/z): [M+Na]+ 
calcd for C30H32O7S, 559.1766; found, 559.1764; [α]25D = +4.25 (c = 0.4, CHCl3). 
 
2-(Allyloxycarbonyl)benzyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(2-methylnaphthyl)-α-D-mannopyranoside 
(4a): To a solution of 3a (2.5 g, 4.2 mmol) in DCM (30 mL), allyl 2-(hydroxymethyl)benzoate (0.9 
g, 4.6 mmol), N-iodosuccinimide (1.0 g, 4.6 mmol) and molecular sieves were added under inert 
atmosphere. The mixture was cooled (0oC) and stirred for 15 minutes before TfOH (0.037 ml, 0.42 
mmol) was added. After the mixture was stirred for 30 minutes Et3N (4mL) was added to neutralize 
the solution and the mixture was diluted with DCM (100 mL). After the mixture was washed with 2M Na2S2O3 solution 
(2 x 30 mL) and brine (2 x 30 mL), the organic layer was dried (Na2SO4), filtered and concentrated in vacuo. Silicagel 
flash column chromatography (0% → 20% - EtOAc in n-heptane) of the residue afforded 4a (2.32 g, 82 %) as pale 
yellow oil. TLC: (EtOAc/n-heptane, 20/80 v/v): Rf = 0.19; 1H NMR (400 MHz, CDCl3) δ 7.97 – 7.25 (m, 16H, Ar), 5.99 
(ddt, J = 17.2, 10.4, 5.7 Hz, 1H, CH allyl), 5.37 (dq, J = 17.2, 1.5 Hz, 1H, CH=CHH allyl), 5.33 (d, J = 3.4 Hz, 1H, H-
3), 5.26 (dq, J = 10.4, 1.3 Hz, 1H, CH=CHH allyl), 5.10 (d, J = 14.4 Hz, 1H, CHH ACB ether), 5.01 (d, J = 1.9 Hz, 1H, 
H-1), 4.95 (d, J = 14.4 Hz, 1H, CHH ACB ether), 4.81 (d, J = 12.5 Hz, 1H, CHH Nap), 4.75 (m, 3H, CH2 allyl, CHH Nap), 
4.71 (d, J = 11.0 Hz, 1H, CHHPh), 4.59 (d, J = 11.1 Hz, 1H, CHHPh), 4.34 – 4.30 (m, 2H, H-6a, H-6b), 4.04 – 3.99 (m, 
2H, H-2, H-4), 3.94 (dd, J = 8.4, 4.6 Hz, 1H, H-5), 2.08 (s, 3H, CH3 Ac), 1.97 (s, 3H, CH3 Ac): 13C NMR (126 MHz, 
CDCl3) δ 170.87, 170.11, 166.44, 139.46, 137.82, 135.20, 133.13, 132.45-125.77, 118.41, 97.47(C-1), 75.80(C-2), 
74.81, 74.81, 73.94(C-3), 73.44(C-4), 73.11, 70.00(C-5), 67.43, 65.57, 63.32(C-6); HRMS (m/z): [M+Na]+ calcd for 
C35H32O8S, 691.2519; found, 691.2513; [α]25D +25.6 (c = 0.67, CHCl3)  
 
2-(Allyloxycarbonyl)benzyl 3,6-di-O-acetyl-2,4-di-O-benzyl-α-D-mannopyranoside (4b):  
To a solution of 3b (1.3 g, 2.36 mmol) in dry DCM (20 mL) allyl 2-(hydroxymethyl)benzoate (0.55 
g, 2.8 mmol) and NIS (0.584 g, 2.60 mmol) were added under inert atmosphere. After addition of 
molecular sieves, TfOH (0.021 mL, 0.236 mmol) was added. The reaction stirred for 30 minutes 
before it was neutralized by addition of Et3N (2 mL) and diluted with DCM (100 mL). The reaction 
mixture was washed with 2M Na2S2O3 solution (2 x 30 mL) and brine (2 x 30 mL). The organic layer was dried (Na2SO4), 
filtered and concentrated in vacuo. Silicagel flash column chromatography (0% → 20% - EtOAc in n-heptane) of the 
residue afforded 4b as pale yellow oil (1.2 g, 82%). TLC: (EtOAc/n-heptane, 20/80 v/v): Rf = 0.33; 1H NMR (500 MHz, 
CDCl3) δ 7.98 (dd, J = 7.8, 1.2 Hz, 1H, -CH Ar), 7.94 (d, J = 7.7 Hz, 1H, -CH Ar), 7.69 (td, J = 7.5, 1.0 Hz, 1H, -CH 
Ar), 7.60 – 7.48 (m, 2H, -CH Ar), 7.37 – 7.21 (m, 9H, -CH Ar), 6.02 (ddt, J = 17.1, 10.6, 5.7 Hz, 1H, -CH allyl ), 5.39 
(dd, J = 17.2, 1.5 Hz, 1H, -CH=CHH allyl), 5.32 (dd, J = 9.3, 3.2 Hz, 1H, H-3), 5.28 (dd, J = 10.4, 1.3 Hz, 1H, -CH=CHH 
allyl), 5.11 (d, J = 14.3 Hz, 1H, -CHH CB), 4.99 (d, J = 1.8 Hz, 1H, H-1), 4.95 (d, J = 14.3 Hz, 1H, -CHH CB), 4.78 (dt, 
J = 5.7, 1.4 Hz, 2H, CH2 allyl), 4.70 (d, J = 11.2 Hz, 1H, -CHHPh), 4.67 (d, J = 12.3 Hz, 1H, -CHHPh), 4.58 (d, J = 11.1 
Hz, 1H, -CHHPh), 4.56 (d, J = 12.2 Hz, 1H, -CHHPh ), 4.31 (d, J = 3.3 Hz, 2H, H-6a, H-6b), 4.01 – 3.95 (m, 2H, H-2, 
H-5), 3.92 (dt, J = 9.9, 3.4 Hz, 1H, H-4), 2.07 (s, 3H, acetyl), 2.00 (s, 3H, acetyl); 13C NMR (126 MHz, CDCl3) δ 170.87, 
170.11, 166.45 , 146.52 , 139.52 , 137.82 , 134.00 , 132.51 , 132.12 , 130.57 , 129.50 – 126.88 (m), 125.83 , 122.07, 
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118.44, 97.42(C-1), 75.75(C-2), 74.81, 73.94(C-3), 73.37(C-4), 72.8, 69.99(C-5), 67.49, 65.59, 63.29(C-6), 21.10, 
20.90; HRMS (m/z): [M+Na]+ calcd for C35H38O10 641.23548; found, 641.23627; [α]25D = +20.7 (c = 0.71, CHCl3). 
 
2-(Allyloxycarbonyl)benzyl 3,6-di-O-acetyl-4-O-benzyl-α-D-mannopyranoside (5) 
To a well stirred emulsion of 4a (3.0 g, 4.5 mmol) in DCM (30 mL) and water (4 mL) DDQ (1.6 g, 
7.2 mmol) was added. The resulting solution was protected from light and stirred at rt for 1.5 hrs. 
The mixture was diluted with DCM (150 mL) and washed (2 x 40 mL) with an aqueous mixture of 
ascorbic acid (1.5 %), citric acid (0.7%) and NaOH (0.9%) to reduce the remaining DDQ. The 
organic layer was dried (Na2SO4), filtered and concentrated in vacuo. Silicagel flash column chromatography (40% → 
60% - EtOAc in n-heptane) of the residue afforded 5 as a pale yellow oil (1.95 g, 82%). TLC: EtOAc/n-heptane, 50/50 
v/v): Rf = 0.22; 1H NMR (500 MHz, CDCl3) δ 7.93– 7.16 (m, 9H, CH Ar), 5.95 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H ddt, J = 
16.2, 10.6, 5.7 Hz, 1H, CH allyl), 5.33 (ddd, J = 17.2, 3.0, 1.5 Hz, 1H, CH=CHH allyl), 5.29 (dd, J = 9.1, 3.2 Hz, 1H, 
CH=CHH allyl), 5.21 (dd, J = 10.4, 1.3 Hz, 1H, H-3), 5.06 (d, J = 14.1 Hz, 1H, CHH ACB ether), 4.89 (d, J = 14.6 Hz, 
1H, CHH ACB ether), 4.88 (s, 1H, H-1), 4.72 (dt, J = 5.7, 1.4 Hz, 2H, CH2 allylic ester), 4.58 (d, J = 11.2 Hz, 1H, , 
CHHPh), 4.50 (d, J = 11.2 Hz, 1H, , CHHPh), 4.23 (t, J = 3.5 Hz, 2H, H-6), 4.09 (dd, J = 2.9, 2.0 Hz, 1H, H-2), 3.89 
(ddd, J = 9.8, 3.9, 2.5 Hz, 1H, H-5), 3.88 – 3.80 (m, 1H, H-4), 2.01 (s, 3H, CH3 acetyl), 2.00 (s, 3H, CH3 acetyl); 13C 
NMR (126 MHz, CDCl3) δ 170.83 , 169.91, 166.50, 139.2 , 137.60, 132.55, 132.08, 130.62, 128.53, 128.01, 127.89, 
127.81, 127.42, 118.51, 99.32(C-1), 74.83, 74.37(C-3), 72.92(C-4), 69.78(C-5), 69.50(C-2), 67.62, 65.65 , 63.07(C-
6), 21.1, 20.89; HRMS (m/z): [M+Na]+ calcd for C28H32O10, 551.1893; found, 551.1890; [α]25D = +67.2 (c = 0.45, 
CHCl3). 
 
2-(Allyloxycarbonyl)benzyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-
mannopyranoside (6): To a solution of 5 (1.6 g, 2.9 mmol) in DCM (20 mL), allyl 2-(hydroxymethyl)benzoate (1.6 g, 
5.9 mmol,) was added under inert atmosphere. After the mixture was cooled to 0oC, molecular 
sieves were added and the mixture was stirred for 15 minutes. BF3.OEt2 (0.75 ml, 5.9 mmol) 
was added and the reaction was stirred until an optimum in auxiliary coupling was observed 
(t=35 min).The reaction was quenched by addition of triethylamine (6 ml) and methanol (10 
mL). After filtration the filtrate was concentrated in vacuo. Silicagel flash column 
chromatography (0% → 20% - EtOAc in n-heptane) of the residue afforded 6 (1.3 g, 70% yield based on recovered 5) 
as pale yellow oil. 0.30 g of 5 was reclaimed. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.47; 1H NMR (500 MHz, CDCl3) 
δ 7.98 (dd, J = 7.8, 1.2 Hz, 1H, CH Ar), 7.56 (d, J = 7.2 Hz, 1H, CH Ar), 7.49 (td, J = 7.6, 1.3 Hz, 1H, CH Ar), 7.41 – 
7.21 (m, 20H, CH Ar), 7.19 – 7.14 (m, 1H, CH Ar), 6.01 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H, CH allyl), 5.39 (dq, J = 17.2, 
1.5 Hz, 1H, -CHH allyl), 5.27 (dq, J = 10.4, 1.3 Hz, 1H, -CHH allyl), 5.22 (dd, J = 9.1, 3.3 Hz, 1H, H-3), 5.11 (d, J = 
14.6 Hz, 1H, -OCHH- ACB), 5.10 (d, J = 1.6 Hz, 1H, H-1), 4.96 (d, J = 14.4 Hz, 1H, -OCHH- ACB), 4.76 (dd, J = 5.7, 
1.3 Hz, 2H, -OCH2- allyl), 4.62 (d, J = 11.1 Hz, 1H, CHHPh), 4.53 (d, J = 11.2 Hz, 1H, CHHPh), 4.46 (dd, J = 8.4, 4.7 
Hz, 1H, H-8), 4.35 (dd, J = 11.8, 2.0 Hz, 1H, H-6a), 4.25 (dd, J = 11.8, 4.7 Hz, 1H, H-6b), 3.96 – 3.85 (m, 2H, H-4, 
H-5), 3.83 (dd, J = 3.3, 1.9 Hz, 1H, H-2), 3.34 (dd, J = 13.6, 8.4 Hz, 1H, H-8a), 3.13 (dd, J = 13.6, 4.7 Hz, 1H, H-8b), 
2.09 (s, 3H, CH3 Ac), 1.81 (s, 3H, CH3 Ac); 13C NMR (126 MHz, CDCl3) δ 170.90, 170.90, 169.84, 166.40, 140.43, 
139.69, 137.85, 136.62, 132.48, 132.15, 130.53, 129.30, 128.93, 128.45, 127.79, 127.49, 127.18, 126.92, 126.07, 
118.40, 97.02(C-1), 80.76(C-7), 75.27(C-2), 74.71, 73.40(C-4), 73.26(C-3), 70.20(C-5), 67.56, 65.56, 63.25(C-6), 
41.96(C-8), 35.44, 20.96; HRMS (m/z): [M+Na]+ calcd for C35H32O8S, 763.2553; found, 763.2547; [α]25D = +57.6 (c 
= 1.0, CHCl3). 
 
2-(Allyloxycarbonyl)benzyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-mannopyranoside (7a):  
To a solution of 6 (1.6 g, 2.2 mmol) in allyl alcohol (20 mL) was added KOtBu (0.24 g, 2.2 mmol) 
under inert atmosphere. The reaction was stirred for 16 h before Dowex was added to neutralize 
the base. The reaction was diluted with DCM (100 mL) and filtrated. The filtrate was washed 
with brine (20 mL) and the organic layer was dried (Na2SO4), filtered and concentrated in vacuo. 
Silicagel flash column chromatography (40% → 80% - EtOAc in n-heptane) of the residue afforded 7a (1.15 g, 81%) as 
a colorless oil. TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.49; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.94 (m, 1H, -CH 
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Ar), 7.49 – 7.43 (m, 2H, -CH Ar), 7.39 – 7.22 (m, 17H, -CH Ar), 7.20 – 7.13 (m, 1H, -CH Ar), 5.99 (ddt, J = 17.2, 10.5, 
5.7 Hz, 1H, -CH- allyl), 5.38 (dq, J = 17.2, 1.5 Hz, 1H, -CH=CHH allyl), 5.27 (ddd, J = 10.5, 2.6, 1.3 Hz, 1H, -CH=CHH 
allyl), 5.11 (d, J = 1.4 Hz, 1H, H-1), 5.06 (d, J = 14.2 Hz, 1H, -OCHH ACB), 4.92 (d, J = 14.2 Hz, 1H, -OCHH ACB),), 
4.87 (d, J = 11.0 Hz, 1H,-CHHPh), 4.76 – 4.72 (m, 2H, -OCH2 allyl), 4.64 (d, J = 11.1 Hz, 1H, -CHHPh), 4.58 (dd, J = 
9.0, 4.1 Hz, 1H, -CH auxiliary), 3.98 (dt, J = 9.1, 4.6 Hz, 1H, H-3), 3.86 (dd, J = 11.7, 2.2 Hz, 1H, H-6a), 3.78 (t, J = 
9.4 Hz, 2H, H-6b, H-5), 3.68 (dd, J = 3.5, 1.7 Hz, 1H, H-2), 3.67 – 3.61 (m, 1H, H-5), 3.37 (dd, J = 13.7, 9.0 Hz, 1H, 
-CHH auxiliary), 3.19 (dd, J = 13.7, 4.1 Hz, 1H, -CHH auxiliary), 2.27 (m, 1H -CH2OH), 2.06 (d, J = 9.3 Hz, 1H, -C-
3HOH); 13C NMR (126 MHz, CDCl3) δ 166.44, 139.81, 139.73, 138.46, 136.42, 132.46, 132.12, 130.60, 129.30, 129.03 
(d, J = 5.4 Hz), 128.77, 128.46, 128.04, 128.02, 127.78, 127.58, 127.29, 126.86, 126.25, 118.47, 96.53(C-1), 
79.96(C-7), 76.38(C-2), 76.24(C-4), 75.08, 71.92(C-5), 71.48(C-3), 67.62, 65.58, 62.18(C-6), 41.60(C-8); HRMS 
(m/z): [M+Na]+ calcd for,C38H40O8S, 679.2342; found, 679.2329; [α]25D = +45.6 (c = 1.0, CHCl3). 
  
2-(Allyloxycarbonyl)benzyl 2,4-di-O-benzyl-α-D-mannopyranoside (7b): 
To a solution of 4b (1.1 g, 1.78 mmol) in allyl alcohol (18 mL) KOtBu (0.2 g, 1.78 mmol) was 
added. The reaction was stirred under inert atmosphere for 16 h. Dowex was added to neutralize 
the base and the mixture was diluted with MeOH (20 mL), filtrated and concentrated in vacuo. DCM 
(100 mL) was added and the solution was washed with brine (20 mL). The organic layer was dried 
(Na2SO4), filtered and concentrated in vacuo. Silicagel flash column chromatography (0% →30% - EtOAc in n-heptane) 
of the residue afforded 7b (0.83 g, 87%) as colorless oil. TLC: (EtOAc/n-heptane, 20/70 v/v): Rf = 0.11; 1H NMR (500 
MHz, CDCl3) δ 7.99 (dd, J = 7.8, 1.0 Hz, 1H, -CH Ar), 7.55 – 7.49 (m, 2H, -CH Ar), 7.42 – 7.28 (m, 11H, -CH Ar), 6.02 
(ddt, J = 17.1, 10.5, 5.7 Hz, 1H, -RCH=CH2 allyl), 5.40 (ddd, J = 17.2, 3.0, 1.5 Hz, 1H, RCH=CHH allyl), 5.29 (dq, J = 
10.5, 1.2 Hz, 1H, RCH=CHH allyl), 5.06 (d, J = 14.0 Hz, 1H, -CHH CB), 5.03 (d, J = 1.3 Hz, 1H, H-1), 4.94 (d, J = 14.1 
Hz, 1H, -CHH CB), 4.91 (d, J = 11.1 Hz, 1H, -CHHPh), 4.78 (dt, J = 5.7, 1.4 Hz, 2H, -CH2 allyl), 4.73 (d, J = 11.8 Hz, 
1H, -CHHPh), 4.67 (d, J = 11.1 Hz, 1H, CHHPh), 4.60 (d, J = 11.8 Hz, 1H, CHHPh) 4.08 (td, J = 9.1, 3.7 Hz, 1H, H-3), 
3.86 (dd, J = 5.2, 2.8 Hz, 1H, H-6a), 3.85 – 3.81 (m, 1H, H-2), 3.78 (ddd, J = 11.8, 7.9, 4.1 Hz, 1H, H-6b), 3.71 (d, J 
= 9.1 Hz, 1H, H-4), 3.69 – 3.64 (m, 1H, H-5); 13C NMR (126 MHz, CDCl3) δ 132.48, 132.07, 130.62, 128.62, 128.49, 
128.11, 128.07, 127.88, 127.85, 127.73, 127.35, 118.50, 96.95(C-1), 78.34(C-2), 77.22, 76.49(C-4), 75.03, 73.02, 
71.87(C-3), 71.63(C-5), 67.44, 65.62, 62.28(C-6); HRMS (m/z): [M+Na]+ calcd for C35H32O8S, 557.2151; found, 
557.2136; [α]25D = +36.4 (c = 0.58, CHCl3). 
 
2-(Allyloxycarbonyl)benzyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl) benzyl-α-D-mannopyranosidurono-
6,3-lactone (8a): To a solution of 7a (0.52 g, 0.80 mmol) in 10% H2O in DCM v/v (8 ml), BAIB (0.77 g, 2.4 mmol) 
was added under stirring. After addition of TEMPO (50 mg, 0.32 mmol) the reaction was stirred 
for 1h at rt. The mixture was quenched by addition of 10% Na2S2O3 solution in H2O w/w (5 mL) 
and was extracted with ethyl acetate (2 x 20 mL). The organic layers were combined, dried 
(Na2SO4), filtrated and concentrated in vacuo. Silicagel flash column chromatography (0% → 20% 
- EtOAc in n-heptane) of the residue afforded 8a (0.31 g, 60 %) as a colorless oil. TLC: (EtOAc/n-
heptane, 20/80 v/v): Rf = 0.33; 1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 7.8, 1.2 Hz, 1H, -CH Ar), 7.76 (d, J = 7.4 
Hz, 1H, -CH Ar), 7.50 (td, J = 7.7, 1.3 Hz, 1H, -CH Ar), 7.42 – 7.24 (m, 10H, -CH Ar), 7.19 – 7.05 (m, 6H, -CH Ar), 
7.01 (ddd, J = 7.2, 3.8, 1.2 Hz, 1H, -CH Ar), 6.03 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H, -CH allyl), 5.40 (ddd, J = 17.2, 3.0, 
1.5 Hz, 1H, -CH=CHH allyl), 5.38 (d, J = 14.5 Hz, 1H, -OCHH ACB), 5.28 (dd, J = 10.4, 1.3 Hz, 1H, -CH=CHH allyl), 
5.08 (d, J = 14.5 Hz, 1H, -OCHH ACB), 4.98 (d, J = 6.7 Hz, 1H, H-1), 4.82 (dd, J = 7.6, 5.8 Hz, 1H, H-7), 4.79 (dt, J 
= 5.7, 1.4 Hz, 2H, -OCH2- allyl), 4.43 (d, J = 12.1 Hz, 1H, CHHPh), 4.42 – 4.39 (m, 1H, H-3), 4.33 (d, J = 12.0 Hz, 1H, 
CHHPh), 4.15 (dd, J = 2.8, 0.9 Hz, 1H, H-5), 3.89 (dd, J = 6.7, 1.4 Hz, 1H, H-2), 3.81 (dd, J = 5.8, 2.9 Hz, 1H, H-4), 
3.38 (dd, J = 13.6, 7.6 Hz, 1H, H-8a), 3.08 (dd, J = 13.6, 5.8 Hz, 1H, H-8b); 13C NMR (126 MHz, CDCl3) δ 170.04(C-
6), 166.33, 140.49, 140.04, 136.47, 136.31, 132.46, 132.22, 130.57, 128.82, 128.78, 128.64, 128.37, 127.90, 127.62, 
127.61, 127.25, 127.04, 125.82, 118.53, 101.85(C-1), 82.19(C-7), 79.51(C-3), 74.85(C-4), 74.07(C-2), 71.56, 
70.34(C-5), 69.84, 65.67, 40.87(C-8); HRMS (m/z): [M+Na]+ calcd for C38H36O8S, 675.2029; found, 675.2023; [α]25D 
= -7.4 (c = 0.76, CHCl3). 
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2-(Allyloxycarbonyl)benzyl 2,4-di-O-benzyl-α-D-mannopyranosidurono-6,3-lactone (8b): To a solution of 7b 
(0.36 g, 0.67 mmol) in 10% H2O in DCM v/v (10 ml), BAIB was added (0.65 g, 2.0 mmol) was added 
under stirring. After addition of TEMPO (42 mg, 0.27 mmol) the reaction stirred for 1h at rt. The 
mixture was quenched with 10% Na2S2O3 solution in H2O w/w (10 mL). The mixture was extracted 
twice with ethyl acetate (20 mL). The organic layers were combined, dried (Na2SO4), filtrated and 
concentrated in vacuo. Silicagel flash column chromatography (0% → 30% - EtOAc in n-heptane) of the residue afforded 
8b (0.28 g, 80%) as a colorless oil. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.38; 1H NMR (500 MHz, CDCl3) δ 8.01 
(dd, J = 7.8, 1.3 Hz, 1H, -CH Ar), 7.73 (d, J = 7.7 Hz, 1H, -CH Ar), 7.49 (td, J = 7.6, 1.3 Hz, 1H, -CH Ar), 7.40 – 7.27 
(m, 11H, -CH Ar), 6.01 (ddt, J = 16.2, 10.6, 5.7 Hz, 1H, -RCH=CH2 allyl), 5.39 (dd, J = 17.2, 1.5 Hz, 1H, RCH=CHH), 
5.37 (d, J = 14.4 Hz, 1H, -CHH- CB), 5.28 (dd, J = 10.4, 1.2 Hz, 1H, RCH=CHH ), 5.14 (d, J = 14.4 Hz, 1H,-CHH- CB), 
4.94 (d, J = 6.7 Hz, 1H, H-1), 4.76 (m, 3H, -CHHPh; -CH2 allyl), 4.68 (m, 2H, CHHPh, H-3), 4.61 (d, J = 11.9 Hz, 1H, 
-CHHPh), 4.52 (d, J = 11.9 Hz, 1H, -CHHPh), 4.24 (dd, J = 2.8, 0.8 Hz, 1H, H-5), 4.00 (dd, J = 6.7, 1.4 Hz, 1H, H-2), 
3.98 (dd, J = 5.8, 2.9 Hz, 1H, H-4); 13C NMR (126 MHz, CDCl3) δ 132.42, 132.11, 130.67, 128.75, 128.52, 128.45, 
128.11, 127.91, 127.89, 127.24, 118.56, 101.62(C-1), 78.81(C-3), 75.15(C-2)?, 75.13(C-4?), 73.13, 71.99, 70.27, 
69.70(C-5), 65.67; HRMS (m/z): [M+Na]+ calcd for C31H30O8, 553.1838; found, 553.1835; [α]25D = +20.5 (c = 1.0, 
CHCl3). 
 
2-(Hydroxycarbonyl)benzyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-
mannopyranoside (9a): To a solution of 6 (0.20 g, 0.27 mmol) in DCM/AcOH (5/1, v/v) (5 mL) was added Pd(PPh3)4 
(94 mg, 0.081 mmol) and the mixture was purged a few times with argon. The reaction was 
stirred for 30 minutes and was concentrated in vacuo. Silicagel flash column chromatography 
(0% → 40% - EtOAc in a mixture of AcOH (1%) in n-heptane) of the residue afforded 9a (0.17 
g, 90%) as a pale yellow oil. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.32; 1H NMR (500 MHz, 
CDCl3) δ 8.00 (dd, J = 7.8, 1.1 Hz, 1H, CH Ar), 7.55 (d, J = 7.7 Hz, 1H, CH Ar), 7.47 (td, J = 7.7, 1.2 Hz, 1H, CH Ar), 
7.32 – 7.04 (m, 16H, CH Ar), 5.17 (dd, J = 8.8, 3.3 Hz, 1H, H-3), 5.10 (d, J = 14.8 Hz, 1H, CHH CB), 5.05 (d, J = 1.7 
Hz, 1H, H-1), 4.90 (d, J = 14.9 Hz, 1H, CHH CB), 4.55 (d, J = 11.2 Hz, 1H, CHHPh), 4.46 (d, J = 11.1 Hz, 1H, CHHPh), 
4.41 (dd, J = 8.5, 4.6 Hz, 1H, H-7), 4.30 (dd, J = 11.8, 1.5 Hz, 1H, H-6a), 4.18 (dd, J = 11.8, 4.6 Hz, 1H, H-6b), 3.90 
– 3.81 (m, 2H, H-4, H-5), 3.79 (dd, J = 3.2, 1.9 Hz, 1H, H-2), 3.28 (dd, J = 13.6, 8.5 Hz, 1H, H-8a), 3.07 (dt, J = 13.6, 
4.0 Hz, 1H, H-8b), 2.01 (d, J = 3.6 Hz, 3H, CH3 Ac), 1.75 (s, 3H, CH3 Ac); 13C NMR (126 MHz, CDCl3) δ 171.81, 171.01, 
170.00, 137.80, 136.62, 133.50, 131.48, 129.28, 128.95, 128.47, 127.83, 126.94, 126.56, 126.08, 125.31, 97.13(C-
1), 80.81(C-7), 75.24(C-2), 74.73, 73.43(C-3), 73.30(C-4), 70.29(C-5), 67.56, 63.28(C-6), 41.90(C-8), 20.98, 20.95; 
HRMS (m/z): [M+Na]+ calcd for C39H40O10S, 723.2240; found, 723.2237; [α]25D = +39.0 (c = 0.13, CHCl3). 
 
2-(Hydroxycarbonyl)benzyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-mannopyranosidurono-
6,3-lactone (9b): To a solution of 8a (0.12 mg, 0.18 mmol) in DCM/AcOH (5/1, v/v) (2.5 mL) was added Pd(PPh3)4 
(61 mg, 0.05 mmol) and the mixture was purged a three times with argon. The reaction was 
stirred for 30 minutes and was concentrated in vacuo. Silicagel flash column chromatography 
(0% → 40% - EtOAc in a mixture of acetic acid (1%) in n-heptane) of the residue afforded 9b 
(0.1 g, 93%) as a pale amorphous solid. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.21; 1H NMR 
(500 MHz, CDCl3) δ 8.05 (dd, J = 7.8, 1.5 Hz, 1H, CH Ar), 7.71 (d, J = 7.8 Hz, 1H, CH Ar), 7.47 
(td, J = 7.6, 1.5 Hz, 1H, CH Ar), 7.37 – 6.77 (m, 16H, CH Ar), 5.32 (d, J = 14.7 Hz, 1H, CHH CB, 5.01 (d, J = 14.7 Hz, 
1H, CHH CB), 4.94 (d, J = 6.6 Hz, 1H, H-1), 4.77 (dd, J = 7.7, 5.6 Hz, 1H, H-7), 4.40 – 4.33 (m, 2H, CHHPh, H-3), 
4.27 (d, J = 12.0 Hz, 1H, CHHPh), 4.11 (dd, J = 2.9, 1.1 Hz, 1H, H-5), 3.84 (dd, J = 6.7, 1.5 Hz, 1H, H-2), 3.75 (dd, J 
= 5.8, 2.9 Hz, 1H, H-4), 3.31 (dd, J = 13.6, 7.7 Hz, 1H, H-8a), 3.02 (dd, J = 13.6, 5.6 Hz, 1H, H-8b) ; 13C NMR (126 
MHz, CDCl3) δ 172.14, 170.16(C-6), 140.90, 140.49, 136.28, 133.35, 131.57, 128.81, 128.74, 128.64, 128.37, 127.90, 
127.59, 127.21, 127.14, 125.86, 101.86(C-1), 82.08(C-7), 79.53(C-3), 74.78(C-4), 74.01(C-2), 71.55, 70.29(C-5), 
69.80, 40.83(C-8); HRMS (m/z): [M+Na]+ calcd for C35H32O8S, 635.1716; found, 635.1703; [α]25D = -4.9 (c = 1.0, 
CHCl3). 
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2-(Hydroxycarbonyl)benzyl 2,4-di-O-benzyl-α-D-mannopyranosidurono-6,3-lactone (9c) 
To a solution of 8b (0.12 g, 0.22 mmol) in 5:1 DCM/AcOH (6 mL) was added Pd(PPh3)4 (0.25 g, 0.22 
mmol) and the mixture was purged three times with argon. The reaction was stirred for 10 minutes 
and concentrated in vacuo. Silicagel flash column chromatography (0% → 30% - EtOAc in a mixture 
of acetic acid (0.5%) in n-heptane) of the residue afforded 9c (90 mg, 85%) as yellow oil. TLC: 
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.27; 1H NMR (400 MHz, CDCl3) δ 8.11 (dd, J = 7.9, 1.3 Hz, 1H, -CH Ar), 7.77 
(dd, J = 7.8, 0.7 Hz, 1H, -CH Ar), 7.73 – 7.65 (m, 1H, CH Ar), 7.53 (td, J = 7.6, 1.4 Hz, 1H, -CH Ar), 7.41 – 7.24 (m, 
12H, -CH Ar), 5.39 (d, J = 14.8 Hz, 1H, CHH allyl), 5.16 (d, J = 14.8 Hz, 1H, CHH CB), 4.97 (d, J = 6.7 Hz, 1H, H-1), 
4.77 (d, J = 11.9 Hz, 1H, CHHPh), 4.70 (d, J = 11.7 Hz, 2H, CHHPh), 4.70 – 4.67 (m, 1H, H-3), 4.63 (d, J = 11.9 Hz, 
1H, CHHPh), 4.52 (d, J = 11.9 Hz, 1H, CHHPh), 4.27 (dd, J = 2.9, 1.1 Hz, 1H, H-5), 4.03 (dd, J = 6.7, 1.5 Hz, 1H, H-
2), 4.00 (dd, J = 5.8, 2.9 Hz, 1H, H-4); 13C NMR (126 MHz, CD2Cl2) δ 170.70(C-6), 170.07, 140.44, 137.76, 136.69, 
133.19, 131.39, 128.62, 128.45, 128.38, 128.35, 128.06, 127.89, 127.85, 127.82, 127.33, 126.82, 101.74(C-1), 
78.71(C-3), 75.25(C-2)?, 75.21(C-4)?, 73.06, 72.00, 70.28, 69.59(C-5); HRMS (m/z): [M+Na]+ calcd for C28H26O8, 
513.1525; found, 513.1522; [α]25D = +9.5 (c = 0.60, CHCl3). 
 
1,4-anhydro-2-O-(R)-(phenylthiomethyl)benzyl-α-D-mannopyranosidurono-6,3-lactone (14b):  
Isolated as a side-product from the reaction mixture from the synthesis of 17; TLC: (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.48; 1H NMR (500 MHz, CDCl3) δ 7.42 – 7.02 (m, 10H, CH Ar), 5.56 
(d, J = 1.5 Hz, 1H, H-1), 5.32 (dd, J = 4.8, 3.6 Hz, 1H, H-4), 4.46 (dd, J = 7.3, 5.8 Hz, 1H, H-
7), 4.21 (dd, J = 7.0, 4.9 Hz, 1H, H-3), 3.99 (dd, J = 3.4, 0.8 Hz, 1H, H-5), 3.48 (dd, J = 7.0, 
1.7 Hz, 1H, H-2), 3.37 (dd, J = 13.8, 7.4 Hz, 1H, H-8a), 3.12 (dd, J = 13.8, 5.8 Hz, 1H, H-8b); 13C NMR (126 MHz, 
CDCl3) δ 171.24(C-6), 139.25, 129.44, 129.02, 128.99, 128.94, 128.90, 128.79, 128.70, 128.60, 128.12, 127.23, 
127.01, 126.21, 125.92, 100.05(C-1), 82.26(C-7), 82.07(C-4), 75.75(C-2), 71.65(C-3), 71.42(C-5), 40.98(C-8); 
HRMS (m/z): [M+Na]+ calcd for C20H18O5S, 393.0773; found, 393.0769; [α]25D = +21.7 (c = 0.46, CHCl3). 
 
1,4-anhydro-2-O-benzyl-α-D-mannopyranosidurono-6,3-lactone (14c): 
To a solution of 9b (45 mg, 0.092 mmol) in DCM (1.5 mL), 2,6-di-t-butyl-4-methylpyridine (47 mg, 0.23 mmol) was 
added. The mixture was dried with MS (4Å) and cooled to -20oC after which Tf2O (19 μL, 0.11 mmol) 
was added. The reaction was stirred for 30 minutes and was then diluted with EtOAc (10 mL) and 
filtrated. The filtrate was washed with H2O (5 mL) and brine (5 mL) after which the organic layer was 
dried (Na2SO4), filtrated and concentrated in vacuo. Silicagel flash column chromatography (10% → 40% 
- EtOAc in n-heptane) of the residue afforded 14c (18 mg, 79 %). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.43; 1H 
NMR (500 MHz, CD2Cl2) δ 7.48 – 7.28 (m, 7H, CH Ar), 5.66 (d, J = 1.9 Hz, 1H, H-1), 5.61 – 5.56 (t, J = 4.15 Hz, 1H, 
H-4), 4.78 – 4.70 (m, 2H, CHHPh, H-3), 4.54 (d, J = 11.4 Hz, 1H, CHHPh), 4.11 – 4.09 (m, 1H, (H-5), 3.74 (dd, J = 
6.5, 1.8 Hz, 1H, H-2); 13C NMR (126 MHz, CD2Cl2) δ 171.54(C-6), 136.93, 128.50, 128.17, 128.06, 100.55(C-1), 
82.29(C-4), 76.08(C-2), 72.21, 71.42(C-3), 71.29(C-5); [α]25D = -2.0 (c = 0.49, CHCl3). 
 
General procedure A for mannosylation  
Mannosyl donor (0.2 mmol) and 2,6-di-t-butyl-4-methylpyridine (0.4 mmol) were dissolved in dry DCM (2 mL). MS (4Å) 
were added and the mixture was cooled to -40oC and stirred for 15 minutes. Tf2O (0.2) mmol was added and the reaction 
was stirred for 15 minutes before the temperature was allowed to warm up to -20oC in 30 min. After the acceptor (0.1 
mmol) was added, the reaction was left to stir at -20oC for 1 h before it was allowed to slowly warm to rt overnight. The 
mixture was diluted with ethyl acetate (10 mL) and the suspension was filtrated. The filtrate was washed with H2O (10 
mL) and brine (10 mL). The organic layer was dried (Na2SO4) and concentrated in vacuo. Silicagel flash column 
chromatography was used to obtain the pure product.  
 
General procedure B for mannosylation 
Mannosyl donor (0.2 mmol) and 2,6-di-t-butyl-4-methylpyridine (0.4 mmol) were dissolved in DCM (10 mL). MS (4Å) 
were added and the mixture was cooled to -78oC and stirred for 15 minutes. Tf2O (0.2) mmol was added and the reaction 
was stirred for 15 minutes before the acceptor (0.1 mmol) was added. The reaction was left to stir at -78oC for 1 hr 
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before it was allowed to warm to room temperature overnight. The mixture was diluted with ethyl acetate (30 mL) and 
the suspension was filtrated. The filtrate was washed with H2O (20 mL) and brine (20 mL). The organic layer was dried 
(Na2SO4) and concentrated in vacuo. Silicagel flash column chromatography was used to obtain the pure product. 
 
General procedure C for the synthesis of mannuronic esters 
Mannuronic acid lactone disaccharide (1 eq) was dissolved in anhydrous methanol (2 mL). Dowex-H+ (0.1 eq) was added 
and the mixture was left to stir for 48 hrs after which the mixture was filtrated and concentrated in vacuo.  
 
General procedure D for mannosylation  
Mannosyl donor (0.2 mmol) and 2,6-di-t-butyl-4-methylpyridine (0.4 mmol) were dissolved in dry DCM (2 mL). MS (4Å) 
were added and the mixture was cooled to -40oC and stirred for 15 minutes. Tf2O (0.2) mmol was added and the reaction 
was stirred for 15 minutes before the temperature was allowed to warm up to -20oC in 30 min. After the acceptor (0.4 
mmol) was added, the reaction was left to stir at -20oC for 1 h before it was allowed to slowly warm to rt overnight. The 
mixture was diluted with ethyl acetate (10 mL) and the suspension was filtrated. The filtrate was washed with H2O (10 
mL) and brine (10 mL). The organic layer was dried (Na2SO4) and concentrated in vacuo. Silicagel flash column 
chromatography was used to obtain the pure product.  
 
General Procedure E for Mannosylation 
Mannosyl donor (2.0 mmol) and 2,6-di-t-butyl-4-methylpyridine (4.0 mmol) were dissolved in DCM (10 mL). MS (4Å) 
were added and the mixture was cooled to -78oC and stirred for 15 minutes. Tf2O (2.0) mmol was added and the reaction 
was stirred for 15 minutes before the acceptor (4.0 mmol) was added. The reaction was left to stir at -78oC for 1 hr 
before it was allowed to warm to room temperature overnight. The mixture was diluted with ethyl acetate (30 mL) and 
the suspension was filtrated. The filtrate was washed with H2O (20 mL) and brine (20 mL). The organic layer was dried 
(Na2SO4) and concentrated in vacuo. Silicagel flash column chromatography was used to obtain the pure product.  
 
Methyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→6)-2,3,4-
tri-O-benzoyl-α-D-glucopyranoside (16): According to the general procedure A. Silicagel flash column 
chromatography (0% → 40% - EtOAc in n-heptane) afforded 16 (59 mg, 61 %) as colorless oil. 
Via general procedure D. Silicagel flash column chromatography (0% → 40% - EtOAc in n-
heptane) afforded 16 (50 mg, 52 %) as a colorless oil. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 
0.34; 1H NMR (500 MHz, CD2Cl2) δ 7.94 – 7.72 (m, 6H, CH Ar), 7.56 – 6.95 (m, 29H, CH Ar), 
6.06 – 6.00 (t, J = 9.8 Hz, 1H, H-3), 5.55 – 5.47 (t, J = 9.8 Hz, 1H, H-4), 5.25 (dd, J = 7.1, 3.2 Hz, 1H, H-2), 5.15 (d, 
J = 3.6 Hz, 1H, H-1), 5.11 (d, J = 5.0 Hz, 1H, H-1’), 4.64 (dd, J = 7.2, 6.4 Hz, 1H, H-7’), 4.41 – 4.30 (m, 2H, CHHPh, 
H-3’), 4.25 – 4.14 (m, 2H, CHHPh, H-5), 3.95 (dd, J = 5.0, 1.1 Hz, 1H, H-2’), 3.88 – 3.82 (m, 2H, H-5’, H-6a), 3.75 
(dd, J = 3.1, 0.9 Hz, 1H, H-4’), 3.58 – 3.48 (m, 2H, H-6b, H-8a’), 3.44 (s, 3H, OCH3), 3.19 (dd, J = 13.1, 7.4 Hz, 1H, 
H-8b’); 13C NMR (126 MHz, CD2Cl2) δ 171.40(C-6’), 165.68, 165.52, 165.51, 139.76, 136.42, 136.33, 133.44, 133.29, 
133.01, 129.83, 129.67, 129.51, 129.01, 128.89, 128.67, 128.51, 128.41, 128.23, 127.86, 127.47, 125.88, 98.84(C-
1’), 96.78(C-1), 79.84(C-7’), 78.18(C-3’), 76.16(C-5’), 72.08(C-2), 71.75, 70.73(C-3), 69.86(C-2’), 69.60(C-4), 
68.68(C-5), 67.85(C-4), 66.79(C-6), 55.47, 40.48(C-8’); 13C-coupled HSQC (101 MHz, CDCl3): δ 98.84(JC1’-H1’ = 172 
Hz, C-1’), 96.78(JC1-H1 = 172 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C55H50O14S, 989.2819; found, 989.2783; [α]25D 
= -27.0 (c = 0.20, CHCl3). 
 
Methyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-β-D-mannopyranosilurono-6,3-lactone (1→4)-2,3,6-
tri-O-benzyl-α-D-glucopyranoside(17): Via general procedure A. After work up of the reaction mixture the 
remaining oil was dissolved in pyridine (2 mL) and Ac2O (1 mL) was added to acetylate any 
remaining acceptor. The mixture was stirred overnight after which it was concentrated in 
vacuo. Silicagel flash column chromatography (0% → 40% - EtOAc in n-heptane) afforded 17 
as a colorless oil, as well as 14b as an inseparable side product (53 mg, 56 %). TLC: 
(EtOAc/n-heptane, 30/70 v/v): Rf = 0.4; 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.10 (m, 30H, CH Ar), 5.62 (d, J = 5.2 
Hz, 1H, H-1’, H-1(14b)), 5.41 – 5.37 (m, H-4(14b)), 5.06 (d, J = 10.5 Hz, 1H, CHHPh), 4.93 (d, J = 10.5 Hz, 1H, 
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CHHPh), 4.74 (d, J = 12.0 Hz, 1H, CHHPh), 4.67 – 4.60 (m, 3H, 2 x CHHPh, H-1), 4.59 – 4.50 (m, 1H, CHHPh, H-
7(14b)), 4.39 (d, J = 11.7 Hz, 1H, CHHPh), 4.33 – 4.26 (m, 2H, CHHPh, H-7’, H-3(14b)), 4.11 (dd, J = 5.8, 0.8 Hz, 
1H, H-3’), 4.10 – 4.01(m, 3H, H-3, H-6a, H-2’, H-5(14b)) 3.93 – 3.82 (m, 3H, H-5’, H-6b, H-5), 3.79 (dd, J = 5.9, 3.0 
Hz, 1H, H-4’), 3.74 – 3.66 (m, 1H, H-4), 3.59 – 3.52 (m, 1H, H-2, H-2(14b)), 3.47 – 3.36 (m, 3H, OCH3, H-8a(14b)), 
3.21 – 3.11 (m, 1H, H-8a’, H-8b(14b)), 3.06 (dd, J = 13.6, 5.6 Hz, 1H, H-8b’); 13C NMR (101 MHz, CDCl3) δ 171.73(C-
6’, C-6(14b)), 140.63, 139.60, 138.83, 138.15, 136.39, 135.88, 129.65, 129.46, 129.00, 128.73, 128.61, 128.46, 
128.36, 128.20, 128.12, 127.88, 127.82, 127.45, 127.26, 127.21, 127.02, 126.79, 126.34, 100.06(C-1(14b)), 
99.64(C-1’), 97.44(C-1), 82.28(C-7(14b)), 82.26(C-7’), 82.07(C-4(14b)), 81.09(C-2), 80.06(C-3), 79.15(C-4), 
77.20(C-3’), 76.22(C-4’), 75.77(C-2(14b)), 74.63(C-2’), 73.94, 73.29, 73.08, 71.65(C-3(14b)), 71.52, 71.42(C-
5(14b)), 70.06(C-6), 69.60(C-5), 68.02(C-5’), 55.18, 41.49(C-8’), 41.00(C-8(14b)); 13C-coupled HSQC (101 MHz, 
CDCl3): δ 99.64( JC1’-H1’ = 176 Hz, C-1’), 97.44(JC1-H1 = 168 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C55H56O11S, 
947.3441; found, 947.3440; [α]25D = -17.7 (c = 0.26, CHCl3). 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside(18): Via general procedure B. Silicagel flash column chromatography (0% → 40% - EtOAc in n-
heptane) afforded 18 (75 mg, 87 %) as an inseparable mixture with 14c. Via general procedure 
E. Silicagel flash column chromatography (0% → 40% - EtOAc in n-heptane) afforded 18 (60 
mg, 70%) as an inseparable mixture with 14c. TLC: (EtOAc/n-heptane, 30/70, v/v): Rf = 0.45; 
1H NMR (500 MHz, CDCl3) δ 8.03 – 7.90 (m, 4H, CH Ar), 7.82 (dt, J = 8.4, 1.5 Hz, 2H, CH Ar), 
7.58 – 7.45 (m, 2H), 7.45 – 7.19 (m, 27H, CH Ar), 6.22 – 6.04 (t, J = 9.8 Hz, 1H, H-3), 5.61 
(d, J = 2.0 Hz, 1H, H-1(14c)), 5.51 (dd, J = 4.6, 3.6 Hz, 1H, H-4(14c)), 5.39 (dd, J = 10.3, 9.5 Hz, 1H, H-4), 5.32 (d, 
J = 5.0 Hz, 1H, H-1’), 5.23 (dd, J = 10.2, 3.6 Hz, 1H, H-2), 5.17 (d, J = 3.6 Hz, 1H, H-1), 4.77 – 4.73 (m, 2H, 2 x 
CHHPh), 4.71 (dd, J = 5.9, 0.9 Hz, 1H, H-3’), 4.67 (ddt, J = 6.6, 5.0, 0.8 Hz, 1H, H-3(14c)), 4.64 (d, J = 11.7 Hz, 1H, 
CHHPh), 4.59 (d, J = 11.6 Hz, CHHPh), 4.50 (dd, J = 11.6, 3.7 Hz, 2H, 2 x CHHPh), 4.30 (ddd, J = 10.0, 8.1, 1.7 Hz, 
1H, H-5), 4.18 (dd, J = 5.0, 1.2 Hz, 1H, H-2’), 4.09 (dd, J = 3.5, 0.9 Hz, 1H, H-5(14c)), 4.04 (dd, J = 5.8, 3.1 Hz, 1H, 
H-4’), 3.94 – 3.89 (m, 2H, H-6a, H-5’), 3.69 – 3.64 (m, 1H, H-6b, H-2 (14c)), 3.34 (s, 3H, CH3 OMe); 13C NMR (126 
MHz, CDCl3) δ 171.54(C-6’), 165.85, 165.67, 137.43, 136.57, 136.31, 133.42, 133.31, 133.00, 130.00, 129.94, 129.65, 
129.30, 129.11, 128.86, 128.76, 128.62, 128.56, 128.51, 128.41, 128.40, 128.33, 128.23, 128.17, 128.05, 128.01, 
127.91, 100.55(C-1(14c)), 99.19(C-1’), 96.53(C-1), 82.20(C-4’), 77.74(C-3’), 76.18(C-4’), 75.80(C-2(14c)), 72.29, 
72.21(C-2), 72.11, 71.32(C-3(14c)), 71.28, 71.25(C-5(14c)), 70.75(C-2’), 70.57(C-3), 69.77(C-4), 68.82(C-5), 
67.56(C-5’), 67.07(C-6), 55.41; 13C-coupled HSQC (126 MHz, CDCl3): δ 100.55( JC1’-H1’ = 175 Hz, C-1’), 99.19(JC1-H1 = 
175 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C48H44O14, 867.2629; found, 867.2633; [α]25D = -12.8 (c = 0.37, CHCl3). 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→4)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside(19): According to the mannosylation general procedure B. After work up of the reaction mixture. 
The remaining oil was dissolved in pyridine (2 mL) and Ac2O (1mL) was added as to acetylate 
any remaining acceptor. The mixture was stirred overnight after which it was concentrated in 
vacuo. Silicagel flash column chromatography (0% → 40% - EtOAc in n-heptane) afforded 19 
(30 mg, 37 %) as colorless oil with 14c (25 mg, 50 %) as major sideproduct. TLC: (EtOAc/n-
heptane, 30/70 v/v): Rf = 0.32; 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.18 (m, 25H), 5.47 (d, J = 5.3 Hz, 1H, H-1’), 5.08 
(d, J = 10.8 Hz, 1H, CHHPh), 4.97 (d, J = 10.7 Hz, 1H, CHHPh), 4.71 (d, J = 12.0 Hz, 1H, CHHPh), 4.63 (dd, J = 5.9, 
0.8 Hz, 1H, H-3’), 4.60 (d, J = 12.1 Hz, 1H, CHHPh), 4.59 (d, J = 4.6 Hz, 1H, H-1), 4.57 (d, J = 11.8 Hz, 1H, CHHPh), 
4.46 – 4.39 (m, 4H, 2 x CHHPh, 2 x CHHPh ), 4.29 (d, J = 12.2 Hz, 1H, CHHPh), 4.06 (dd, J = 5.2, 0.9 Hz, 1H, H-2’), 
4.02 – 3.98 (m, 2H, H-3, H-4’), 3.87 (dd, J = 10.8, 4.0 Hz, 1H, H-6a), 3.82 (dd, J = 2.9, 1.1 Hz, 1H, H-5’), 3.77 (ddd, 
J = 9.7, 3.8, 1.7 Hz, 1H, H-5), 3.73 – 3.68 (m, 1H, H-4), 3.68 – 3.62 (m, 1H, H-6b), 3.54 (dd, J = 9.4, 3.5 Hz, 1H, H-
2), 3.34 (s, 3H, CH3 OMe); 13C NMR (101 MHz, CDCl3) δ 171.62(C-6’), 139.77, 138.72, 138.13, 137.24, 136.45, 128.69, 
128.53, 128.47, 128.44, 128.19, 128.15, 128.12, 128.05, 127.99, 127.92, 127.86, 127.72, 127.42, 127.26, 127.09, 
100.36(C-1’), 97.56(C-1), 81.21(C-2), 79.68(C-4), 79.52(C-3), 76.38(C-3’), 76.34(C-4’), 74.41, 73.11, 73.08, 
72.25(C-2’), 71.81, 71.62, 69.46(C-5), 68.90(C-6), 67.77(C-5’), 55.15; 13C-coupled HSQC (101 MHz, CDCl3): δ 
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100.36( JC1’-H1’ = 172 Hz, C-1’), 97.56(JC1-H1 = 168 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C48H50O11, 825.3251; 
found, 825.3231. 
 
Methyl  4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-β-D-mannopyranosyl methyluronate (1→6)-
2,3,4-tri-O-benzoyl-α-D-glucopyranoside (20): 16 (60 mg, 0.062 mmol) via general protocol C afforded 20 (56 
mg, 90%) as a white amorphous solid. TLC: (EtOAc/n-heptane, 30/70 v/v): Rf = 0.20; 
1H NMR (400 MHz, CDCl3) δ 8.04 – 7.90 (m, 5H, CH Ar), 7.88 – 7.81 (m, 2H, CH Ar), 
7.58 – 7.18 (m, 32H, CH Ar), 7.16 – 7.08 (m, 1H, CH Ar), 6.20 – 6.11 (t, J = 9.8 Hz, 
1H, H-3), 5.55 – 5.43 (dd, J = 9.8, 10.1 Hz, 1H, H-4), 5.36 – 5.25 (dd, J = 10.2, 3.6 
Hz, 1H, H-2), 5.17 (d, J = 3.6 Hz, 1H, H-1), 5.10 (dd, J = 8.0, 5.5 Hz, 1H, H-7’), 4.73 
(d, J = 11.1 Hz, 1H, CHHPh), 4.58 – 4.49 (m, 2H, CHHPh, H-1’), 4.21 (ddd, J = 10.1, 6.5, 1.9 Hz, 1H, H-5), 4.16 (dd, 
J = 11.4, 1.9 Hz, 1H, H-6a), 3.91 – 3.83 (m, 2H`, H-2’, H-4’), 3.79 (d, J = 8.4 Hz, 1H, H-5’), 3.71 (s, 3H, CH3, methyl 
ester), 3.70 – 3.54 (m, 2H, H-6b, H-8a’), 3.53 – 3.41 (s, 3H, CH3, OMe), 3.38 – 3.29 (m, 1H, H-8b’), 2.41 (d, J = 9.7 
Hz, 1H, 3-OH’); 13C NMR (101 MHz, CDCl3) δ 169.04(C-6’), 165.82, 165.79, 165.78, 165.48, 133.54, 133.37, 133.12, 
129.95, 129.89, 129.67, 129.23, 129.10, 128.86, 128.82, 128.79, 128.67, 128.50, 128.43, 128.35, 128.29, 127.90, 
127.75, 127.63, 125.81, 116.21, 102.54(C-1’), 96.90(C-1), 81.69(C-7’), 77.70(C-4’), 74.54, 74.45(C-2’), 74.39(C-5’), 
72.63(C-3’), 72.08(C-2), 70.44, 69.48(C-4), 69.11(C-6), 68.87(C-5) 55.64, 52.36, 40.17(C-8’); 13C-coupled HSQC 
(101 MHz, CDCl3): δ 102.54( JC1’-H1’ = 156 Hz, C-1’), 96.90(JC1-H1 = 176 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for 
C56H54O15S, 1021.3081; found, 1021.3048; [α]25D = -10.0 (c = 0.20, CHCl3). 
 
Methyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-β-D-mannopyranosyl methyluronate (1→4)-2,3,6-
tri-O-benzyl-α-D-glucopyranoside (21): 17 (33 mg, 0.036 mmol) via general procedure C afforded 21 (31 mg, 
91%) as pale yellow oil. TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.5; 1H NMR: (500 
MHz, CDCl3) δ 7.46 – 7.13 (m, 33H, CH Ar), 5.64 (d, J = 1.7 Hz, H-1(14c)), 5.40 (dd, 
J = 4.8, 3.5 Hz, H-4(14c)), 5.17 (d, J = 10.7 Hz, 1H, CHHPh), 5.01 (dd, J = 7.6, 5.8 
Hz, 1H, H-7’), 4.78 (d, J = 12.1 Hz, 1H, CHHPh), 4.75 – 4.66 (m , 3H, CHHPh, CHHPh, 
H-1), 4.63 – 4.56 (m, 1H), 4.56 – 4.47 (m, 1H, H-7(14c) CHHPh), 4.41 (s, 1H, H-1’), 
4.35 – 4.26 (m, 1H, CHHPh, H-3(14c)), 4.08 – 4.06 (m, H-5(14c)), 3.93 – 3.81 (m, 2H, H-3, H-4), 3.75 (t, J = 9.1 
Hz, 1H, H-4’), 3.66 – 3.58 (m, 2H, H-5, H-5’), 3.57 (s, 3H, CH3 methyl ester), 3.56 – 3.48 (m, 2H, H-6a, H-2), 3.47 – 
3.35 (m, 5H, H-2’, H-6b, OCH3), 3.23 – 3.15 (m, 1H, H-3’); 13C NMR (126 MHz, CDCl3) δ 168.86(C-6’), 139.45, 139.32, 
138.25, 137.28, 136.53, 129.17, 129.04, 128.96, 128.86, 128.70, 128.64, 128.56, 128.34, 128.28, 128.12, 128.06, 
128.03, 127.90, 127.81, 127.78, 127.63, 127.12, 125.87, 101.94(C-1’), 98.36(C-1), 81.87(C-7’), 80.41(C-3), 79.09(C-
2), 78.86(C-4), 77.56(C-4’), 75.63, 75.14(C-2’), 74.70(C-5’), 74.66, 73.56, 73.07(C-3’), 69.61(C-5), 68.35(C-6), 
55.41, 52.16, 40.34(C-8’); 13C-coupled HSQC (126 MHz, CDCl3): δ 101.94( JC1’-H1’ = 155 Hz, C-1’), 98.36(JC1-H1 = 170 
Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C56H54O15S, 1021.3081; found, 1021.3048; [α]25D = -7.8 (c = 0.57, CHCl3). 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosyl methyluronate-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (22): 18 (70 mg, 0.083 mmol) via general protocol C afforded 22 (65 mg, 89%) as colorless oil. 
TLC: (EtOAc/n-heptane, 50/50 v/v): Rf = 0.59; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.92 
(m, 3H, CH Ar ), 7.87 – 7.83 (m, 2H, CH Ar), 7.55 – 7.49 (m, 2H, CH Ar), 7.45 – 7.25 
(m, 23H, CH Ar), 6.15 (tt, J = 9.5, 1.8 Hz, 1H, H-3), 5.61 (d, J = 1.9 Hz, H-1(14c)), 
5.52 – 5.47 (m, 1H, H-4, H-4(14c)), 5.26 – 5.19 (m, 2H, H-1, H-2), 5.07 (d, J = 11.8 
Hz, 1H, CHHPh), 4.87 – 4.56 (m, 6H, 4 x CHHPh, H-1’, H-3(14c)), 4.50 (d, J = 11.6 Hz, 1H, CHHPh), 4.31 – 4.26 (m, 
1H, H-5), 4.19 (dd, J = 11.1, 1.8 Hz, 1H, H-6a), 4.10 (dd, J = 3.5, 0.8 Hz, 1H, H-5(14c)), 3.97 – 3.86 (m, 3H, H-4’, 
H-2(14c)), 3.83 (d, J = 8.4 Hz, 1H, H-5’), 3.74 (td, J = 9.0, 8.5, 3.6 Hz, 1H, H-3’), 3.71 – 3.63 (m, 5H, OCH3, H-6b, 
H-2’), 3.41(s, 3H, CH3 methyl ester), 2.60 (d, J = 9.7 Hz, 1H, 3-OH’); 13C NMR (101 MHz, CDCl3) δ 168.92(C-6’), 
165.85, 165.77, 165.52, 138.10, 138.04, 133.74, 133.52, 133.39, 133.17, 133.12, 129.95, 129.90, 129.66, 129.22, 
129.06, 128.83, 128.63, 128.48, 128.44, 128.38, 128.29, 128.27, 128.06, 127.97, 127.80, 102.33(C-1’), 96.83(C-1), 
82.19(C-4(14c)), 77.67(C-4), 76.30(C-2), 75.84(C-2(14c)), 74.58, 74.56, 74.28(C-5’), 72.53(C-3’), 72.13(C-2), 
71.31(C-3(14c)), 71.23(C-5(14c)), 70.42(C-3), 69.46(C-4), 69.01(C-6), 68.87(C-5), 55.44, 52.31; 13C-coupled 
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HSQC (101 MHz, CDCl3): δ 102.33( JC1’-H1’ = 160 Hz, C-1’), 96.83(JC1-H1 = 172 Hz, C-1); HRMS (m/z): [M+Na]+ calcd 
for C49H48O15, 899.2891; found, 899.2879; [α]25D = -20.0 (c = 0.14, CHCl3). 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosyl methyluronate (1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside 
(23): 19 (30 mg, 0.037 mmol) via general protocol C. Silicagel flash column 
chromatography of the crude mixture (0% → 40% - EtOAc in n-heptane) afforded 23 
as an amorphous white solid (25 mg, 80%). TLC: (EtOAc/n-heptane, 35/65 v/v): Rf = 
0.32; 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.20 (m, 25H), 5.11 (d, J = 10.9 Hz, 1H, 
CHHPh), 4.94 (d, J = 11.7 Hz, 1H, CHHPh), 4.78 (d, J = 11.4 Hz, 1H, CHHPh), 4.72 (d, J = 10.2 Hz, 1H, CHHPh), 4.67 
(d, J = 11.9 Hz, 1H, CHHPh), 4.60 – 4.56 (m, 3H, CHHPh, CHHPh, H-1), 4.55 – 4.49 (m, 2H, CHHPh, H-1’), 4.38 (d, J 
= 12.1 Hz, 1H, CHHPh), 3.96 – 3.78 (m, 3H, H-3, H-4, H-4’), 3.72 – 3.61 (m, 2H, H-5, H-5’), 3.60 (d, J = 2.5 Hz, 2H, 
H-6a, H-6b), 3.56 (s, 3H, CH3 methyl ester), 3.55 – 3.46 (m, 2H, H-2’, H-2), 3.38 (bs, 4H, CH3 OMe, H-3’); 13C NMR 
(101 MHz, CDCl3) δ 168.86(C-6’), 139.41, 138.29, 138.23, 138.10, 137.45, 128.67, 128.48, 128.37, 128.35, 128.17, 
128.13, 128.11, 128.04, 127.94, 127.89, 127.80, 127.73, 127.11, 101.71(C-1’), 98.36(C-1), 80.33(C-3), 79.14(C-2), 
78.21(C-4), 77.78(C-4’), 77.76(C-2’), 75.39, 75.02, 74.73, 74.66(C-5’), 73.69, 73.58, 73.28(C-3’), 69.59(C-5), 
68.39(C-6), 55.39, 52.20; 13C-coupled HSQC (101 MHz, CDCl3): δ 101.71( JC1’-H1’ = 156 Hz, C-1’), 98.36(JC1-H1 = 168 
Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C49H54O12, 857.3513; found, 857.3524; [α]25D = -6.1 (c = 0.38, CHCl3). 
 
Methyl 4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-β-D-mannopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-
D-glucopyranoside (24): To a cooled (0oC) solution of 16 (20 mg, 0.021 mmol) in THF (2 mL) a 1M solution of K-
selectride in THF (0.043 mL) was added. The mixture was left to stirr for 5 min after 
which it was quenched with water (1 mL). The solution was diluted with ethyl acetate 
(10 mL) and washed with water (5 mL) and brine (5 mL). The organic layer was dried 
(Na2SO4) and concentrated in vacuo. Silicagel flash column chromatography of the 
residue (0% → 50% - EtOAc in n-heptane) afforded 24 as a white solid (18 mg, 90 %); 
TLC: (EtOAc/DCM), 30/70 v/v): Rf = 0.3; 1H NMR (500 MHz, CD2Cl2) δ 7.93 – 7.71 (m, 
6H, CH Ar), 7.52 – 6.89 (m, 24H), 6.02 (t, J = 9.9 Hz, 1H, H-3), 5.50 (t, J = 9.9 Hz, 1H, H-4), 5.27 – 5.20 (m, 1H, H-
2), 5.14 (t, J = 6.8 Hz, 1H, H-7’), 5.11 (d, J = 3.6 Hz, 1H, H-1), 4.74 (d, J = 11.1 Hz, 1H, CHHPh), 4.50 (d, J = 11.1 
Hz, 1H, CHHPh), 4.37 (s, 1H, H-1’), 4.14 (ddd, J = 10.1, 5.4, 1.8 Hz, 1H, H-5), 4.04 – 3.96 (m, 1H, H-6a), 3.75 (dd, J 
= 11.8, 2.7 Hz, 1H, H-6a’), 3.71 (d, J = 3.3 Hz, H-2’), 3.65 (dd, J = 11.8, 4.6 Hz, 1H, H-6b’), 3.58 (dd, J = 11.5, 5.4 
Hz, 1H, H-6b), 3.52 – 3.46 (m, 2H, H-4’, H-8a’), 3.46 – 3.41 (m, 1H, H-3’), 3.36 (s, 3H, CH3 OMe), 3.20 (dd, J = 13.0, 
6.9 Hz, 1H, H-8b’), 3.14 (ddd, J = 9.0, 4.5, 2.8 Hz, 1H, H-5’), 2.06 (d, J = 9.3 Hz, 1H, 3-OH); 13C NMR (126 MHz, 
CD2Cl2) δ 165.68, 165.55, 165.25, 140.17, 138.66, 136.86, 133.51, 133.36, 133.14, 129.70, 129.68, 129.51, 129.29, 
129.19, 129.01, 128.85, 128.81, 128.72, 128.50, 128.44, 128.28, 128.27, 127.87, 127.60, 127.58, 125.73, 102.48(C-
1’), 97.01(C-1), 81.15(C-7’), 76.32(C-4’), 75.64(C-5’), 75.48(C-2’), 74.64, 73.81(C-3’), 72.07(C-2), 70.53(C-3), 
69.22(C-4), 68.90(C-5), 68.54(C-6), 62.15(C-6’), 55.55, 40.40(C-8’); 13C-coupled HSQC (126 MHz, CD2Cl2): δ 
102.48( JC1’-H1’ = 155 Hz, C-1’), 97.01(JC1-H1 = 175 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C55H54O14S, 993.3132; 
found, 993.3169. [α]25D = -9.0 (c = 0.85, CHCl3).  
 
Methyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-mannopyranosyl-(1→6)- 2,3,4-
tri-O-benzoyl-α-D-glucopyranoside (25): Via general procedure A. Silicagel flash column chromatography (0% → 
40% - EtOAc in n-heptane) afforded 25 (87 mg, 82 %) as a colorless oil. TLC: (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 8.04 – 7.81 (m, 6H), 7.54 – 
7.09 (m, 24H), 6.13 (t, J = 9.8 Hz, 1H, H-3), 5.53 – 5.46 (m, 1H, H-4), 5.23 (dd, J = 10.1, 
3.7 Hz, 1H, H-2), 5.19 (d, J = 3.7 Hz, 1H, H-1), 5.15 (dd, J = 8.8, 3.1 Hz, 1H, H-3’), 4.93 
(d, J = 1.8 Hz, 1H, H-1’), 4.61 (d, J = 11.3 Hz, 1H, CHHPh), 4.51 (d, J = 11.3 Hz, 1H, 
CHHPh), 4.43 (dd, J = 8.5, 4.6 Hz, 1H, H-7’), 4.29 (dd, J = 11.8, 1.5 Hz, 1H, H-6a’), 4.22 
(ddd, J = 13.0, 5.7, 2.7 Hz, 1H, H-5), 4.15 – 4.08 (m, 1H, H-6b’), 3.92 – 3.82 (m, 1H, H-4’, H-5’, H-6a), 3.71 (dd, J = 
3.2, 1.9 Hz, 1H, H-2’), 3.56 (dd, J = 10.8, 2.4 Hz, 1H, H-6b), 3.43 (s, 3H, CH3 OMe), 3.31 (dd, J = 13.6, 8.5 Hz, 1H, 
H-8a), 3.11 (dd, J = 13.6, 4.6 Hz, 1H, H-8b), 2.04 (s, 3H, CH3 Ac), 1.78 (s, 3H, CH3 Ac); 13C NMR (126 MHz, CDCl3) δ 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 107
Stereoselective beta-Mannosylation via NGP
4
107
 
107 
170.85, 169.70, 165.79, 165.77, 165.22, 140.44, 137.96, 136.66, 133.35, 133.31, 133.05, 129.94, 129.90, 129.70, 
129.17, 128.93, 128.46, 128.43, 128.41, 128.39, 128.33, 128.26, 127.76, 126.89, 126.01, 97.16( C-1’), 96.72(C-1), 
80.80(C-7’), 75.18(C-2’), 74.47, 73.10(C-4’), 73.00(C-3’), 72.15(C-2), 70.47(C-3), 69.97(C-5’), 69.60(C-4), 68.30(C-
5), 66.16(C-6), 63.22(C-6’), 55.53, 41.89(C-8’), 20.93; 13C-coupled HSQC (126 MHz, CDCl3): δ 97.16( JC1’-H1’ = 170 
Hz, C-1’), 96.72(JC1’-H1’ = 170 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C59H58O16S, 1077.3343; found, 1077.3378; 
[α]25D = +28.9 (c = 0.85, CHCl3). 
 
Methyl 3,6-di-O-acetyl-4-O-benzyl-2-O-(R)-(phenylthiomethyl)benzyl-α-D-mannopyranosyl-(1→4)- 2,3,6-
tri-O-benzyl-α-D-glucopyranoside (26): Via general procedure A. Silicagel flash column chromatography (0% → 
40% - EtOAc in n-heptane) afforded 26 (72 mg, 71 %) as colorless oil. TLC: 
(EtOAc/toluene, 15/85, v/v): Rf = 0.56; 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.13 (m, 28H, 
CH Ar), 6.92 (dd, J = 7.9, 1.3 Hz, 2H, CH Ar), 5.42 (d, J = 2.2 Hz, 1H, H-1’), 5.10 (dd, J 
= 8.9, 3.0 Hz, 1H, H-3’), 5.03 (d, J = 12.3 Hz, 1H, CHHPh), 4.75 (d, J = 12.3 Hz, 1H, 
CHHPh), 4.66 – 4.57 (m, 3H, 2x CHHPh, H-1), 4.51 (dd, J = 14.4, 11.7 Hz, 2H, 2x CHHPh), 
4.23 (d, J = 11.5 Hz, 1H, H-6a’), 4.16 – 4.10 (m, 1H, H-7’), 4.05 (dd, J = 11.5, 4.1 Hz, 
1H, H-6b’), 3.94 – 3.86 (m, 1H, H-3), 3.82 (m, 2H, H-4’, H-5’), 3.79 – 3.71 (m, 4H, H-4, H-5, H-6a, H-6b), 3.70 – 3.63 
(m, 1H, H-2’), 3.51 (dd, J = 9.6, 3.5 Hz, 1H, H-2), 3.38 (s, 3H, CH3 OMe), 3.13 (dd, J = 13.3, 8.5 Hz, 1H, H-8a’), 2.89 
(dd, J = 13.3, 4.6 Hz, 1H, H-8b’), 1.99 (s, 3H, CH3 Ac), 1.70 (s, 3H, CH3 Ac); 13C NMR (126 MHz, CDCl3) δ 170.78, 
169.81, 140.51, 139.23, 138.09, 137.88, 137.28, 128.97, 128.82, 128.42, 128.40, 128.35, 128.28, 128.20, 128.14, 
127.89, 127.82, 127.77, 127.65, 127.56, 126.64, 126.38, 125.78, 99.64(C-1’), 97.76(C-1), 81.16(C-3), 80.97(C-7), 
79.84(C-2), 77.24(C-4), 76.29(C-2), 74.56, 74.33, 73.33(C-4’), 73.25, 73.15, 72.76(C-3’), 70.85(C-5’), 69.69(C-5), 
69.10(C-6), 63.48(C-6’), 55.27, 41.90(C-8’), 20.93, 20.82; 13C-coupled HSQC (126 MHz, CDCl3): δ 99.64( JC1’-H1’ = 
175 Hz, C-1’), 97.76(JC1-H1 = 170 Hz, C-1); HRMS (m/z): [M+Na]+ calcd for C59H64O13S, 1035.3965; found, 1035.3950; 
[α]25D = +12.8 (c = 0.46, CHCl3). 
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Abstract: Uronic acids are important constituents of polysaccharides found on the cell 
membranes of many different organisms. Uronic acid 6,3-lactones are interesting glycosyl 
donors to prepare uronic acid containing oligosaccharides because they display a fixed 
conformation and, as a consequence, have unique reactivity and stereoselectivity. Galacturonic 
acid 6,3-lactones are known to provide α-galactosides upon glycosylation via a β-triflate 
intermediate. This chapter explores the use of gluco- and mannuronic acid 6,3-lactones which 
by contrast primarily produce β-products. This complete reversal of facial selectivity is attributed 
to the remote group participation (RGP) of C-4 ethers or esters during glycosylation. Evidence 
for this mode of reaction was provided by the use of a C-4 Boc protected glycosyl donor which 
produced a 1,4-anhydro ether indicating stabilization of the oxocarbenium ion by C-4 RGP. 
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5.1 – Introduction 
 
Uronic acids are important constituents of polysaccharides found on the cell membranes of many 
different organisms.[1] Uronic acid 6,3-lactones are interesting glycosyl donors to prepare uronic 
acid containing oligosaccharides because they display a fixed conformation and unique reactivity 
and stereoselectivity. A good example is the highly β-selective glycosylation behavior of 
mannuronic acid 6,3-lactone 1 (Scheme 1, also see Chapter 4).  The β-stereoselectivity was 
attributed to the remote group participation (RGP) of the C-4 ether during glycosylation (Scheme 
1).[2] Unfortunately, formation of the β-mannoside was accompanied by the formation of a 1,4-
anhydro byproduct (3a) which lowers the overall yield of the reaction and complicates 
purification. 
 
 
   
Scheme 1: Glycosylation of 1 affords an inseparable mixture of 2 and 3a. 
 
 
 
Galacturonic acid 6,3-lactone 6 contains an equatorial C-4 substituent and thus RGP cannot 
occur. Interestingly, glycosylations using preactivation conditions (Ph2SO/Tf2O) affords α-
galactosides as glycosylation takes place via a β-triflate intermediate,[3] whereas in situ 
activation affords  β-galactosides. This inversion of stereoselectivity was rationalized via the 3H4 
intermediate, which upon pseudo axial (β-face) attack directly leads to the favored 1C4 
conformation (Scheme 2).[4] This striking reversal of stereoselectivity led us to investigate the 
influence of the C-2 and C-4 stereochemistry on the glycosylation outcome via either of the 
aforementioned mechanisms.  
To this end we prepared a 2,4-dibenzyl manno-, gluco- and galacturonic acid lactone donor 
which differ in C-2 and C-4 stereochemistry (4[5], 5[3] and 6[6], resp., Scheme 2). The orientation 
of the C-4 substituent in the manno- and glucosyl donors allows for RGP which should lead to a 
β-glycoside, whereas the C-4 substituent in a galactosyl donor is unable to perform C-4 RGP. 
The conformation of the oxocarbenium ion intermediates resulting from uronic acid lactone 
donors 4-6 are shown in Scheme 2 are expected to be similar. Due to the presence of the 6,3-
lactone, the expected preferred conformation would be the 3H4 half-chair. Pseudo axial attack 
should be the preferred mode of attack and would lead to β-product as well. Anomeric triflates 
can also be reactive intermediates that are displaced in an SN2-like manner.[7] We expect the β-
anomeric triflates to be more stable due to the anomeric effect and in case of glucose and 
galactose may be further stabilized by the ∆-2 effect.[8] The ∆-2 effect is present when the C-2 
substituent is axially oriented which, due to the locked 1C4 conformation, is the case in gluco 
and galacto configured uronic acid 6,3 lactones. 
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Scheme 2: Three major mechanistic pathways in uronic acid 6,3-lactones. The 3H4 halfchair conformer is intrinsically 
favored due to the 6,3-lactone bridge (β-selective). C-4 participation is possible in manno- and gluco configured donors 
(β-selective). β-Triflate formation is expected in donor with gluco- and galacto stereochemistry due to the ∆-2 effect (α-
selective). 
 
5.2 – Glycosylation results I 
 
Galacturonic acid 6,3-lactone 6 was pre-activated at low temperature using Ph2SO/Tf2O[9] and 
subsequent addition of the glycosyl acceptor resulted in the formation of the α-glycoside with 
excellent stereoselectivity (α/β = 20/1, Table 1, entry 1). This in line with earlier reports and is 
the result of glycosylation via a β-triflate intermediate.[3] By contrast, pre-activation of 
mannuronic acid- and glucuronic acid 6,3-lactone under the same conditions did not lead to 
glycosylation products (Table 1, entries 4 and 7). Instead, the major product was 1,4-anhydro 
compound 3a/b which is the result of RGP of the C-4 benzyl ether followed by formation of 
3a/b and benzyl triflate. In case of mannoside 4, a small amount disaccharide was produced 
as mainly the β-anomer (7%), whereas glucoside 5 seems to be so reactive, that it immediately 
decomposes or forms 3b. In order to minimize the formation of this byproduct we explored the 
use of a pre-mix protocol in which activation of the glycosyl donor takes place in presence of 
the glycosyl acceptor. For this purpose, we used the NIS/AgOTf promoter system.[10] An earlier 
study explored the use of NIS/TfOH[11] to activate galacturonic acid lactone 3, but this proved 
to be unsuccessful. The use of AgOTf instead of TfOH proved to be crucial as under these 
conditions disaccharide was formed in a high yield (86%). As expected, the stereoselectivity in 
this case was much lower as the β-triflate intermediate was not pre-formed under these 
conditions.  
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Table 1: Glycosylation results of the uronic acid 6,3-lactone donors 1-3. 
 a protocols: Ph2SO, Tf2O, DTBMP, DCM, -78oC then 10; or 10, NIS, DCM, AgOTf (cat), -10oC; or 10, NIS, DCM, AgClO4 
(cat), -10oC, b isolated yield, c ratios were determined in crude reaction mixtures using key integrals in 1H-NMR spectra, 
d as an inseparable mixture with 4. 
 
Glycosylation of mannuronic acid lactone 4 using NIS/AgOTf did lead to an improved yield of β-
disaccharide (22%) with respect to the pre-activation protocol, however a significant amount of 
1,4-anhydro sugar 3a was still formed (Table 1, entries 4-5). However, in case of glucuronic 
acid lactone 5, glycosylation using NIS/AgOTf again led to the exclusive formation of byproduct 
3b. These results indicate that the tendency to form 1,4-anhydro byproduct 3 is much greater 
in the glucuronic acid lactone, than in the corresponding manno configured analogue. We 
strongly believe that 3b is also the product Furukawa et al. found when they performed a similar 
glycosylation with glucoronic acid lactone 5 using NIS/TfOH.[12] Another advantage of silver salts 
for the activation of NIS is that the role of the counter ion can be easily investigated. Hence, we 
performed glycosylations with NIS/AgClO4 to investigate the role of the counter ion on the 
stereoselectivity and byproduct formation. In case of galacturonic acid lactone 5, the 
disaccharide was formed with high yield and a slightly lower stereoselectivity compared to 
NIS/AgOTf, as expected. In the case of mannuronic acid lactone 4, the use of AgClO4 led to the 
same results as AgOTf indicating that the counter ion is not a critical determinant of 
stereoselectivity. In addition, the counter-ion does not seem to play an important role in terms 
of byproduct formation as the glycosylation yields are similar (Table 1, entries 5-6). The above 
results show that byproduct (3) formation can be suppressed to some extend by the use of a 
pre-mix strategy, yet these donors are still quite inefficient in terms of the glycosyl donor. An 
excess of donor needs to be used to obtain acceptable yields of disaccharide. The glycosylations 
using the carboxybenzyl leaving group, seen in Chapter 4, glycosylated in much better yields, 
yet with significant formation of 1,4-anhydro byproduct 3a as well. However, thioglycosides are 
 
entry donor protocola yield (%)b α / βc  entry donor protocola yield (%)b 3x (%) α / βc 
1 
 
Ph2SO 
Tf2O 
94 20/1  4 
 
Ph2SO 
Tf2O 
7 3a 16d 1/20 
2 
AgOTf 
NIS 
86 4.6/1  5 
AgOTf 
NIS 
22 3a 30d 1/20 
3 
AgClO4 
NIS 
84 2.5/1  6 
AgClO4 
NIS 
16 3a 32d 1/20 
 
 
    7 
 
Ph2SO 
Tf2O 
0 3b 32 - 
     8 
AgOTf 
NIS 
0 3b 100 - 
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preferable as they are resistant to many functional group manipulations and thus are very 
versatile synthons for the total synthesis of multistep oligosaccharides.[13] To improve this 
methodology we focused on other protecting groups at C-4 that could perform RGP, but would 
not lead to byproduct formation and hence would drastically improve donor efficiency while 
maintaining β-selectivity. Yu et al. proved remote participation of a C-4 acetyl ester,[14] similar 
to the well-known C-2 acetyl neighboring group participation (NGP), and inspired us to introduce 
this functionality (11a) which should then afford β-glycosides (13, Scheme 3). 
 
 
Scheme 3: Hypothesized glycosylation mechanism of C-4 acetyl donor 11a 
 
5.3 – Synthesis of C-4 acetyl donors 
 
The synthesis of C-4 acetyl donor 11a and 11b started from known 4,6-benzylidene precursors 
14a[2, 15] and 14b,[16] respectively (Scheme 4). The C-2 and C-3 alcohols were orthogonally 
protected with a benzyl- and 2-methylnapthyl ether, respectively. Acidic hydrolysis of the 4,6-
benzylidene (15a) and subsequent regioselective oxidation of the diol (17a) using TEMPO/BAIB 
afforded mannuronic acid 17a in good yield (79%).[17]  
 
 
Scheme 4: Synthesis of donors 11a and 11b. Reagents and conditions: i) NaH, NAPBr, DMF, 50oC, 16h, 15a 98%, 
15b 96%; ii) p-TsOH, MeOH, 16a, 16h, 88%, 16b, 4h, 76%; iii) TEMPO, BAIB, DCM/H2O (9:1 v/v), 2h, 17a 64%, 17b 
79%; iv) DDQ, DCM/H2O, 2h, (7.5/1 v/v) 18a 70%, 18b 87%; v) Ac2O, 70oC, 1.5h, 11a 88%, 11b 56%. BAIB = 
[bis(acetoxy)iodo]benzene, DDQ = 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, NAP = 2-methylnapthalene, TEMPO = 
2,2,6,6-Tetramethylpiperidine 1-oxyl. 
 
DDQ oxidation of the 2-methylnaphthyl ether afforded the corresponding C-3 alcohol (18a) 
which was lactonized using acetic anhydride.[18] Under the same conditions, the C-4 alcohol was 
acetylated affording the desired mannuronic acid 6,3-lactone donor 11a in good yield (88%). A 
similar sequence was used to prepare glucuronic acid 6,3-lactone donor 11b affording similar 
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yields, except for the lactonization step (56%). This is probably due to unfavorable essential 
change of conformation from all-equatorial (4C1) to all-axial (1C4), in order to facilitate lactone 
formation. 
 
5.4 – Glycosylation results II 
 
Next, we explored the reactivity of donors 11a and 11b in a glycosylation reaction (see Table 
2). Activation was achieved with NIS/AgOTf and, with acceptor 10, both donors gave the 
corresponding disaccharides in a high yield using only a small excess of the donors showing that 
the introduction of the C-4 acetyl group prevented byproduct formation as intended. Mannose 
donor 11a showed excellent β-selectivity (α/β = 1/20), whereas glucose donor 11b formed 
mostly the β-product albeit with very modest selectivity (α/β = 1/2.5). We expected that most 
of the α-product was the result of a reaction via the β-triflate and hence expect a higher β-
selectivity with the NIS/AgClO4 promoter system. Surprisingly, using this activation method 
caused the β-selectivity to decrease (α/β = 1/1). Aside from the C-2 stereochemistry, the 
orientation of the anomeric leaving group is also different in 11a and 11b. Therefore, a possible 
explanation for the difference in stereoselectivity may be the SN2-like displacement of the 
activated thiophenyl moiety, which would provide β-mannosides for mannose donor 11a, and 
α-glucosides for glucose donor 11b.[19] Finally, we investigated the selectivity with the much 
less reactive secondary alcohol acceptor 21. For both donors 11a and 11b yields dropped 
significantly as is regularly reported with this acceptor, but satisfyingly, the selectivity remained 
the same (α/β = 1/20 for mannose donor 11a).  
  
Table 2: Glycosylation results of the uronic acid 6,3-lactone donors 11a-b. 
 
entry donor R1OH LA yield (%)a α / βb  entry donor R1OH LA yield (%)a α / βb 
1 
 
10 AgOTf 88 <1/20 
 3 
 
10 AgOTf 81 1/2.5 
      4 10 AgClO4 70 1/1 
2 21 AgOTf 51 <1/20 
 5 21 AgOTf 53 1/2 
    a isolated yield; b ratios were determined in the crude reaction mixture using key integrals in 1H-NMR spectra. 
 
5.5 – Mechanistic study 
 
Next, we set out to provide evidence for the remote participation of the C-4 acetyl ester using 
an elegant method reported by Jernstedt et al.[20] Utilizing a tert-butyloxycarbonyl (Boc) group 
as participating group leads to the formation of a stable cyclic carbonate after loss of isobutene. 
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The formation of such cyclic carbonates was later used by Crich et al. to prove NGP and RGP in 
carbohydrates.[21] To this end we synthesized C-4 Boc donor 22 via a modified literature 
procedure, albeit in a modest yield (Scheme 5).[22]  
 
 
Scheme 5: Synthesis of donor 22. 
 
 
Activation of mannose donor 22 with the NIS/AgOTf system in the absence of glycosyl acceptor 
led to a complete reaction within an hour. After identification via 1H-NMR spectroscopy we found 
1,4-anhydro sugar 3a, instead of expected 1,4-carbonate 25 (Scheme 6). We hypothesize that 
compound 3a could either be formed via the formation of cation 23, followed by elimination of 
carbon dioxide and isobutene, or by formation of dioxolenium 24, then elimination of isobutene 
(25), followed by silver triflate mediated decarboxylation. The fact that we were unable to 
observe carbonate 25 abstains us from drawing the conclusion that the acyl moiety participates, 
however, the formation of compound 3a does prove RGP of the C-4 substituent, either via 
intermediate 23 or via intermediate 24. 
 
 
Scheme 6: Mechanistic study of C-4 RGP did not provide carbonate 25, and was thus inconclusive. 
 
5.6 – Conclusion 
 
We have shown that in mannose donors, in the 1C4 conformation, the axial C-4 substituent is 
able to participate and thereby exclusively provides β-mannosides. Even though trapping of the 
intermediate dioxolenium intermediate did not provide the expected carbonate, the obtained 
1,4-anhydro ether provided sufficient proof of remote group participation. However, this remote 
group participation might not be a reactive intermediate as the glucose donors only have a slight 
preference to form β-glucosides. Therefore, the triflate intermediate, the 3H4 oxocarbenium 
intermediate, or direct SN2 displacement of the thioether should also be considered as reactive 
pathways. In conclusion, we developed an efficient synthetic route towards a mannuronic 6,3-
lactone donor, which smoothly undergoes a one-pot β-directing stereoselective glycosylation.  
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5.7 – Experimental 
 
General Methods: For general methods, please refer to section 2.9. 
 
General Glycosylation procedures: 
 
Method A: Ph2SO/Tf2O 
A solution of lactone (1 eq), diphenyl sulfoxide (1.2 eq) and 2,6-di-tert-butyl-4-methylpyridine (2.5 eq) in DCM (0.03M) 
was stirred over activated 4Å MS for 30 min. The mixture was cooled to -78°C before Tf2O (1.1 eq) was added. The 
mixture was allowed to warm to -45°C in 15min followed by addition of acceptor (1.5). Stirring was continued and the 
reaction mixture was allowed to warm to 0°C. The reaction mixture was diluted with EtOAc and washed with water. The 
water/layer wash extracted twice with EtOAc. The collected organic layers were dried (MgSO4), filtered and concentrated 
under reduced pressure. Flash chromatography (EtOAc/PE) and removal of the eluent afforded the corresponding title 
compound. 
 
Method B: NIS/AgOTf 
Acceptor (1.2 eq), donor (1 eq) and 4Å MS were added to dry DCM (0.03M) under inert atmosphere and the mixture 
was stirred at -10°C for 15 minutes. N-iodosuccinimide (1.2 eq) and AgOTf (0.15 eq) were added and the reaction was 
stirred at -10°C for 1h. Et3N was added and the reaction was quenched with 10% Na2S3O3 in H2O w/w. The mixture was 
diluted with ethyl acetate and filtrated. The filtrate was washed with H2O and brine. The organic layer was dried (MgSO4), 
filtered and concentrated in vacuo. After acetylation of the excess of acceptor, silica gel flash column chromatography 
(20% → 60% - EtOAc in n-heptane) of the residue afforded the products. 
 
Method C: NIS/AgOCl4 
Acceptor (1.2 eq), donor (1 eq) and 4Å MS were added to dry DCM (0.03M) under inert atmosphere and the mixture 
was stirred at -10°C for 15 minutes. N-iodosuccinimide (1.2 eq) and AgClO4 (0.15 eq) were added and the reaction was 
stirred at -10°C for 1h. Et3N was added and the reaction was quenched with 10% Na2S3O3 in H2O w/w. The mixture was 
diluted with ethyl acetate and filtrated. The filtrate was washed with H2O and brine. The organic layer was dried (MgSO4), 
filtered and concentrated in vacuo. After acetylation of the excess of acceptor, silica gel flash column chromatography 
(20% → 60% - EtOAc in n-heptane) of the residue afforded the products. 
 
1,4-anhydro-2-O-benzyl-α-D-mannopyranosidurono-6,3-lactone (3a):  
To a solution of 4 (45 mg, 0.092 mmol) in DCM (1.5 mL), 2,6-di-t-butyl-4-methylpyridine (47 mg, 0.23 
mmol) was added. The mixture was dried with MS (4Å) and cooled to -20oC after which Tf2O (19 μL, 
0.11 mmol) was added. The reaction was stirred for 30 minutes and was then diluted with EtOAc (10 
mL) and filtrated. The filtrate was washed with H2O (5 mL) and brine (5 mL) after which the organic 
layer was dried (Na2SO4), filtrated and concentrated in vacuo. Silicagel flash column chromatography (10% → 40% - 
EtOAc in n-heptane) of the residue afforded 3a (18 mg, 79%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.43; 1H NMR 
(500 MHz, CD2Cl2) δ 7.48 – 7.28 (m, 5H), 5.66 (d, J = 1.9 Hz, 1H, H-1), 5.59 (t, J = 4.2 Hz, 1H, H-4), 4.78 – 4.70 (m, 
2H, H-3), 4.54 (d, J = 11.4 Hz, 1H), 4.11 – 4.09 (m, 1H, H-5), 3.74 (dd, J = 6.5, 1.8 Hz, 1H, H-2); 13C NMR (126 MHz, 
CD2Cl2) δ 171.54(C-6), 136.93, 128.50, 128.17, 128.06, 100.55 (C-1), 82.29 (C-4), 76.08 (C-2), 72.21, 71.42 (C-3), 
71.29 (C-5). 
 
1,4-anhydro-2-O-benzyl-α-D-glucopyranosidurono-6,3-lactone (3b):  
To a solution of 5 (45 mg, 0.092 mmol) in DCM (1.5 mL), 2,6-di-t-butyl-4-methylpyridine (47 mg, 0.23 
mmol) was added. The mixture was dried with MS (4Å) and cooled to -20oC after which Tf2O (19 μL, 
0.11 mmol) was added. The reaction was stirred for 30 minutes and was then diluted with EtOAc (10 
mL) and filtrated. The filtrate was washed with H2O (5 mL) and brine (5 mL) after which the organic 
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layer was dried (Na2SO4), filtrated and concentrated in vacuo. Silicagel flash column chromatography (10% → 40% - 
EtOAc in n-heptane) of the residue afforded 3b (18 mg, 79%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.43; 1H NMR 
(500 MHz, CD2Cl2) δ 7.41 – 7.30 (m, 5H), 5.73 (d, J = 1.4 Hz, 1H, H-1), 5.51 (dd, J = 4.9, 3.1 Hz, 1H, H-4), 4.66 (ddd, 
J = 4.9, 1.4, 0.8 Hz, 1H, H-3), 4.66 (d, J = 11.4 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 3.94 (dt, J = 3.0, 0.6 Hz, 1H, H-
5), 3.80 (s, 1H, H-2). 13C NMR (126 MHz, CD2Cl2) δ 171.25, 136.37, 131.04, 129.32, 128.74, 128.53, 128.44, 128.03, 
124.79, 102.99 (C-1), 82.26 (C-2), 80.37 (C-3), 79.24 (C-4), 71.69, 69.99 (C-5). 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (7): Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (28 mg, 0.06 mmol), 4 (50 mg, 0.11 mmol) 
and were added to dry DCM (3 mL) under inert atmosphere and the mixture was stirred at -
10°C for 15 minutes. N-iodosuccinimide (30 mg, 0.13 mmol) and AgOTf (5.7 mg, 0.022 mmol) 
were added and the reaction was stirred at -10°C for 1h. Et3N was added and the reaction 
was quenched with 10% Na2S3O3 in H2O w/w (1 mL). The mixture was diluted with ethyl 
acetate (50 mL) and filtrated. The filtrate was washed with H2O (20 mL) and brine (20 mL). 
The organic layer was dried (MgSO4), filtered and concentrated in vacuo. After acetylation of the excess of acceptor, 
silicagel flash column chromatography (15% → 40% - EtOAc in n-heptane) of the residue afforded 7 (30%) as a an 
inseperable mixture with 3a (22%) (49 mg total yield). TLC: (EtOAc/n-heptane 40/60 v/v): Rf =0.45.  1H NMR δ 8.01 
– 7.93 (m, 4H), 7.84 – 7.79 (m, 2H), 7.55 – 7.46 (m, 2H), 7.44 – 7.19 (m, 17H) 6.13 (t, J = 9.8 Hz, 1H, H-3’), 5.59 
(d, J = 2.0 Hz, 1H, H-1(3a)), 5.50 (dd, J = 4.9, 3.5 Hz, 1H, H-4(3a)), 5.40 (dd, J = 10.4, 9.4 Hz, 1H, H-4’), 5.32 (d, J 
= 5.0 Hz, 1H, H-1), 5.23 (dd, J = 10.2, 3.6 Hz, 1H, H-2’), 5.17 (d, J = 3.5 Hz, 1H, H-1’), 4.77 – 4.69 (m, 3H, H-3), 
4.67 – 4.63 (m, 1H, H-3(3a)), 4.63 (d, J = 11.9 Hz, 2H), 4.59 (d, J = 11.6 Hz, 1H), 4.50 (d, J = 11.7 Hz, 1H), 4.48 (d, 
J = 11.6 Hz, 1H), 4.30 (ddd, J = 10.1, 7.9, 1.9 Hz, 1H, H-5’), 4.18 (dd, J = 5.0, 1.3 Hz, 1H, H-2), 4.08 (dd, J = 3.5, 
1.0 Hz, 1H, H-5(3a)), 4.03 (dd, J = 5.8, 3.0 Hz, 1H, H-4), 3.92 (dd, J = 11.6, 1.9 Hz, 1H, H-6’a), 3.90 (dd, J = 3.0, 
1.1 Hz, 1H, H-5), 3.69 – 3.63 (m, 2H, H-6’b, H-2) 3.35 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 171.48 (C-6), 165.78, 
165.61, 137.38, 133.36, 133.24, 132.93, 129.93, 129.87, 129.57, 129.24, 129.06, 128.81, 128.69, 128.54, 128.48, 
128.44, 128.34, 128.33, 128.24, 128.16, 128.09, 127.98, 127.94, 127.85, 100.46(C-1(3a)), 99.13 (C-1), 96.50(C-1’), 
82.14 (C-4), 77.68 (C-3), 76.13 (C-4’), 75.78 (C-2(3a)), 72.19, 72.13 (C-2’), 72.04, 71.27 (C-3(3a)), 71.23, 71.20 
(C-5(3a)), 70.71 (C-2), 70.54 (C-3’), 69.71 (C-4’), 68.76 (C-5’), 67.51 (C-5), 66.99 (C-6’), 55.36; 13C-coupled HSQC 
(126 MHz, CDCl3): δ 99.13 (JC1-H1 = 175 Hz), 96.50 (JC1’-H1’ = 175 Hz); HRMS (m/z): [M+Na]+ calcd for C48H44O14, 
867.2629; found, 867.2620. 
 
Methyl 2,4-di-O-benzyl-β-D-galactopyranosilurono-6,3-lactone-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (9): Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (42 mg, 0.08 mmol), 5 (75 mg, 0.17 mmol) 
and were added to dry DCM (3 mL) under inert atmosphere and the mixture was stirred 
at -10°C for 15 minutes. N-iodosuccinimide (41 mg, 0.18 mmol) and AgOTf (8.5 mg, 
0.03 mmol) were added and the reaction was stirred at -10°C for 1h. Et3N was added 
and the reaction was quenched with 10% Na2S3O3 in H2O w/w (1 mL). The mixture was 
diluted with ethyl acetate (50 mL) and filtrated. The filtrate was washed with H2O (20 mL) and brine (20 mL). The 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. After acetylation of the excess of acceptor, silicagel 
flash column chromatography (20% → 60% - EtOAc in n-heptane) of the residue afforded 9 as a yellow oil (44 mg, 
49%). TLC: (EtOAc/n-heptane 40/60 v/v): Rf =0.45. 1H NMR (500 MHz, CDCl3) δ 8.01 – 7.78 (m, 6H), 7.68 – 7.62 
(m, 1H), 7.54 – 7.27 (m, 22H), 6.12 (t, J = 9.6 Hz, 1H, H-3’), 5.61 (t, J = 9.9 Hz, 1H, H-4’), 5.21 – 5.16 (m, 2H, H-1’, 
H-2’), 4.93 (d, J = 12.0 Hz, 1H), 4.90 (d, J = 2.5 Hz, 1H, H-1), 4.67 (dd, J = 5.0, 1.8 Hz, 1H, H-3), 4.58 (d, J = 11.9 
Hz, 1H), 4.55 (d, J = 11.9 Hz, 1H), 4.51 (d, J = 1.3 Hz, 1H, H-5), 4.51 (d, J = 12.1 Hz, 1H), 4.22 (ddd, J = 10.1, 4.4, 
2.9 Hz, 1H, H-5’), 4.14 (dd, J = 11.6, 4.3 Hz, 1H, H-6’a), 4.03 (t, J = 1.5 Hz, 1H, H-4), 3.97 (dd, J = 4.9, 2.5 Hz, 1H, 
H-2), 3.79 (dd, J = 11.5, 2.9 Hz, 1H, H-6’b), 3.42 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 171.71, 165.80, 165.77, 
165.05, 137.61, 136.80, 133.37, 133.36, 133.06, 131.04, 129.92, 129.88, 129.83, 129.81, 129.66, 129.62, 129.31, 
129.25, 129.07, 129.03, 128.59, 128.53, 128.47, 128.45, 128.40, 128.37, 128.25, 128.22, 128.19, 128.01, 127.80, 
127.79, 127.74, 127.72, 124.78, 98.82 (C-1), 97.01 (C-1’), 80.33 (C-3), 75.53 (C-5), 74.41 (C-2’), 74.23, 72.04(C-
2), 71.91 (C-4), 71.55, 70.49 (C-3’), 69.42 (C-4’), 68.62 (C-5’), 68.33 (C-6’), 55.73. 13C-coupled HSQC (126 MHz, 
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CDCl3): δ 98.82 (JC1-H1 = 164 Hz), 97.01 (JC1’-H1’ = 173 Hz); HRMS (m/z): [M+Na]+ calcd for C48H44O14, 867.2629; found, 
867.2668. 
 
Phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-methylnaphthyl)-1-thio-α-D-manno-pyranoside (15a):  
To a cooled solution (0°C) of phenyl 4,6-O-benzylidene-2-O-benzyl-1-thio-α-D-mannopyranoside 
(1.00 g, 2.22 mmol) in anhydrous DMF (20 mL) was added sodium hydride (60 percent dispersion 
in mineral oil, 0.266 g, 11.10 mmol) under inert atmosphere. 2-(Bromomethyl) naphthalene 
(0.736 g, 3.33 mmol) was added and the reaction was allowed to warm up to rt for 2 h, after which it was quenched 
with MeOH and evaporated under reduced pressure. A NH4Cl solution (35 ml) and water (35 ml) were added, and the 
mixture was extracted with diethyl ether (3x 50 ml) and the combined ethereal extracts were dried (MgSO4). After 
filtration, the solvent was removed in vacuo and the residue purified by flash column chromatography on silica gel (0% 
→ 15% - EtOAc in n-heptane) to obtain 15a as a colorless solid (1.29 g, 98%). TLC: (EtOAc/n-heptane, 20/80 v/v): Rf 
= 0.53; 1H NMR 400 MHz, CDCl3) δ 7.89 – 7.67 (m, 4H), 7.57 – 7.22 (m, 18H), 5.67 (s, 1H), 5.52 (d, J = 1.4 Hz, 1H, 
H-1), 4.95 (d, J = 12.5 Hz, 1H), 4.81 (d, J = 12.5 Hz, 1H), 4.78-4.70 (m, 2H), 4.36 (t, J = 9.4 Hz, 1H, H-4), 4.34 – 
4.20 (m, 2H, H-5, H-6a), 4.07 (dd, J = 3.2, 1.5 Hz, 1H, H-2), 4.03 (dd, J = 9.5, 3.2 Hz, 1H, H-3), 3.90 (t, J = 9.9 Hz, 
1H, H-6b); 13C NMR (101 MHz, CDCl3) δ 137.70, 137.60, 135.81, 133.71, 133.29, 132.97, 131.63, 129.11, 128.89, 
128.44, 128.21, 128.10, 128.07, 127.95, 127.87, 127.65, 127.61, 126.28, 126.15, 126.15, 126.02, 126.01, 125.80, 
125.63, 101.60, 87.08 (C-1), 79.03 (C-4), 77.96 (C-2), 76.24 (C-3), 73.05, 72.96, 68.53 (C-6), 65.49 (C-5). 
 
Phenyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-methylnaphthyl)-1-thio-α-D-glucopyranoside (15b):  
Sodium hydride (60 percent dispersion in mineral oil, 0.33 g, 13.87 mmol) was added to a 
stirred solution of 14b (2.5 g, 5.55 mmol) in anhydrous DMF (30 mL) cooled to 0°C under 
inert atmosphere. 2-(Bromomethyl) naphthalene (1.84 g, 8.32 mmol) was added and the 
reaction was allowed to warm up to rt and stirred for 2 h when it was quenched with MeOH and evaporated under 
reduced pressure. A sat. aq. NH4Cl solution (35 ml), water (35 ml) and the waterlayer was extracted with 3x30ml DCM. 
The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. Flash column chromatography on 
silica gel (0% → 15% - EtOAc in n-heptane) afforded 15b as an inseparable mixture with phenyl 4,6-O-benzylidene-3-
O-benzyl-2-O-(2-methylnaphthyl)-1-thio-α-D-glucopyranoside (1:0.44) as a colorless oil. (3.16 g, 96%). TLC: 
(EtOAc/n-heptane, 50/50 v/v): Rf = 0.53; 1H NMR (500 MHz, CDCl3) δ 7.90 – 7.64 (m, 4H), 7.60 – 7.21 (m, 18H), 
5.61 (s, 1H), 5.08 (d, J = 11.4 Hz, 1H), 4.94 (d, J = 11.5 Hz, 1H), 4.89 (d, J = 10.3 Hz, 1H), 4.84 (d, J = 10.2 Hz, 1H), 
4.77 (d, J = 9.8 Hz, 1H, H-1), 4.42 – 4.35 (m, 1H, H-6a), 3.89 (dd, J = 9.6, 8.4 Hz, 1H, H-3), 3.82 (t, J = 10.3 Hz, 1H, 
H-6b), 3.74 (t, J = 9.4 Hz, 1H, H-4), 3.54 (dd, J = 9.8, 8.4 Hz, 1H, H-2), 3.53-3.45 (m, 1H, H-5).  13C NMR (101 MHz, 
CDCl3) δ 137.99, 137.23, 135.72, 133.26, 133.11, 133.01, 132.31, 129.01, 128.98, 128.39, 128.27, 128.25, 128.17, 
128.11, 128.09, 127.93, 127.88, 127.86, 127.64, 126.87, 126.84, 126.21, 126.19, 126.03, 125.98, 125.85, 101.23, 
88.33 (C-1), 82.92 (C-3), 81.45 (C-4), 80.54 (C-2), 75.90, 75.32, 70.26 (C-5), 68.72 (C-6). 
 
Phenyl 2-O-benzyl-3-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranoside (16a): 
A mixture of 15a (2.784 g, 4.71 mmol) and p-TsOH·H2O (0.896 g, 4.71 mmol) in MeOH (47 mL) 
was stirred at room temperature for 5 h. The solution was diluted with EtOAc (100 mL) and the 
mixture was consecutively washed with sat. aq. NaHCO3 (2 x 40 mL) and brine (40 mL). The organic 
layer was dried over MgSO4, filtered and concentrated in vacuo. Silicagel flash column chromatography (0% → 60% 
EtOAc in n-heptane) of the residue afforded 16a (2.08 g, 88%) as a yellow amorphous solid. TLC: (EtOAc/n-heptane, 
40/60 v/v): Rf = 0.16; 1H NMR (500 MHz, CDCl3) δ δ 7.89 – 7.75 (m, 4H), 7.54 – 7.19 (m, 13H), 5.56 (d, J = 1.6 Hz, 
1H, H-1), 4.73 (d, J = 11.9 Hz, 1H), 4.68 (d, J = 12.2 Hz, 1H), 4.65 (d, J = 11.9 Hz, 1H), 4.57 (d, J = 12.1 Hz, 1H), 
4.19 – 4.09 (m, 2H, H-4, H-5), 4.05 (dd, J = 3.1, 1.6 Hz, 1H, H-2), 3.93 – 3.80 (m, 2H, H-6a, H-6b), 3.80 – 3.73 (m, 
1H, H-3), 2.47 (d, J = 1.8 Hz, 1H, 4-OH), 1.99 – 1.89 (m, 1H, 6-OH); 13C NMR (126 MHz, CDCl3) δ 137.63, 135.07, 
133.79, 133.27, 133.09, 131.91, 129.16, 128.48, 128.47, 127.95, 127.93, 127.91, 127.76, 127.75, 126.78, 126.30, 
126.13, 125.70, 85.99 (C-1), 79.68, 77.27, 77.01, 76.76, 75.49, 73.24, 72.20, 71.81, 67.37, 62.75; HRMS (m/z): 
[M+Na]+ calcd for C30H30O5S, 525.1712; found, 525.1701. 
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Phenyl 2-O-benzyl-3-O-(2-methylnaphthyl)-1-thio-α-D-glucopyranoside (16b): 
A mixture of 15b (2.00 g, 3.98 mmol) and p-TsOH·H2O (0.896 g, 4.71 mmol) in MeOH (47 mL) 
was stirred at room temperature for 5 h. The reaction solution was diluted with EtOAc (100 mL), 
and the mixture was consecutively washed by sat. aq. NaHCO3 (2 x 40 mL) and brine (40 mL). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo. Silicagel flash column chromatography 
(0% → 60% - EtOAc in n-heptane) of the residue afforded 16b and phenyl 3-O-benzyl-2-O-(2-methylnaphthyl)-1-thio-
α-D-glucopyranoside (1:0.44) as an inseparable mixture as a yellow solid (2.08 g, 88%). TLC: (EtOAc/n-heptane, 50/50 
v/v): Rf = 0.09; 1H NMR (500 MHz, CDCl3) δ 7.86 – 7.72 (m, 4H), 7.58 – 7.24 (m, 12H), 5.11 (d, J = 11.7 Hz, 1H), 
4.99 (d, J = 10.3 Hz, 1H), 4.88 (d, J = 11.7 Hz, 1H), 4.78 (d, J = 10.4 Hz, 1H), 4.75 (d, J = 9.5 Hz, 1H, H-1), 3.93 – 
3.84 (m, 1H, H-6), 3.81 – 3.71 (m, 1H, H-6’), 3.66 – 3.48 (m, 3H, H-2, H-3, H-4), 3.41 – 3.32 (m, 1H, H-5), 2.27 (d, 
J = 2.6 Hz, 1H, 4-OH), 2.04 – 1.96 (m, 1H, 6-OH). 13C NMR (126 MHz, CDCl3) δ 137.77, 135.59, 133.49, 133.28, 
133.05, 131.76, 129.08, 129.06, 128.73, 128.62, 128.49, 128.27, 128.00, 127.92, 127.85, 127.74, 127.72, 127.70, 
127.69, 126.77, 126.31, 126.12, 125.59, 87.76 (C-1), 85.93 (C-3), 80.95 (C-2), 79.11 (C-5), 75.48 (CH2-NAP), 70.51 
(C-4), 62.80 (C-6); HRMS (m/z): [M+Na]+ calcd for C30H30O5S, 525.1712; found 525.1703. 
 
Phenyl 2-O-benzyl-3-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranosiduronic acid (17a):  
To a solution of 16a (2.08 g, 4.15 mmol) in 10% H2O in DCM (v/v) (41.5 mL), BAIB (4.01 g, 12.4 
mmol) was added under stirring. After addition of TEMPO (0.259 g, 1.66 mmol) the reaction was 
stirred for 1h at rt. The mixture was quenched by addition of 10% Na2S3O3 solution in H2O w/w (50 
mL) and was extracted with ethyl acetate at pH 3 (3 x 40 mL). The organic layers were combined, dried over MgSO4, 
filtrated and concentrated in vacuo. Silicagel flash column chromatography (0% → 60% EtOAc in n-heptane + 2% acetic 
acid) of the residue afforded 17a as a pale yellow amorphous solid (1.37 g, 64.1%). TLC: (MeOH/DCM/acetic acid, 
10/88/2 v/v/v): Rf = 0.70; 1H NMR (500 MHz, CDCl3) δ 7.86 – 7.78 (m, 4H), 7.54 – 7.19 (m, 13H), 5.61 (d, J = 2.3 
Hz, 1H, H-1), 4.84 (d, J = 12.0 Hz, 1H), 4.77 (d, J = 12.1 Hz, 1H), 4.69 (d, J = 12.1 Hz, 1H), 4.64 (d, J = 9.4 Hz, 1H, 
H-5), 4.59 (d, J = 12.1 Hz, 1H), 4.40 (t, J = 9.1 Hz, 1H, H-4), 3.98 (t, J = 2.7 Hz, 1H, H-2), 3.80 (dd, J = 9.0, 3.0 Hz, 
1H, H-3); 13C NMR (126 MHz, CDCl3) δ 173.63 (C-6), 137.46, 135.13, 133.23, 133.14, 133.05, 131.71, 129.21, 128.43, 
128.30, 127.98, 127.95, 127.89, 127.69, 126.71, 126.17, 126.01, 125.76, 86.02 (C-1), 78.20 (C-3), 75.68 (C-2), 
72.72, 72.43, 71.72 (C-5), 68.43 (C-4); HRMS (m/z): [M+Na]+ calcd for C30H28O6S, 539.1504; found, 539.1497. 
 
Phenyl 2-O-benzyl-3-O-(2-methylnaphthyl)-1-thio-α-D-glucopyranosiduronic acid (17b): To a solution of 16b 
(2.0 g, 3.98 mmol) in 10% H2O in DCM (v/v) (21 mL), BAIB (2.6 g, 8.07 mmol) was added 
under stirring. After addition of TEMPO (0.12 g, 0.80 mmol) the reaction was stirred for 1h at rt. 
The mixture was quenched by addition of 10% Na2S3O3 solution in H2O w/w (50 mL) and was 
extracted with ethyl acetate at pH 3 (3 x 40 mL). The organic layers were combined, dried over MgSO4, filtrated and 
concentrated in vacuo. Silicagel flash column chromatography (0% → 60% - EtOAc in n-heptane + 2% acetic acid) of 
the residue afforded 17b as an inseparable mixture with Phenyl 3-O-benzyl-2-O-(2-methylnaphthyl)-1-thio-α-D-
glucopyranosiduronic acid (1.63 g, 79%). TLC: (EtOAc/n-heptane/acetic acid, 60/38/2 v/v/v): Rf = 0.08; 1H NMR (500 
MHz, CDCl3) δ 12.62 (br, s, 1H), 7.86 – 7.65 (m, 5H), 7.62 – 7.12 (m, 12H), 5.16 – 4.71 (m, 4H), 4.71 (d, J = 9.8 Hz, 
1H, H-1), 3.94 – 3.80 (m, 1H, H-4, H-5), 3.69 – 3.59 (m, 1H, H-3), 3.55 – 3.44 (m, 1H, H-2); 13C NMR (126 MHz, 
CDCl3) δ 171.79, 137.77, 135.59, 133.23, 132.76, 132.74, 132.42, 129.15, 128.46, 128.39, 128.20, 128.14, 128.10, 
128.00, 127.93, 127.66, 126.80, 126.06, 126.05, 126.01, 125.91, 88.14 (C-1), 85.03 (C-3), 79.55 (C-2), 76.68 (C-5), 
75.67, 75.57, 71.88 (C-4). HRMS (m/z): [M+Na]+ calcd for C30H28O6S, 539.1504; found 539.1491. 
 
Phenyl 2-O-benzyl-1-thio-α-D-mannopyranosiduronic acid (18a):  
To a well stirred emulsion of 17a (1.37 g, 2.66 mmol) in DCM and H2O (7.5/1 v/v) (20 mL) was 
added DDQ (0.965 g, 4.25 mmol) and the suspension was protected from light and stirred at rt for 
1.5h. The mixture was diluted with DCM (100 mL) and washed (2 x 20 mL) with 10% Na2S3O3 in H2O 
w/w at pH 3, to reduce the remaining DDQ. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. 
Silicagel flash column chromatography (0% → 10% - MeOH in DCM + 2% acetic acid) of the residue afforded 18a as a 
pale yellow amorphous solid (0.700 g, 70%). TLC: (MeOH/DCM/acetic acid, 10/88/2 v/v): Rf = 0.43; 1H NMR (500 
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MHz, MeOD-d4) δ 7.49 – 7.38 (m, 4H), 7.36 – 7.23 (m, 6H), 5.53 (d, J = 2.8 Hz, 1H, C-1), 4.70 (d, J = 11.8 Hz, 1H), 
4.66 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 8.6 Hz, 1H, H-5), 4.05 (t, J = 8.7 Hz, 1H, H-4), 3.93 (t, J = 3.0 Hz, 1H, H-2), 
3.81 (dd, J = 8.8, 3.3 Hz, 1H, H-3), 3.35 (s, 1H); 13C NMR (126 MHz, MeOD-d4) δ 173.01 (C-6), 139.36, 135.21, 
132.81, 132.41, 130.10, 129.99, 129.37, 129.29, 129.10, 128.83, 128.68, 128.62, 128.31, 86.98 (C-1), 79.90 (C-2), 
74.77 (C-5), 73.72, 72.24 (C-3), 70.57 (C-4). 
 
Phenyl 2-O-benzyl-1-thio-α-D-glucopyranosiduronic acid (18b): 
To a well stirred emulsion of 17b (1.6 g, 3.10 mmol) in DCM and H2O (7/1 v/v) (24 mL) was 
added DDQ (1.1 g, 4.65 mmol) and the emulsion was protected from light and stirred at rt for 1.5 
h. The mixture was diluted with DCM (100 mL) and washed with 10% Na2S3O3 in H2O (3x50 mL) 
at pH 3. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. Silica gel flash column 
chromatography (0% → 10% - MeOH in DCM + 2% acetic acid) of the residue afforded 18b as a yellow solid (1.01 g, 
87%). TLC: (MeOH/DCM/acetic acid, 20/78/2 v/v/v): Rf = 0.26; 1H NMR 1H NMR (500 MHz, CDCl3) δ 10.17 (s, 1H), 
7.58 – 7.49 (m, 2H), 7.44 – 7.28 (m, 8H), 4.90 (d, J = 10.8 Hz, 1H,), 4.77 (d, J = 10.8 Hz, 1H), 4.71 (d, J = 9.7 Hz, 
1H, H-1), 3.83 (d, J = 7.8 Hz, 1H, H-4), 3.75 – 3.67 (m, 2H, H-5, H-3), 3.39 (t, J = 8.7 Hz, 1H, H-2); 13C NMR (126 
MHz, CDCl3) δ 170.66 (C-6), 137.72, 132.60, 132.42, 129.27, 128.56, 128.35, 128.26, 128.13, 87.84 (C-1), 79.27, 
77.53, 76.00, 75.36, 71.11. 173.14 (C-6), 139.46, 135.30, 132.91, 130.20, 129.47, 129.39, 128.93, 128.72, 87.08 
(C-1), 80.00 (C-2), 74.87 (C-3), 73.81 (C-4), 72.33, 70.66 (C-5). 
 
Phenyl 4-O-acetyl-2-O-benzyl-1-thio-α-D-mannopyranosidurono-6,3-lactone (11a): 
A solution of 18a (0.131 g, 0.348 mmol) in Ac2O (55.2 mL) was kept at 70°C for 1.5h, then cooled to 
rt and the reaction mixture was co-evaporated with toluene (3 x 50 mL). Silicagel flash column 
chromatography (15% → 35% - EtOAc in n-heptane) of the residue afforded 11a as a colorless solid 
(0.122 g, 88%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.48; 1H NMR 500 MHz, CDCl3) δ 7.57 – 
7.48 (m, 2H, -CH Ar), 7.41 – 7.28 (m, 8H, -CH Ar), 4.96 (dd, J = 5.9, 3.1 Hz, 1H, H-4), 4.90 (d, J = 
8.9 Hz, 1H, H-1), 4.87 (dt, J = 5.9, 1.3 Hz, 1H, H-3), 4.80 (d, J = 11.6 Hz, 1H, CHHPh), 4.67 (d, J = 11.6 Hz, 1H, 
CHHPh), 4.44 (dd, J = 3.1, 1.0 Hz, 1H, H-5), 3.69 (dd, J = 8.9, 1.5 Hz, 1H, H-2), 1.96 (s, 3H, CH3 Ac); 13C NMR (126 
MHz, CDCl3) δ 169.27 (C-6), 168.47, 136.85, 133.54, 131.36, 128.98, 128.55, 128.45, 128.25, 128.12, 83.97 (C-1), 
76.54 (C-3), 73.05, 72.92 (C-2), 71.97 (C-5), 69.80 (C-4), 20.38. 
 
Phenyl 4-O-acetyl-2-O-benzyl-1-thio-α-D-glucopyranosidurono-6,3-lactone (11b): 
A solution of diol 18b (0.500 g, 1.33 mmol) in Ac2O (2.5 mL, 26,5 mmol) was kept at 70°C for 1.5 h, 
then cooled to rt and the reaction mixture was co-evaporated with toluene (3x50 mL). Silicagel flash 
column chromatography (15% → 35% - EtOAc in n-heptane) of the residue afforded 11b as a colorless 
solid (0.30 g, 56%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.50; 1H NMR (500 MHz, CDCl3) δ 7.52 – 
7.45 (m, 2H), 7.38 – 7.27 (m, 8H), 5.59 (d, J = 2.2 Hz, 1H, H-1), 5.11 (dt, J = 5.0, 2.0 Hz, 1H, H-3), 
4.94 (ddd, J = 5.0, 3.5, 1.0 Hz, 1H, H-4), 4.58 (ad, J = 11.2 Hz, 1H), 4.54 (ad, J = 11.2 Hz, 1H), 4.23 (d, J = 3.2 Hz, 
1H, H-5), 4.10 – 4.01 (m, 1H, H-2), 1.89 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 170.24, 169.42 (C-6), 136.36, 132.95, 
132.48, 128.89, 128.40, 128.21, 128.03, 85.04 (C-1), 76.54 (C-2), 73.14, 71.95 (C-3), 68.53 (C-5), 68.18 (C-3), 
20.26. 
 
Methyl 4-O-acetyl-2-O-benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (13): Methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside (0.087 g, 0.171 mmol), 18a (0.057 g, 0.142 
mmol) and 4Å MS were added to dry DCM (3 mL) under inert atmosphere and the mixture 
was stirred at -10°C for 15 minutes. N-iodosuccinimide (0.038 g, 0.171 mmol) and AgOTf 
(7.3 mg, 0.028 mmol) were added and the reaction was stirred at -10°C for 1h. Et3N was 
added and the reaction was quenched with 10% Na2S3O3 in H2O w/w (1 mL). The mixture 
was diluted with ethyl acetate (50 mL) and filtrated. The filtrate was washed with H2O (20 
mL) and brine (20 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. After acetylation of 
the excess of acceptor, silicagel flash column chromatography (15% → 50% - EtOAc in n-heptane) of the residue 
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afforded 13 as a colorless solid (0.092 g, 81%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.25; 1H NMR (500 MHz, 
CDCl3) δ 7.97 (dt, J = 8.4, 1.3 Hz, 4H), 7.85 – 7.80 (m, 2H), 7.54 – 7.45 (m, 2H), 7.44 – 7.21 (m, 12H), 6.14 (t, J = 
9.8 Hz, 1H, H-3’), 5.40 (dd, J = 10.4, 9.4 Hz, 1H, H-4’), 5.30 (d, J = 4.9 Hz, 1H, H-1), 5.24 (dd, J = 10.2, 3.6 Hz, 1H, 
H-2’), 5.18 (d, J = 3.6 Hz, 1H, H-1’), 5.02 (dd, J = 6.0, 3.2 Hz, 1H, H-4), 4.93 (dddd, J = 6.1, 1.2, 1.2, 1.2 Hz, 1H, H-
3), 4.80 (d, J = 11.6 Hz, 1H), 4.66 (d, J = 11.6 Hz, 1H), 4.32 (ddd, J = 10.1, 7.9, 1.9 Hz, 1H, H-5’), 4.10 (dd, J = 3.2, 
1.0 Hz, 1H, H-5), 4.03 (dd, J = 5.0, 1.3 Hz, 1H, H-2), 3.94 (dd, J = 11.4, 1.9 Hz, 1H, H-6’a), 3.66 (dd, J = 11.5, 8.0 
Hz, 1H, H-6’b), 3.36 (s, 3H), 2.09 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 170.26 (C-6), 169.26, 165.75, 165.62, 165.56, 
137.03, 133.38, 133.24, 132.92, 129.88, 129.83, 129.54, 129.19, 129.00, 128.72, 128.46, 128.33, 128.30, 128.13, 
128.03, 127.80, 98.97 (C-1), 96.48 (C-1’), 76.47 (C-3), 72.09 (C-2’), 71.15, 70.76 (C-4), 70.46 (C-3’), 70.37 (C-2’), 
69.69 (C-4’), 68.64 (C-5’), 67.28 (C-5), 67.11 (C-6), 55.32, 20.43; 13C-coupled HSQC (101 MHz, CDCl3): δ 98.97 (JC1-
H1 = 173 Hz), 96.48 (JC1’-H1’ = 173 Hz); HRMS (m/z): [M+Na]+ calcd for C43H40O15, 819.2265; found 819.2269. 
 
Methyl 2,4-di-O-benzyl-β-D-mannopyranosilurono-6,3-lactone-(1→4)-2,3,6-tri-O-benzyl-α-D-gluco-
pyranoside (19): Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (0.141 g, 0.303 mmol), 
18a (0.061 g, 0.151 mmol) and were added to dry DCM (3 mL) under inert atmosphere 
and the mixture was stirred at -10°C for 15 minutes. N-iodosuccinimide (0.041 g, 0.182 
mmol) and AgOTf (7.8 mg, 0.030 mmol) were added and the reaction was stirred at -10°C 
for 1h. Et3N was added and the reaction was quenched with 10% Na2S3O3 in H2O w/w (1 
mL). The mixture was diluted with ethyl acetate (50 mL) and filtrated. The filtrate was washed with H2O (20 mL) and 
brine (20 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. After acetylation of the excess 
of acceptor, silicagel flash column chromatography (15% → 40% - EtOAc in n-heptane) of the residue afforded 19 as a 
colorless solid (0.058 g, 50.6%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.43; 1H NMR (500 MHz, CDCl3) δ 7.40 – 
7.21 (m, 20H, CH Ar), 5.42 (d, J = 5.2 Hz, 1H, H-1), 5.08 (d, J = 10.8 Hz, 1H), 4.94 (dd, J = 6.0, 3.1 Hz, 1H, H-4), 
4.92 (d, J = 10.8 Hz, 1H), 4.83 (dd, J = 6.0, 1.1 Hz, 1H, H-3), 4.70 (d, J = 12.0 Hz, 1H), 4.60 (d, J = 2.9 Hz, 1H, H-
1’), 4.59 (d, J = 12.2 Hz, 1H), 4.49 (s, 2H), 4.46 (d, J = 12.2 Hz, 1H), 4.35 (d, J = 12.2 Hz, 1H), 4.05 – 3.99 (m, 2H, 
H-3’, H-5), 3.91 (dd, J = 10.9, 4.0 Hz, 1H, H-6’a), 3.83 (dd, J = 5.2, 1.1 Hz, 1H, H-2), 3.78 (ddd, J = 10.0, 4.0, 1.9 
Hz, 1H, H-5’), 3.73 – 3.67 (m, 1H, H-4’), 3.67 (dd, J = 10.8, 2.0 Hz, 1H, H-6’b), 3.54 (dd, J = 9.4, 3.4 Hz, 1H, H-2’), 
3.34 (s, 3H), 2.06 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 170.25 (C-6), 169.26, 139.61, 138.62, 137.98, 136.71, 128.52, 
128.36, 128.14, 128.12, 128.03, 127.89, 127.80, 127.57, 127.31, 127.19, 127.03, 99.98 (C-1), 97.42 (C-1’), 81.19 
(C-2’), 79.60 (C-4’), 79.39 (C-3’), 74.96 (C-3), 74.34, 73.08, 72.96, 71.42, 71.37 (C-2), 71.03 (C-4), 69.30 (C-5’), 
68.77 (C-6’), 67.65 (C-5), 55.11, 20.42; 13C-coupled HSQC (101 MHz, CDCl3): δ 99.98 (JC1-H1 = 172 Hz), 97.42 (JC1’-
H1’ = 167 Hz); HRMS (m/z): [M+Na]+ calcd for C43H46O12, 777.2887; found, 777.2872. 
 
Methyl 4-O-acetyl-2-O-benzyl-α/β-D-glucopyranosilurono-6,3-lactone-(1→6)-2,3,4-tri-O-benzoyl-α-D-
glucopyranoside (20): 11b (42 mg, 0.11 mmol) and methyl 2,3,4-tri-O-benzoyl-α-D-
glucopyranoside 10 (64 mg, 0.13 mmol) were dissolved in dry DCM (3 mL) under inert 
atmosphere. MS (4Å) were added, the mixture was cooled to -10°C and stirred for 15 minutes. 
N-iodosuccinimide (28 mg, 0.126 mmol) and AgOTf (5.4 mg, 0.02 mmol) were added and the 
reaction was stirred at -10°C for 1 h. Et3N was added and the reaction was quenched with 
10% Na2S3O3 in H2O w/w (1 mL). The mixture was diluted with ethyl acetate (50 mL) and filtrated. The filtrate was 
washed with H2O (20 mL) and brine (20 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. 
After acetylation of the excess of acceptor, silicagel flash column chromatography (15% → 50% - EtOAc in n-heptane) 
of the residue afforded 20 (68 mg, 81%) as a colorless oil. TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.25; Major isomer 
β(1→6) 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.83 (m, 6H), 7.54 – 7.24 (m, 14H), 6.15 (t, J = 9.8 Hz, 1H, H-3’), 5.53 
(t, J = 9.9 Hz, 1H, H-4’), 5.27 (dd, J = 10.1, 3.7 Hz, 1H, H-2’), 5.22 (d, J = 3.7 Hz, 1H, H-1’), 5.16 (ddd, J = 6.2, 2.9, 
1.8 Hz, 1H, H-3), 5.05 (s, 1H, H-1), 4.83 – 4.79 (m, 1H, H-4), 4.65 (d, J = 11.0 Hz, 1H), 4.56 (d, J = 11.0 Hz, 1H), 
4.29 – 4.20 (m, 1H, H-5’), 4.16 – 4.07 (m, 1H, H-5), 4.02 (d, J = 3.7 Hz, 1H, H-2), 3.96 (dd, J = 11.5, 2.0 Hz, 1H, H-
6’a), 3.65 (dd, J = 11.5, 6.4 Hz, 1H, H-6’b), 3.46 (s, 3H), 1.82 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 170.70, 169.98, 
165.74, 165.67, 165.42, 136.81, 133.44, 133.27, 132.99, 129.88, 129.86, 129.58, 129.22, 129.04, 128.79, 128.44, 
128.41, 128.34, 128.19, 128.02, 101.04 (C-1), 96.83 (C-1’), 75.77, 73.39, 72.01, 71.61, 70.48, 69.29, 68.44, 68.11, 
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 122
Chapter 5
122
 
122 
67.95, 66.90, 55.45, 20.33; 13C-coupled HSQC (126 MHz, CDCl3): δ major β(1→6) = 101.04 (JC1-H1 = 172 Hz), 96.83 
(JC1’-H1’ = 172 Hz), α(1→6) =  98.91 (JC1-H1 = 162 Hz), 97.02 (JC1’-H1’ = 172 Hz); (m/z): [M+Na]+ calcd for C43H40O15, 
819.2265; found 819.2269. 
 
Methyl 2,4-di-O-benzyl-α/β-D-glucopyranosilurono-6,3-lactone-(1→4)-2,3,6-tri-O-benzyl-α-D-gluco-
pyranoside (21): 11b (0.061 g, 0.151 mmol) and methyl 2,3,6-tri-O-benzyl-α-D-
glucopyranoside (0.141 g, 0.303 mmol) were dissolved in dry DCM (3 mL) under inert 
atmosphere. MS (4Å) were added and the mixture was stirred for 15 minutes at -10°C. N-
iodosuccinimide (0.041 g, 0.182 mmol) and AgOTf (7.8 mg, 0.030 mmol) were added and 
the reaction was stirred at -10°C for 1h. Et3N was added and the reaction was quenched 
with 10% Na2S3O3 in H2O. The mixture was diluted with ethyl acetate (50 mL) and filtrated. The filtrate was washed 
with H2O (2x20 mL) and brine (20 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. After 
acetylation of the excess of acceptor, silicagel flash column chromatography (15% → 40% - EtOAc in n-heptane) of the 
residue afforded 21 (0.058 g, 50.6%) as a colorless oil. TLC: (EtOAc/n-heptane, 40/60 v/v): Rf = 0.43; β(1→6) anomer: 
1H NMR (500 MHz, CDCl3) δ 7.46 – 7.20 (m, 18H), 7.12 – 7.07 (m, 2H), 5.46 (d, J = 1.3 Hz, 1H, H-1), 5.05 – 4.97 (m, 
1H, H-3), 4.97 (d, J = 10.6 Hz, 1H), 4.92 (d, J = 10.6 Hz, 1H), 4.82 (ddd, J = 4.9, 3.5, 0.9 Hz, 1H, H-4), 4.76 (d, J = 
12.2 Hz, 1H), 4.62 (d, J = 12.2 Hz, 1H), 4.59 (d, J = 3.7 Hz, 1H, H-1’), 4.53 (d, J = 11.9 Hz, 1H), 4.43 (d, J = 11.9 
Hz, 1H), 4.33 (d, J = 10.7 Hz, 1H), 4.27 (d, J = 10.7 Hz, 1H), 4.16 – 4.14 (m, 1H, H-5), 3.99 (t, J = 9.1 Hz, 1H, H-3’), 
3.96 – 3.67 (m, 4H, H-2, H-4’, H-5’, H-6’a), 3.60 (dd, J = 11.0, 1.7 Hz, 1H, H-6’b), 3.52 (dd, J = 9.5, 3.6 Hz, 1H, H-
2), 3.36 (s, 3H), 1.70 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.58, 169.81, 139.04, 138.08, 138.04, 136.64, 128.41, 
128.35, 128.30, 128.18, 128.07, 128.04, 127.96, 127.87, 127.56, 127.55, 127.54, 127.42, 101.10 (H-1), 97.99 (H-
1’), 80.29, 80.23, 76.66, 76.64, 75.05, 73.33, 73.30, 72.78, 71.56, 69.43, 68.70, 68.39, 68.13, 55.28, 20.17; 13C-
coupled HSQC (126 MHz, CDCl3): β(1→4) δ 101.10 (JC1-H1 = 173 Hz), 97.99 (JC1’-H1’ = 169 Hz), α(1→4) = 98.82 (JC1-H1 
= 163 Hz), 97.79 (JC1’-H1’ = 170 Hz); HRMS (m/z): [M+Na]+ calcd for C43H46O12, 777.2887; found, 777.2872. 
 
Phenyl 2-O-benzyl-4-O-tert-butyloxycarbonyl-1-thio-α-D-mannopyranosidurono-6,3-lactone (22): 
To a solution of 18a (109 mg, 0.29 mmol) in DMF (4 mL) was added Boc2O (1.26 g, 5.80 mmol) and 
the reaction was stirred at 70°C for 1.5h, then cooled to rt and the reaction mixture was co-evaporated 
with toluene (3 x 50 mL). Silicagel flash column chromatography (15% → 35% - EtOAc in n-heptane) 
of the residue afforded 22 as a colorless solid (48 mg, 36%). TLC: (EtOAc/n-heptane, 40/60 v/v): Rf 
= 0.48; 1H NMR (500 MHz, CDCl3) δ 7.57 – 7.51 (m, 2H), 7.38 – 7.28 (m, 8H), 4.92 (d, J = 9.0 Hz, 1H, H-1), 4.89 (dt, 
J = 5.9, 1.3 Hz, 1H, H-3), 4.86 (dd, J = 5.9, 3.0 Hz, 1H, H-4), 4.75 (d, J = 11.6 Hz, 1H), 4.60 (d, J = 11.6 Hz, 1H), 
4.48 (dd, J = 3.1, 1.1 Hz, 1H, H-5), 3.76 (dd, J = 8.9, 1.4 Hz, 1H, H-2), 1.49 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
168.52 (C-6), 151.56, 137.03, 132.74, 131.79, 129.05, 128.50, 128.15, 128.12, 127.93, 84.33 (C-1), 84.25 (C-2), 
76.82 (C-3), 73.16, 72.99 (C-2), 72.10 (C-5), 71.56 (C-4), 27.61. 
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6.1 – Summary and perspective 
 
  6.1.1 – Gluco-type sugars 
 
Controlling the stereoselective outcome of the chemical glycosylation reaction remains one of 
the most challenging aspects of oligosaccharide synthesis. Especially the synthesis of the 1,2-
cis glycosidic linkage hampers the progress of the glycomics field. In 2005 Boons and coworkers 
used a (1S)-phenyl-2-(phenylsulfanyl)ethyl participating group on O-2 to efficiently synthesize 
1,2-cis (α-)glucosides via a β-sulfonium ion.[1] This method, however, relies on the labor 
intensive introduction of a chiral auxiliary, as well as having a withdrawing acyl functionality on 
C-3 to ensure excellent α-selectivity (Figure 1). Furthermore, the exact mechanism of sulfonium 
ion mediated glycosylation is a topic of much debate. As a result, while this methodology seems 
promising, it needs fine-tuning in order to be viable as a reliable and broadly applicable 
methodology. Additionally, there have been several groups working on the gluco-type sulfonium 
ion mediated glycosylation reaction in the last decade. However, the 1,2-cis linkage in manno-
type and the 2-deoxy-2-amino derivatives are equally important and the sulfonium 
intermediates could play a vital role in their reliable synthesis. 
 
 
 
Figure 1: Chirality of auxiliary is and an acyl moiety on C-3 are vital for 1,2-cis selectivity. 
 
 
The overall aim of the work presented in this thesis was the development of generally 
applicable methodology for stereoselective glycosylation. The work presented in Chapter 2 
and Chapter 3 was aimed at simplifying the use C-2 auxiliaries to prepare 1,2-cis-
glucosides and galactosides. To this end, use of the Thorpe-Ingold effect on auxiliary 
participation was investigated, which led to the development of highly selective acetylated 
galactosyl donor 2 (α/β = 19/1, Scheme 1).[2] In contrast, fully benzylated counterpart 3 
was not as selective (α/β = 4/1, Scheme 1). The work in Chapter 3 described the 
development of a new method to activate thioglycosides to afford β-sulfonium ions. Careful 
optimization of the protecting groups as well as the electron-donating property of the 
anomeric thioether to fine-tune the delicate, crucial charge distribution of the reactive 
glycosylation intermediates led to selective glucosyl and galactosyl donors. Adding electron-
withdrawing substituents on the benzyl protecting groups increased α-selectivity, albeit up 
to an α/β ratio of 13/1, still leaving room for improvement (4, Scheme 1). Achiral auxiliaries 
are less selective than chiral auxiliaries and hence combining the new activation method 
with chiral auxiliaries has the potential to further improve α-stereoselectivity (5, Scheme 
1).  
516222-L-bw-mensink
Processed on: 12-1-2018 PDF page: 127
Summary, Perspective and Outlook
6
127
 
127 
 
Scheme 1: Would a combination of the newly developed activation system and a chiral auxiliary reliably 
afford 1,2-cis glycosides?  
 
Furthermore, a broadly applicable glycosylation procedure should comprise both the 
synthesis of α- and β-glycosides and should ideally originate from the same building block. 
The synthesis route introduced in Chapter 3 allows for late stage introduction of the C-2 
directing group, i.e. the final step before glycosylation. Introduction of a C-2 acetyl group 
reliably results in β-glycosides and, if the α-selective glycosylation can be perfected, e.g. by 
using donor 5, a universal building block synthesis with subsequent stereoselective 
glycosylations emerges. 
 
The formation of the α-product in the β-sulfonium ion model is dependent on the persistence of 
this intermediate compared to the oxocarbenium ion, as SN2-like displacement of the first can 
only result in α-products and SN1-like glycosylation of the latter results in a mixture of anomers. 
Other important factors that may influence the reaction mechanism are parameters such as 
temperature and solvent. Detailed analysis of product formation followed by variable 
temperature NMR (VT-NMR) studies and the temperature at which the reaction initiates can be 
pinpointed, and should be kept at that temperature. This may maximize the formation of α-
glycoside and could give potentially important information for follow-up studies. As chemists use 
countless different donors and acceptors, all with their own unique reactivity, this temperature 
would differ for every single donor-acceptor combination, still it would be interesting to know 
whether an isocratic temperature influences the anomeric outcome in a positive way. 
 
It is well known that solvents can also have a profound influence on the reaction mechanism, 
yet this solvent effect has never been investigated on glycosyl sulfonium ions. During a cursory 
solvent screening for the glycosylation of the 2,4-DCB glucose donor, we observed increased α-
selectivity when a 20% Et2O/DCM solvent mixture was used (α/β = 9/1 vs 11/1. This is 
consistent with the reported α-selective properties of the Et2O solvent and a cooperative effect 
of the glycol auxiliary could be responsible for the improvement. Further research in solvent 
optimization may therefore be explored to improve α-selectivity. 
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6.1.2 – Manno-type sugars 
 
1,2-cis (β-)Mannosylation using sulfonium intermediates was investigated in Chapter 4. This 
was achieved using a lactone induced ringflip, albeit with an inseparable 1,4-anhydro byproduct 
(14, Scheme 2). The discovery of remote participation of the O-4 moiety debates the importance 
of the β-sulfonium intermediate. Substituting the O-4 benzyl (12a) for an O-4 acetyl group 
(12b) in Chapter 5, remedied the formation of the byproduct and afforded stereoselective β-
mannuronic acid lactones (13b). 
 
 
 
Scheme 2: Stereoselective β-mannosylation. a) Lactonization of 10 and subsequent glycosylation afforded an 
inseparable mixture of 13a and 14; b) Lactonization of 11 with Ac2O afforded 12b which upon glycosylation afforded 
only 13b. 
 
 
These mannuronic acid lactones could serve as valuable building blocks for future research. For 
example, reducing mannuronic acid lactone 13b with K-selectride will generate mannose (15), 
which can be an attractive way to prepare 1,2-cis mannosides found in the human core N-
glycan. Acidic opening of 13b in methanol will access mannuronic acid methyl ester 16, which, 
together with L-guluronic acid, can be used to synthesize uronic acid alginates. Furthermore, 6-
deoxy-D-manno-heptopyranose 17 could potentially be accessed by selective reduction to the 
aldehyde, followed by a Wittig reaction and reduction of the resulting alkene. Submitting the 
aforementioned alkene to dihydroxylation would afford glycero-D-manno-heptose derivatives 
(18) which are important carbohydrate constituents of the lipopolysaccharide of gram negative 
bacteria.[3] Furthermore, as the O-4-acetyl group is the directing group during the glycosylation 
reaction, introducing an azide functionality on C-2 could be used to access the 1,2-cis-
mannosamine derivatives.  
 
 
Scheme 3: Selective opening of the mannuronic acid lactones affords various potential building blocks. 
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 6.1.3 – Concluding remarks 
  
In conclusion, we have developed a three-step synthetic route towards a pre-donor on which a 
desired C-2 α- or β-directing group could be introduced (2-hydroxyethyl or acetyl, resp.). 
Subsequent β-glycosides can reliably be synthesized, however, future work is still needed to 
improve α-selectivity during glycosylation reactions. Additionally, we have discovered a new 
mode of participation in 1C4 locked mannoside glycosylations, which could be exploited to 
generate various β-mannoside derivatives, possibly including β-mannosamines. 
 
6.2 – Outlook 
 
As was mentioned in section 6.1.1., the stereoselective synthesis of 1,2-cis glucosamines using 
a sulfonium ion intermediate is an interesting endeavor. We were inspired by the work of 
Turnbull and coworkers,[8] who managed stereoselective 1,2-cis glycosylation via pre-formation 
of the oxathiane system. m-CPBA mediated oxidation of the sulfur, followed by aromatic 
electrophilic substitution using triflic anhydride and 1,3,5-trimethoxybenzene to activate the 
donor. Therefore, we synthesized allyloxycarbonyl (Alloc) protected amino sugar 19. A reductive 
amination was initiated by Pd(PPh3)4 mediated removal of the Alloc protecting group, forming 
the imine. Reduction of the imine then afforded thiomorpholine 20, albeit in low yield. 
Unfortunately, we were only able to obtain 20 a single time and subsequent efforts to 
resynthesize 20 failed. Consequently, the essential glycosylation reaction remains unexplored.  
 
 
 
Scheme 4: Reductive amination of 19 afforded thiomorpholine 20. Subsequent glycosylation is still unexplored. 
 
 
Next, we investigated the glycosylation methodology developed by Boons and coworkers,[1] 
which after departure of a C-1 imidate leaving group uses a participating C-2 auxiliary to achieve 
high 1,2-cis selectivities. The aforementioned nucleophilicity of the amine can be reduced by 
attaching an electron-withdrawing substituent on the amine, e.g. a sulfonyl group. In addition, 
sulfonamide sulfonium 25 has an axial oxygen which has shown to exhibit a positive effect on 
the stereoselective outcome when compared to bicyclic ring systems that do not contain this 
axial substituent.[9] Synthesis of the donor involves introduction of the auxiliary using 
chloromethane sulfonyl chloride and sodium hydride, affording 21. Subsequent nucleophilic 
substitution using thiophenol and triethyl amine (TEA) afforded 22, which was then deacetylated 
using hydrazinium acetate (23). Work-up involved an aqueous extraction and concentration of 
the organic layer and subsequent installation of the imidate failed. In order to attempt another 
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imidation of 23, we needed to resynthesize it. Unfortunately, after many attempts synthesis of 
compound 22 proved unsuccessful and this synthesis route had to be abandoned. 
 
 
Scheme 5: Synthesis route to donor 24. Resynthesizing 22 failed and so the glycosylation remains unexplored. 
 
Finally, the Tf2O mediated activation of the 2-hydroxylethyl auxiliary, as discussed in Chapter 3, 
could be further extended to stereoselective synthesis of 1,2-cis aminoglycosides. We chose a 
tosyl protecting group in order to reduce the nucleophilicity of the amine’s lone pair. Following 
an elegant two-step literature procedure, thioether 28 was synthesized from perbenzylated 
glucal in excellent yield.[10] A two-step installation of our previously designed 2-hydroxyethyl 
auxiliary obtained glucosyl donor 29. We then followed the activation of this donor using variable 
temperature NMR studies and surprisingly found α-configured sulfonium ion 30. Raising the 
temperature then resulted in glucal 31 via trans di-axial elimination. 
 
 
Scheme 6: Three step synthesis route to donor 29. Glycosylation afforded glucal 31. 
 
The section above shows that carbohydrate reactions are delicate procedures and not always 
seem to follow logic, as using the apparent same reaction conditions multiple times fails to afford 
an identical product. Out of the attempted methodologies for the stereoselective glycosylations, 
the route shown in Scheme 5, which uses an integrated sulfonamide in the β-sulfonium ion, is 
worth pursuing as the axial oxygen has proven to positively improve 1,2-cis selectivity. 
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64 – Experimental  
 
General methods: for general methods please refer to section 2.9. 
 
Acetophenone 3,4,6-tri-O-acetyl-2-amino(allyloxycarbonyl)-2-deoxy-β-glucothiopyranoside (19): Et3N (3 
eq.) and  2-bromoacetophenone (2 eq.) in acetonitrile were added to a solution of 3,4,6-
tri-O-acetyl-2-amino-allyloxycarbonyl-2-deoxy-1-thio-β-D-glucopyranosyl in acetonitrile. 
The mixture was stirred at rt. for 1h, and was then concentrated in vacuo. The residue was 
dissolved in DCM, washed with brine, dried with MgSO4 and concentrated. 19 was obtained using silicagel flash column 
chromatography (EtOAc/n-heptane 40/60%). 1H NMR (500 MHz, CDCl3) δ 7.95 (d, 2H), 7.58 (t, J = 10.5, 4.3 Hz, 1H), 
7.47 (t, 2H), 5.90 – 5.74 (m, 1H), 5.38 – 5.03 (m, 5H), 4.75 (d, J = 10.3 Hz, 1H), 4.63 – 4.41 (m, 2H), 4.21 (dd, J = 
12.4, 5.0 Hz, 1H), 4.15 – 4.02 (m, 3H), 3.86 (q, J = 10.1 Hz, 1H), 3.77 – 3.64 (m, 1H), 2.08 – 1.97 (m, 9H). 
 
2-phenyl -(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyrano)-<1,2-d>-1-thiomorpholine (20): 
Pd(PPh3)4 was added to a solution of 19 and dimethyl malonate in dry THF. The mixture was stirred 
for 16h, an excess of NaCNBH3 was added and the mixture was stirred overnight. The mixture was 
then washed with brine and water, dried with MgSO4 and concentrated in vacuo. Silicagel flash 
column chromatography (EtOAc/n-heptane 40/60%) afforded the product. Recrystallization in CDCl3 afforded colorless 
needles, yield could not be determined.  1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 12.0 Hz, 1H), 7.62 – 7.49 (m, 1H), 
7.49 – 7.42 (m, 1H), 7.41 – 7.29 (m, 3H), 5.12 (dd, J = 7.2, 2.7 Hz, 2H), 4.49 (d, J = 8.7 Hz, 1H), 4.28 (dd, J = 12.4, 
5.0 Hz, 1H), 4.14 (dd, J = 12.4, 2.1 Hz, 1H), 3.97 (dd, J = 10.7, 2.2 Hz, 1H), 3.90 – 3.75 (m, 1H), 3.22 – 3.11 (m, 
1H), 2.92 (dq, J = 13.5, 10.7 Hz, 1H), 2.64 (dd, J = 13.5, 2.3 Hz, 1H), 2.18 – 1.94 (m, 9H). HRMS (m/z): [M+Na]+ 
calcd for C20H25NO7S, 446.1249; found, 424.1250. 
 
Acetyl 3,4,6-tri-O-acetyl-2-deoxy-2-N-(chloromethyl)sulfonamido-β-D-glucopyranoside (21):  
A solution of 1,3,4,6-tetraacetyl-2-deoxy-2-amino-β-D-glucopyranoside·HCl (2.66 mmol) in 
anhydrous DCM (15 mL) was cooled to 0˚C, treated with Et3N (4.61 mmol), followed by 
chloromethanesulfonyl chloride (5.71 mmol). The mixture was left to stir at rt for 2h. The solution 
was concentrated under reduced pressure and redissolved in EtOAc (150 ml). The solution was 
washed with H2O (2x 150 ml) and brine (100 ml). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo. Silicagel flash column chromatography (0% to 40%, EtOAc in n-heptane) afforded 21 (0.78 g, 65%) TLC: 
(EtOAc/n-heptane, 50/50 v/v), Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 6.10 (d, J = 9.9 Hz, 1H), 5.73 (d, J = 8.7 Hz, 1H, 
H-1), 5.26 (dd, J = 10.4, 9.4 Hz, 1H, H-3), 5.13 – 4.93 (m, 1H, H-4), 4.52 (s, 2H), 4.28 (dd, J = 12.5, 4.5 Hz, 1H, H-
6), 4.12 (dd, J = 12.5, 2.3 Hz, 1H, H-6), 3.92 (ddd, J = 10.1, 4.5, 2.2 Hz, 1H, H-5), 3.70 (td, J = 10.2, 8.7 Hz, 1H, H-
2), 2.22 (s, 3H), 2.15 (s, 3H), 2.09 (s, 3H), 2.06 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 171.45, 170.72, 169.52, 169.40, 
92.12 (C-1), 72.54 (C-5), 72.43 (C-3), 68.19 (C-4), 61.54 (C-6), 57.02 (C-2), 56.35 (CH2) 21.01, 20.88, 20.70, 20.59. 
 
Tosyl 3,4,6-tri-O-benzyl-1-amino-2-deoxy-2-iodo-α-D-mannopyranoside (27):  
A suspension of glucal 26 (1.160 g, 2.68 mmol) and p-TsOH (3.74 mmol) in dry DCM (15 mL) and 
NIS (3.16 mmol) was stirred at 0 °C for 1h. The solution diluted with 100 ml DCM and quenched 
with a sat. aq. Na2S2O3 solution. The organic layer was separated and washed with H2O (2x 150 ml) 
and brine (100 ml). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. Silicagel flash column 
chromatography (0% to 30%, EtOAc in n-heptane) afforded 27 (1.247g, 65%). TLC: (EtOAc/n-heptane, 50/50 v/v), 
Rf=0.80; 1H NMR: (500 MHz, CDCl3) δ 7.76 – 7.71 (m, 2H), 7.37 – 7.07 (m, 17), 6.11 (d, J = 7.7 Hz, 1H), 5.60 (dd, J 
= 7.7, 3.1 Hz, 1H, H-1), 4.69 (d, J = 10.9 Hz, 1H), 4.62 (d, J = 11.4 Hz, 1H), 4.57 – 4.54 (m, 1H, H-2), 4.52 (d, 1H), 
4.43 (d, J = 2.2 Hz, 1H), 4.41 (d, J = 1.7 Hz, 1H), 4.37 (d, J = 12.1 Hz, 1H), 3.84 (t, J = 7.9 Hz, 1H, H-4), 3.51 (dd, J 
= 10.8, 4.1 Hz, 1H, H-6), 3.45 (ddd, J = 8.2, 4.1, 2.8 Hz, 1H, H-5), 3.14 (dd, J = 7.7, 3.9 Hz, 1H, H-3), 3.05 (dd, J = 
10.7, 2.7 Hz, 1H, H-6’),  2.32 (s, 3H); 13C NMR: (126 MHz, CDCl3) δ 143.73, 138.12, 137.80, 137.44, 137.21, 129.51, 
129.32, 128.43, 128.40, 128.38, 128.32, 128.28, 128.06, 127.91, 127.78, 127.72, 127.68, 127.66, 127.54, 127.43, 
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127.34, 86.22, 85.59, 83.36 (C-1), 78.82, 77.17 (C-3), 74.78, 74.59 (C-5), 73.31, 73.22 (C-4), 71.38, 67.59 (C-6), 
31.15 (C-2), 21.47. 
 
 2,4,6-Trimethoxyphenyl 3,4,6-tri-O-benzyl-2-tosylamino-2-deoxy-1-thio-α-D-glucopyranoside (28): 
LiHMDS (1,0 M) in THF (8.87 mmol) was added dropwise to a stirred solution of 2,4,6-
trimethoxythiophenol (8.87 mmol) in dry DMF (5 mL) at -40°C. Iodide sugar 27 (2,11 g, 2.96 
mmol) in DMF (15 mL) was then added dropwise. After 1h, the reaction was stirred an additional 
16h at rt. The solution was concentrated in vacuo and redissolved in EtOAc (150 ml). The solution was washed with H2O 
(2x 150 ml) and brine (100 ml). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. Silicagel 
flash column chromatography (0% to 30%, EtOAc in n-heptane) afforded 28 (1.87 g, 80%). TLC: (EtOAc/n-heptane, 
30/70 v/v), Rf = 0.3; 1H NMR: (500 MHz, CDCl3) δ 7.85 – 7.79 (m, 2H), 7.49 – 7.08 (m, 15H), 6.12 (s, 2H), 5.89 (d, 
J = 5.0 Hz, 1H), 5.06 (d, J = 10.4 Hz, 1H), 4.74 (d, J = 11.1 Hz, 1H), 4.70 (d, J = 10.4 Hz, 1H), 4.48 (d, J = 11.1 Hz, 
1H), 4.44 (s, 2H), 4.18 (d, J = 10.1 Hz, 1H, H-1), 3.83 (s, 6H), 3.80 (s, 3H), 3.74 – 3.68 (m, 2H, H-3, H-6), 3.60 (dd, 
J = 11.1, 5.2 Hz, 1H, H-6’), 3.47 (t, J = 8.7 Hz, 1H, H-4), 3.38 (ddd, J = 9.0, 5.2, 2.5 Hz, 1H, H-5), 3.18 (ddt, J = 
10.1, 8.2, 4.1 Hz, 1H, H-2), 2.34 (s, 3H); 13C NMR: (126 MHz, CDCl3) δ 162.62, 162.26, 162.02, 143.36, 138.34, 
138.01, 137.00, 129.41, 128.40, 128.33, 128.22, 128.21, 128.07, 127.72, 127.71, 127.67, 127.49, 127.46, 100.10, 
91.59, 90.76, 90.59, 88.77 (C-1), 84.11 (C-3), 79.84 (C-5), 77.95 (C-4), 75.26, 74.57, 73.45, 69.50 (C-6), 59.04 (C-
2), 56.41, 55.99, 55.41, 55.40, 29.69, 21.53. 
 
2,4,6-Trimethoxyphenyl 3,4,6-tri-O-benzyl-2-(2-hydroxyethyl)amino-2-deoxy-1-thio-α-D-glucopyranoside 
(29): To a cooled solution of amine 28 (200 mg, 0.25 mmol) in dry DMF (5 mL) was added NaH 
(1.25 mmol) the mixture  was stirred for 30 min and warmed up to rt. 2-(2-
bromoethoxy)tetrahydro-2H-pyran (1mmol) was added and the mixture was stirred at rt for 16h. 
The reaction was quenched with MeOH and concentrated in vacuo. The mixture was redissolved in MeOH, then p-TsOH 
was added until the pH = 3 and stirred for 2h. The reaction was quenched with MeOH, concentrated in vacuo and 
redissolved in EtOAc (150 ml). The solution was washed with H2O (2x 150 ml) and brine (100 ml). The organic layer 
was dried over MgSO4, filtered and concentrated in vacuo. Silicagel flash column chromatography (0% to 50%, EtOAc 
in n-heptane) afforded 29 (162 mg, 77%); TLC: (EtOAc/n-heptane, 50/50 v/v), Rf = 0.4; 1H NMR (500 MHz, CDCl3) δ 
8.17 – 8.04 (m, 2H), 7.50 – 6.99 (m, 15H), 6.12 (s, 2H), 5.68 (d, J = 10.2 Hz, 1H, H-1), 4.99 (d, J = 10.0 Hz, 1H), 
4.92 (d, J = 10.1 Hz, 1H), 4.83 (d, J = 10.8 Hz, 1H), 4.71 (m, 1H, H-3), 4.63 (d, J = 10.8 Hz, 1H), 4.39 (d, J = 11.7 
Hz, 1H), 4.32 (d, J = 11.7 Hz, 1H), 3.91 (s, 1H), 3.82 (s, 6H), 3.78 (d, J = 10.9 Hz, 2H, H-6), 3.75 (s, 3H), 3.72 – 3.65 
(m, 2H, H-6’, H-4), 3.60 (dd, J = 5.3, 2.3 Hz, 2H, H-5), 3.51 (t, J = 10.3 Hz, 1H, H-2), 3.34 (dd, J = 5.9, 3.4 Hz, 1H), 
2.40 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 161.86, 143.90, 138.49, 137.92, 136.73, 129.27, 128.66, 128.40, 128.21, 
127.8, 127.70, 127.54, 127.43, 97.80, 91.14, 84.40 (C-1), 83.2 (C-3), 80.66 (C-4), 79.5 (C-5), 75.35, 74.77, 74.53, 
73.73, 73.57, 68.88 (C-6), 66.51 (C-2), 61.56, 60.19, 55.99, 55.98, 55.53, 55.25, 54.21, 21.97, 21.54. 
 
3,4,6-Tribenzyl-2-deoxy-2-((2-(2,4,6-trimethoxyphenyl)ethyl)tosylamino-D-glucal (31):  
Donor 29 (22 mg, 1 mmol) and 2,6-di-tert-butyl-4-methylpyridine (2 mmol) were dissolved in DCM-d2 
(1.5 mL). MS (4Å) were added and the mixture was cooled to -30°C. Tf2O (1 mmol) was added and the 
temperature was allowed to warm up to 10°C. After 10 minutes the reaction was cooled again to -30 
°C, affording 31. 1H NMR (400 MHz, CDCl3, 6.52 ppm (H-1)) δ 6.52 (d, J = 4.9 Hz, 1H), 4.74 (dd, J = 
11.0, 5.0 Hz, 1H), 4.27 – 4.11 (1H), 4.04 (d, J = 9.9 Hz, 1H), 4.00 – 3.89 (1H), 3.81 (d, J = 11.7 Hz, 1H), 3.60 (d, J 
= 11.3 Hz, 1H). 1H-1H TOCSY (400 MHz, CDCl3, 4.32 ppm (H-1)) δ 4.32 (s, 1H), 4.04 (s,1H), 3.77 – 3.68 (m, 2H), 3.58 
(d, J = 3.7 Hz, 1H), 3.55 (d, J = 3.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 173 (C-2); 1H-13C HSQC No signal on 173 
ppm: quaternary carbon. 
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Summary 
 
In nature we can distinguish between three classes of macromolecules being DNA, proteins and 
carbohydrates (sugars). With the deciphering of the genetic code of the human genome it 
became clear that this alone is not sufficient to map all biological processes. In time it became 
clear that, apart from DNA and proteins, carbohydrates play an important role in many biological 
processes and synthesis of these substances is desired over time consuming and low yielding 
extraction from e.g. plants. 
However, the synthesis of carbohydrates involves the connection of two monomers via a 
glycosidic bond and often this is accompanied with a mixture of two products, called anomers. 
Reliable synthesis of the 1,2-trans anomer can be achieved by using an acetyl functionality on 
the C-2 position, however stereoselective synthesis of the 1,2-cis anomer remains tedious to 
date. An elegant solution to this problem was published in 2005 and uses intramolecular 
participating of a C-2 sulfur auxiliary. Although not yet perfect, this methodology is promising 
for reliable 1,2-cis glycosylations. This thesis describes the optimization of 1,2-cis glycosylations 
using sulfonium intermediates. 
 
Chapter 1 describes the development of 1,2-cis glycosylations in the past two decades. One of 
the most important discoveries is that participation of a C-2 (S)-(phenylthiomethyl) benzyl group 
achieves full 1,2-cis selectivity, most likely via SN2 substitution of a 1,2-trans sulfonium 
intermediate. It should be noted that this is not the case with systems that are activated by 
benzyl protecting groups of the remaining hydroxyls. 
 
The discovery that a 1,2-trans-sulfonium intermediate can lead to selective 1,2-cis 
glycosylations, triggered our interest to improve this methodology. In Chapter 2 we tried to 
stabilize the 1,2-trans sulfonium intermediate by introducing two geminal methyl groups on the 
auxiliary, which speeds up cyclization following the Thorpe-Ingold effect. However, nuclear 
magnetic resonance (NMR) experiments revealed the presence of a 1,2-cis sulfonium 
intermediate, which leads to the undesired 1,2-trans glycoside via SN2 substitution. Warming 
up this intermediate reveals the formation of the desired 1,2-trans sulfonium intermediate, 
which in the NMR time domain remains the sole compound when cooled down again. Subsequent 
glycosylation, however, affords a mixture of anomers which suggests that the sulfonium 
intermediate might just be a resting state and does not participate in the reaction mechanism. 
In addition to the glucose series, we also included its C-4 epimer, galactose, in our research and 
discovered a donor which reliably affords 1,2-cis galactosides (α/β = 19:1). 
  
A novel activation methodology for glycosylation is introduced in Chapter 3. Key factors are the 
fast building block synthesis and the ability for late stage introduction of the appropriate 
directing group. Introduction of an acetyl moiety reliably affords 1,2-trans glycosides and 
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introduction of the newly developed ethanol auxiliary provides 1,2-cis glycosides. Activation of 
the latter is achieved with Tf2O at -40°C, after which raising the temperature results in the 
crucial 1,2-trans sulfonium intermediate. Subsequent addition of an acceptor at low 
temperatures then results in 1,2-cis glycosylation.  
This newly developed methodology enabled us to study the electronic effects of protecting 
groups on the stereoselectivity. Introduction of an electron-donating 2,4,6-trimethoxyphenyl 
group on the sulfur significantly improved stereoselectivity compared to the phenyl protecting 
group (α/β = 4:1 vs 2.5:1, resp.). The same effect was observed for galactose counterpart (α/β 
= 7:1 vs 3:1, resp.). We then turned to the protecting groups on the remaining hydroxyls and 
found that, in the glucose series, 2,4-dichlorobenzyl protecting groups provided improved 
stereoselectivity as compared to benzyl groups (α/β = 9:1 vs 4:1, resp.). The galactose series 
provided even better selectivity with α/β = 13:1. 
 
1,2-cis Mannosylation using sulfonium intermediates was, to our knowledge, not explored before 
and Chapter 4 describes this development using a ringflip. Switching from the 4C1 to the 1C4 
conformation enables a 1,2-trans sulfonium intermediate to be formed, which after SN2 
substitution then leads to a 1,2-cis mannoside. This ringflip was forced by introducing a 6,3-
lactone via a TEMPO/BAIB mediated oxidation of a 3,6-diol. Glycosylations achieved complete 
stereoselectivity, however, control experiments with donors not bearing the C-2 auxiliary also 
provided complete stereoselectivity (albeit with significant addition of an inseparable by-
product). Closer examination of the by-product revealed the formation of an 1,4-anhydro ether, 
which is formed via participation of the C-4 moiety. This was the first time participation of a C-
4 benzyl group was reported. 
 
Inspired by the discovery of the C-4 ether participation in mannose in the previous chapter, we 
developed a similar glucose 6,3-lactone in Chapter 5. However, this resulted in a 1,4-anhydro 
ether as the sole isolated product. Replacing the C-4 benzyl by an acetyl group provided product 
formation, albeit with low selectivity (α/β = 1:2). In contrast, the mannose counterpart provided 
full 1,2-cis stereoselectivity, without formation of the by-product.  Unfortunately, mechanistic 
studies with a C-4 tert-butyloxycarbonyl group did not provide clarification of the reaction 
mechanism as again the 1,4-anhydro ether was obtained, rather than the expected carbonate. 
 
Chapter 6 reflects on the previous chapters in this thesis and provides suggestions for future 
research in the field of 1,2-cis stereoselectivity in carbohydrate chemistry. This chapter also 
includes unpublished work regarding 1,2-cis aminoglycosylation, with interesting angles that 
are worth pursuing in the future. 
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Samenvatting 
 
In de natuur kunnen we drie klassen macromoleculen onderscheiden, DNA, proteïnen en 
koolhydraten (suikers). Echter de ontcijfering van genetische codes van het menselijk genoom 
blijkt onvoldoende om alle biologische processen te verklaren, waardoor aan het licht is gekomen 
dat koolhydraten daar ook een grote invloed op hebben. Echter synthese van koolhydraten 
wordt bemoeilijkt door de binding tussen twee afzonderlijke koolhydraten, de glycosidische 
band. De koppeling van twee koolhydraten middels deze glycosidische band gaat vaak gepaard 
met een slechte opbrengst en een mengsel van twee producten, anomeren. Betrouwbare 
synthese van het 1,2-trans anomeer maakt gebruik van een acetyl groep op de C-2 positie, 
echter het 1,2-cis anomeer levert vaak problemen op. In 2005 is daar een elegante oplossing 
voor gekomen die gebruikt maakt van een intramoleculaire participerende C-2 zwavel groep, 
welke overigens nog niet werkt voor alle suikers. Dit proefschrift beschrijft de optimalisatie van 
de 1,2-cis glycosylering door middel van intramoleculaire participerende groepen. 
 
Hoofdstuk 1 beschrijft de ontwikkeling van 1,2-cis glycosyleringen die in de laatste twee 
decennia plaatsgevonden heeft. Een van de belangrijkste ontdekkingen is dat participatie van 
een C-2 (S)-(phenylthiomethyl) benzyl groep, waarschijnlijk via SN2 substitutie van een trans-
sulfonium ion, volledige selectiviteit oplevert. Hierbij moet wel vermeld worden dat dit niet het 
geval is als het systeem volledig geactiveerd is door benzyl bescherming. 
 
De ontdekking dat een trans-sulfonium intermediair kan leiden naar selectieve 1,2-cis 
glycosyleringen, maakte dat we in Hoofdstuk 2 de desbetreffende methode probeerde te 
verbeteren. Hier werd geprobeerd het sulfonium ion te stabiliseren door middel van de 
introductie van twee geminale methylen op de C-2 hulpgroep die dan gebruik maken van het 
Thorpe-Ingold effect. Echter werd er met nucleaire kernspin (NMR) experimenten ontdekt dat 
eerst een 1,2-cis intermediair gevormd wordt, welke na substitutie leidt naar het ongewenste 
1,2-trans product. Als dit intermediair opgewarmd wordt, vormt het gewenste 1,2-trans 
intermediair, welke in het NMR-tijdsdomein het enige product blijft, ook wanneer het systeem 
weer gekoeld wordt. Daaropvolgende glycosylering levert echter een anomeer mengsel op, wat 
de suggestie wekt dat dit intermediair slechts een rust toestand is en niet participeert in het 
reactiemechanisme. In aanvulling op de glucose serie hebben we ook de C-4 epimeer, galactose, 
in ons onderzoek meegenomen en vonden we dat deze bijna volledig selectief reageert naar het 
1,2-cis product (α/β = 19:1). 
 
In Hoofdstuk 3 hebben we een nieuwe activatie methode ontwikkeld voor glycosyleringen. 
Sleutel factoren zijn de snelle bouwblok synthese en de mogelijkheid om in een zeer laat stadium 
de participerende groep te introduceren. De introductie van een acetyl resulteert in betrouwbare 
synthese van 1,2-trans glycosides en een ethanol hulpgroep resulteert in 1,2-cis glycosides. 
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Laatstgenoemde wordt geactiveerd door Tf2O op -40°C, vervolgens opgewarmd om het 
sulfonium intermediair te vormen en dan weer afgekoeld waarna de acceptor wordt toegevoegd 
en de glycosylering plaatsvindt. Deze nieuwe ontwikkelde methode maakte het mogelijk om 
efficiënt de electronische effecten van beschermgroepen op de stereoselectiviteit te bestuderen. 
Introductie van een 2,4,6-trimethoxyphenyl groep blijkt de selectiviteit aanzienlijk te verhogen 
ten opzichte van een phenyl groep (α/β = 4:1 vs 2.5:1, resp.). Hierna hebben we in glucose de 
beschermgroepen aan de resterende alcoholen aangepast en vonden we dat de introductie van 
2,4-dichloorbenzyl beschermgroepen voor een sterk verbeterde selectiviteit zorgde ten opzichte 
van de benzyl beschermgroep (α/β = 9:1 vs 4:1, resp). In dezelfde studie voor de galactose 
serie werd zelfs een selectiviteit bereikt van α/β = 13:1. 
 
1,2-cis mannosylering met behulp van sulfonium ionen was, naar ons weten, nog niet eerder 
gepubliceerd. Hoofdstuk 4 beschrijft de ontwikkeling van een 1,2-cis selectieve mannose donor 
welke gebruikt maakt van een ‘ringflip’. Door van de 4C1 naar de 1C4 conformatie te gaan, is de 
formatie van een 1,2-trans sulfonium intermediair mogelijk, welke via SN2 substitutie resulteert 
in een 1,2-cis mannoside. Deze ‘ringflip’ werd geforceerd door een TEMPO/BAIB gemedieerde 
oxidatie reactie van een 3,6 diol, welke resulteert in een 6,3-lacton.  Glycosyleringen hiervan 
resulteerde in complete selectiviteit, maar controle experimenten, welke niet de C-2 
participerende groep bevatten, resulteerden in dezelfde selectiviteit. Hierbij kwam wel een 
bijproduct die niet te scheiden viel van het product. Verdieping in dit bijproduct resulteerde in 
de ontdekking van een 1,4-anhydro suiker, welke gevormd wordt door participatie van de C-4 
ether. Dit was dan ook de eerste keer dat participatie van de C-4 positie gerapporteerd is. 
 
Geïnspireerd door de ontdekking van C-4 ether participatie in mannose ontwikkelde we in 
Hoofdstuk 5 een soortgelijke glucose 6,3-lactone donor met als resultaat dat het alleen het 
ongewenste 1,4-anhydro ether opleverde. Introductie van een acetyl groep op de C-4 positie 
gaf wel product formatie, al was de reactie vrij non-selectief (α/β = 1:2). De mannose variant 
gaf daarentegen volledige 1,2-cis selectiviteit, zonder bijproduct. Mechanistische studies met 
een tert-butyloxycarbonyl groep op C-4, leverde weer het 1,4-anhydro product op in plaats van 
het verwachte carbonaat. Hierdoor is het nog onduidelijk welke zuurstof nu participeert in het 
mechanisme. 
 
In Hoofdstuk 6 wordt gereflecteerd op de vorige hoofstukken uit dit proefschrift en worden 
suggesties gegeven voor toekomstig onderzoek op het gebied van selectiviteit in de 
suikerchemie. Tevens is hier ongepubliceerd werk te vinden over ons werk aan 1,2-cis 
aminoglucosyleringen, welke zeker de moeite waard zijn voor toekomstig onderzoek. 
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Dankwoord 
 
Het laatste hoofdstuk van dit proefschrift is misschien wel het leukst om te schrijven. Hoewel 
de doctorsgraad voor dit proefschrift alleen aan mij kan worden toegekend, heb ik het bereiken 
hiervan aan veel mensen te danken. Dit hoofdstuk is dan ook toegewijd aan alle mensen die me 
bijgestaan hebben tijdens dit promotietraject. 
 
Als allereerst wil ik Thomas bedanken voor het vertrouwen dat je me gegeven hebt, niet alleen 
door mij deze fantastische plek toe te kennen, maar ook tijdens de rest van ons vier jarige 
onderzoek. Ik sta er nog steeds van te kijken hoeveel je van de suikerchemie weet en dat geldt 
niet alleen voor het synthetische, maar ook het biologische aspect. Ook kon ik het intens 
waarderen dat ik op ieder moment zomaar je kantoor binnen kon stormen om een vraag te 
stellen, of soms gewoon voor een praatje over Koen, Max of die fantastisch mooie oranje motor. 
Het was een eer en vooral een waar genoegen om je allereerste Ph.D. kandidaat te mogen zijn 
en ik hoop dat er nog velen mogen volgen. Succes verder! 
 
Floris, bedankt voor het geven van de mogelijkheid om een doctoraal onderzoek in je groep te 
doen. Tijdens onze tweewekelijkse besprekingen was je altijd erg geïnteresseerd in mijn 
projecten en met je grenzeloze kennis van de organische chemie had je (bijna) altijd wel een 
nieuwe suggestie voor een reactie die maar niet wilde lukken. 
 
I would also like to thank my manuscript committee, prof. dr. Binne Zwanenburg, prof. dr. 
Geert-Jan Boons en dr. Marcus Pedersen for critically reading my manuscript. 
 
Jorge allereerst wil ik je nogmaals bedanken voor je altruïstische begeleiding tijdens mijn 
masterstage, fijn ook om te horen dat alles weer op zijn pootjes terecht is gekomen! Mede 
dankzij jou heb ik de fijne kneepjes van de organische chemie geleerd en werd mijn interesse 
in synthetisch onderzoek verder aangewakkerd. Super bedankt voor het voorleggen van dit 
uitdagende promotieonderzoek, zelf had ik het anders waarschijnlijk niet gevonden! 
 
Een van de belangrijkste aspecten tijdens mijn Ph.D. periode is het begeleiden van studenten, 
waarvan ik een heel leger gehad heb (bachelor of master en in veel gevallen beiden). Het 
mooiste van deze samenwerkingen is dat je ze professioneel ziet groeien en als bonus kon ik 
vaak jullie mooie resultaten gebruiken voor een publicatie. Eerst vond ik het raar om te horen, 
maar ik ben later toch wel aan het idee gewend geraak: de ‘Mensink Minions’ zoals jullie jezelf 
noemden. Sam, volgens mij kwam je al twee maanden nadat ik begonnen was je bachelor stage 
doen en heeft Thomas mij toen veel geholpen met je begeleiding. Je onnavolgbare synthese van 
het thiomorpholine intermediair is altijd aan me blijven knagen, vooral omdat de prachtige NMR 
vier jaar lang boven mijn monitor heeft gehangen. Helaas bleek die route niet reproduceerbaar 
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en hebben we het later via andere routes geprobeerd. Tijdens je masterstage heb je met je die-
hard synthese mentaliteit de basis gelegd voor hoofdstuk 3, welke zeker gepubliceerd gaat 
worden. Binnenkort begin je aan je eigen Ph.D. periode, waar je je weer lekker kan uitleven in 
het lab. Bedankt en succes! Sander en Femke, in onderzoek zit het soms mee en soms tegen 
en jullie hadden helaas vooral last van het laatstgenoemde. Bedankt voor jullie inzet gedurende 
jullie stages. Hidde, wat een biertje al niet teweeg kan brengen. Op het laatste moment switchte 
je van masterproject naar de suikerchemie en volgens mij heeft je dit geen windeieren gelegd. 
Het is je op het lijf geschreven en je stage leverde een mooie Angewandte op als welverdiende 
gedeelde eerste auteur. Je tomeloze interesse, inzet en wilskracht zijn niet onopgemerkt 
gebleven en hebben je een mooie promotieplek opgeleverd. Ik twijfel er niet over dat je een 
succesvolle carrière toekomt. Maurits, bedankt dat je met zowel je bachelor als je masterstage 
een bijdrage hebt geleverd aan mijn Ph.D. Onze communicatie verliep niet altijd even soepel, 
maar gelukkig heeft je dat niet weerhouden om mooie verslagen af te leveren. Hoofdstuk drie 
bevat een groot deel van je werk. Laura, organiseren is toch wel een sleutelwoord voor jou. 
Tijdens je stages was je altijd bijzonder georganiseerd en had alles onder controle, maar iets 
leuks buiten werk organiseren kan je ook wel aan jou overlaten. Je mooie werk staat in 
hoofdstuk 3 en 6 verwerkt, bedankt hiervoor! Wilke, het zonnetje in het lab, zelden zie ik je 
zonder lach op je gezicht. Je nauwkeurigheid remt je soms een beetje af in het lab, maar heeft 
wel degelijk geleid tot een zeer mooi resultaat wat mede staat beschreven in hoofdstuk 5. 
Thanks! Jeroen, een ware machine in het lab. Je hebt ontzettend veel werk verricht, wat heel 
erg gewaardeerd wordt. Je bachelor stage leidde vrij probleemloos tot het werk wat in hoofdstuk 
5 beschreven staat. Echter, tijdens je masterstage ben je erachter gekomen dat onderzoek niet 
altijd over rozen gaat en het siert je dan ook dat je je niet gewonnen wilde geven. We zijn 
uiteindelijk van project geswitched, waardoor de machine weer op gang kwam en talloze 
bruikbare resultaten leverde, wat beschreven staat in hoofdstuk 3. 
 
Is het nou Thorsten, Thorben of Torben en Heisse of Heise? Daar is nogal eens verwarring over 
geweest. Waar geen verwarring over is, is dat je een fijne collega was. Een beetje op jezelf, 
maar altijd klaar voor het geven van goed advies. Je hoeft nu eindelijk niet meer tandenknarsend 
voor je zuurkast te staan, want het tijdperk met ongewenste Duitse slager of ‘das rote pferd’  is 
eindelijk achter je! Succes met het afronden van je proefschrift en je verdere carrière in Utrecht! 
 
Verder wil ik de rest van de Boltje groep bedanken voor de geweldige tijd die we samen gehad 
hebben, zowel op als buiten het lab. De gezelligheid van de Boltje-uitjes zullen me altijd 
bijblijven, karaokeavond, de Sinterklaasborrel bij Torben (waar hij overigens als enige non-
bierdrinker een hele tijd ziek van is geweest, is dat toeval?), curling, voetgolf, kerstmarkt in 
Duitsland (en wij maar zeggen dat je niet kan rekenen op de NS), karten, maar ook voor de Age 
of Empire potjes waar we mee begonnen aan het einde van mijn Ph.D. Ook ben ik dankbaar 
voor het feit dat het irritante geluid van de oneindig aantal luchthoorns van de Gebroeders 
Scooter langzaam uit mijn oren zal vervagen. Stephanie, Timo, Tim, Wobbe, Guido, Victor, 
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Emiel (super bedankt voor het helpen met het meten van de optische rotaties, zonder jouw 
hulp was dat nooit op tijd gelukt), Peter, Jordy, Joëlle, Lotte, Maik, Daan, Stijn en Nick. 
Jullie maakten het een gezellige werkplek. 
 
Ik ben me er van bewust dat het mooie werk dat ik in het lab heb uitgevoerd niet had gekund 
zonder de ondersteuning van de niet altijd zichtbare maar toch erg belangrijke krachten achter 
de schermen. Jacky, Marieke, Desiree en Paula, bedankt voor jullie onmisbare 
administratieve bijdrage, maar ook voor de vele praatjes die toch wel vaak gepaard gaan bij 
een bezoekje aan jullie kantoor. Peter van Dijk en Jan-Do (of Peter?) bedankt voor de alle 
bestellingen die jullie voor me verwerkt hebben en voor vele praatjes over bijvoorbeeld Formule 
1 actualiteiten of de zoektocht naar een nieuw huisje. Peter van Galen, bedankt voor het 
draaiende houden van het toch wel erg oude, maar onmisbare werkpaard, de LCQ-Max en 
natuurlijk voor alle HRMS metingen. Paul, first of all thank you for significantly upgrading the 
NMR facilities, which has given essential insight in much of my research. With your ever 
enthusiastic attitude, you provided countless suggestions for clarification of reaction 
intermediates, or determination of glycosylation ratios. Also, for me you are the BBQ-king! 
Simply the best ribs I’ve ever eaten!!! Dani, your knowledge of synthetic organic chemistry 
seems to have no limits and your door (yes, you have an office now!) is always open for a 
synthetic challenge. Thanks! 
 
Je kan er op je werk niet omheen, collega’s. Die zijn er zeker niet voor de opvulling van U’tjes, 
maar vooral ook voor de gezelligheid. Ik wil graag alle collega’s (student of medewerker) van 
de Rutjes en van Hest groep bedanken voor de gezelligheid tijdens onder andere (koffie) 
pauzes en de vrijdagmiddagborrels bij de Aesculaaf. Abbas (‘The Nutty Professor’ bedankt voor 
al je gezelligheid, onbaatzuchtige hulp, nootjes, baklava, koekjes, linzensoep en andere 
lekkernijen), Alejandra, Anika, Annika, Bastiaan, Bram, Britta, Caroline, Daniël, Danny 
(lillekerd), David, Eduardo, Fleur, Freek, Imke, Ivan, Joep, Julia, Lise, Lianne, Luuk (Rrrrr), 
Marcel, Maria, Matthijs, Nanda, Paloma, Pascal, Peter, René, Ruud, Saskia, Selma, Stefan, 
Willem-Jan en ieder ander die ik wellicht vergeten ben.  
 
Werk verloopt het soepelst als je je goed voelt en daar zorgen vrienden voor. Daarom wil ik 
graag van deze gelegenheid gebruik maken om ze te bedanken. Ivan, thank you very much for 
being there for me in difficult times. I’ll never forget the endless games of Rocket League, good 
nights out and of course our surfing holiday to Portugal. I really hope we keep seeing each other 
after our Ph.D’s. Aswin, Daniël, Floris, Martijn, Paul en Tom, als oud-studiegenoten zijn we 
ondertussen uitgewaaierd door heel Nederland. Gelukkig vinden we altijd wel tijd om weer wat 
met elkaar af te spreken voor een biertje of een weekendje Poppel. Richelle, bedankt dat je 
me altijd gesteund en vooruit geholpen hebt. Han & Willem, Nicolien & Frank, Robbert & 
Joyce, Teun & Jeroen, Sander & Chantal en Sietse & Andreea, bedankt voor jullie 
regelmatige interesse in mijn onderzoek en vooral voor de ontspanning daaromheen met onder 
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andere de jaarlijkse (mannen) wintersport-uitjes en pretpark- thuis- of kroegbezoekjes. Stijn 
& Marlijn voor de spelletjesavonden en in het bijzonder voor de broodnodige wiskundige steun 
tijdens mijn schakelprogramma. Een andere uitlaatklep was voetballen bij de heren van Kunde 
1. Het was altijd intens gezellig in de kleedkamer of tijdens de derde helft en dat is toch wel 
hetgeen wat ik het meest aan het voetballen mis.  
 
Voor het super coole coverdesign wil ik graag Evie bedanken. Lief dat je dit voor me wilde doen, 
ik ben er echt heel erg blij mee! 
 
Pap, Mam, Gerard en Niels, de (niet altijd zo) stille krachten achter de schermen. Ze zeggen 
dat je bij familie vaak geen woorden nodig hebt om je waardering te tonen, maar daar ben ik 
het niet helemaal mee eens. Jullie staan altijd voor me klaar en hebben me gesteund door weer 
en wind en dat mag best gezegd worden. Zonder jullie was ik zover niet gekomen. Enorm 
bedankt! 
 
Als laatste wil ik graag mijn lieve vriendin Lianne bedanken. Samen het promotietraject 
doorlopen zorgt ervoor dat je weet waar de ander soms doorheen moet en je wist me altijd weer 
recht te sturen als ik dreigde te ontsporen. Gelukkig was je er ook bij op de momenten dat er 
iets gevierd moest worden, met een flesje bubbels of lekker uit eten. Ik kijk heel erg uit naar 
onze toekomst: samen motorrijden, samen Formule 1 bezoeken, samen reizen, of samen met 
een lekker biertje op de bank. Als het maar samen is. Ik hou van je! 
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